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Abstract 
Rheumatoid arthritis (RA) is a chronic, progressive and systemic auto-
immune disease.  However, there is very little research on how patients experience 
daily symptoms and their impact on life, nor how patients self-manage their 
symptoms on current treatment regimes.  Flares of RA lead to major drug treatment 
decisions, yet there is no standardised definition of flare to support these decisions.  
Further, there is a dearth of literature addressing the decision-making process 
surrounding flare help-seeking.  A mixed methods, pragmatic approach was taken to 
address these issues, employed iteratively in three studies: semi-structured 
interviews, Q-methodology and a longitudinal survey of daily symptoms for three 
months, alongside self-management and flare help-seeking. 
The interviews identified that even on current aggressive medication, in daily 
life patients experience continuing symptoms that vary within and between patients, 
and can be significant. When discussing their RA, patients used metaphors to 
enhance their explanations of inexplicable phenomena, such as flare. They fluctuate 
between living with their RA in the background, moving into the foreground, and at 
times having to deal with RA in the foreground. Each day patients attempt to 
balance the physical and emotional impact of RA with independence, a sense of 
normality and identity, by employing a stepped approach to self-management 
(“Mediation Ladder”), which leads to a life of Fluctuating Balances.  When self-
management is difficult, the Fluctuating Balances Model tips and their RA shifts into 
the foreground.  The interview themes informed the two Q-methodology studies, 
which demonstrated four different experiences of daily life: “Feeling Good”, “Taking 
Active Control”, “Keeping RA in its Place” and “Struggling Through” (reported 
predominantly by men) and two ways in which patients differed in their decision-
making process for seeking medical help for an RA flare: “Definite Decision” and 
“Cautious Indecision”.  Items ranked as important were used to inform the survey 
studies, which identified that patients do not necessarily experience their highest 
symptoms when they are in flare. Thus two different flare-types have been identified: 
“Inflammatory Flare” (defined by pain and inflammation) and “Avalanche Flare” 
(defined by the cascading effect of inflammatory symptoms, emotions and life 
events).  Patients are prompted to seek help when the impact of the flare becomes 
unmanageable. 
These findings have implications for clinical practice.  First, the improved 
understanding of daily life with RA can be used to talk realistically with new patients 
about levels of symptoms and the Fluctuating Balances of daily life.  Second, there 
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is a need for agreed terminology between patients and professionals to define flare. 
Third, clinicians need to be aware that men are “struggling through” with their RA. 
Fourth, using or responding to metaphors may facilitate communication between 
patients and professionals.  Future research needs to develop a greater 
understanding of men’s experiences of RA and support needs; to design an 
outcome measure for the novel concept of “Avalanche Flare”; and a fully-powered 
study to identify daily symptom patterns and potentially predict future symptom/flare 
patterns that might inform treatment decisions. 
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Notes to the reader 
 
It is acknowledged that a person with RA has a self-identity that incorporates many 
roles, and being an RA patient is only one of these roles.  However, to conserve 
words the term ‘RA patient’ has been used throughout this thesis instead of ‘person 
who has RA’. 
 
Sections of this thesis have been sign-posted thoughout to assist the reader.  In 
order to conserve words these have been written in the format Chapter x.x.x, for 
example Chapter 6.5.4, although it is acknowledged that this would be Chapter 6, 
Section 5, Sub-section 4 if reported in full. 
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Chapter 1:  Introduction to the thesis 
The intention of this thesis is to explore the daily fluctuation and flare 
symptoms of people with rheumatoid arthritis, how they self-manage these and their 
help-seeking behaviours.  As an introduction to the thesis, this chapter provides a 
description of rheumatoid arthritis, the charity that funded this research, the unit 
where the researcher was based, and the researcher herself.  The aims and 
structure of the thesis are also outlined in this chapter. 
1.1 Rheumatoid Arthritis 
Rheumatoid arthritis (RA) is a chronic, progressive and systemic auto-
immune disease.  The disease can progress rapidly, causing synovitis and 
damaging cartilage and bone around the joints (Emery et al, 2008b).  The American 
College of Rheumatology (ACR) criteria for the classification of RA are that criteria 1 
to 4 (below) must be present for at least six weeks, and that RA is defined by four or 
more of these seven variables (Arnett et al, 1988): 
1. Morning stiffness 
2. Arthritis of three or more joint areas 
3. Arthritis of the hands 
4. Symmetric arthritis 
5. Rheumatoid nodules 
6. Serum rheumatoid factor 
7. Radiographic changes 
Inflammation causes pain and fatigue and damage causes disability and loss 
of mobility.  The literature relating to the symptoms and impact that patients 
experience as part of their life with RA will be explored in Chapter 2 of this thesis. 
The prevalence of RA in most industrialised countries varies between 0.3% 
and 1% (WHO, 2003), with RA affecting more women (70%) than men (Crowson et 
al, 2011).   Studies conducted in the 1990s have shown that patients with RA may 
have shorter life expectancy (Wolfe et al, 1994), with mortality being related to 
systemic effects of the disease, such as cardiovascular co-morbidity, rather than 
side-effects of drugs (Rasker and Cosh, 1992; Symmons et al, 1998).  However, 
more recent studies suggest there is no longer a difference in mortality between RA 
patients and the general population (Peltomaa et al, 2002; Kapetanovic et al, 2011), 
which may reflect better inflammatory control.  The aetiology of RA is currently 
unknown (Yoshitomi and Sakaguchi, 2005) and the condition is presently incurable. 
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1.2 Arthitis Research UK  
Founded in 1936 (as the Empire Rheumatism Council), Arthritis Research 
UK are the leading arthritis research charity in the UK, funding work which is 
expected to make a real difference to people’s lives (Arthritis Research UK, 2011a).  
Arthritis Research UK funded the research for this thesis, but they had no influence 
on the findings or publications. 
1.3 Academic rheumatology unit 
Based in the Bristol Royal Infirmary, the academic rheumatology unit is a 
multidisciplinary unit comprising staff from University of the West of England (UWE), 
University of Bristol (UoB) and University Hospitals Bristol NHS Trust (UHBT).  The 
unit provides care for patients with arthritis and similar conditions and undertakes 
research into its causes and treatment.  The unit also provides education about 
arthritis for health care professionals, students, patients and the general public.  The 
academic setting in the unit is adjacent to the clinical setting, which provides ready 
access to patients.  The unit has pioneered patient involvement in research (Hewlett 
et al, 2006) and patient-initiated consultations (Kirwan et al, 2003; Hewlett et al, 
2005b), as such this may have created a specific population of patients, and 
therefore patients in these studies were recruited from more than one NHS Trust to 
ensure an unbiased view.   
1.4 The researcher 
1.4.1 Prior knowledge 
The researcher began this research project with a grounding in the health 
psychology of long term conditions, but without any prior knowledge of RA.  She 
started by learning about personal experiences of RA from her patient research 
partners and through sitting in on rheumatologist and specialist nurse clinics in 
addition to familiarising herself with the RA literature. 
1.4.2 Epistemological position 
The researcher considers herself a pragmatist, and therefore has taken a 
pragmatic approach to this thesis.  Pragmatism has been suggested as a framework 
that has the potential to embrace both qualitative and quantitative approaches 
(Tashakkori and Teddlie, 1998; Fishman, 1999) and that supports the mixed 
methods paradigm (Feilzer, 2010), which suits the aims of this thesis.  An important 
philosophical issue in research concerns the relative importance of paradigms, 
research methods and research questions.  It has been proposed that research 
methods are of secondary importance to research paradigms (Guba and Lincoln, 
Chapter 1: Introduction 
24 
 
1994).  However, pragmatists consider the research question to be more important 
than either the method they use or the world-view that underlies the method 
(Tashakkori and Teddlie, 1998).  Pragmatists do not reject epistemologies 
altogether, but instead reject the ‘top-down’ approach that privileges epistemology 
over methods and emphasises ontological issues above all others (Morgan, 2007).  
Pragmatic research is guided by the researcher’s desire to produce socially useful 
knowledge (Friedrichs and Kratochwil, 2009).  Thus the researcher considers herself 
a pragmatist, as she does not feel bound to any epistemological or ontological 
standpoint, and the thesis takes a pragmatic approach as the research questions 
were established prior to the methodology. 
1.5 Summary of rationale, aims and research questions 
More detailed descriptions of the rationale and specific study aims are 
provided in subsequent chapters. 
1.5.1 Thesis rationale 
There is a lack of research examining daily life with RA and how patients 
self-manage this on current modern treatment regimes.  The literature review 
(Chapter 2) has identified that there is no current agreement on how patients and 
professionals define flare and only one small qualitative study (Kett et al, 2010) 
could be found that addressed how patients manage their flares and make the 
decision to seek help for their RA flare. 
1.5.2 Thesis aims 
 To explore the individual experience and impact of RA in daily life and flare 
and how patients self-manage these 
 To obtain consensus on patients’ experiences of daily life with RA 
 To obtain consensus on patients’ help-seeking behaviours in an RA flare 
 To characterise the level, variation and clustering of symptoms in daily life 
1.5.3 Thesis research questions 
 What is the nature and effect of the daily symptoms experienced in 
rheumatoid arthritis and how do patients self-manage these? 
 How do patients conceptualise and describe a flare and differentiate it from 
normal variation or periodic episodes of disease activity?  
 What are the level, variation and clustering of symptoms experienced in daily 
life and in flare?   
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1.6 Thesis structure 
In order to meet the research aims, the thesis has been divided into ten 
chapters (including the current chapter).  This has been structured in the format of 
three background literature review chapters, followed by the methods and 
methodology chapter, which considers all three studies.  This is followed by four 
chapters presenting the results of the three studies and includes a brief discussion 
relevant to the specific study.  Study 1 underwent secondary analysis, hence the 
additional results chapter (metaphor analysis).  The thesis ends with the discussion, 
which draws conclusions and makes recommendations for clinical practice and 
future research (Chapter 10). 
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Chapter 2:  Daily Symptoms of Rheumatoid Arthritis and 
Flare 
This chapter explores the literature on the daily fluctuation of symptoms 
experienced by people with rheumatoid arthritis and how these symptoms affect 
their psychological status and impacts on their daily life.  It explores the literature on 
the concept of flare and how this differs from the daily fluctuation of symptoms. It 
also addresses the literature on the potential difference in patients’ and 
professionals’ perspectives. 
2.1  Fluctuations of RA symptoms in daily life 
People newly-diagnosed with RA have many questions concerning the 
effects RA may have on them in daily life (Radford et al, 2008).  Due to the 
unpredictable and fluctuating nature of RA, clinicians often have difficulty in 
explaining what everyday life with RA is like.  This literature review therefore starts 
by identifying what is known about the symptoms of RA.   
2.1.1  Joint stiffness and synovitis 
Both swelling (synovitis) and stiffness form part of the criteria for classifying 
RA according to the American Rheumatism Association (Arnett et al, 1988). The 
revised criteria state that at least four of 7 criteria must be present in order for RA to 
be diagnosed.  These criteria include 1) morning stiffness in and around joints 
lasting at least one hour before maximal  improvement; 2) soft tissue swelling of 3 or 
more joint areas observed by a physician; 3) swelling of the proximal 
interphalangeal, metacarpophalangeal or wrist joints; 4) symmetric swelling in 3 or 
more joint areas; 5) Rheumatoid Nodule; 6) Rheumatoid factor by method positive in 
<5% normal population; 7) Radiographic changes on wrist/hands: erosions or juxta-
articular osteoporosis. 
2.1.1.1 Synovitis 
Synovitis is inflammation of the synovial membrane that lines joints and 
tendon sheaths. Joints become swollen, tender and warm, and stiffness limits their 
movement (Majithia and Geraci, 2007).  RA affects multiple joints (it is a 
polyarthritis), most commonly small joints of the hands and feet but larger joints like 
the shoulder and knee can also be involved (Majithia and Geraci, 2007). 
The clinical measure of inflammation relies on the assessment of 
tenderness, swelling, warmth and redness by observation and palpation (Buchanan 
and Tugwell, 1983).  Joint tenderness is a subjective sign that depends on the pain 
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threshold of the patient as well as the strength of the stimulus, whilst joint swelling is 
a semi-objective sign that depends on the perception of the examiner (Thompson 
and Kirwan, 1995).   
Swollen joint counts correlate significantly with the erythrocyte sedimentation 
rate (ESR) or C-reactive protein (CRP) but less well with pain scores (Thompson et 
al, 1987; Felson et al, 1993), which indicates a closer relationship with synovial 
inflammation than tenderness.  However, although joint swelling appears to be a 
more accurate measure of synovial inflammation than tenderness, the latter has 
been shown to be more sensitive to change (Thompson et al, 1988). 
2.1.1.2 Joint stiffness 
Joint stiffness can be caused by inflammation of the structures in and around 
the joints and leads to an increase in the amount of synovial fluid within the joint.  
This causes the feeling of tightness that patients refer to as stiffness (Hill, 2006).  
Joint stiffness for RA patients is often accompanied by pain.  One study that used a 
mixed methods approach to investigate early morning stiffness (EMS) in 93 patients 
with RA and 46 patients with non-inflammatory joint disease reported that 40% of 
patients studied mentioned pain as often as stiffness (Hazes, Hayton and Silman, 
1993).  However, it is not clear whether patients only consider joint stiffness when 
asked about EMS, or whether there is also overall muscle stiffness. 
As mentioned in section 2.1.1, EMS in and around joints lasting at least one 
hour before maximal  improvement is part of the criteria for defining RA (Arnett et al, 
1988), whilst EMS that lasts less than 15 minutes is part of the ACR remission 
criteria (Ranganath, Khanna and Paulus, 2006).  The duration rather than the 
severity of morning stiffness is often used as a measure of disease activity.  
However, one study reported that severity rather than duration of EMS was found to 
be a better discriminator between active and inactive RA (Hazes et al, 1993). 
An increase in EMS can be an indicator of an RA flare and is experienced by 
90% of patients in a flare (Vlieland et al, 1997).  Further, patients requiring change in 
disease modifying anti-rheumatic drugs (DMARDs) have greater EMS than patients 
with stable RA (lasting an average of 75mins versus 8mins) (Soubrier et al, 2006).  
Research suggests that rheumatologists use EMS as a crucial variable in decision-
making for changing medication during an RA flare.  EMS is the highest or second 
highest (after swollen joint count) influence on the rheumatologist’s judgement about 
flare (Kirwan et al, 1984; Soubrier et al, 2006). 
A focus group study with RA patients across 5 countries explored patients’ 
conceptualisation of RA flare (Hewlett et al, 2012).  They found that patients named 
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EMS as an important influence on their decision to seek medication review.  
However, EMS was not included in the ACR core set for assessing disease activity 
as it cannot currently be measured with sufficient sensitivity and specificity (Sokka, 
2011). 
An extensive literature search did not identify any current objective measure 
for either swollen, stiff or tender joints.  The Disease Activity Score (DAS), devised 
by professionals, is a weighted, composite score comprising what the authors 
claimed,  are 3 objective measures of inflammation (physician-evaluated tender 
joints, swollen joints, inflammatory markers) and 1 subjective measure (patient 
opinion, smallest weighting) (Van der Heijde et al, 1993).  The modified disease 
activity score (DAS-28: Prevoo et al, 1995) includes 28-joint counts instead of a 
comprehensive joint count.  However, joint tenderness is a subjective sign that 
depends on the pain threshold of the individual as well as the strength of the 
stimulus.  An individual’s pain threshold could be influenced by physical and 
psychological factors quite separate from the inflammation in the joint (Thompson 
and Kirwan, 1995), whilst the strength of the stimulus has been shown to vary 
considerably between clinicians (Thompson et al, 1991). Similarly, physician-
evaluated joint swelling also has a subjective component, likely to become more 
sensitive to even minor swelling with experience. If stiff and swollen joints are both 
required to form a working definition of disease activity, it may be necessary for an 
objective measure of both symptoms to be designed.  Patients in remission may 
have no swollen or painful joints (Pinals, Masi and Larsen, 1981), while those about 
to change therapies because of flare have at least 3 or more affected joints 
(Deighton et al, 2010), yet this still does not clarify what daily life is like for the 
majority of patients who are neither in remission nor flare. 
2.1.2  Disability 
Disability is an umbrella term covering impairment, activity limitations and 
participation restrictions.  Impairment refers to a problem in body function or 
structure, activity limitation is a difficulty in carrying out a particular task or action 
and participation restriction refers to a problem experienced by an individual in 
involvement in life situations (WHO, 2012).   
Synovitis (Section 2.1.1.1) can lead to tearing or tethering of soft tissues 
such as ligaments and tendons, with subsequent impairment.  Synovitis also causes 
erosion of the joint surface and together these events can cause loss of joint 
stability, leading to impairment, activity limitation and participation restriction 
(Majithia and Geraci, 2007). 
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Disability can be measured using the Health Assessment Questionnaire 
(HAQ) from 0-3 (none to dependency) (Fries et al, 1980).  Disability was defined by 
one researcher as occurring at a HAQ value of at least 2 for at least two years 
(Wolfe, 2002).  However, measuring the ‘facts’ of disability is insufficient to 
understand the personal effect of limited ability on the patient.  The personal impact-
health assessment questionnaire (PI-HAQ) demonstrated that patients with similar 
disability levels have different levels of personal impact arising from that disability 
(Hewlett, Smith and Kirwan, 2002).  Thus a HAQ value of less than 2 with one 
patient could have a greater impact on them than a HAQ value of greater than 2 has 
on another person.  It is therefore insufficient to reduce patients’ disability to a figure 
derived from one questionnaire (HAQ) measuring only function. 
A cross-sectional survey compared the HAQ scores of 1,095 people with RA, 
with the HAQ scores of 1,533 control participants matched by age and sex found 
that overall there were greater levels of disability (HAQ score ≥1) in the RA 
population (Sokka et al, 2003).  However, whilst RA patients aged 30-79 were above 
the reference values (>95th percentile of the scores for the control group) in 17-45% 
of women and 7-32% of men, patients ≥80years were similar to the age and sex 
matched controls (Sokka et al, 2003), suggesting that impact of disability due to RA 
appears to be greater in younger and middle-aged people than in elderly patients. 
Although disability is found in an RA population, tight control of RA disease 
activity has been shown to have significant association with lower functional 
disability levels after an average 3.6 years of follow-up when a DAS-28 value of <2.6 
was considered tight control (Tanaka et al, 2008).  The mean HAQ scores have 
been shown to decrease rapidly at two weeks after the start of Infliximab therapy 
(from 1.5 to 0.9) and to subsequently remain stable for the following two years 
(Nagasawa et al, 2009).  Further, a study (Hallert, Husberg and Bernfort, 2012) 
comparing the annual incidence of disability pension due to RA (as an estimation of 
permanent work disability) before (1990) and after (2009) the introduction of biologic 
drugs found the incidence of disability pension to have decreased.  In 1990 the 
proportion of disability pensions caused by RA was 1.9% of the total disability 
pensions, which decreased to 1% in 2009.  Thus it appears that under current more 
aggressive treatments the disability outlook for patients may be better than it was 
many years ago. 
2.1.3  Pain 
Despite significant advances in drugs treatments many patients with RA 
continue to experience musculoskeletal pain (Kvien, 2004).  In fact survey studies 
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have reported that two thirds of RA patients have inadequate pain relief (Taylor et al, 
2010), even when their disease is considered to be well controlled (Wolfe and 
Michaud, 2007).  Further, a longitudinal study that followed 15,282 RA patients over 
4 years (Courvoisier et al, 2012) found pain to be the only significant predictor of 
psychosocial health, which may suggest that anti-rheumatic treatments have 
insufficient effect on pain. 
Using a 7-point Pain scale (where ‘no pain at all’ was 0 and ‘moderate pain’ 
was 3) the mean pain rating of 35 RA patients, measured seven-times daily for one 
week, was 2.1 with a range of 0 to 4.1 (Stone et al, 1997).  Pain was shown to be 
highest (with a mean of 2.3) in the early morning, decreased to a mean of 1.9 by 
noon then remained stable throughout the remainder of the day (Stone et al, 1997).  
The patients in this study appear to be representative of an RA population in terms 
of demographic and clinical data.  However, none of the patients were recruited in 
either a flare or remission and collecting data for one week may not be sufficient to 
capture the full picture of the fluctuating nature of RA.  Stiffness in the mornings is a 
common symptom of RA, therefore one possibility is that the patients in Stone et al’s 
study confused pain and stiffness in their responses.  Further explanations are that 
pain and stiffness are related to each other or that each symptom occurs in the 
mornings independently of each other. 
Although treatments for RA are becoming increasingly patient-centred, 
meaning that patients’ preferences for treatment and disease outcomes are taken 
into consideration, they do not take into account which of the outcomes are most 
important to patients (Carr et al, 2003).   Patients have reported that the relative 
importance of pain and mobility change over time, with pain being most important in 
early disease and mobility or independence holding more importance later (Carr et 
al, 2003).   
In previous studies, patients have reported pain as their most important 
symptom (Parker et al, 1988; Minnock, Fitzgerald and Bresnihan, 2003).  However, 
these studies are now becoming out-dated as they were conducted prior to the 
acknowledgement of fatigue as a valid symptom of RA and therefore failed to ask 
about fatigue. 
2.1.4  Fatigue 
Fatigue is a significant symptom experienced almost universally by RA 
patients, often on a daily basis.  Fatigue has been highlighted by RA patients as an 
important treatment outcome (Carr et al 2003), with patients making a definite 
distinction between everyday tiredness and a complete systemic fatigue that was 
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related to their arthritis.  One of the first formal studies of fatigue in RA (Belza et al, 
1993) found that more than 60% of the variance in fatigue in RA was explained by 
demographic, psychosocial, and ‘disease related’ factors, the latter explaining two 
thirds of the variance.  In terms of impact and importance, patients rate their fatigue 
as similar to pain (Wolfe and Michaud, 2004; Hewlett et al, 2005a).   
Using a 7-point fatigue scale (where ‘no fatigue at all’ was 0 and ‘moderate 
fatigue’ was 3) the mean fatigue rating of 35 RA patients, measured seven-times 
daily for one week, was 1.6 with a range of 0 to 5.0 (Stone et al, 1997).  Fatigue was 
shown to be moderate (with a mean of 1.35) in the early morning, dropping to its 
lowest levels from 10am to noon (with a mean of 1.05), followed by a steep increase 
of fatigue for the rest of the day reaching its highest point at 8pm (with a mean of 
2.20). 
Some patients experience fatigue as ‘heaviness or weight’ whilst other 
patients experience an extreme, absolute and exhausting fatigue, leaving them 
unable to carry on, sometimes with a sudden and dramatic onset (Hewlett et al, 
2005a).  Fatigue seems to vary from person to person and from instance to instance 
in duration and frequency.  RA fatigue is distinguished from normal tiredness as it is 
‘not earned’ (not preceded by activity) and does not resolve with rest (Hewlett et al, 
2005a).   
Patients more frequently select feeling well and less fatigue in their top three 
important outcomes (20%, 15%) than the commonly measured disease activity 
outcomes of side effects from drugs (13%), stiffness (12%) and swelling (9%) 
(Hewlett et al, 2005a).  An earlier study (Minnock, Fitzgerald and Bresnihan, 2003) 
reported that 65-69% of patients identified treatment priority as pain compared with 
only 36% of patients selecting pain within their top three important outcomes in 
Hewlett et al’s (2005a) study.  However, Minnock et al (2003) were using the AIMS2 
which comprises 12 professionally-determined categories, which does not include 
patient-generated important outcomes such as fatigue and well-being.  When the 
sample was re-surveyed to include the additional option of fatigue, fatigue replaced 
pain as the most frequent patient priority (fatigue 65%, pain 48%) (Minnock and 
Bresnihan, 2004) 
RA patients believe that professional support for fatigue is rare as the 
emphasis is on physical problems and disease activity.  Most patients will not 
discuss fatigue with their health professional, but those who do feel it is dismissed 
(Hewlett et al, 2005a).  Patients feel uncertain about how to self-manage their 
fatigue and perceive a lack of support from their rheumatology team around this 
issue (Hewlett et al, 2005a).  
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A cognitive behavioural therapy (CBT) intervention to improve fatigue self-
management has been developed (Hewlett et al, 2011).  This intervention was 
delivered by a clinical psychologist and consisted of 6 x 2 hour sessions (weeks 1-6) 
with a 1 hour consolidation session (week 14).  This intervention was compared to a 
control group of patients who received a 1 hour didactic group session delivered by 
a rheumatology specialist nurse based on patient information leaflets.  The 
researchers reported an effect of the CBT intervention on fatigue impact, coping and 
perceived severity. 
There is, as yet, no agreement regarding the causes of fatigue with studies 
on correlates and predictors of fatigue providing contradictory results (Repping-
Wuts, van Riel and van Achterbeng, 2009). Some patients perceive disturbed sleep 
as an important cause of fatigue, whilst others report sleeping well, but that the 
sleep is un-refreshing (Hewlett et al, 2005a).   
2.1.5  Sleep disturbance 
Sleep in people with RA is often disturbed; this could be due to pain, causing 
a restless night; along with stiffness and disability, which may limit the ability to turn 
over unaided. RA and sleep appear to have a two-way relationship, with each 
directly affecting the other. 
In a survey of 937 people with RA, arthritis was reported to disrupt sleep in 
approximately one third of the sample (32.8%, Jordan et al, 2000).  In a recent study 
(Goodchild et al, 2010), 25 women with RA and 19 women with Primary Sjogrens 
Syndrome (PSS) were issued with an Actiwatch, which is similar in size and weight 
to a wrist watch and when worn on the wrist detects restless movements likely to be 
incompatible with sleep (Lavie et al, 1992), and were monitored for 35 consecutive 
days.  Sleep inefficiency (percentage of time in bed not spent asleep) was found to 
be a mean of 10.3% in the women with RA in comparison to 14.0% in the women 
with PSS.  However, this was not compared to a healthy control group and it is 
therefore unclear as to what extent the women with RA in this sample differ from the 
healthy population. 
Goodchild et al (2010) also found moderate associations between sleep 
inefficiency and mental fatigue indicating that those who slept less tended to report 
more problems with impaired concentration and memory.  This study also showed 
that the relationship between discomfort before bed and fatigue the following day 
depended on sleep that night.  On nights when sleep was more disturbed, the 
association between discomfort in the evening and greater fatigue the next 
afternoon was stronger. 
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RA patients with poorer sleep quality report more pain and fatigue; this has 
been found within patients as well as between patients, with patients reporting more 
pain and fatigue on days with poorer reported sleep quality (Stone et al, 1997).  
Further, the amount of variance in fatigue explained by discomfort and sleep 
combined was found to be less than the amount explained by the previous day’s 
fatigue (Goodchild et al, 2010), showing clear consequences of sleep disturbance in 
people with RA. 
Patients with self-reported arthritis-related sleep disruption are more likely 
than those without sleep disturbance to pursue multiple sources of self care and 
medical care.  However, those patients who have a disruption to their leisure 
activities are less likely to seek medical care than those patients with sleep-
disruption (Jordan et al, 2000). This raises the question as to whether sleep 
disturbance is more difficult to live with than disrupted leisure time; people with RA 
may accept that it is inevitable that they will experience disruption to their leisure 
activities, but perhaps are not willing to accept disruption of sleep as a consequence 
of RA.   
2.2  The impact of RA on daily life 
A qualitative study identified ‘uncertainty’ as a common theme in RA 
(Stenström, Bergman and Dahlgren, 1993), and reported that the participants were 
uncertain about their own interpretations of their symptoms and whether they would 
be able to receive adequate help to master their disease and manage their everyday 
lives.  Uncertainty was also reported due to unpredictable exacerbations and 
remissions of disease, and its unpredictable long term course. However, this study 
is now somewhat dated and therefore may not reflect experiences of daily life with 
current treatments.  Further, this study used only 9 patients (all of whom were 
female) therefore saturation of ideas may not have been reached.  The interviews 
explored patients’ experiences of daily life, but they did not enquire as to how 
patients manage their daily symptoms or how they are able to distinguish between a 
‘bad day’ and a flare.  How patients manage their symptoms will be discussed in 
Chapter 3 and flare will be discussed in Section 2.3 of this chapter. 
Living with RA means having to relate, over time, to an increasingly non-
compliant body; a body with RA does not move as desired (Plach, Stevens and 
Moss, 2004).  The fluctuation and uncertainty of RA and a non-compliant body can 
impact on patients’ abilities to continue doing activities that are necessary or 
pleasurable.  This impact will now be discussed. 
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2.2.1  Loss of participation  
It has been widely reported that RA interferes with hobbies, pastimes and 
with sexual activities (Blake et al, 1987; Reisine, Goodenow and Grady, 1987; 
Tugwell et al, 1987; Cornelissen, Rasker and Valkenburg, 1988).  In one study 70% 
of the women surveyed reported that RA interferes with their hobbies and pastimes 
and 50% reported that their RA interferes with sexual activity (Reisine et al, 1987).  
The intrusiveness of RA has been reported to be greatest in areas of active 
recreation, work and health (Devins et al, 1993) with the intrusiveness of RA 
increasing as physical function worsens (Devins et al, 1992). 
Individuals’ daily activities are typically composed of a mix of obligatory, 
committed and discretionary activities (Katz and Morris, 2007).  Obligatory activities 
are those required for survival and self-sufficiency; including hygiene and self-care 
activities, walking inside, walking outside and using transportation or driving.  
Committed activities are associated with one’s principal productive social roles; 
these include paid work, household responsibilities, child and family care whilst 
discretionary activities include socializing, exercising, engaging in leisure activities 
or other activities that the individual engages in for relaxation or pleasure.  Achieving 
‘balance’ in life activities usually involves spending an adequate amount of time in 
each domain.  Having a satisfactory balance of activities makes a substantial 
contribution to health and well being, whilst time use imbalances are associated with 
lower life satisfaction (McKinnon, 1992; Katz and Morris, 2007). 
Time diaries were used to estimate the allocation of time to various activities 
of daily life and found that RA patients spent more time on personal care and 
hygiene, household chores, shopping and errands than the control group (Yelin et 
al, 1987).  Due to functional difficulties, RA patients may need to restructure the way 
in which they use time.  A survey of 375 women revealed that individuals with higher 
HAQ disability scores (mean 1.04) were more likely to spend ≥2 hours each day on 
personal care, resting and doing things to take care of their RA than those with 
lower HAQ scores (Katz and Morris, 2007).  Those individuals with higher HAQ 
scores were also more likely to spend no time at all doing housework, paid work, 
leisure activities, hobbies or volunteer work. 
A core set of patient-derived priority outcomes, developed through nominal 
group technique and postal surveys, has been proposed: the Rheumatoid Arthritis 
Patient Priorities – Pharmacological Interventions (RAPP-PI: Sanderson et al, 2010).  
The RAPP-PI consists of eight outcomes that were generated and prioritised by 
patients as being essential in measuring the patient perspective of the impact of RA.  
These are: pain, activities of daily living, (visible) joint damage, mobility, life 
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enjoyment, independence, fatigue and valued activities.  This demonstrates the 
importance that patients place on participation in both daily activities and valued 
activities.  
A focus group study with 23 RA patients found that patients lose some of 
their valuable activities, either because it is no longer possible to do them or 
because it is not worthwhile doing them when they cause pain, stiffness or fatigue.  
These patients described life as a ‘roller-coaster’ (Lütze and Archenholtz, 2007).  
However, the patients in this study had a maximum disease duration of 5 years and 
therefore may not have represented the views of the wider RA population.  Over a 5-
year period, individuals with RA stopped performing an average of 10% of the 
activities that they had valued at baseline (Katz, 1995), but this study was conducted 
17 years ago and may not reflect daily life with RA on current therapies. 
2.2.2 Psychological well-being 
The overall effect of RA on individuals’ valued life activities appears to affect 
their psychological well-being.  Loss of the ability to engage in recreational activities 
and social interactions, in particular has been reported to significantly increase the 
risk of new onset depression (Katz and Yelin, 2001; n=654).  A salient feature of 
depression is a loss of gratification or pleasure; activities that used to bring 
satisfaction seem dull and joyless, leading to a loss in interest in hobbies, recreation 
and family activities (Beck,1979).  Katz and Yelin (2001) controlled for this 
cause/effect issue by excluding patients with high levels of depressive symptoms at 
any time between baseline and baseline +3 years (when the results for this study 
were reported from).  However, this study was a reanalysis of data collected 
between 1989 and 1998 and therefore may not reflect life on current modern 
treatments.  
It is possible that the depressive symptoms could be caused not merely by 
the reduction in activities but by the distinction between what a patient is able to do 
and what they think they should be able to do (Calman, 1984).  This idea was raised 
in relation to quality of life, hypothesising that quality of life can only be described 
and measured in individual terms and depends on present lifestyle, past experience, 
hopes for the future, dreams and ambitions.  A good quality of life can be said to be 
present when the hopes of an individual are matched and fulfilled by experience.  
The opposite is also true: poor quality of life occurs when experiences do not match 
prior hopes (Calman, 1984).  One model proposed that patients have expectations 
of how they will be treated, the amount of pain they will have and how effective their 
treatment will be (Carr, Gibson and Robinson, 2001). It is proposed that when 
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expectations are matched by current experience there is no quantifiable impact on 
quality of life, but whenever the experience of health falls short of expectations there 
is an impact.  The researchers suggested that the impact of chronic disease on 
quality of life can be minimised by helping patients to adjust their expectations and 
adapt to their changed clinical status (Carr, Gibson and Robinson, 2001).   
2.2.3  Paid employment and RA 
As described in the preceding paragraphs, RA can impact on patients’ lives 
by putting up barriers to being able to go about their daily routine.  An even bigger 
barrier is presented when patients wish to continue paid employment despite their 
RA.  One study, which followed 160 RA patients for a mean of 8.6 years from 
symptom onset (Barrett et al, 2000), found that 4% of participants had stopped 
working on health grounds within 12 months of symptom onset, 26.3% within two 
years and 41.6% within 9 years.  However, as this study was published 12 years 
ago, with patients diagnosed for a mean of 8.6 years, it described patients 
diagnosed over 20 years ago and therefore may not reflect patients’ current 
experiences on modern medication. 
A number of studies have estimated the societal economic costs of RA 
(Yelin, 1996; Clarke et al, 1997; Merkesdal et al, 2001).  However, they did not 
include the cost of the disease-related impacts of reduced performance while at 
work (presenteeism) nor of changing occupations (Maetzel et al, 2004).  A more 
recent study conducted in Canada (n=383; Li, Gignac and Anis, 2006) found that 
lost productivity due to RA costs $12,352CAN per person per year (£7,842).  The 
majority of this was a result of presenteeism, accounting for 41% of the total loss, 
followed by wage loss from stopping working or changing jobs (37%), decreased 
hours of work (12%) and absenteeism (10%). 
Interviews with 50 employed patients found that early morning pain and 
stiffness and difficulty communicating their working needs were the two most striking 
barriers to employment (Robinson and Walters, 1979).  A recent study reported that 
fatigue was consistently identified as the symptom most limiting patients’ ability to 
work (Lacaille et al, 2007).  Some participants reported turning down opportunities 
such as training or promotions due to their fatigue, as this enabled them to preserve 
energy.  However, this was often at the expense of job satisfaction, career 
advancement and personal fulfilment (Lacaille et al, 2007).   Patients raised 
concerns that the daily variation in their abilities to perform tasks due to the daily 
fluctuation in their symptoms affected their credibility with co-workers and 
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supervisors, while unpredictable arthritis flares and symptom fluctuation made it 
difficult to plan work and to keep work commitments.  
As discussed earlier, pain is highest in the early morning, decreases through 
to noon and is stable for the remainder of the day, whereas there is a steep increase 
in fatigue from noon reaching its highest point at 8pm (Stone et al, 1997).  This 
could therefore be one of the reasons why the patients in Lacaille et al’s (2007) 
study found fatigue to be the biggest barrier to work.  If pain is highest in the early 
morning and eases off during the day then individuals may be able to predict that 
the pain will ease off throughout the day and may therefore be reassured about 
going to work. However, they may be waiting for their fatigue to become worse and 
worse as the day goes on, therefore feeling the need to preserve energy.  Another 
explanation could be that fatigue creates more barriers as pain is perceived as 
controllable with the correct medication, whereas fatigue has been described as 
‘overwhelming and uncontrollable’ (Hewlett et al, 2005a). 
An assessment of 723 RA patients found that the ability to maintain paid 
work after the onset of the disease is significantly related to reports of both less pain 
and fewer depressive symptoms, irrespective of disease severity (Fifield, Reisine 
and Grady, 1991).  The paid work effect was still present even after controlling for 
the effects of pain on depression and depression on pain.  They also found that 
work loss alone is associated with higher levels of pain and depression at all levels 
of disease severity.   
Sections 2.1 and 2.2 reported the range of RA symptoms and the effects of 
RA on the struggle to maintain valued activities and paid work.  At times when 
inflammation is active these symptoms and consequences will escalate, culminating 
in an RA flare. 
2.3  Flare 
“If I were free of flares I would experience life anew, I believe with the joy of a child” 
(James May, Patient Research Partner, OMERACT 10). 
 Flare is a term that is commonly used by both patients and clinicians to 
describe a worsening of symptoms.  However, while this word is widely recognised 
by physicians and patients and adopted in research papers, there are no commonly 
accepted parameters to define disease worsening, characterise its severity, or 
describe its onset and duration (Bingham et al, 2009a).  In UK patient leaflets, the 
term flare has been used with limited explanation such as “You may have flare-ups 
when your symptoms become worse than normal” (Arthritis Research UK, 2011b) 
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2.3.1  Patterns of flares 
It is not known exactly how patients with RA experience a flare nor whether 
they return to a non-symptomatic state following a flare, or return to a baseline of 
constant but manageable RA symptoms.  In ankylosing spondylitis (AS), a 
rheumatological condition in which there is inflammation of the spine (Brophy and 
Calin, 2002), two main types of flare pattern have been reported: constant 
symptoms and intermittent symptoms (Stone et al, 2008).  This study reported that 
those who returned to a level of constant symptoms clearly predominate over those 
with intermittent symptoms and that constant symptoms were associated with worse 
health status measures (Fig 2.1).  To discover these patterns of AS, patients were 
presented with four graphs and asked to choose which graph best represented their 
disease activity.  However, these graphs were constructed by the researchers rather 
than by patients and are reductionist as patients possibly chose a graph of ‘best fit’ 
rather than one that truly represented their disease.  Despite these limitations, this 
was the first paper to investigate the idea of patterns of flares in rheumatic diseases 
and their association with outcome of AS. This idea has yet to be explored in RA. 
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Figure 2.1: The Flare Illustration shown to patients 
Stone et al, Rheumatology, 2008 47(8):1213-1218, by kind permission of Oxford University Press 
2.3.2  Defining flare in clinical practice 
Disease Modifying Anti-Rheumatic Drugs (DMARDs) and biologic agents 
(e.g. anti-TNF) control inflammation and improve long-term outcome (Emery et al, 
2008a).  They are initiated or changed during episodes of flare.  Although flare 
informs treatment decisions, there is no standardised definition to support these 
decisions.  For instigating and assessing Anti-TNF therapy in the UK, a flare level 
was agreed by clinicians and The National Institute for Clinical Excellence (NICE) 
(TA130, 2007) as a DAS-28 of >5.1, sustained over 4 weeks.   
2.3.3  Defining flare in clinical trials of medication  
An area that is in particular need of a definition of flare is within clinical trials 
(Bingham et al, 2009a).  In randomised control trials (RCTs) of RA medications, the 
lack of a standardised definition means that entry criteria for flare are individually set 
for each trial, as are the variables and parameters to describe worsening of disease 
or flare within the RCT.  The problem of flare definition is not limited to RA: 10 recent 
studies of gout-flare all provided different definitions of flare (Taylor et al, 2009).  
The following patterns of disease 
activity are represented 
graphically. Pattern (A) Flares 
and remissions. During the 
remissions patients would be 
symptom free. Pattern (B) Flares 
with disease activity in between 
flares. Pattern (C) Severe flare 
lasting a long time and followed 
by return to a baseline for a long 
period of time without any 
symptoms. Pattern (D) This was 
similar to (C) except that patients 
did not return to a symptom-free 
baseline but had continued 
symptoms that were constant in 
nature over time thereafter. 
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This lack of a standardised flare definition is clearly a problem in RCTs as it limits 
the validity of conclusions drawn and comparison between studies. 
OMERACT (Outcome Measures in Rheumatology) is an informal 
international network initiated in 1992 aimed at improving outcome measurement in 
rheumatology. The drug safety working group developed the rheumatology common 
toxicity criteria (RCTC) in 1999, building on the oncology common toxicity criteria.  
At OMERACT 8, the drug safety working group determined that a standardised 
definition of flare was needed for the RCTC effort (Woodworth et al, 2007). 
A number of RCTs (Den Broeder 2002; De Man 2008; Van den Bemt et al, 
2008) have used the inverse European League Against Rheumatism (EULAR) 
response criteria (van Gestel and Prevoo, 1996) to define a flare.  The EULAR 
response criteria (van Gestel and Prevoo, 1996) defined a good response as >1.2 
improvement in the DAS from baseline, and a DAS attained during follow up of ≤2.4.  
Non-responders were defined as patients with an improvement of ≤0.6 or patients 
with an improvement of >0.6 but ≤1.2 and a DAS attained during follow up of >3.7.  
The remaining patients were classified as moderate responders.  Based on this 
definition, the reversed EULAR criteria defines flare as an increase in DAS-28 
exceeding 1.2, or an increase in DAS-28 exceeding 0.6 and a current DAS-28 of 
over 5.1 (high disease activity).  However, although the EULAR response criteria are 
suitable for defining a positive response, they fail to describe worsening when taking 
the patient’s perceptions into account (Leeb et al, 2006).  This study found that a 
DAS-28 reduction of at least 26.5% was necessary for a patient-perceived 
improvement in disease activity.  However, a DAS-28 increase of only 10.5% was 
needed to identify a patient-perceived worsening in disease activity.  In contrast, 
physician’s perceptions of change in disease activity were relatively symmetric 
(Leeb et al, 2006). 
Alternative definitions of flare used in RCTs have included a 50% or greater 
diminution in improvement in the combined swollen and tender joint count from 
baseline to the time at which response was initially achieved (Rahman et al, 2007); 
an exacerbation of the disease that may have required additional treatment or 
necessitated a visit to a health care professional (Stone et al, 2008); a patient-
perceived increase in disease activity leading to the patients’ wish to quit the study 
and/or the requirement for a change in medication (Fransen et al, 2001).  Some 
studies failed to provide criteria for flare for the purpose of their study.  One study 
defined a flare as joint inflammation, pain, stiffness, and reduced mobility and 
function but gave no specific symptom levels (Ostensen, 2001), whilst another 
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reported significantly fewer disease flares as a treatment outcome, but did not define 
flare (Hammond and Freeman, 2001). 
2.3.4  Defining flare from the patient’s perspective 
The first paper to explore disease flare from the patient’s perspective found 
that AS patients experience localised flares that were characterised by pain and 
immobility in one body area. In contrast, generalised flares involved the whole body 
with all symptoms being experienced to the extreme; patients were ‘crippled’ with 
pain, which was accompanied by fatigue and emotional distress (Brophy and Calin, 
2002).  Patients reported flares lasting from a few days to a few weeks and with no 
specific pattern, they could occur anything from twice in a year to every 5 years.  
However, the methodology in this study was weak with participants having been 
recruited from an intensive pain management programme, and therefore only 
included patients with this one experience of care.  Not all interviews were tape-
recorded, thus seriously questioning the validity of the data. 
In a second qualitative study with AS patients (Mengshoel, 2008), three 
aspects of living with AS were reported: ‘ordinary life condition’, ‘slowed down life 
condition’ and ‘disrupted life condition’.  ‘Disrupted life condition’ was characterised 
by intense, inexplicable and unmanageable pain that could not be reversed by one’s 
own actions and prevented all or most ordinary activity.   In ‘disrupted life condition’ 
the reported AS pain fell into 2 patterns; either localised to one part of the body or 
distributed to several parts.  The localised pain was described as a feeling that the 
joints were locked and as an inability to move whereas the widespread pain was 
described as similar to influenza and included difficulty in carrying out even the most 
basic of personal care tasks.  Although the word flare was not used in this paper 
(Mengsoel, 2008), it demonstrates the variation in symptoms that occur within an 
episode of high disease activity.  This paper classified the experience by effect on 
the patient’s life condition and not by symptoms experienced.  Although this was a 
less clinical approach, perhaps patients would be able to relate better to describing 
their disease according to how it affects their daily activities. 
At OMERACT 9 a Special Interest Group (SIG) initiated a process by which 
a consensus-based definition of flare could be developed that could be used for 
multiple purposes (Bingham et al, 2009b).  This group identified a lack of research 
defining flare from the perspective of RA patients, therefore at OMERACT 9 they 
invited 11 patient delegates to informally discuss flare in a separate break-out group 
(in order to limit the influence on their discussion by professional delegates).  The 11 
patients with inflammatory arthritis (mainly RA) reported flare as a wide range of 
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physical, emotional and cognitive symptoms (Bingham et al, 2009b).  Pain was 
recognised as a critical factor in defining flare, and it was reported that pain could be 
global or related to single or multiple joints, which supports findings reported by 
Brophy and Calin (2002).  The findings from the SIG indicated that patients and 
professionals potentially have different views on the definition of a flare.  Patients 
reported flu-like symptoms, early warning signs and raised the idea that synovtis 
does not necessarily have to be present.  
The patients that were involved in the breakout group were not necessarily 
representative of all RA patients as these were patients who have a heavy 
involvement in the research process, who may have a better sense of self-
awareness and may be more educated about their RA than the average person with 
RA.  Whilst the OMERACT SIG reported some interesting findings, this was not 
intended to be a research study but an informal discussion as a preliminary 
exploration and the groups were not digitally-recorded, nor data systematically 
analysed. Therefore the OMERACT SIG suggested that further research is needed 
in order to explore the new ideas that were raised (Bingham et al, 2009b). 
To develop the work from the OMERACT SIG discussed above 14 focus 
groups were carried out across five countries with a total of 68 participants (Hewlett 
et al, 2012).  They reported that symptoms and early warnings of flare caused 
patients to increase their self-management strategies and as those failed; patients 
began defining this as flare, which led to seeking help. This was underpinned by 
uncertainty and influenced by the individual context. 
Patients are able to differentiate the symptoms of flare from daily RA 
symptoms by their intensity, quality and constancy.  Symptoms include joint swelling 
and stiffness; morning stiffness; difficulty with functioning; fatigue, which is different 
to normal RA fatigue; flu-like symptoms; disturbed sleep; cognitive shut-down; and 
emotional distress (Hewlett et al, 2012).   For a person with RA to be able to define 
their symptoms as a flare, the symptoms need to be unprovoked, persistent and ‘not 
normal’ for their RA; these are the tipping points for patients seeking help as the 
uncertainty of whether their symptoms are due to flare decreases (Fig 2.2) (Hewlett 
et al, 2012).    
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Figure 2.2:  The patient journey to seeking help for RA flare 
Hewlett et al, Rheumatology, 2012  51(1):69-76, by kind permission of Oxford University Press 
 
Flare definitions and tipping points are individual and may vary with 
experience.  However, the individual context, which influenced the themes identified 
by Hewlett et al (2012), were potentially lost through the focus group methodology. 
As human beings will conform to the majority even in small groups (Asch, 1958), it 
may not have been possible to delve into patients’ individual stories in a focus group 
session.  Patients’ experiences of flare and their tipping points of help-seeking 
should therefore ideally be explored through one to one interviews.  In addition, a 
longitudinal study is needed to understand daily symptom levels and explore the 
individual experiences and patterns or typologies of RA flare.     
2.3.5  Early warning signs of flare 
A prodrome is an early symptom (or set of symptoms) that might indicate the 
start of a condition before specific symptoms occur. There appears to be no 
prodrome literature in RA but prodrome is seen in other conditions.  Prodromal 
symptoms occur in 40–60% of people who experience migraines and include altered 
mood, fatigue, visual aura and stiff muscles, among other symptoms. These 
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symptoms usually precede the headache phase of the migraine attack by several 
hours or days, and experience teaches the patient how to detect that a migraine 
attack is near (Kelman, 2004).  Patients with refractory, localisation-related epilepsy 
have been shown to be able to predict their seizures.  In a prospective study, 
patients completed daily measures of the occurrence, time and characteristics of all 
seizures, if present.  Seizure self-prediction was assessed by asking patients ‘Do 
you think you will have a seizure in the next 24 hours?’  (Haut et al, 2007).    The 
researchers acknowledged that the self-prediction of seizures may have reflected a 
patient’s awareness of their typical seizure pattern.  For example, a patient who 
experiences seizure clusters was potentially predicting the second or third seizure in 
a cluster.   
However, unlike people with RA, people with migraine and epilepsy are free 
from symptoms in between episodes and therefore may more easily identify early 
warning signs than people with RA who rarely return to an asymptomatic baseline 
state.  Asthma is a condition in which patients may not always return to an 
asymptomatic baseline state, but in which a prodromal state has been proposed.  A 
retrospective study of young asthma patients found that 70% of patients recognised 
an itching sensation on the lower face or anterior neck in association with the 
asthmatic attacks (Orr, 1979).  However, this was a retrospective study and patients 
were potentially recalling the symptoms with the benefit of hindsight and in addition 
they were prompted by a specific question to recall itching symptoms. 
Some patients in the OMERACT SIG reported early signs of a flare, such as 
fatigue and/or night/day time sweats which may suggest a prodrome (Bingham et al, 
2009b). A qualitative study on learning to live with RA reported that women became 
experts at recognising the onset of flare (Shaul, 1995), but did not specify how.  In a 
focus group study with 67 RA patients across five countries (Hewlett et al, 2012), 
some experienced patients reported noticing ‘early warning’ signs of flare.  These 
patients reported the presence of flu-like symptoms, fatigue or symptoms in 
particular joints.  However, it is possible that these patients were only able to identify 
the onset of a flare with the benefit of hindsight and this therefore needs testing in a 
prospective study.     
A diary study of daily symptoms would need to be performed to capture both 
the period of time leading up to a flare and the flare itself in order to be sure that a 
prodrome of flare exists in RA.  Identification of symptoms of early flare (prodrome) 
might provide an opportunity for a rapid intervention to abort a major flare (e.g. 
intramuscular depomedrone).   Earlier treatment of RA results in greatly reduced risk 
of joint deformities, physical disability and premature death (Tikly, 2009).  Thus the 
 Chapter 2: Daily Symptoms of Rheumatoid Arthritis and Flare 
 
 
45 
 
ability to detect early warning signs and provide treatment whilst patients are in the 
early stages of a flare would have the potential for improved outcome. 
2.3.6  Defining flare from the professional’s perspective 
The existing outcome measures available for rheumatic diseases have been 
reviewed, with a particular focus on RA (Fransen and van Riel, 2009).  It was 
concluded that a measure of disease activity is needed, but the need for a measure 
of flare was not specifically highlighted. 
The OMERACT 9 SIG had professional breakout groups as well as the 
aforementioned patient break-out group (Bingham, 2009b).  The professional 
breakout group raised an important concern that the word flare was not translatable 
or used in all languages.  Each of the 4 professional breakout groups indicated that 
for professionals, joint counts (swelling and tenderness) were critical to include in an 
overall definition of flare.  Other important components that these groups identified 
included patient and physician reported global assessments of disease activity and 
patient reported pain and fatigue. As mentioned in Section 2.3.4 this was discussion 
only, and the group are currently conducting a formal research study.  However, the 
marked differences in the opinions of patients and professionals certainly highlight 
the need for further research in this area. 
2.3.7  Patient versus professional perspective  
Lack of agreement between patients and professionals is widely reported.  
An investigation into the concordance between clinician and patient assessment of 
physical and mental health status studied 7 clinicians and 166 patients and found 98 
cases (59%) of perfect agreement between patients and clinicians (Kwoh et al, 
1992).  On average, the more severe the physical impairment, the more likely the 
clinician was to rate the disability as more severe than the patient.  However, for 
mental distress, the clinician was more likely to rate low distress as more severe 
than the patient did.  Patients and clinicians may enter the consultation process with 
different objectives and patient priorities may differ from those of health care 
professionals (Carr and Donovan, 1998).  Kwoh et al (1992) raised an important 
question: If patients and clinicians disagree as to the patient’s present health status, 
how can they determine when the patient’s health status has changed? And how, 
therefore, can they assess the effectiveness of therapy? 
In the OMERACT 9 SIG breakout groups, while patients indicated that pain 
was always present during a flare, they did not necessarily include synovitis, this 
contrasted with the professionals group who deemed synovitis as essential for a 
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flare and possibly the only requirement.  Any definition of flare would need to be 
developed taking both patients’ and professionals’ perspectives into account. 
2.4  Summary 
In daily life, RA patients experience stiff and swollen joints, pain and fatigue, 
which can mean patients may have to reduce both work-based and leisure activities.  
However, these studies were largely conducted before current more intensive 
therapeutic regimes were in use, utilising new drugs and new combinations with 
tighter control of inflammation. In addition, few studies attempted to explore daily 
life.  Whilst patient-perceived flare often underpins requests for help and treatment 
decisions, with potentially significant impact on outcome, there is no current 
consensus for defining flare.  Current research suggests a serious mismatch 
between patient and clinician perception of flare, with patients perceiving a range of 
flare symptoms and even a prodrome, of which clinicians are unaware.  
 Little is known about daily variation in symptoms within current treatment 
regimes nor patient language for flare, nor how they differentiate flare from normal 
daily variation. If these features can be identified, it may be possible to improve 
explanations to newly-diagnosed patients, clarify discussions regarding flare, identify 
disease patterns that are prognostic indicators of outcome and thus potentially 
target treatments.       
Current research suggests that patients experience impact of RA on their 
lives in both daily life and flare. The following Chapter will therefore address ways in 
which patients have adapted and adjusted to living with RA, how they self-manage 
their symptoms in daily life and flare and how these strategies may change with 
experience.  
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Chapter 3: Coping, self-management and adaptation 
Chapter 2 examined daily fluctuation of RA symptoms and RA flares and 
how these differ and affect a patient’s psychological status impacting on their daily 
life. This chapter explores self-management and coping strategies used by patients 
and discusses the process of adapting and adjusting to life with RA.  
3.1 Coping 
The terms ‘coping’ and ‘self-management’ have been used interchangeably 
in the literature (Kralik et al, 2004).  However, a qualitative study (Nicklin et al, 
2010b), which identified items and developed the wording for measures of RA 
fatigue from a patient’s perspective, also found that patients were able to distinguish 
between coping and managing.  Broadly speaking patients suggested that ‘manage’ 
related to practical issues, whilst ‘cope’ related to their emotions (Nicklin et al, 
2010b).  Coping has been described in terms of active versus avoidant coping 
techniques and emotion-focused versus problem-focused techniques.  It is possible 
that patients making a distinction between coping and managing may be 
distinguishing between emotion- and problem- focused coping techniques.  Thus for 
the purpose of this thesis, ‘coping’ is used as an overarching term encompassing 
self-management as a function of ‘problem-focused coping’.  Crisis theory (Moos, 
1982; Moos and Schaefer, 1986) proposed coping as part of the adjustment process 
to a crisis situation, which will therefore be explained first to contextualise coping 
and adjustment. 
3.1.1 Crisis Theory 
Crisis theory (Moos, 1982; Moos and Shaefer, 1986) claimed that during a 
crisis, such as having an illness, the adjustment that the person makes depends on 
their coping process, which is dependent on three factors: illness related factors; 
background and personal factors; and physical and social environmental factors (Fig 
3.1). 
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Figure 3.1: Diagram of Crisis Management Theory 
 
Illness-related factors: These are concerned with the threat that patients 
perceive their health problem poses to them such as being disabling, disfiguring, 
painful or life-threatening.  The greater the threat patients perceive the more 
difficulty they are likely to have in coping with their condition (Cohen and Lazarus, 
1979; Moos, 1982).  Thus a patient with RA who perceives themselves as disabled 
due to their RA may be less able to cope with it. 
Background and personal factors: People who cope well with chronic ill 
health tend to have ‘hardy’ or resilient personalities that allow them to see positives 
in difficult situations (Pollock, Christian and Sands, 1990).  The ways people cope 
with a long term condition can also depend on age, gender, socio-economic status, 
philosophical or religious beliefs, emotional maturity and self-esteem (Moos and 
Schaefer, 1986).  The timing of a health problem in the person’s life span can also 
affect the impact that the condition has on them, for example people who are 
diagnosed with a disabling condition in early adulthood are more likely to resent 
losing the chance to develop their lives in the direction they planned (Moos, 1982).  
Thus it is possible that younger RA patients may have more difficulty coping. 
Physical and social environmental factors: The physical environment 
includes the person’s home, which can impede coping if patients have difficulty 
moving around their home or performing self-care tasks.  Thus it is possible that 
patients with RA, who have had their home adapted for their needs would have a 
better ability to cope with their RA.  People’s social environments are also important 
for coping, for example the presence of social support.   
Coping process: The three contributing factors discussed above combine to 
influence the coping process that an individual uses to cope with a crisis, such as a 
long term condition.  Crisis theory has proposed that coping begins with cognitive 
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appraisal of the meaning or significance of the health problem.  The outcome of this 
appraisal leads the patient to form a range of adaptive tasks and to apply a range of 
coping skills to deal with these tasks.  For example, one potential adaptive task is to 
control negative feelings and retain a positive outlook for the future, which patients 
may address through coping skills such as minimizing the seriousness of the 
situation (Moos, 1982). 
Outcome of the crisis: For a long term condition, the desired outcome of the 
coping process is for the patient to learn to adapt and adjust to their condition, which 
has the potential to improve their quality of life.  This can include patients 
reconceptualising their idea of normality (Section 3.2.1). 
This model includes coping skills and an outcome of adjustment, but does 
not specify the use of a particular type of coping nor what constitutes adjustment.  
Thus the following sections address coping skills and adjustment relevant to RA. 
3.1.2 Action-focused and avoidance-focused coping 
The Vanderbilt Pain Management Inventory (VPMI) is a measure of coping 
that has provided a method of classification of coping: active coping and passive or 
avoidant coping.  This divides coping strategies according to the expected outcome 
(Brown and Nicassio, 1987). 
Active coping strategies are those strategies used by patients when they are 
attempting to control their pain or to function in spite of their pain, whereas passive 
coping strategies relinquish control of the pain to others, or allow other life areas to 
be adversely affected by pain (Brown and Nicassio, 1987).  These definitions were 
expanded by specifying that active coping strategies involve an attempt by the 
patient to deal with the pain by using their own resources, whereas passive coping 
strategies are characterised by helplessness and/or reliance on others (Nicholas, 
Wilson and Goyen, 1992). 
Generally speaking active coping strategies, whether behavioural or 
emotional, are thought to be more helpful ways to deal with stressful events, and 
passive or avoidant coping strategies appear to be a psychological risk factor or 
marker for adverse responses to stressful life events (Holahan and Moos, 1987). 
However, a systematic review of longitudinal studies that examined coping 
strategies and psychological distress in RA (Vriezekolk et al, 2011) found little 
evidence for passive coping strategies being associated with an increase of 
psychological distress, but the methodology of many of the studies included in this 
systematic review were weak.    It is suggested that the flexible use of a variety of 
coping strategies across situations may be beneficial to adjustment to a chronic 
Chapter 3: Coping self-management and adaptation 
50 
 
illness (Zeidner and Saklofske, 1996), this may be particularly important in RA due 
to the fluctuating symptoms and unpredictable disease course associated with it 
(Vriezekolk et al, 2011). 
A cross-sectional study (López-Martínez et al, 2008) addressed coping 
strategies, using the VPMI, in patients with chronic pain.  This study found that 
higher levels of active coping were associated with lower levels of depression and 
higher levels of functioning, whereas higher levels of passive coping were 
associated with higher levels of depression, higher levels of pain and lower levels of 
functioning.  However, the cross-sectional design of this study meant that pain 
coping as a dynamic process was not captured, which would be important to 
consider in relation to the fluctuating nature of RA symptoms and causal 
relationships could not be identified. 
3.1.3 Emotion-focused and problem-focused coping 
Coping has also been divided into problem-focused and emotion-focused 
coping (Lazarus and Folkman, 1984).  Problem-focused coping involves focusing on 
the specific problem or situation and trying to find a way of changing it or avoiding it 
in the future.  Emotion-focused coping involves managing the emotions associated 
with the stressful situation, even if the situation itself cannot be changed.  This 
theory appears to relate well to the needs of dealing with a long term condition that 
has both practical and emotional consequences and will therefore be used as a 
framework for the self-management and coping strategies discussed in this thesis. 
A cross-sectional study with 434 RA patients (Englbrecht et al, 2012) found 
that problem-focused coping contributed to coping effectiveness, which in turn was 
positively related to general health perception.  This suggests that problem-focused 
coping has a positive influence on the quality of life of RA patients.  However, the 
cross-sectional design of this study meant that a causal relationship could not be 
identified.  An emotion-focused intervention for patients with inflammatory arthritis 
(Zangi et al, 2009) involved 10 x 4.5 hour sessions over a period of four months.  
Each session related to a different aspect of living with a chronic illness and 
addressed these through mindfulness-based exercises (in which patients were 
invited to become aware of disease-related emotions, thoughts and bodily 
experiences), creative exercises (such as guided imagery, music, drawing and 
poetry) and reflection on patients’ own experiences.  This intervention reduced pain 
and fatigue in patients one year after participating (Zangi et al, 2009).  However, this 
was not an RCT and therefore patients’ symptoms could have improved naturally or 
be explained by other factors such as change in medication. 
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Emotion- and problem-focussed coping techniques have different strategies 
associated with them.  Thus the strategies relevant to RA will be presented 
individually under their respective coping techniques. 
 3.2 Emotion-Focused Coping 
3.2.1 Normalisation 
A qualitative study with RA patients (Sanderson et al, 2011a) proposed six 
distinct typologies of normality. The first was ‘disrupted normality’, which involves 
overwhelming symptoms that make normal life impossible. The second was 
‘struggling for normality’, which described patients who will present a normal life, 
whatever the cost.  Thirdly, ‘fluctuating normality’ in which daily life with RA was 
considered normal, but being in a flare was thought of as abnormal.  The fourth 
typology was ‘returning to normality’, which seems to apply to patients whose 
symptoms are well controlled and feel able to carry on life in the way they used to 
before their diagnosis. The fifth was ‘continuing normality’, which relates to patients 
who have very mild RA and do not appear to have experienced disruption to their 
normal lives.  Finally, ‘resetting normality’ meant patients had reconceptualised their 
idea of normality and included their RA and its flares in their definition of normal.   
Although these specific normality typologies have not yet been explored in other 
chronic illnesses, the importance of the general concept of normality has been 
reported (Bury, 1982). 
A qualitative study that explored the experiences of mid-life women living 
with a chronic illness (Kralik, 2002) found that learning to live with a chronic illness 
involves a process of shifts in self-identity as the patient attempts to hold onto the 
sense of self that they had before they were diagnosed.  This transitional process 
was called the ‘quest for ordinariness’ (Kralik, 2002) and involved developing an 
altered perception of self, so that illness may become part of life.  They claimed that 
shifts in self-identity involve an ongoing process of negotiation between what 
patients want to do, and what they are able to do.  In order to discover this, patients 
reported pushing the boundaries that their illness imposes on them and taking 
calculated risks (Kralik, 2002).  This ‘quest for ordinariness’ (Kralik, 2002) could also 
be called normalisation; any behavioural attempt used to maintain a normal life, 
including strategies of covering up, keeping up and pacing (Wiener, 1975), it holds 
similarities with Sanderson’s (2011a) ‘resetting normality’ typology. 
3.2.2 Social Support 
Social support is regarded as a necessary component to promote physical, 
psychological, social and emotional well-being (Wortman and Conway, 1985).  In a 
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qualitative study with 40 RA patients (Ryan et al, 2003), social support was identified 
as a major contributing factor positively influencing control perceptions.  However, 
inappropriate support (e.g. being over-protective) was viewed as a form of social 
control that had negative consequences for the individual, leading to feelings of 
helplessness.  Further, a cross-sectional study with 229 RA patients (Riemsma et al, 
1998) found that ‘problematic social support’ (support that is seen as non-supportive 
by the patient even though the providers’ actions may be well-meant) was 
associated with higher levels of fatigue.  However, the cross-sectional design meant 
that causal relationships could not be determined. 
A descriptive study examining the relationships between quality of life of 68 
women with RA and their perceived levels of social support found significant 
associations between the levels of social support and physical health scales, social 
activity and affect scales (Minnock, Fitzgerald and Bresnihan, 2003).  However, the 
design of this study meant that a causal relationship could not be identified.  Further, 
this study was conducted only with women and therefore has overlooked the 
potentially different experiences of male patients, who do not access social support 
in the same way as women (Charmaz, 1994). 
A qualitative study (Radford et al, 2008) explored the support needs of RA 
patients who were either newly diagnosed or experienced patients.  This study 
found that the provision of emotional support was important to patients, who 
suggested being given more protected time and a safe environment, for 
professionals to listen to them, to be given help with low mood and to be able to 
meet others with RA.  Thus social support does not necessarily consist of the 
patient’s friends and family alone, but can include the medical team and other 
patients with RA.  However, this study did not include any male patients and only 
included one younger patient, who may have very different support needs for their 
RA.    
One aspect of social support is emotional disclosure, which is the process of 
writing or talking about personally stressful or traumatic events.  Two studies with 
RA patients have reported physical improvements following an emotional disclosure 
intervention.  One (Kelley, Lumley and Leisen, 1997) reported improvements in 
physical functioning, pain and affective disturbance three months after a verbal 
disclosure intervention.  Whilst the other (Smyte et al, 1999) reported reductions in 
clinician-assessed disease activity over a four month period following a written 
disclosure intervention.  A more recent study (Wetherell et al, 2005) compared RA 
patients who wrote or talked about a traumatic experience with a control group who 
wrote or talked about the events of a particular day.  This study found that emotional 
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disclosure had a positive effect on mood outcomes ten weeks after the intervention, 
but not on clinical or physiological measures.   
3.3 Problem-Focused Coping 
3.3.1 Self-Management 
A wide variety of self-management methods are recommended for people 
with RA.  These are therapeutic activities prescribed, taught or recommended by 
health professionals in collaboration with the patient, with the aims of reducing pain 
and inflammation, reducing the risk of deformities and developing and maintaining or 
improving function (Hammond,1998). A cross-sectional study (Hammond, 1998) 
identifying self-management strategies used by 41 RA patients found that the 
majority of patients used technical aids and rest on a daily basis, half used exercise 
and/or heat (although only half of these patients used these methods daily) and a 
small proportion of patients used joint protection daily.  However, this was a survey 
study and therefore patients did not have the opportunity to raise self-management 
techniques that were not included in the questionnaire.  Pacing and planning is also 
a recommended self-management technique for RA patients (Luqmani et al, 2006).  
These previously identified self-management strategies will be discussed. 
3.3.1.1 Joint protection 
Joint protection includes the application of alternative working methods, 
balancing activity and rest and the use of technical aids to improve daily task and 
role performance whilst protecting vulnerable or painful joints from further damage 
(Niedermann et al, 2010).  An RCT of an educational-behavioural joint protection 
programme (Hammond and Freeman, 2001) found that in comparison with the 
control group, the joint protection group had significantly improved hand pain, 
general pain, early morning stiffness, number of self-reported flares, number of visits 
to the doctor and activities of daily living.  This suggests that joint protection can 
help slow the progression of the effects of RA.  The separate elements of joint 
protection (Niedermann et al, 2010) are discussed below. 
3.3.1.2 Technical aids 
Technical aids are gadgets used to reduce stress on joints (Hammond, 
1998).  One multi-centre survey study examined the use and effect of technical aids 
with 284 RA patients at one and two years following diagnosis (Thyberg et al, 2004).  
This study found that two years after diagnosis 78% of women and 54% of men 
were using technical aids.  The most frequently reported beneficial effect of 
technical aids were improved eating and drinking.  Further, the patients who 
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reported using technical aids had more severe disease and more pronounced 
disability than those who did not.  This indicates that people who are more in need 
of technical aids are the ones who use them.  However, technical aids for chronic 
illness can be associated with stigma due to social perceptions of the particular aid, 
which can be particularly important with younger patients, and the visibility of the 
illness resulting from the use of aids in public (Parette and Scherer, 2004).  Thus 
patients who do not disclose themselves as RA patients to others may be reluctant 
to use technical aids in public. 
3.3.1.3 Rest 
Historically, bed rest was the advised management method of RA due to 
concerns about the excessive use of inflamed joints (Jones, 1909) and the lack of 
effective pharmacological interventions to reduce synovitis at that time.  This theory 
appears to have been applied to patient care without validation until 1963, when in 
an RCT 68 RA patients were randomised into two groups.  The first group were 
treated in bed for four weeks by immobilisation in plaster casts.  The second group 
were also confined to bed for 4 weeks, but performed daily active exercises 
(physiotherapy).  The range of movement and functional capacity improved in both 
groups, but disease activity was significantly more reduced in the immobilised group 
(Partridge and Duthie, 1963).  However, the risks of immobilisation are now well 
known.  Loss of muscle strength during immobilisation may add up to 1-2% daily 
(Suzuki et al, 1994) and is more pronounced in the presence of joint disease or 
injury (Rutherford, Jones and Round, 1990), as well as issues of pressure sores, 
and the social consequences of long-term hospitalization. 
In a survey study of 41 RA patients, rest was found to be the second most 
common method of self-management (after technical aids), which most people used 
daily (Hammond, 1998).  Although rest is important to RA patients, many patients 
with chronic illness find it difficult to find a balance between activity and rest due to 
experiencing guilt when resting (Kralik et al, 2004).   
3.3.1.4 Exercise 
Despite the importance of rest in RA, exercise is also now considered an 
important component in the management of RA, with reported physiological and 
psychological advantages for the patient.  In terms of the physiological benefits, one 
study that assessed the benefits of a six-week hand exercise programme in RA 
(Brorsson et al, 2009) found that it improved patients’ hand force and hand function.  
However, this study did not compare patients in the programme to a control group of 
RA patients, but to healthy controls.  A prospective RCT (Baillet et al, 2009) 
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assessed the ability of an exercise programme to improve patients’ disability.  The 
exercise programme involved exercises for the upper and lower limbs being 
performed five times weekly in a gymnasium (45min/day) and in a hydrotherapy pool 
(60min/day), whilst the control group received a multidisciplinary information 
programme.  This RCT found that patients who were in the exercise programme had 
a reduced HAQ and reported better quality of life than the control group.  However, 
this study did not record patients’ baseline levels of physical activity, which could 
influence the changes seen.  Further, a programme that involved exercising for 
105minutes five times weekly may be unrealistic to expect the majority of patients to 
manage due to other commitments and responsibilities. 
Psychological benefits of exercise for RA patients have also been reported.  
In an RCT of RA patients following a twelve-week dance-based exercise 
programme, positive changes in depression, anxiety, fatigue and tension were 
observed (Noreau et al, 1995). However, this study does not take into account the 
potentially beneficial effects of social support and humour, which this programme 
may have also provided.  Thus it cannot claim that the exercise component of the 
dance-based programme was responsible for patients’ improved affect. 
Whilst RA patients believe exercise to be an important factor in treatment, 
uncertainty about what exercises to do and how to do them without causing harm 
prevents many patients from exercising (Lambert et al, 2000).  Patients require 
knowledge of the specifics of exercise prescription in order to include exercise as 
part of their RA treatment (Law et al, 2010).  Significant increases in the use of 
exercise have been identified amongst osteoarthritis and RA patients after attending 
the Arthritis Self-Management Programme, a community-based arthritis education 
programme (Lorig et al, 1985).   Thus patient education is important in the use of 
exercise as a self-management strategy for RA. 
One barrier to exercising for RA patients is that patients perceive a lack of 
exercise knowledge in health professionals.  Further, patients have reported 
perceiving contradictions between health professionals in terms of whether pain 
caused by exercise is related to joint damage or not (Law et al, 2010).  A further 
barrier is the joint pain itself; this was found to be a prominent factor in predicting 
patients’ exercise behaviour (Wilcox et al, 2006).  Pain was described as a barrier in 
terms of the presence of pain preventing patients from exercising, experiencing pain 
during exercise reduced their willingness to exercise and pain post exercise 
discouraged them from exercising in future.  Other barriers included fatigue, mobility 
and co-morbidities, all of which were reported to make exercise more difficult for 
patients.  However, these were qualitative studies and therefore did not assess 
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patients’ exercise behaviour at regular intervals to discover how these vary with the 
fluctuating symptoms of RA. 
3.3.1.5 Pacing and planning 
It is now considered that rest and exercise are complementary elements of 
the management of active disease and the best balance should be found between 
the beneficial effects of rest and exercise for each patient (van den Ende et al, 
2000).  In fact the guidelines for the management of RA (Luqmani et al, 2006) 
suggest that patients are encouraged to pace activities and to recognise their 
physical activity limits, facilitating a realistic adjustment of their expectations. 
A qualitative study in the USA with 20 RA patients and a qualitative study in 
the UK with 15 RA patients found that patients use re-prioritising and pacing in order 
to manage their fatigue (Tack 1990; Hewlett et al, 2005a).  This can involve starting 
a task, having a rest and then coming back to the task later or choosing one task 
over another such as spending time with children rather than doing the housework.  
However, these studies focused on fatigue and therefore did not explore whether 
patients used pacing and planning to control other symptoms.  A qualitative study 
with 9 patients with arthritis (Kralik et al, 2004) found pacing, planning and 
prioritising to be an important theme.  Daily activities were paced to tolerate or not 
aggravate the pain, whilst planning and prioritising were closely linked with 
accepting and managing the action needed for change.  However, this was a small 
qualitative study with patients who had either osteo or rheumatoid arthritis, but the 
difference was not specified.  Further, many of the participants had other co-
morbidities such as diabetes, osteoporosis and palsy, which may have affected the 
way in which patients report their self-management due to the potential difficulty of 
separating out multiple co-morbidities. 
A survey study addressing patients’ self-management techniques in RA 
(Hammond, 1998) did not include items relating to pacing or planning, indicating that 
some clinicians may not consider these as practical management techniques.  
Further, a review of 145 papers relating to the self-management approach to chronic 
conditions did not identify the use of pacing and planning (Barlow et al, 2002).  Thus 
although pacing and planning is used by patients to manage their symptoms, which 
has been identified through qualitative studies and anecdotal evidence, it is not a 
technique included in quantitative studies of self-management, yet it is explicitly 
taught in RA self-management programmes (Hewlett et al, 2001). 
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3.3.1.6 Hot and cold therapies 
The guidelines for rheumatology self-management (Luqmani et al, 2006) 
suggest that heat (e.g. a hot bath) and cold applications (e.g. ice packs) may 
provide short term symptomatic relief of pain and stiffness.  However it is noted that 
there is no recommendation for long-standing benefit.  Heat therapies include hot 
baths, hot packs and hot wax and work by increasing skin and joint temperature and 
blood flow and thus reducing joint stiffness (Oosterveld et al, 1992; Reitman and 
Esses, 1995).  Cold therapies include ice bags, ice packs, cold baths and cold packs 
and work by decreasing skin and joint temperature and blood flow and thus reducing 
inflammation (Oosterveld et al, 1992; Reitman and Esses, 1995).  Further, cold 
therapies have been shown to have analgesic effects (Ernst and Fialka, 1994; 
Schmidt et al, 1979).  The technique of alternative hot and cold therapies is thought 
to reduce pain and inflammation by increasing the peripheral circulation by removing 
metabolic wastes, stimulating the central nervous system and increasing blood flow 
to the muscles (Calder, 1996). 
In one study 30 patients with RA had their pain thresholds measured before 
and after both a warm bath and an ice massage (Curkovic et al, 1993).  Both heat 
and cold were found to significantly raise the pain threshold immediately after the 
treatment application.  Patients’ pain thresholds were still raised at 10 and 30 minute 
time points after the ice massage, but this was not seen for the warm bath (Curkovic 
et al, 1993), indicating that cold therapies may have longer lasting effects than heat 
therapies.  A survey of the self-management techniques of 41 RA patients 
(Hammond, 1998) found that half of the patients used heat therapies for their RA, 
with half of these using heat daily.  The majority of the patients in this study reported 
beliefs that heat therapy was beneficial.  However, this study did not ask patients 
about the use of cold therapies.   A qualitative study involving interviews with 9 
patients about their experiences of managing their RA does not mention the use of 
hot or cold therapies (Kralik et al, 2004). This suggests that whilst hot and cold 
therapies are used by some patients, they are not considered important to all 
patients as a tool to manage their RA. 
3.3.2 Flare self-management 
There is a scarcity of research that addresses how patients specifically 
manage the symptoms and consequences of their RA flares.  One qualitative study 
(Kett et al, 2010) conducted interviews specifically to explore an ethnically diverse 
group of RA patients.  This study found that patients who did not believe there was a 
cause to their flares were more likely to use strategies aimed at managing their 
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symptoms such as using analgesics or distraction techniques. In contrast, those 
who believed they could identify the cause of their flare were more likely to use 
strategies aimed at eliminating these perceived causes such as altering their diet 
(Kett et al 2010).  However, the authors do not explain how the interviews were 
translated for the purpose of analysis: if they were translated by the researcher this 
has the potential for researcher-bias in terms of how they translated the data 
(Temple and Young, 2004).  Further, this was a retrospective study with patients 
who had experienced a flare at some point in their disease trajectory (Kett et al, 
2010) and therefore did not capture patients’ reported self-management techniques 
whilst they were experiencing a flare.   
A further qualitative study (Hewlett et al, 2012) used focus groups with 67 RA 
patients across five countries to explore patients’ perspectives of RA flares.  This 
study found that when in a flare, patients increase their usual level of self-
management strategies by resting, pacing, applying heat or cold and escalating 
medications such as gluco-corticoids, often without seeking medical advice.  
Patients may be able to successfully self-manage early warnings of flare or divert 
minor flares, whereas unprovoked, persistent symptoms lead patients to redefine 
their flare as ‘uncontrollable’ (Hewlett et al, 2012, Fig 2.2).  Flare symptoms 
becoming uncontrollable (even with increased self-management strategies) and 
patients no longer being able to run their normal lives, prompts patients to seek 
professional help for their RA flare (Hewlett et al, 2012).  However, this study was 
not conducted with patients who were currently experiencing a flare.  Further, it only 
identified one tipping point for help-seeking and neither self-management nor help-
seeking were the main aims of this study, which was to identify the components of 
flare. 
There is therefore limited literature that addresses patient’s self-management 
techniques when they are in an RA flare.  The ability to capture patients’ self-
management strategies prior to and during an RA flare would provide novel data in 
this area.  Having explored emotion- and problem-focused coping, the literature on 
adaptation and adjustment will be explored as these are the desired outcomes of 
effective coping and self-management (Moos, 1982; Moos and Schaefer, 1986). 
3.4 Adaptation and adjustment 
The terms adaptation and adjustment are often used interchangeably in the 
literature (e.g. Zautra et al, 2008) and will be used interchangeably in this thesis due 
to the lack of a distinct difference in definitions having been published.  In relation to 
the cancer literature, adjustment has been defined as “the cognitive and behavioural 
Chapter 3: Coping self-management and adaptation 
59 
 
responses the patient makes to the diagnosis of cancer” (Watson et al, 1988, p203).  
However, this bland definition indicates that adjustment is static.  A more recent 
explanation of adjustment to cancer involves an active psychosocial process, which 
may include both positive and negative consequences for the patient (Brennan, 
2001).  Thus adjustment will be discussed in both practical and psychological terms. 
3.4.1 Practical adjustment 
One qualitative study used focus groups with 23 patients to address how 
patients adapt to life with RA (Lütze and Archenholtz, 2007). This study reported 
that patients with RA change their activities according to their energy level so as not 
to ‘pay’ for their activities the following day.  The authors of this paper use the term 
‘dose’ their activities, which is similar to the concept of pacing (Luqmani et al, 2006).  
RA can be a power struggle between the symptoms and consequences of the 
disease in everyday life, and the patient’s will to experience well-being and gain 
control over their body (Arvidsson et al, 2011).  Thus patients will sometimes stretch 
their limits in order to do something special or just because of the need to feel 
‘normal’ (Lütze and Archenholtz, 2007). This would be a reasoned decision after 
weighing up that the potential consequences (exhaustion) would be outweighed by 
the benefits (being normal), and is different to carrying on doing things without 
thought (boom and bust behaviour). 
Patients use a range of different strategies in order to be able perform 
activities, for example having a shower to relieve stiffness before going to work.  
Patients report that these strategies have been acquired through trial and error 
rather than having been taught to use them.  They also discuss ways in which they 
have attempted to adjust their valued activities in order to retain them, such as doing 
them less often, in another way or finding an equivalent activity (Lütze and 
Archenholtz, 2007). 
Adjustment to another rheumatological condition AS has also been 
investigated (Mengshoel, 2008), through 12 qualitative interviews exploring the way 
in which AS patients adapt to everyday life.  It was found that although the disease 
course of AS, like RA, is unpredictable, patients were able to identify three aspects 
of living with AS, which were characterised as ‘ordinary life condition’, ‘slowed down 
life condition’ and ‘disrupted life condition’.  The researchers report that during 
ordinary life and slowed down life, the increased discomfort was prevented or 
reversed by patients adapting everyday activities and their environment.  However, 
during the disrupted life period intense, inexplicable and unmanageable pain that 
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could not be reversed by one’s own actions prevented all or most ordinary activity.  
This ‘disrupted life condition’ is particularly relevant to RA flares (Chapter 2.3). 
3.4.2 Psychological adjustment 
Patients with a long term condition can experience anxiety, depression and 
other negative emotions (Taylor and Aspinwall, 1996).  In comparison with healthy 
controls or with patients with other long term conditions, RA patients demonstrate 
poorer psychological well-being (Smedstad et al, 1996).  How patients cope with 
these emotions can affect how well they adjust to their condition (de Ridder et al, 
2008).  A cross-sectional study of 59 women with RA (Curtis et al, 2005) found that 
adaptive strategies such as acceptance and active coping had the strongest 
association with high positive affect, whereas disease status did not.  However, the 
cross-sectional design of this study meant that causal relationships could not be 
identified. 
 A qualitative study involving 30 women with RA proposed that patients go 
through stages in order to adjust to living with RA (Shaul, 1995).  The first stage was 
identified before diagnosis as ‘becoming aware’, which was characterised by Shaul 
as ‘early twinges’. These were often ignored and not seen as a problem until the first 
flare occurred, thus proving to the patients that they had a problem, and prompted 
them to seek help.  The second stage labelled ‘learning to live with it’ was 
characterised by learning to manage symptoms that interfered with normal 
functioning.  This means that patients would need to reprioritise their daily life and 
for most this stage also involves learning new ways of doing things, of coping with 
multiple physical and emotional symptoms and meeting role responsibilities.  In this 
stage patients incorporate their illness into their self image and although the illness 
is unpredictable, they are better prepared to cope with a flare (Shaul, 1995). 
3.4.3 Mastery and self-actualisation 
The final stage of adjustment is identified as Mastery (Shaul, 1995).  This is 
the stage in which patients emerge with a new identity that they have constructed, 
including a different perception of health and a different emphasis on family 
relationships, work and leisure.  This stage does not reflect acquiring mastery over 
the disease, but obtaining mastery in living with RA and a redefinition of what 
constitutes quality of life.  In order to achieve Mastery, the individual must gain a 
sense of empowerment over the situation and develop a repertoire of coping 
strategies (Shaul, 1995). 
The idea of Mastery is similar to Maslow’s (1968) Self Actualisation which is 
the pinnacle point he claims we should strive to achieve, topping his Hierarchy of 
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Needs.  The Hierarchy of Needs is often represented as a pyramid and contains 5 
layers, with the most basic, lowest level needs at the bottom and Self Actualisation’ 
at the top. According to Maslow one cannot conceive of fulfilling a higher need 
before the more basic needs are met.  The four lower layers of the hierarchy consist 
of what Maslow called ‘deficiency needs’ which are respectively; physiological (e.g. 
the need for food, water, air); safety (e.g. the need for security of employment, 
family, health etc); love/belonging (e.g. the need for friendship, love, intimacy); and 
finally esteem (e.g. the need for self-esteem, confidence). 
In order to obtain Self Actualisation Maslow states that the previous needs 
must not only be achieved, but mastered.  Maslow describes ‘self actualisation’ as 
becoming everything that one is capable of becoming and says this level of need 
pertains to what a person’s full potential is and obtaining that potential.  This 
perhaps has parallels with Shaul’s Mastery as patients reach a stage where they are 
able to identify their limits and by adjusting their daily lives can be the best they can 
be within and sometimes in spite of the limits. However, RA is a fluctuating 
unpredictable condition, therefore it may not be possible to maintain a state of 
Mastery.   
Maslow (1954) can be heavily criticised in his ethos that only ‘exemplary 
people’ were worth studying (such as Albert Einstein, Eleanor Roosevelt & Frederick 
Douglas), as he stated: 
 “The study of crippled, stunted, immature and unhealthy specimens 
can only yield a cripple psychology and a cripple philosophy” p236 
 
However, it does seem that his theory developed from this ‘exemplary’ 
population, or at least a variation on this theory, may be able to be generalised to a 
population of people with RA who may not be ‘exemplary’ by Maslow’s standards, 
but who have managed to gain mastery over their lives. 
3.5 Summary 
A number of self-management and coping techniques exist that patients 
draw upon.  Some techniques may be recommended by health professionals and 
others the patient may discover themselves with trial and error, either way patients 
appear to achieve better physiological and psychological outcomes through the 
effective use of self-management and coping strategies.  Effective use of emotion- 
and problem-focused coping strategies can enable patients to adapt to their RA and 
obtain Mastery of their RA or Self Actualisation.  
Although much is reported in the literature about how patients self-manage 
their RA, very little is known about whether there is any difference in self-
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management on current more aggressive drug therapies or how patients self-
manage their RA flares.  Failure of self-management strategies have been 
described as the tipping point for seeking medical help for RA flares.  However, 
previous studies have not included patients that were currently experiencing a flare.  
Whilst failure of self-management strategies have been identified as the 
tipping point for seeking help for RA flares, other tipping points for this may also 
exist.  Thus Chapter 4 will review the help-seeking literature, the factors that affect 
help-seeking behaviours and the psychological models that attempt to explain these 
behaviours. 
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Chapter 4: Help-seeking behaviours  
Chapter 3 identified that failure of self-management strategies prompt people 
with RA to seek medical help for their flare.  This chapter reviews the literature 
relating to help-seeking behaviours in RA and/or other health conditions.  The 
importance of patients’ help-seeking for an RA flare is discussed, the psychological 
models that might explain health behaviours are examined and the factors that may 
affect patients’ help-seeking behaviours are explored, 
4.1 Benefits of early help-seeking behaviours 
Early diagnosis and treatment is crucial in RA (Emery, 2002) to avoid 
irreversible joint damage, which may lead to permanent disability and increased 
personal suffering (Townsend et al, 2010).  Evidence supports the initiation of 
disease-modifying anti-rheumatic drugs (DMARDs) within 3 months of the onset of 
RA in order to prevent joint damage (Nell et al, 2004). 
A literature search from 1806-2012 (search terms: rheum*, arthritis, flare, 
early, treatment, therapy) identified no studies that have addressed the benefits of 
treating patients as early as possible when they are experiencing an RA flare.  
However, it has been found that tight control of inflammation with DMARDs, 
especially early in the course of RA, reduces long-term morbidity and mortality 
(Strand and Singh, 2007).  In the Tight Control of Rheumatoid Arthritis (TICORA) 
study, patients who were randomised to the ‘intense’ treatment arm, where DMARD 
therapy was escalated to achieve a target low disease activity state, did significantly 
better in terms of function and radiological damage compared to patients in the 
routine treatment arm, where disease activity scores were not measured and 
patients were managed at the discretion of the rheumatologist (Grigor et al, 2004).  
This finding is similar to the Disease Control and Complications Trial (DCCT) in 
diabetes, which found that intensive therapy reduced complications, improved 
quality of life and could be expected to increase length of life (DCCT Research 
Group, 1996).  The evidence supporting tight control of inflammation indicates the 
possibility that patients receiving treatment as soon as possible for their RA flares 
may have a better long term outcome in terms of joint damage, disability and even 
mortality. 
During the process of diagnosing RA, delay in the presentation to primary 
care is the main reason why patients are seen late by a rheumatologist (Kumar et al, 
2007).  Further, anecdotal evidence suggests that patients with established RA, who 
phone the rheumatology helpline in a flare, have already waited a substantial 
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amount of time before contacting the team.  Thus considering the potential benefits 
of early help-seeking for an RA flare, it is important to unpick why patients may wait 
before seeking help. 
4.2 Health and illness behaviours 
A distinction has been made between three different types of ‘health 
behaviour’: health behaviour; illness behaviour; and sick-role behaviour (Kasl and 
Cobb, 1966).  Health behaviour is an activity undertaken by a person believing 
themselves to be healthy, for the purpose of preventing disease or detecting it in an 
asymptomatic state.  Illness behaviour is any activity undertaken by a person who 
feels ill, to define the state of their health and to discover a suitable remedy.  Sick-
role behaviour is an activity undertaken for the purpose of getting well, by those who 
consider themselves ill.  It includes receiving treatment from appropriate therapists, 
generally involves a whole range of ‘dependent’ behaviours and includes the belief 
that ill people are not held responsible for their normal roles, thus the person adopts 
the ‘sick-role’.  Illness behaviour and sick-role behaviour may appear similar, but in 
illness behaviour the patient takes an active role in their health, whilst in sick-role 
behaviour the patient takes a passive role, in which they depend on others.  Illness 
behaviour seems more appropriate to describe RA patients’ help-seeking 
behaviours as they take an active role in self-managing their RA (Chapter 3), 
including seeking help from the medical team when they believe they are in an RA 
flare in order to receive treatment to control their symptoms (Hewlett et al, 2012). 
4.3 Psychological models explaining help-seeking behaviours 
A number of psychological models have been proposed to describe health 
behaviours, in the broad sense of the term (Kasl and Cobb, 1966).  However, not all 
these models include the help-seeking aspect of health and illness behaviours, thus 
the Stages of Change Model (Proshaska, DiClemente and Norcross, 1992) and 
Conflict Theory Model (Janis and Mann, 1977) have not been included in this thesis, 
due to insufficient inclusion of help-seeking behaviours.  The models that will be 
discussed below are: Health Belief Model (HBM); (Multi-dimensional) Health Locus 
of Control (MHLC); Theory of Planned Behaviour (TPB); Social Cognition Theory 
(SCT); and Self-Regulatory Model (SRM). 
4.3.1 Health Belief Model 
The Health Belief Model (HBM: Becker and Rosenstock, 1984) proposes that 
health behaviour depends directly on the outcome of two assessments (Fig 4.1); 
perceived threat and perceived benefits and barriers.  Three factors influence 
perceived threat: perceived susceptibility; perceived seriousness; and cues to 
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action.   In terms of patients’ help-seeking behaviours for an RA flare, the HBM 
suggests that patients assess the perceived threat suggested by their flare 
symptoms.  Patients could assess the likelihood that their symptoms will develop 
into a flare (perceived susceptibility) and consider the physical and social 
consequences of being in a flare (perceived seriousness).  Cues to action might 
include the symptoms themselves and the advice patients receive from lay referral 
from their friends and family.  Alongside these perceptions of threat, people evaluate 
the perceived benefits and barriers of taking action, weighing the pros and cons of 
performing a particular health behaviour.  Therefore in terms of RA, patients may 
weigh up the benefits of treatment for their flare with the barriers of their other 
responsibilities, thus not wanting to waste their own time (Sheppard et al, 2008) or 
not wanting to ‘bother’ the doctor (Kett et al, 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: The Health Belief Model 
 
Meta-analyses of the HBM have found different results of the HBM’s ability to 
predict behaviour: barriers, benefits and susceptibility were good predictors of 
behaviour, whereas severity was not (Janz and Becker, 1984); the HBM was 
predictive of behaviour, but only weakly in comparison to SCT and the Theory of 
Reasoned Action (Zimmerman and Vernberg, 1994); the HBM produced 
substantially larger effect sizes in retrospective than prospective studies, suggesting 
that the HBM does not have predictive ability (Harrison, Mullen and Green, 1992); 
and that barriers and benefits were good predictors of behaviour, whereas severity 
and susceptibility were not (Carpenter, 2010).   
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Whilst some research suggests that the factors described by the HBM do 
influence decisions of whether and how soon to access health services (Becker and 
Rosenstock, 1984), others have found a weak relationship between these factors 
and likelihood of accessing healthcare (Harris and Guten, 1979).  This suggests that 
other factors are also important in decisions to seek treatment, such as influences 
from friends and family or previous experience of help-seeking. 
4.3.2 (Multi-dimensional) Health Locus of Control 
The Health Locus of Control (HLC) originated from Rotter’s (1954) Social 
Learning Theory, which proposes that the likelihood of a behaviour occurring in a 
given situation is a function of the person’s expectancy that the behaviour will lead 
to a particular reinforcement (e.g. “If I seek help for my RA flare I expect to be given 
medication that will relieve my symptoms”), and the extent to which they value that 
reinforcement.  Rotter (1966) proposed that as well as having expectancy beliefs for 
specific situations, people also have generalised expectancy beliefs that can be 
applied across situations.  Thus the HLC was developed as a generalised 
expectancy relating to the perceived relationship between a person’s actions and 
experienced outcomes.  
The HLC distinguishes between internal and external locus of control belief 
orientations.  People with an Internal HLC believe they have the ability to influence 
and determine features that affect their lives, thus events are seen as a 
consequence of their own actions, which they are able to control.  In contrast, 
people with an External HLC believe that events are unrelated to their actions and 
are therefore determined by factors beyond their personal control.  Using this model, 
patients with an External HLC  would therefore be more likely to believe that there 
was nothing they could do about an RA flare, whereas patients with an Internal HLC 
may be more likely to be proactive and seek help for an RA flare due to beliefs that 
they can control their situation. 
It was argued that with the external HLC, it is possible to distinguish between 
external control exerted by powerful others and the influence of chance (Levenson, 
1974).  Thus a revised version was developed: the Multidimensional Health Locus of 
Control (MHLC: Wallston, Wallston and DeVillis, 1978).  In this revised model, 
beliefs are measured across three dimensions: Internal HLC, which remains the 
same; Powerful others HLC, in which people believe their health is under the control 
of powerful others; and Chance HLC, in which people believe their health is owing to 
chance.  The MHLC predicts that people with an internal HLC would be more likely 
to engage in health promoting activities.  However, in terms of help-seeking for a 
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long-term condition, the belief in the role of powerful others may be advantageous 
(Wallston, 1989) as patients may be more likely to believe that the medical team are 
there to help them, and would therefore be more likely to seek help. 
There are a number of criticisms of the MHLC as a theory to explain health 
behaviours.  First, the locus of control does not take into account the value that 
people place on their health, which might be a strong predictor of help-seeking 
behaviour (Weiss and Larsen, 1990; Wallaston, 1992).  There is no theoretical 
reason to expect the locus of control to predict health behaviours among people that 
place low value on their health (Wallston and Wallston, 1980).  Indeed one study 
(Weiss and Larson, 1990) found that people placing high value on their health 
correlated significantly with internal HLC beliefs and a health behaviour index, which 
was not found for people who placed low value on their health.   Second, the MHLC 
can be criticised for explaining behaviour in terms of generalised behaviour-
reinforcement expectancy beliefs (Ajzen and Fishbein, 1977) and it is possible that 
people hold different control beliefs for different behaviours (Kirscht, 1972).  
Therefore the MHLC may explain patients’ help-seeking behaviours for their RA 
flares to some extent, but it does not take into account whether their RA is a priority 
for them, or whether they have specific control beliefs about help-seeking for their 
RA flares.  It is possible that patients with previous experiences of help-seeking for 
their RA flare may be influenced by this when considering their future help-seeking 
behaviour. 
4.3.3 Theory of Planned Behaviour 
According to the Theory of Planned Behaviour (TPB: Ajzen, 1985), an 
expanded version of the Theory of Reasoned Action (Ajzen and Fishbein, 1980), 
people decide their intention in advance of most voluntary behaviours, they 
therefore propose that intentions are the best predictors of what people will do.  This 
theory indicates that three judgements determine a person’s intention to perform a 
behaviour (Fig 4.2), which will be illustrated with a fictitious patient considering 
seeking help for an RA flare. 
Attitude regarding the behaviour: A judgement of whether or not the 
behaviour is a good thing to do.  This judgement is based on two expectations: the 
likely outcome of the behaviour (such as “If I seek medical help my flare will be 
halted”) and whether the outcome would be rewarding (such as “If my RA flare is 
halted I will be in less pain and can go back to my normal daily life”). 
Subjective Norm: This judgement reflects the impact of social pressure or 
influence on the behaviour’s acceptability or appropriateness.  This includes beliefs 
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about others’ opinions (such as “My friends and family think I should seek medical 
help for my flare”) and motivation to comply with those opinions (as in “I want to do 
what they want”). 
Perceived Behavioural Control: This is the person’s expectation of success 
in performing the contemplated behaviour (such as “I believe I will be able to attend 
a hospital appointment”).  This judgement is similar to the concept of self-efficacy 
(Bandura, 1986) (Section 4.3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: The Theory of Planned Behaviour 
 
The Theory of Planned Behaviour proposes that these judgements combine 
to produce an intention that leads to performance of the behaviour.  The individual 
judgements have been shown by many studies to influence intentions and behaviour 
(Conner and McMillan, 2004).  
One criticism of this model is that the theory does not include people’s prior 
experiences with the behaviour (Conner and McMillan, 2004), this is an important 
factor to consider in terms of patients deciding whether to seek help for an RA flare.  
Previous studies looking at exercising and alcohol and drug use (Bentler and 
Speckart, 1979; Godin et al, 1987) have found that people’s history of performing a 
health behaviour strongly predicts their future practice of that behaviour.  Thus 
patients who have previously sought help for an RA flare may be more likely to do 
so in the future, but this potentially predictive factor would not be recognised by the 
Theory of Planned Behaviour. 
4.3.4 Social Cognition Theory 
In Social Cognition Theory (Bandura, 1977) people’s motivation and action 
are assumed to be based on three types of beliefs: situation-outcome (beliefs about 
what consequences will occur without taking action e.g. “If I don’t seek help for my 
flare I might be causing further joint damage”), action-outcome (the belief that a 
given behaviour will or will not lead to a given outcome e.g. “If I seek help for my 
flare I will be given medication that will relieve my symptoms” ) and perceived self-
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efficacy (SE) (the belief that a behaviour is or is not within their own control e.g. “I 
believe that I could seek medical help for my flare”). 
There is a causal ordering between the three beliefs (Schwarzer, 1992).  
Situation-outcome beliefs influence behaviour via their impact on action-outcome 
expectancies (e.g. a patient in an RA flare believes that if they do nothing their flare 
will get worse and cause long term damage, which motivates the patient to consider 
actions to minimise the potential consequences).  Action-outcome expectancies are 
assumed to impact on behaviour via their influence on goals, behavioural intentions 
and SE expectancies.  SE expectancies are thought to have a direct impact on 
behaviour as optimistic self-beliefs predict actual behavioural performance 
(Bandura, 1992).  It also has an indirect effect via its influence on intentions as 
people generally intend to perform behaviours that they perceive to be within their 
control (Schwarzer, 1992). 
One study comparing self-efficacy for pain and functioning in RA (Somers et 
al, 2010), found that patients with higher disease severity had lower levels of self-
efficacy for controlling pain and other symptoms and for performing functional tasks.  
It is possible that SE may predict patients’ help-seeking behaviours.  It would 
therefore be important to discover how patients perceive their access to the medical 
team and thus if they believe that help-seeking is within their control or whether 
there are barriers to help-seeking that are outside of their control.  
4.3.5 The Self-Regulatory Model 
The Self-Regulatory Model (SRM) (Leventhal and Cameron, 1987; Leventhal 
et al, 1997) is a social cognition model, which is also known as The Illness 
Perceptions Model, The Illness Representations Model, The Parallel Process Model, 
The Common-Sense Model of Self-Regulation’ or simply Leventhal’s Model.  The 
model consists of 3 stages (Fig 4.3) that regulate behaviour: Illness perceptions; the 
action plan or coping stage; and the appraisal stage in which the individual 
evaluates the success or failure of coping strategies.  Illness perceptions are 
structured around five dimensions (Lau and Hartman, 1983; Leventhal, Diefenbach 
and Leventhal, 1992): Identity, which are the symptoms and the label given to the 
illness (e.g. “My symptoms constitute an RA flare”); Cause of illness, which can be 
genetic, environmental or behavioural factors (e.g. “My flare is caused by the 
weather”); Timeline or course of illness; Controllability/Curability; and 
Consequences, which can be perceived physical, psychological or economic 
consequences.  (e.g. “My flare affects my ability to do my normal activities”) 
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The illness perceptions were revised and expanded to 9 illness perceptions, 
with two items expanded and two novel items added (Moss-Morris et al, 2002).  
Factor analysis of controllability/curability found that the items loaded onto two 
separate factors (Moss-Morris et al, 2002), personal control (e.g. “There is nothing I 
can do to control my flare symptoms”) and treatment control (e.g. “Medication would 
relieve my flare symptoms”).  The timeline subscale was also divided into two 
separate subscales of acute/chronic timeline (e.g. “My flare will last a long time”) 
and cyclical timeline (e.g. “My flare symptoms are very unpredictable”).  Finally two 
new illness perceptions of Emotional representations (e.g. “My flare makes me feel 
angry and worried”) and Illness coherence, which is the extent to which people’s 
illness ‘makes sense to them’ (e.g. “My RA flare symptoms are puzzling to me”)  
were also added (Moss-Morris et al, 2002). 
Theoretically these revised illness perceptions might explain help-seeking 
behaviours for RA flares, patients who identified their symptoms as an RA flare and 
who attributed the cause of their flare symptoms to fluctuations in disease (rather 
than an external cause, such as the weather) may be more likely to seek help.  
Further, patients who believe that their flare will last a long time unless they seek 
medical help (acute/chronic timeline) and whose symptoms are fluctuating 
uncontrollably (cyclical timeline) may be more likely to seek help as these 
perceptions may lead to the feeling of losing control.  Patients with the perception 
that they are able to manage their symptoms alone (personal control) may be less 
likely to seek help than those who think that they need medication to control their 
symptoms (treatment control).  In terms of emotional representations, patients may 
be more likely to seek help if their symptoms cause negative emotions such as 
anger and worry.  Finally, patients may be more likely to seek help when their 
symptoms affect their quality of life (consequences). 
The SRM is a parallel processing model, where perceptions of a health 
threat take place on both a cognitive level for regulation of danger, and an emotional 
level for the regulation of fear.  Each of the two parallel processing systems has a 
feedback loop, thus if a particular coping strategy is perceived to be ineffective, an 
alternative coping response may be adopted, which may result in a change in illness 
perceptions (Lawson, Bundy and Harvey, 2007). 
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Figure 4.3: The Self-Regulatory Model 
Hagger and Orbell, Psychology and Health, 2003 18(2): 141-184, with kind permission Taylor & 
Francis 
 
4.3.5.1 Application of the Self-Regulatory Model 
The SRM has been used to explain health behaviours in a number of health 
conditions.  In RA, a belief in adverse consequences was associated with more 
visits to the outpatient clinic, fatigue and higher anxiety (Scharloo et al, 1999). The 
SRM proposes that people use common sense in constructing their illness 
perceptions based on their knowledge and experiences, and they actively test these 
out by their use of emotion- and problem-focused coping efforts (Hale, Treharne and 
Kitas, 2007).  A study with RA patients found that avoidant coping did not predict 
fatigue after 1 year and this coping style did not appear to be related to perceiving 
RA to have serious consequences (Treharne et al, 2005).  However, the authors 
note that this could be due to coping scales not being sensitive enough and not 
being culturally relevant due to having been developed in the United States. 
The SRM has also been used in other conditions, such as acute myocardial 
infarction (AMI).  These patients’ experiences have been found to support the SRM 
as they report a sequence of appraisal and reappraisal of symptoms, coloured by 
emotional responses to the event (Dempsey, Dracup and Moser, 1995).  The SRM 
has been used to design a number of interventions to improve delay times in help-
seeking with AMI patients (e.g. Dracup et al, 1995; Dracup and Moser, 1997).  The 
SRM has also been used to identify factors associated with non-attendance to 
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diabetes clinics (Lawson, Bundy and Harvey, 2007) and to identify different clusters 
of chronic pain patients and thus customise treatment (Hobro, Weinman and 
Hankins, 2004).  It has also been used to determine how illness perceptions 
influence both coping and outcomes in a diverse range of long term conditions e.g. 
chronic fatigue syndrome (Moss-Morris et al, 1996); psoriasis (Fortune et al, 2000); 
and multiple sclerosis (Vaughan, Morrison and Miller, 2003). The SRM has been 
used in a variety of long term conditions to explain patients’ help-seeking behaviours 
and has been used in RA to explain patients’ coping behaviours and to predict 
potential outcomes.  It therefore appears to be a relevant model with which to 
evaluate the decision-making process and help-seeking behaviours of patients with 
RA.  However, there may be other variables such as gender and social support that 
influence help-seeking behaviours, which are not included in the models above and 
will now be discussed.    
4.4 Factors affecting help-seeking  
One small qualitative study has been identified that reported patients’ RA 
flare help-seeking behaviours (Kett et al, 2010).  This study was conducted with an 
ethnically diverse population and found that whilst White British patients’ reasons for 
avoiding help-seeking were due to feeling they could cope and being too proud to 
ask for help, South Asian patients’ reasons were related to the language barrier and 
lack of rapport with their medical team.  This study identified that the prompt for 
help-seeking was severity of symptoms.  However, help-seeking was only one small 
aspect of this qualitative study and therefore patients’ experiences and beliefs have 
not previously been explored in depth. 
Due to the lack of literature discussing RA flare help-seeking behaviours, the 
literature will be explored for help-seeking behaviours in patients with other health 
conditions.  The literature around patients’ help-seeking behaviours during the 
process of obtaining a diagnosis will also be considered as there may be similarities 
to seeking help for an RA flare.    
4.4.1 Gender 
There are conflicting data regarding whether there are gender differences in 
delay in seeking treatment.  Several studies have found no difference in delay times 
between men and women seeking help for acute cardiac symptoms (e.g. Dracup 
and Moser, 1997; Moser et al, 2005), whilst others found that women delay help-
seeking for an AMI longer than men (e.g. Bowker et al 2000) or vice versa (White 
and Johnson, 2000).  A qualitative study (Albarran, Clarke and Crawford, 2007) 
found that women with an AMI present with non-specific or no chest pains, making 
Chapter 4: Help-seeking behaviours 
73 
 
the symptoms difficult for them to interpret, therefore relying on the symptom of 
chest pain to detect AMI may delay women in seeking treatment.   
There are differences in the reasons that men and women delay help-
seeking (Moser et al, 2005).  Men delay help-seeking when they are unaware of the 
benefits of treatment, whilst women delay due to not wishing to trouble the medical 
team (Moser et al, 2005).  It has also been found that men with cancer are reluctant 
to seek help as they perceive it is not a masculine thing to do (Smith, Pope and 
Botha, 2005).  People can and do behave in ways that both cohere with and 
contradict their normative gender behaviours when seeking health care, therefore 
gender cannot be considered a ‘stand alone’ factor in determining help-seeking 
behaviours (Galdas et al, 2010). 
4.4.2 Social Support 
When dealing with complex health decisions the majority of people will draw 
on their social network for advice, confirmation and support (Schoenberg et al, 
2003).  The process of family members and friends assisting in interpreting bodily 
changes and helping to decide on a course of action is referred to as the ‘lay referral 
system’ (Freidson, 1960).  Lay referral networks can teach and reinforce patterns of 
self-care, validate or contradict people’s interpretations of their symptoms, 
encourage or discourage professional consultation, provide reassurance or simply 
allow people to voice concerns, thus affirming the person’s importance and 
supporting their self-esteem (Stoller, 1998).   
In patients with RA who are pre-diagnosis, family and friends have been 
used as ‘lay consultants’ to seek advice and validation from before seeking medical 
help (Shaul, 1995; Sakalys, 1997).  These ‘lay consultants’ also advised patients on 
symptom control, possible cures and occasionally that symptoms may be indicative 
of RA (Bury, 1982; Sheppard et al, 2008).  For men, their wives have been found to 
be the primary lay referral source, possibly due to the traditional health gate-keeping 
role of women (Stoller, 1998).  However, husbands do not necessarily serve the 
same role for women, reflecting women’s’ wider range of lay referral sources and 
possibly a desire not to ‘trouble’ their husbands (Schoenberg et al, 2003).  In 
diabetes, the quality of the relationship has been shown to correlate to perceived 
social support and adherence to self-care behaviours in men, but this correlation 
was not seen with women (Gillibrand and Stevenson, 2007). This may further 
explain the differences between help-seeking behaviours in men and women 
(Section 4.4.1).  It has also been found that some people have sought people with 
similar experiences online, instead of friends and family, which has helped them to 
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decide whether to seek help or self-manage their condition (Hay et al, 2008; 
Townsend et al, 2010). 
Lay referral systems may not always be helpful to patients.  Some culturally 
specific advice, which suggested that symptoms represented a curse or that 
complementary medicines should be used, caused people to delay longer in help-
seeking (Kumar et al, 2010).  Further, family members, particularly older relatives, 
who have told patients that they are over-reacting or causing a fuss, can cause them 
to severely delay seeking medical help (Sheppard et al, 2008). 
Thus the evidence in pre-diagnosed RA suggests that patients use lay 
referral networks as part of their decision-making process in seeking medical help.  
However, these lay referral networks do not always facilitate patients’ help-seeking 
and can sometimes delay it.  This supports findings in patients pre-diagnosis for 
breast cancer (Unger-Saldana and Infante-Castaneda, 2011) and patients who are 
experiencing an AMI (Schoenberg et al, 2003).  Further, patients experiencing an 
AMI are more likely to seek help if a friend or family member phones for help as the 
responsibility is then removed from the patient and they report feeling less guilty 
about the possibility of wasting the doctor’s time (Pattenden et al, 2002).   
4.4.3 Symptoms 
Patients’ help-seeking behaviours can be attributed both to the type of 
symptoms they experience and the way in which they are interpreted.  Patients with 
RA who are pre-diagnosis often experience joint pain that recurs intermittently, 
causing a delay in help-seeking (Sheppard et al, 2008).  This may be due to the 
uncertainty of whether the symptoms are serious enough to seek help, which would 
support previous qualitative research (Hewlett et al, 2012).  Indeed, help-seeking 
behaviours in patients with RA who are pre-diagnosis have been influenced by the 
cause that they attribute their symptoms to, and how serious they think their 
symptoms are (Sheppard et al, 2008).  In pre-diagnosed RA, there is no association 
between the age of the patient and the extent of the delay (Kumar et al, 2007).  This 
may be due to a different cause being attributed to the symptoms, as patients 
across the age spectrum report that they feel too young to have arthritis (Sheppard 
et al, 2008); and many patients have developed their own explanatory models for 
their symptoms based on recent physical experiences (Bury, 1982; Sheppard et al, 
2008).   
These findings in RA support those in other conditions, such as AMI in which 
patients’ help-seeking has been found to be determined by perceived severity of 
their symptoms, experiencing  a stuttering symptom pattern (symptoms came and 
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went) and the anxiety they experience (Moser et al, 2005).  Some patients 
experiencing an AMI rationalise their symptoms, for example attributing them to 
stress, which could slow the help-seeking process (Turris and Johnson, 2008).  In 
contrast to the RA findings, older women experiencing AMI symptoms delay 
substantially (although not significantly) longer than younger women, it is suggested 
that this is due to multiple co-morbidities making it difficult for patients to attribute a 
cause to their symptoms (Dracup et al, 1995).  In fact patients with diabetes who 
experience an AMI experience confusion over the cause of their symptoms (Mayer 
and Rosenfeld, 2006).  Further, patients with diabetes (Lawson et al, 2005) and 
patients with AMI symptoms (Turris and Johnson, 2008) were reluctant to seek help 
when the symptoms were not visible to others.  This may be due to the societal 
discourse that symptoms need to be visible to a bystander in order to be thought 
serious (Turris and Johnson, 2008).  Thus patients who consider their symptoms to 
be unimportant may be unlikely to consider the potential future consequences of not 
seeking help (Lawson et al, 2005). 
Patients experiencing AMI symptoms have expressed concerns that their 
symptoms may be diagnosed as non-cardiac in origin and have reported fears of 
embarrassment at having wasted the time of the medical team (Arslanian-Engoren, 
2006).  Others were concerned that they did not deserve medical help as they felt 
they had caused the symptoms themselves due to certain activities or poor lifestyle 
(Turris and Johnson, 2008).  Some patients felt guilty about wasting the NHS’s 
resources even though they knew they needed to seek help (Pattenden et al, 2002).   
4.4.4 Barriers to help-seeking 
Barriers to help-seeking in RA patients who are pre-diagnosis have been 
identified as patients’ worries about wasting their own or the doctor’s time (Sheppard 
et al, 2008).  They also report prioritising other life events and other people over 
their need to seek help (Sheppard et al, 2008). 
Patients with diabetes have cited difficulties with attending their clinic 
appointment as a barrier to seeking help (Lawson et al, 2005).  Factors that affect 
this can include appointment time, distance from home and lack of transport 
(Lawson et al, 2005).  Patients with diabetes also explained that attending diabetes 
clinic emphasised the negative aspect of their disease through seeing other patients 
and listening to the doctor (Lawson et al, 2005).  However, patients reported that 
clinic avoidance led to feelings of depression, fear of diabetes, diabetic 
complications, fear of treatment and an uncertain future. (Lawson et al, 2005). 
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Further restrictions can be caused by work and lifestyle.  Diabetes patients 
are often reluctant to ask their employers for time off work for appointments (Lawson 
et al, 2005).  Women experiencing AMI symptoms choose to maintain their normal 
daily life routine and ignore their symptoms in order to ‘maintain integrity’, with some 
women reporting finishing the school run before seeking help (Turris and Johnson, 
2008).   
4.5 Summary 
Early aggressive treatment for early RA and tighter control of inflammation 
provides significantly better treatment outcomes for patients.  It is proposed that 
patients who receive early treatment for their RA flares will also experience better 
long term outcomes as this could prevent the long term inflammatory damage.  Little 
is known about the decisions made by patients when they are in an RA flare; how 
they decide to seek help and why they wait. 
Current research suggests that in patients with RA who are pre-diagnosis 
and in similar long term conditions, help-seeking behaviours are determined by a 
wide variety of factors.  Although all these factors can in some way predict patients’ 
help-seeking behaviours, they cannot be considered in isolation, as patients cannot 
be expected to always act according to their normative roles and rationality cannot 
be assumed.  Thus an interaction of these factors may contribute to help-seeking. 
Psychological models of health behaviours provide a more rounded 
explanation of patients’ help-seeking behaviours taking into account their emotions, 
beliefs and perceptions rather than demographic characteristics.  The self-regulatory 
model appears to be the most appropriate to explore RA patients’ help-seeking 
behaviours having been used effectively with previous help-seeking behaviour 
studies and with RA patients.  Discovering why patients delay help-seeking for their 
RA flares would provide important information for clinicians, enabling them to 
encourage RA patients to seek help sooner, thus improving their long-term outcome.   
4.6 Summary of the overall literature review 
The preceding literature review chapters have demonstrated that there is a 
dearth of literature addressing patients’ experiences of daily life on current modern 
treatment regimes and there is currently no agreed definition for RA flare (Chapter 
2).  Whilst there are a range of self-management strategies suggested to patients, 
there is a lack of research that address which strategies patients use and how bad 
their symptoms have to be for them to consider self-managing whilst on current 
modern treatment regimes (Chapter 3).  Finally, although studies have addressed 
help-seeking behaviours in patients with RA who are in the process of obtaining a 
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diagnosis, only one small qualitative study could be found that addressed patients’ 
decisions for help-seeking in an RA flare, which was only examined by one 
question.  Thus patients’ help-seeking behaviours for RA flare have been seriously 
overlooked in the literature (Chapter 4). 
The gaps in knowledge therefore are how patients experience RA in daily life 
and flare on current modern treatment regimes; how they self-manage; and how 
they decide to seek-help for an RA flare.  Thus the aim of this thesis is to investigate 
these gaps in knowledge and the following chapter describes the methodology and 
methods used to address this. 
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Chapter 5: Methodology and Methods 
This chapter presents the rationale for a mixed methods approach.  The 
methods for each of the 3 studies are described and justified.  This chapter also 
describes the involvement of patient research partners in these studies. 
5.1 Thesis aims 
The aims of the thesis are: 
 To explore the individual experience and impact of RA in daily life and flare 
and how patients self-manage these 
 To obtain consensus on patients’ experiences of daily life with RA 
 To obtain consensus on patients’ help-seeking behaviours in an RA flare 
 To characterise the level, variation and clustering of symptoms in daily life 
 
Three phases have been designed to address these aims: semi-structured 
interviews (Study 1) will explore patients’ experiences of RA in both daily life and 
flare, and how they manage these.  The variation of these experiences and 
decisions on help-seeking will then be explored for clusters or patterns, using Q-
methodology (Study 2, utilising data from Study 1) presented to a fresh cohort of 
patients.  Finally, the daily symptoms and help-seeking behaviours that patients 
identified as most important in Study 2, will be examined in quantitative terms 
through daily measures of symptoms (Study 3a); and a questionnaire regarding 
help-seeking, capturing patients who phone the rheumatology helpline for an 
appointment for their flare (Study 3b). 
5.2 Mixed methods 
There is inconsistency in the literature about exactly what constitutes mixed 
methods research (Sandelowski, 2000; Bryman, 2007; Tashakkori and Creswell, 
2007).  However, it has been suggested that the defining characteristics of a mixed 
methods approach include: qualitative and quantitative methods within the same 
research project; a research design that clearly specifies the sequencing and priority 
given to the qualitative and quantitative data; an explicit account of how the 
qualitative and quantitative aspects of the research relate to each other; and 
pragmatism as the philosophical underpinning for the research (Denscombe, 2008).   
5.2.1 Traditional research paradigms and mixed methods 
It is traditionally understood that qualitative and quantitative approaches 
represent incompatible paradigms (“the set of beliefs and practices that guide a 
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field”: Morgan, 2007:49), due to being underpinned by fundamentally different 
assumptions about the nature of reality (ontology) and ways of knowing and 
understanding (epistemology) (Dures et al, 2011).  Traditionally researchers have 
been divided between the positivist scientific model of research (quantitative) and 
the interpretative or constructivist model of research (qualitative) (Howe, 1985) and 
the approach in health care research was almost exclusively of the positivist 
approach, which is still considered by many to be the ‘gold standard’ (Doyle, Brady 
and Byrne, 2009).   
Constructivism proposes that there are multiple realities and different 
interpretations may result from any research endeavour, which can be shaped by 
particular circumstances (Appleton and King, 2002).  In contrast, positivism 
proposes that there is a single reality and therefore seeks to identify the causal 
relationships through objective measurement and quantitative methods.  The 
positivist viewpoint is that research outcomes are not biased by the values of the 
detached positivist researcher unlike in the constructivist paradigm, where the 
researcher is immersed in the work (Firestone, 1987).  There is an assumption that 
positivism is objective, whilst constructivism is subjective.  However, it has been 
strongly argued that no research is wholly free from value judgements (Howe, 
1985). 
Despite the debate in the literature surrounding the issues of combining 
qualitative and quantitative research methods (Howe, 1985; Bryman, 2007; Morgan, 
2007), it has been proposed that mixed methods constitute a third paradigm, 
capable of bridging the gap between qualitative and quantitative positions (Johnson 
and Onwegbuzie, 2004).  Thus the philosophy of pragmatism is typically associated 
with mixed methods (Dures et al, 2011).  Pragmatism maintains that the 
consequences are more important than the research process and therefore that ‘the 
end justifies the means’ (Doyle, Brady and Byrne, 2009).  It therefore advocates 
choosing the best method to answer the research question, rather than being driven 
by the researcher’s epistemological or ontological standpoint (Johnson and 
Onwegbuzie, 2004).  Further, pragmatists seek functional knowledge and consider 
the impact of research on practice (Maxcy, 2003).   
5.2.2 Rationale for mixed methods 
A review of 232 social science mixed methods studies (Bryman, 2006) 
identified 16 reasons for conducting mixed methods research.  These have been 
summarised to provide 8 individual rationales and benefits of using mixed methods 
designs (Doyle, Brady and Byrne, 2009): 
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Triangulation: this allows for greater validity in a study by seeking 
corroboration between qualitative and quantitative data.  In this thesis, any 
similarities and differences between the findings of the individual studies are 
discussed in Chapter 10. 
Completeness: a combination of research approaches provide a more 
complete and comprehensive picture.  Thus in this thesis it was felt that a mixed 
methods approach would enable patients’ individual experiences to be explored, 
whilst also identifying clusters of experience and identifying patterns of symptoms, 
which could not all be explored through either qualitative or quantitative methods 
alone.  
Answering different research questions: It has been argued that mixed 
methods research enables research questions to be answered that cannot be 
answered by qualitative or quantitative research methods alone (Creswell and Plano 
Clark, 2007).  Thus as discussed above, this thesis would not benefit from being 
bound to one methodological paradigm. 
Offsetting weaknesses and providing stronger inferences: using a mixed 
methods approach can allow for the limitations of each approach to be neutralised, 
whilst strengths are built upon (Bryman, 2006).  Thus in this thesis the qualitative 
approach provided insight and understanding of patients’ individual experiences, 
which could not be identified through a quantitative approach; and the quantitative 
approach enabled prioritising (ranking) of opinions and a numerical understanding of 
how patients experience RA symptoms, which could not be identified through a 
qualitative approach. 
Explanation of findings: mixed methods studies can use one research 
approach to explain data generated from a study using the other research approach.  
Study 2 used this approach with qualitative and quantitative data complementing 
each other to explain clusters of experience.   
Illustration of data: using a qualitative research approach to illustrate 
quantitative findings.  In this thesis, the qualitative analysis from Study 1 has been 
revisited throughout the research process in an attempt to explain subsequent 
quantitative findings. 
Hypothesis and instrument development and testing:  These have been 
combined into one item, due to their similarity.  A qualitative phase of a study may 
be undertaken to develop either a hypothesis or items for inclusion in a 
questionnaire, to be used in a quantitative phase of the study.  Thus a mixed 
methods approach has been used here as the findings from Study 1 were used to 
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provide items to form the Q-set to be used in Study 2, from which the findings were 
used to provide items for the survey in Study 3. 
5.2.3 A qualitatively driven model of mixed methods 
The overall research goal for this thesis was to gain a better understanding 
of patients’ experiences and the impact of RA on their daily life and in flare, and how 
they self-manage these.  In terms of sequencing, it was decided to begin with a 
qualitative approach due to the lack of existing qualitative research into daily life, 
flare and self-management on current modern treatment regimes, which indicated 
that patients had not been given a voice in this area, and thus any items or 
measures developed would be imposed by the researcher’s viewpoint.  Due to her 
belief that the design of the subsequent quantitative studies should be grounded in 
the findings from the initial qualitative study, the researcher chose a sequential 
mixed methods design (Dures et al, 2011), meaning that each study informed the 
next.  This sequential and qualitatively led approach to a mixed methods design has 
been termed a ‘sequential exploratory strategy’ (Creswell, 2009). 
5.3 Patient research partner involvement 
Traditionally a patient’s role in research was seen as the ‘research object’, 
providing data at the request of the researcher (Schipper et al, 2010).  However, 
patients have a personal experience of disease that is not available to most 
researchers (Hewlett et al, 2006) and can therefore bring a valuable and different 
perspective to a study; enhancing the study design, practicality, recruitment, data 
interpretation and dissemination (Department of Health, 1999).  The involvement of 
patients in the research process is becoming more widely accepted in both research 
studies (e.g. White and Verhoef, 2005, Hewlett et al, 2006) and conferences (e.g. 
Kirwan et al, 2005).  The inclusion of a patient on the research team was crucial for 
these reasons, and because this research investigates patients’ experiences. 
The phrase “Patient Research Partners” (PRP) is used in this thesis to reflect 
both the person’s status as a patient with RA and their contribution as a partner in 
the research process (Hewlett et al, 2006; de Witt et al, 2011).  The PRP is 
considered an equal member of the research team, sharing the decision-making 
with the professionals (Abma, Nierse and Widdershoven, 2009).  There is the 
potential for power-imbalance in the research team due to PRPs bringing 
experiential knowledge rather than scientific knowledge (Abma, 2005).  However, 
this experience is valued equally with other team members’ knowledge and 
experience, such as research methods. 
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Pam Richards (PRP) has been involved from the beginning of this study, 
including the design process.  Pam has been invited to all the research meetings as 
a colleague with experience of living with RA, rather than as a patient.  The PRP is 
not representative of all patients, but has a personal experience of living with the 
condition, which the other researchers cannot contribute.  Other PRPs were 
involved in this research when more than one opinion was needed.  Pam has been 
a PRP for a number of years and is therefore familiar with the research process, 
whilst her opinions are highly valued as an expert patient, it was at times appropriate 
to receive input from PRPs who are more “research-naïve”, such as to check 
understanding of patient information sheets as Pam now has a good knowledge of 
research and clinical ‘jargon’. 
The specific contribution of the PRPs to this research will be outlined 
separately for each study in the appropriate sections and the detailed methods for 
each study are now presented. 
5.4 Study 1: Understanding the patient perspective (Interviews) 
5.4.1 Objectives for Study 1 
1. To investigate patients’ perceptions of the range and characteristics of 
daily symptoms, normal variation, episodic patterns of disease activity 
and flare 
2. To investigate clustering of symptoms and early warning signs of flare 
3. To investigate how symptoms are managed and how the decision to 
seek help is reached 
4. To explore a visual representation of disease patterns 
5.4.2 Method for Study 1: Semi-structured interviews 
One to one interviews were chosen over focus groups as the aims of this 
study were to explore patients’ experiences.  As human beings have a tendency to 
conform to the majority (Asch, 1955; 1958) it was decided that one to one interviews 
would ensure that patients’ individual experiences were investigated, rather than 
obtaining a consensus of the strongest voices. 
Semi-structured interviews were conducted as they allow structure to be 
combined with flexibility; the interviews were based on a topic guide, but with a 
flexible structure allowing topics to be covered in the order most suited to the 
interviewee, and for the questions to be expanded or clarification sought (Ritchie 
and Lewis, 2003).  The social science research model sees knowledge as ‘given’ 
through the interview process, explaining this through the ‘miner metaphor’; this 
compares knowledge to buried metal: the miner (interviewer) unearths the valuable 
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metal without contaminating it (the interviewer discovers meanings and experiences 
without polluting the data with leading questions) (Kvale, 1996). 
5.4.3 Identification and sampling 
Ethics approval was granted by the Frenchay REC (10/H0107/17). Patients 
were invited to participate if they had had a confirmed diagnosis of RA (Arnett et al, 
1988) for a minimum of two years, and if they had experienced a flare during their 
disease trajectory.  Patients were purposively sampled to reflect a range of age, 
gender, disease duration, disability and drug treatment. 
Patients were identified as relevant to the study by a member of their care 
team when they attended a clinic appointment at Bristol Royal Infirmary (BRI), 
University Hospitals Bristol NHS Trust (UHBT) and Cossham Hospital, North Bristol 
NHS Trust (NBT) and then introduced to the researcher.  The researcher then 
explained the research to the patient and gave them a patient information sheet with 
a reply slip to take away with them (Appendices A1 and A2).  The researcher 
phoned all patients who returned the reply slip to arrange a mutually convenient 
date for the interview. 
5.4.4 Interview process 
A topic guide (Fig 5.1) was developed by the researcher based on the 
literature available and in discussion with the supervisory team and the PRPs.  The 
topic guide was used to facilitate discussion and ensure that all the relevant points 
were covered.  Participants were first asked to “tell me what your daily life with RA is 
like”; the topic guide was then used as a prompt rather than strict interview schedule 
in order to allow new ideas to emerge.  The interviews followed an iterative process 
(Ritchie and Lewis, 2003), and so as new concepts emerged during data analysis 
these were explored in subsequent interviews. 
Interviews were conducted in the Academic Rheumatology Unit at the BRI 
and at Cossham Hospital. Patients interviewed at the BRI were interviewed in non-
clinical rooms, although still within a medical setting, whilst (due to lack of space) 
patients interviewed at Cossham Hospital were interviewed in one of the consulting 
rooms.  Interviewing a patient in a consulting room is not ideal as there is the 
possibility of a power-imbalance being created by the researcher being seen as a 
‘professional’ (Richards and Emslie, 2000).  The researcher attempted to counteract 
this by ensuring that the desk was cleared (e.g. the computer keyboard, leaflets etc. 
all put aside) and by providing the patient with the chair that the professional would 
take in a medical consultation.  
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Study 1: Interview topic guide 
 
A. Can you tell me what your daily life with RA is like? 
Prompts: Good day/bad day, what’s a normal day? How long to get ready? normal? 
What’s difficult regularly?, symptoms?, impact? What would a normal day be like, at 
the moment? 
B. Can you tell me about how your daily symptoms vary? 
Prompts: everyday symptoms? How often are they experienced? Variation? 
 
C. How do you manage your daily symptoms? 
Prompt:  adjustments? 
 
D. What words would you use to describe the daily variation in your symptoms? 
 
E. What happens when you have a period of high disease activity? 
 
F. How can you tell that this period of high disease activity or ‘flare’ is different from 
daily symptom variation? 
 
G. Do you get early warning signs that a ‘flare’ is coming? 
 
H. How do you manage a ‘flare’? 
       Prompt: anything to lessen/control? 
 
I. How do you decide when it is time to see a member of the Rheumatology team? 
 
J. If we could measure a ‘flare’ on a scale, what would the points on the scale say? – 
e.g. pain scale 
 
K. Do you have anything else you would like to mention that we’ve not discussed? 
 
L. If your RA were an animal what type of animal would it be? 
 
Figure 5.1: Interview topic guide 
 
At the beginning of each interview the researcher explained to the patient 
that she was a PhD student and is therefore non-medical, to allow patients to 
separate the interviewer from the clinical setting.  Participants gave informed 
consent (Appendix B) and completed a pre-interview questionnaire (Appendices C1 
and C2) comprising demographic questions, the Health Assessment Questionnaire 
(HAQ; Fries et al, 1980) and the patient global (Pt Global) measure of the Disease 
Activity Score (DAS; van der Heijde et al, 1993).  The HAQ is 20 disability items 
covering 8 categories (dressing and grooming, rising, eating, walking, hygiene, 
reach, grip, activities).  Patients rate these from 0 to 3 (0: without any difficulty; 3: 
unable to do), and the worst scores for each category are summed, then averaged 
to yield a total score of 0 to 3 (high is bad).  The patient global measure is a visual 
analogue scale (10cm), which asks patients to rate how well they are doing with 
their RA, from very well (0) to very badly (10). These data provided background 
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information and a measure of each participant’s level of disability and patient-
reported disease severity.   
After the interview participants were asked to complete two blank graphs 
(Appendices D1 and D2).  The first graph addressed daily life; the researcher asked 
the patients to draw a line to represent the fluctuation of severity of symptoms in 
daily life, across a period of time defined by the patient (e.g. over the past year or 
since their RA began). The second graph addressed flare; the researcher asked the 
patient to draw a line to represent the duration and severity of a single flare.   
The interviews generally lasted between 45 and 90 minutes.  One interview 
was observed by the researcher’s academic supervisor (SH) to check the quality of 
the interviewing.  Two interviews were observed by the participants’ husbands as 
the participants did not wish to be interviewed alone.  The interviews were audio 
recorded and transcribed verbatim.  A list of drug names (Appendix E) were 
provided to transcribers to aid accuracy and instructions for transcribing were given.  
The researcher checked the transcripts for accuracy and anonymised names and 
identities. 
5.4.5 Patient research partner involvement 
The interview schedule was developed through discussions with the PRPs 
and pilot interviews with PRPs (AK and PR).  The initial pilot interview enabled the 
novice researcher to practice her interviewing skills and to learn from feedback from 
the PRP (AK) regarding her technique and the question order.  Following this pilot 
interview, it was decided that the graphs should be placed at the end of the 
interview.  This decision was made as the researcher and PRP felt that the 
interviewer-interviewee rapport was improved by the end of the interview, therefore 
making the patient more comfortable in carrying out a more abstract task.  The 
second pilot interview (with PR) enabled the researcher to refine her interviewing 
technique and practice the revised order of the interview schedule.  
5.4.6 Thematic analysis 
Thematic analysis (TA) is a method for identifying, analysing and reporting 
patterns (themes) within data.  It minimally organises and describes the data set in 
rich detail (Braun and Clarke, 2006) and allows for interpretation of various aspects 
of the research topic (Boyatzis, 1998).  Both interpretative phenomenological 
analysis (IPA: Smith and Osborn, 2003) and grounded theory (Corbin and Strauss, 
1990) were considered as alternative methods of analysis for Study 1, and the 
reason that TA was thought preferable for this study will now be discussed. 
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The phenomenological aspect of IPA involves the use of descriptive and 
close analysis of lived experience to understand how meaning is created through 
embodied perception (Sokolowski, 2000), whilst the interpretative element 
acknowledges that the researcher is making sense of the participant’s experience in 
a way that addresses a particular research question (Smith and Osborn, 2003).  
Although at first this approach appears relevant for exploring patients’ experiences 
of RA, the strict theoretical framework of IPA explores personal experiences within 
individuals, trying to understand their individual perceptions of a subject, and does 
not compare experiences with other individuals (Smith and Osborn, 2003).  Further, 
the in-depth nature of IPA has lead to recommendations of small samples of 3-6 
participants (Smith, Flowers and Larkin, 2009).  Thus it was felt that IPA was not a 
suitable method to explore experiences across a range of RA patients. 
In contrast grounded theory aims to generate a plausible and useful theory 
that is grounded in the data (McLeod, 2001) and requires analysis to be directed 
towards theory development (Holloway and Todres, 2003).  It was felt that this 
approach was too constrictive for the aims of Study 1 and would not allow individual 
experiences to emerge.  It may be possible to carry out a grounded theory-lite 
approach (Braun and Clarke, 2006), in which the researcher subscribes to the 
theoretical commitments of grounded theory, but does not necessarily produce a full 
worked-up theory.  However, the researcher agreed with Braun and Clarke (2006) in 
that a ‘named and claimed’ thematic analysis enables equally effective analysis as a 
grounded theory-lite approach, but without being constricted by any theoretical 
commitments. 
TA is not wedded to any pre-existing theoretical framework and can 
therefore work both to reflect reality and to unpick or unravel the surface of ‘reality’ 
(Braun and Clarke, 2006).  This creates a more flexible approach in comparison to 
IPA (Smith and Osborn, 2003) or grounded theory (Corbin and Strauss, 1990).  TA 
can be an essentialist or realist method; reporting experiences, meanings and the 
reality of participants, or it can be a constructionist method; examining the way in 
which events, realities, meanings and experiences are the effects of a range of 
discourses operating within society.  It was therefore felt that TA would effectively 
meet the aims of Study 1 and that the flexible epistemology would complement the 
pragmatic approach of this mixed methods thesis. 
In TA, themes within the data can be identified in one of two ways; an 
inductive (“bottom-up”) way (Boyatzis, 1998) or in a deductive (“top-down”) way 
(Crabtree and Miller, 1999).   Inductive analysis is a way of coding the data without 
trying to fit it into a pre-existing coding frame, or the researcher’s analytic 
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preconceptions (Braun and Clarke, 2006).  In contrast, deductive analysis begins 
with an a priori template of codes and attempts to fit the data into these.  Inductive 
TA has therefore been chosen for the initial analysis of these data because it is data 
driven rather than analyst driven and the aim of Study 1 was to explore patients’ 
experiences, which may not fit into a pre-existing coding frame.  Deductive TA was 
then used for the secondary analysis of these data, which involved identifying both 
prompted and unprompted metaphors used by patients.  The prompted metaphors 
were in response to the question 'if your RA were an animal what type of animal 
would it be?' and the unprompted metaphors were those used by patients 
throughout the interview, prior to answering the animal question.  For the purpose of 
this study metaphors included any rhetorical figures of speech that acheive their 
effects through association, comparison or resemblance.  Thus antithesis, 
hyperbole, metonym and simile were all considered types of metaphor (McArthur, 
1992).  
5.4.7 Thematic analysis process 
There is no clear agreement in the literature about what TA is and how one 
should carry it out (e.g. Boyatzis, 1998; Tuckett, 2005).  However, Braun and 
Clarke’s (2006) method has been followed since it provides a rational and detailed 
approach: 
5.4.7.1 Coding 
Phase 1: Familiarisation with the data: The first stage of the TA coding 
process involves the researcher immersing herself in the data to become familiar 
with the depth and breadth of the content.  In order to do this the researcher 
checked the transcripts with the audio recordings and then read and re-read the 
transcripts to search for meanings and patterns.  The transcription process itself is a 
way to familiarise oneself with the data (Riessman, 1993) and therefore the 
researcher transcribed two of the interviews herself. 
Phase 2: Generating initial codes: This phase involves the production of 
initial codes from the data.  Codes identify a feature of the data that appears 
interesting to the researcher and refer to the most basic element of the raw data that 
can be assessed in a meaningful way (Boyatzis, 1998).  Thus units of meaning were 
extracted and a code was applied that described its meaning. 
The researcher coded the data using the software package NVivo 8 for 
Windows (QSR, 2008) as a management tool.  This involved tagging and naming 
selections of text from each interview to create ‘free nodes’.  At this stage the 
researcher coded as many potential units of meaning as possible, even if a link 
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could not be seen to the aims of the thesis.  Quotes from the interviews were placed 
in as many ‘nodes’ as they fit into and at the researcher’s discretion, surrounding 
data for each relevant quote was included to retain its context (Bryman, 2001). 
Phase 3: Searching for themes: This phase re-focuses the analysis at the 
broader level of themes, rather than codes; it involves sorting the different codes 
into potential themes, and collating all the relevant coded data extracts within the 
identified themes.  At this stage different codes may combine to form an overarching 
theme, or an initial code itself may form an overarching theme.  The researcher 
used NVivo 8 (QSR, 2008) to manage this process (rearranging the ‘free nodes’ 
(initial codes) into ‘tree nodes’ to create different levels of themes (main overarching 
themes and sub-themes within them)). 
Phase 4: Reviewing themes: This phase involves refining the themes 
created in the previous phase.  Data within themes should cohere together 
meaningfully (internal homogeneity), whilst there should be clear and identifiable 
distinctions between themes (external heterogeneity) (Patton, 1990).  The 
researcher reviewed and refined the themes to produce a thematic map that has 
validity in relation to the data set and reflects the meanings evident in the data set 
as a whole (Braun and Clarke, 2006). 
Phase 5: Defining and naming themes: In this phase the themes are defined 
by identifying the ‘essence’ of what each theme is about and determining what 
aspect of the data each theme captures.   
Phase 6: Rigour and reflexivity: To ensure rigour in qualitative research it is 
recommended that the analysed data should be auditable (Guba and Lincoln, 1985).  
In this context, auditable means that another researcher could arrive at the same or 
comparable, but not contradictory, conclusions given by the researcher’s data 
(Sandelowski, 1986).  Thus a proportion of the transcripts were independently 
analysed by two researchers and a PRP (PR), who reached comparable 
conclusions to the researcher. 
Further, the researcher constantly engaged in reflexivity throughout the 
analysis process (Mays and Pope, 2000).  The researcher did not have any previous 
experience with rheumatoid arthritis prior to beginning this thesis, but had begun a 
literature review prior to conducting the interviews.  Thus the researcher’s 
preconceptions of what patients would tell her were minimal.  Further, the 
researcher acknowledged that due to her age, she may have built a better rapport 
with younger participants and it was therefore important that their stories did not 
dominate over other participants’.   This impact on the analysis was reduced by the 
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researcher keeping a research diary and constantly acknowledging these influences 
(Koch, 1994). 
Data from the qualitative interviews (Study 1) were carried into Study 2, in 
which clusters or patterns of experience were sought relating to patients’ daily life 
with RA and their process of decision-making in an RA flare.  
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5.5 Study 2: Elucidating clusters of experience (Q-methodology) 
5.5.1 Objectives for Study 2 
1. To obtain consensus on the experience of living with RA from day-to-day 
2. To obtain consensus on patients’ decision-making surrounding help-
seeking behaviours when in a flare  
5.5.2 Methods for Study 2: Consensus methods 
Q-Methodology is one technique that can be used to obtain diverse opinions 
in a subject area, aiming to sample the range and concordance of views expressed, 
not to make claims about the percentage of people expressing them (Kitzinger, 
1987).  Nominal Group Technique (NGT; Gallagher et al, 1993) and the Delphi 
Technique (Jones and Hunter, 1995) were considered as alternative methods for 
this study as they both aim to provide one overall consensus of opinion (Fink et al, 
1984).  NGT uses a structured meeting to gather information from relevant experts 
about a given issue.  It consists of two rounds in which participants rate, discuss and 
then re-rate a series of items (Gallagher et al, 1993).  Delphi Technique involves the 
presentation of a questionnaire to relevant experts to seek their opinion on a 
particular issue, the questionnaires are then returned, the data are summarised and 
a new questionnaire is designed based on the responses. This second-round 
questionnaire is then returned to each participant showing the overall group 
response and the participant’s own response from round one. Participants are asked 
to reconsider their initial response considering the first round’s overall results. 
Repeat rounds of this process are carried out until consensus has been reached 
(Jones and Hunter, 1995).  This section explores the idea of consensus and whether 
it is truly achievable. 
The first issue is that are no firm rules for specifying acceptable levels of 
agreement and establishing when a consensus is reached.  With NGT the 
researcher facilitating the group is responsible for deciding when each step in the 
process has been adequately completed and deciding when agreement has been 
reached (Fink et al, 1984).  With consensus in NGT being at the discretion of the 
researcher it is therefore somewhat subjective and open to bias. 
Determining consensus in a Delphi study is also subject to interpretation.  
Consensus has been claimed to be reached at different degrees, for example 80% 
of participants’ votes fall within two categories on a seven-point scale (Ulschak, 
1983) or at least 70% of participants rate 3 or higher on a 4-point Likert-type scale 
(Green, 1982); or stability of participants’ responses in successive iterations 
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(Scheibe, Skutsch and Schofer, 1975).  It therefore appears that defining consensus 
itself is problematic. 
A further problem is whether consensus techniques are able to adequately 
represent the opinions of the population being studied or whether they are only able 
to provide the ‘bland generalities’ that represent the lowest common denominator of 
the debate (Rennie, 1981).  Jones and Hunter (1995) warn that the existence of 
consensus does not mean that the ‘correct’ answer has been found and there is a 
danger of deriving collective ignorance rather than wisdom.   
Instead of deriving one overall consensus, which can be criticised as an 
unrealistic average of beliefs, Q-methodology typically derives between one and five 
factors each representing groups or clusters of opinions or beliefs.  The factors 
produced from a Q-methodological study are orthogonal (they are independent and 
at 90° to one another).  Each factor therefore represents a different and independent 
understanding of the issue (Stainton Rogers, 1995).   
5.5.3 Consensus technique comparison 
One of the issues used to compare Q-methodology, NGT and Delphi was 
conformity bias.  This is the tendency to behave similarly to others in a group, even 
if doing so goes against your own judgement.  This was famously demonstrated in 
Asch’s (1955; 1958) conformity study, in which participants were seated in groups of 
8 to 10 other people, who they believed to be other participants, but were in fact 
confederates of the researcher.  The group were asked one at a time which of the 
lines in ‘Exhibit 2’ (Fig 5.3) were the same as the line in ‘Exhibit 1’ and the 
confederates all gave the same incorrect answer.  When the real participant was 
asked the question second to last in the group, 37 out of 50 (74%) participants 
conformed to the majority and chose the incorrect answer at least once.  It is of note 
that during debriefing after the experiment, the majority of participants said that they 
did not truly believe their conforming answers, but had agreed with the group for fear 
of being thought of as ‘peculiar’ (Asch, 1955; 1958). 
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Figure 5.2: Diagram presented to participants in Asch’s (1958) conformity study 
Reproduced with kind permission Copyright © 1955 Scientific American Inc. All rights reserved 
 
 
The Delphi technique claims to achieve consensus and has less chance of 
bias due to conformity than NGT.  However, Delphi is time-consuming, it eliminates 
personal contact, it creates the opportunity for moulding participant opinions and 
participants still feel a subtle obligation to conform to the rest of the group when 
group scores are included in each round; Delphi’s liabilities outweigh its assets 
(Sackman, 1975). 
NGT also claims to achieve consensus, it is the least time consuming of the 
three methodologies and involves personal contact with the participants.  However, 
NGT creates the potential for bias in the form of conformity to the group participants 
and the level of consensus is decided by the researchers.  Although NGT is 
preferable to Delphi, the consensus it reaches seems to eliminate the individual 
context from the research and therefore would not be the most appropriate method 
for this thesis. 
Q-methodology does have its faults; it is time consuming, limitations are 
placed on participants due to predetermined statements and the analysis is subject 
to the researcher’s interpretation.  However, the latter two arguments will be 
addressed (Section 5.5.5) and the time-consuming aspect is not a sufficient reason 
to dismiss a methodology.  Q-methodology provides participants with personal 
contact, anonymity, removes any bias due to conformity and will effectively retain 
the individual context obtained through the Study 1 interviews, whilst still providing 
an averaging of ideas (see Table 5.1 for a summary of this comparison).
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Table 5.1: Comparison of methods considered for Study 2 
 
Method Process Advantages Disadvantages Example Study 
Q-Methodology 
 (Brown, 1996; McKeown 
and Thomas, 1988) 
 Each participant ‘Q-sorts’ the 
statements across a forced 
distribution grid from ‘disagree’ to 
‘agree’ 
 Q-Sorts are entered and analysed 
using PCQ for Windows to produce 
correlations, by-person factor analysis 
and factor scores 
 Factors are then interpreted 
qualitatively using the statements, 
comments booklets and demographic 
and clinical data 
 Individual differences are retained 
 Anonymity of participants 
 Involves personal contact with 
participants 
 Participants complete the Q-sort 
individually,  therefore removing 
any chance of conformity bias 
 Time-Consuming 
 Participants are given statements 
to sort rather than generating 
them  themselves 
 Interpretation lies with the 
researcher, thus there is a risk of 
bias 
 Four different patterns of fatigue 
in rheumatoid arthritis patients: 
results of a Q-sort study 
(Nikolaus et al, 2010)  
Nominal Group Technique 
(Gallagher et al, 1993) 
 Individual participants rank items, 
followed by a group discussion of 
ranking followed by a second 
individual ranking 
 Importance / agreement scores are 
calculated across the group 
 Participants generate the ideas 
 Least time-consuming consensus 
method 
 Involves personal contact with 
participants 
 Anonymity of participants is not 
possible 
 Chance of conformity to the 
majority 
 Individual differences lost in one 
overall consensus 
 Level of consensus is decided  by 
the researchers 
 Utilizing qualitative data from 
nominal groups: Exploring the 
influences on treatment 
outcome prioritization with 
rheumatoid arthritis patients 
(Sanderson et al, 2012) 
Delphi Technique 
 (Jones and Hunter, 1995) 
 Two or more rounds of postal 
questionnaires are sent to participants 
to ascertain level of agreement / 
importance on items 
 Group results and the individuals 
results are returned to participants so 
others’ opinions can be taken into 
account 
 Participants generate the ideas 
 Systematic process which allows 
for change in opinion 
 Anonymity of participants is 
possible 
 
 Time consuming (minimum 
administration time 45 days, 
Delbecq et al, 1994) 
 Eliminates personal contact with 
participants 
 Chance of conformity to the 
majority 
 Individual differences lost in one 
overall consensus 
 Identifying core domains to 
assess flare in rheumatoid 
arthritis: an OMERACT 
international patient and 
provider combined Delphi 
consensus  
(Bartlett et al, 2012) 
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5.5.4 Q-Methodology 
Q-methodology involves participants sorting a set of statements into the 
order of their agreement.  They are sorted across a normal distribution grid, thus 
allowing a small number of statements into the high and low agreement spaces and 
forcing the majority of the statements into a neutral stance.  Q-methodology was 
invented in 1935 by William Stephenson, evolving from factor analytic theory 
(Brown, 1996; 1997).  Stephenson believed that life as lived from the standpoint of 
the person living it, is typically passed over by quantitative research methods and 
therefore was interested in providing a way to reveal the subjectivity involved in any 
situation (Brown, 1996).  Q-methodology combines the strengths of both qualitative 
and quantitative research (Dennis and Goldberg, 1996), providing a bridge between 
the two paradigms (Sell and Brown, 1984).  Q-methodology involves 3 stages; 
developing a set of statements to be sorted; participants sorting the statements 
along a continuum of preference; and analysing and interpreting the data (Brown, 
1993).   
The set of opinion statements for use in Q-methodology are most typically 
collected through personal interviews and focus groups.  In addition, sources such 
as journal articles or any other sources relevant to the issue may be used; this 
collection of items is called the ‘concourse’ (Brown, 1993).  From the concourse a 
subset of statements is selected to form the Q-sample (the group of statements to 
be rank-ordered by the participants).  The concourse should be sampled 
systematically and the sample statements should be tested in one or more pilot 
studies to ensure content validity (Valenta and Wigger, 1997).   
Once the statements are finalised, participants are asked to rank-order 
statements (agree to disagree), which is known as ‘Q-sorting’.  The statements are 
opinion only, not fact; Q-methodology assumes that opinions are subjective and can 
be shared, measured and compared (McKeown and Thomas, 1988; Stainton 
Rogers, 1995).  The sorting matrix (Fig 5.2) provided for participants in Q-
methodology forces the Q-sort into the shape of a quasi-normal distribution.  There 
are fewer statements that can be placed at the extreme ends and more that are 
allowed to go into the middle area (the middle area represents almost neutral 
reaction).  The symmetry and predetermined numbers of statements in each 
category facilitate the quantitative methods of correlation and factor analysis 
(McKeown and Thomas, 1988). 
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LIVING WITH RA DAY BY DAY MEANS..... 
 
Least Agree                                               Most Agree 
 
-5 -4 -3 -2 -1 0 1 2 3 4 5 
                      
                      
                    
                  
              
              
     
  
     
 
 
Figure 5.3: An example of the sorting matrix/grid used in Q-Methodology  
Nb: This example shows a grid for 39 statements (as used for the Daily Life Q-sort in Study 2) 
 
 
In Q-methodology, data analysis uses correlation and by-person factor 
analysis, meaning that statistical analysis is not performed by variable, trait or 
statement, but by person.  People correlate with others with similar opinions based 
on their Q-sorts.  Q-methodology therefore results in the grouping of expressed 
opinion profiles based on the similarities and differences in which the statements are 
arranged by each participant (McKeown and Thomas, 1988). 
Q-methodology has its roots in educational psychology (Stephenson, 1935), 
although it is now most widely used in health psychology (Stainton Rogers, 1991).  
To date it has been used in a wide variety of research fields including; chronic pain 
(Eccleston et al, 1997); irritable bowel syndrome (Stenner, Dancey and Watts, 
2000); self-harm (James and Warner, 2005); smoking behaviours (Collins, Maguire 
and O’dell, 2002); quality of life (Stenner et al, 2003); partnership love (Watts and 
Stenner, 2005a); and feminism (Kitzinger, 1999; Senn, 1993).  Q-methodology has 
been described as a ‘fun instrument’ in which the participants enjoy moving the 
statements until they are fully satisfied (Prasad, 2001).   
5.5.5 Limitations of Q-methodology 
Unlike NGT and the Delphi technique where participants themselves 
generate the ideas to be sorted, in Q-methodology predetermined statements are 
used, therefore placing limitations on participants (Cross, 2005).  However, the 
statements are generated by sampling the concourse (including items generated in 
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either individual or group interviews) then the statements are sifted, ordered and 
condensed, and should therefore provide a representative pool of opinions for 
participants to sort (Stainton Rogers, 1995).  In Study 2 the majority of the 
statements were produced from individual interviews, which were conducted until 
data saturation was reached, along with statements identified through a literature 
review.  The Q-set was also trialled with a patient partner, rheumatology 
professionals and the researcher’s supervisory team until the researcher was 
satisfied.  To further confirm the validity of the study, participants can be asked to 
report any statements they feel are missing from the Q-set.  Whilst additional 
statements cannot be included in the Q-set as it would disturb the normal 
distribution, this information can demonstrate how accurately the Q-set captures the 
opinions of the participants (Stainton Rogers, 2009).  Participants were invited to do 
this in Study 2. 
Q-methodology can also be criticised due to the risk of bias at the 
interpretation stage, as this task lies with the researcher (Pope, Ziebland and Mays, 
2000); how the researcher interprets the factors may be influenced by their personal 
stance, for example their professional background (Stainton Rogers, 1995).  
However, strategies to protect the rigour include; creating an account of method and 
data which can stand independently so that another trained researcher could 
analyse the same data in the same way and come to essentially the same 
conclusions; more than one researcher from different disciplines analysing the data; 
and being constantly reflexive about the entire research process (Mays and Pope, 
2000).  These strategies have all been used in Study 2. 
A further criticism of the reliability of Q-methodology is that when it is 
repeated on the same participant it does not necessarily yield the same results 
(Cross, 2005).  However, Brown (1980) maintained that Q-methodology can be 
replicated with 85% consistency even up to a year later.  Either way, there is no 
expectation that participants will express the same view on two separate occasions 
as it is the idea being captured, not the person (Stainton Rogers, 1991).   
5.5.6 Identification and sampling 
Ethics approval was granted by the South West 4 REC (10/H0102/77). 
Patients were invited to participate if they had had a confirmed diagnosis of RA 
(Arnett et al, 1988) for a minimum of two years, and who had experienced a flare 
during their disease trajectory.  Patients were purposively sampled to reflect a range 
of age, gender, disease duration, disability and drug treatment.  Patients were 
identified as relevant to the study by a member of their care team when they 
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attended a clinic appointment at the BRI, UHBT, Cossham Hospital, NBT and St 
Peter’s Hospital, Ashford and St Peter’s Hospital Trust (ASPH) and then introduced 
to the researcher.  The researcher then explained the research to the patient and 
gave them a patient information sheet with a reply slip to take away with them 
(Appendices F1 and F2).  The researcher phoned all patients who returned the reply 
slip to arrange a mutually convenient date to take part in the study. 
5.5.7 Q-methodology process 
5.5.7.1 Developing the set of statements (Q-set) 
The statements were developed from the Study 1 interviews.  The transcripts 
were thoroughly read and each new idea was recorded as a statement for the Q-
sort.  Two lists were created, one relating to daily life with RA and the other to RA 
flare help-seeking behaviours.   Three of the flare help-seeking statements in the 
final draft of items came from a literature review rather than the interviews (Chapter 
8.3), to ensure that all the ideas forming the concourse were represented in the Q-
sort.  Whilst every attempt was made to retain the Study 1 participants’ original 
wording, this was not always possible to ensure that the items would be understood 
by all Study 2 participants.  The items were reworded to form a statement which 
finished either the sentence ‘Living with RA day by days means...’ for the daily life 
Q-sort; or “When I am in an RA Flare...” for the flare help-seeking  Q-sort.   
The drafts were then shared with the full supervisory team including PRP 
(PR) and refined to ensure that the statements were comprehensible, would not 
cause any emotional distress and sufficiently sampled the concourse.  Further, any 
duplicate items or items that had the polar opposite meaning of items that were 
retained, were removed because participants can sort each statement positively or 
negatively and therefore the opposing viewpoint is not necessary.  The final items 
for the daily life and flare help-seeking Q-sorts were printed onto cards, the size of 
an individual space on the sorting grid, and laminated.  The Q-sorting grids were 
printed onto A1 size laminated posters (Appendices G1 and G2).  Velcro was 
attached to both the cards and the posters to ensure patients were able to pick up 
the cards easily and so that once the cards were attached to the posters they could 
not be dislodged. 
5.5.7.2 Participant numbers (P-set) 
Large numbers of participants are not required for an effective Q-study 
because in Q-methodology participants are the variables and the number of 
variables employed in a single research study is invariably limited (Watts and 
Stenner, 2012).  In R-methodology (conventional factor analysis), a minimum ratio of 
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two participants to every study variable is suggested (Kline, 1994) and it has been 
argued that this ratio is inverted for Q-studies, suggesting a minimum of two Q-set 
items to every participant (Kline, 1994).  However, in practice this could be 
problematic as a small Q-set could lead to the P-set being too small to encompass 
the range of beliefs held (Watts and Stenner, 2012) for example one Q-study (Watts 
and Stenner, 2005b) used a 60-item Q-set and 50 participants. Whilst 40 to 60 
participants have been recommended for a Q-study (Stainton Rogers, 1995), 
Stephenson (1953) proposed that good quality studies and analyses could be 
conducted with as few as a single participant.  
5.5.7.3 Sorting the statements 
Patients were given the option of taking part in the study at their own home 
or in the hospital.  All patients who completed the Q-sorts at UHBT and some 
patients who completed the Q-sorts at ASPH were provided with non-clinical rooms.  
Due to lack of space, patients who took part in the study at NBT and the remaining 
patients from ASPH carried out the Q-Sorts in one of the consulting rooms.  The 
researcher made attempts to reduce the power imbalance as described in section 
5.4.4. 
Although Q-methodology does not usually require one-to-one attention from 
the researcher, it was decided that with an RA population one-to-one attention 
would ensure that the researcher was able to help patients who may not have the 
dexterity and reach of a healthy population.  The researcher explained to each 
patient that she is a PhD student and is therefore non-medical.  This was intended 
to allow patients to separate the researcher from the clinical setting.  Participants 
gave informed consent (Appendix H) and completed the same pre-interview 
questionnaire as in Study 1 (Appendices C1 and C2). 
First participants were asked to do the daily life Q-sort.  They were given all 
of the statements and asked to sort them into piles of “Agree”, “Disagree” and 
“Neutral”.  Participants were then asked to take their “Agree” pile and place these in 
order of agreement onto the grid.  They were then asked to do the same with the 
“Disagree” pile and finally the “Neutral” pile.  Participants were offered rubber 
thimbles to assist with their grip and for the researcher to place any statements that 
the participants felt unable to reach.   
Participants were then given the opportunity to review and alter their Q-sort.  
Once they were happy with their selection the researcher asked them to comment 
on the reasons they had chosen the 3 statements at each extreme end of the grid, 
and any thoughts and feelings they had about those statements.  Participants were 
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then free to comment on any other statements that they wished to.  Participants 
were also asked whether they thought any statements were missing from their 
options.  The researcher recorded these comments in a comments booklet (Results: 
Chapter 8.2).  The researcher then recorded the numbers from the back of the 
statements onto the corresponding spaces on an A4 scale version of the Q-sort grid.  
Following the daily life Q-sort participants were asked to repeat the process with the 
flare help-seeking Q-sort.  The entire study process lasted no longer than one hour.  
The results were then anonymised, allocating each participant a reference number. 
5.5.8 Patient research partner involvement 
The draft statements used in the Q-sort were reviewed by the PRPs for 
content and comprehension.  Through the advice of PRPs some statements were 
re-worded for being either too complex or too negative.  PRPs were also consulted 
about the practical implications of conducting a Q-methodology study with an RA 
population, which resulted in the statement cards being laminated and rubber 
thimbles being made available to participants.  The Q-sort was piloted with PRPs to 
ensure that statements could be placed on the grid without them over-stretching and 
that patients would have enough strength in their hands to detach the statements 
from the grid. 
5.5.9 Q-methodology analysis 
Q-methodology has been termed a quasi-quantitative or quali-quantological 
method (Stenner and Stainton-Rogers, 2004), both of which aim to explain the 
hybrid nature of the method in which qualitative and quantitative methods are 
combined to produced a rounded interpretation of the data, rather than a mixed 
methods approach (section 5.2) in which individual qualitative and quantitative 
studies are carried out within the same research project. Thus the Q-methodology 
analysis process involves factor extraction, factor rotation, and factor interpretation. 
5.5.9.1 Factor extraction and rotation 
All the Q-sorts that have been gathered in the Q-study overall, i.e. all the 
viewpoints that the participants have expressed, represent 100% of the meaning 
and variability present in the study, which is known as the study variance (Watts and 
Stenner, 2012).  The function of factor analysis is to account for as much of the 
study variance as possible i.e. to explain as much as possible about the 
relationships that exist between the many Q-sorts in the group, through the 
identification of any sizeable portions of shared meaning that are present in the 
data.  These shared meanings are the factors, which will be considerably less than 
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the number of Q-sorts in the study, hence factor analysis is known as a data 
reduction technique (Watts and Stenner, 2012). 
In Study 2 centroid factor analysis has been used, which is the oldest factor 
extraction technique and is highly regarded by Q-methodologists due to its 
computational ease and simplicity (Brown, 1980).  It is recommended for novice Q-
researchers (Watts and Stenner, 2012) and it is the only method of factor analysis 
currently offered by Q-methodology computer software programmes (PQMethod: 
Schmolck, 2012; PCQ for Windows: Stricklin and Alemida, 2001).   
Centroid analysis involves first deciding on how many factors to extract 
(Section 5.5.9.2).  The PCQ for Windows software then searches for a first shared 
pattern (or sorting configuration) in the data and thus extracts the first portion of 
common variance (Factor 1).  The factor loading provides information on the extent 
to which each individual Q-sort can be said to exemplify, or is typical of the pattern 
produced by Factor 1.  The software then searches for the second portion of 
common variance (Factor 2) and so on.  In factor analysis, the first factor extracted 
will usually account for the largest amount of study variance (Watts and Stenner, 
2012). 
Eigenvalues (EVs) and variance provide further information, with these 
relating to each factor rather than each Q-sort.  A factor’s EV is calculated by 
summing the squared loadings of all the Q-sorts on the particular factor.  The 
following calculation is used by the software package to determine each factor’s EV, 
where Q-sort N is indicative of the total number, or final Q-sort in the study (Brown, 
1980: 222): 
EV for Factor 1 = (Q-sort 1 loading on Factor 1)² + (Q-sort 2 loading on 
Factor 1)² + (Q-sort 3 loading on Factor 1)² + ... (Q-sort N loading on Factor 1)² 
A factor’s variance is then derived from its EV using the following equation 
(Brown, 1980: 222): 
Variance for Factor 1 = 100 x (EV ÷ no. Of Q-sorts in study) 
The final set of factors should account for as much of the study variance as 
possible (Brown, 1980) and thus high factor EVs and variance are desirable (Watts 
and Stenner, 2012). 
Following factor extraction, the factors were rotated using orthogonal 
varimax rotation.  The purpose of this is to ensure that each Q-sort defines (has a 
high factor loading in relation to) only one of the study factors.  Thus the factors are 
positioned so that the overall solution maximises the amount of study variance 
explained.  Varimax rotation is easy to use, effective with larger data sets, objective 
and reliable (Watts and Stenner, 2012). 
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5.5.9.2 Deciding how many factors to extract 
The reasons for the number of factors extracted specifically for each of the 
two Q-sort studies in Study 2 will be described in the results (Chapter 8.4.2).  This 
section provides an explanation of two theories that exist for this decision-making 
process, which have each influenced the decisions made in Study 2.  
The Kaiser-Guttman criteria (Guttman, 1954; Kaiser, 1960) states that the 
cut-off point for extraction of factors should be those with EVs less than 1.00, this is 
because an extracted factor with an EV of less than 1.00 accounts for less variance 
than a single Q-sort (Watts and Stenner, 2005b).  However, whilst being an effective 
cut-off point for rejecting factors, if used as a criterion to retain factors this often 
results in an overly large number of factors (Kline, 1994; Wilson and Cooper, 2008). 
In contrast, Brown’s (1980) ‘magic number seven’ criterion (Brown, 1980) 
suggested that seven factors is the default number for extraction and that this is the 
point to start from.  However, more recently Watts and Stenner (2012) have 
proposed that whilst the objective criteria of both the Kaiser-Guttman technique and 
magic number seven should still be taken into consideration, the decision should 
rely more on the feel of the data and the researcher’s experience.  They suggest 
starting with extracting one factor for every 6 to 8 participants, but emphasise that 
this is based not on an objective criteria, but on their own experience (Watts and 
Stenner, 2012). 
5.5.9.3 Z scores and factor exemplifying Q-sorts 
Once the factors have been extracted the total weighted scores for each item 
are produced, showing which items each factor have ranked as most positively or 
most negatively.  However, these weighted scores do not allow for cross-factor 
comparisons due to different numbers of Q-sorts contributing to the total in each 
factor (Watts and Stenner, 2012).  In order to facilitate cross-factor comparisons, the 
total scores are converted into z (or standard) scores.  The following calculation is 
used by the software package to determine each factor’s z score: 
Z score for Statement 1 (in relation to Factor 1) = (Total weighted score for 
Statement 1 – Mean of total weighted scores for all items) ÷ SD of total weighted 
scores for all items 
The z scores for each statement are then converted into a single factor 
exemplifying Q-sort, which is a single Q-sort configured to represent the viewpoint of 
a particular factor.  The factor exemplifying Q-sort always conforms to the same 
distribution used in the original data collection (e.g. Fig 5.3) and is constructed with 
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reference to the size and rank order of the z scores, thus the item with the highest z-
score would be placed in the +5 position on the exemplifying Q-sort. 
5.5.9.4 Factor interpretation 
Once the exemplifying Q-sorts were created, they needed to be interpreted 
for meaning.  The holistic nature of Q-methodology has been emphasised in terms 
of interpretation (Stephenson, 1936) and the aim is to combine individual items in 
the identified factor to create one gestalt (holistic) explanation (Watts and Stenner, 
2012).  Previously, there has been no guidance for how to conduct this interpretation 
(Brown, 1980), but the researcher was personally advised by Dr Simon Watts to use 
a crib sheet and abductive logic, followed by the use of demographic data and 
patients’ comments to aid interpretation (since published: Watts and Stenner, 2012):    
The Crib sheet: This is a way of organising the data and ensuring that no 
important issues are overlooked.  It also provides a wider system of organisation for 
the interpretative process and encourages holism by comparing every item in a 
factor.  The crib sheet, or table of by-factor rankings presents the relative rankings 
for each statement given by each factor (Results Tables 8.5 and 8.15).  The 
researcher highlighted all of the items that ranked either higher or lower in one factor 
in comparison to the other factors.  This enables the issues about which one factor 
viewpoint is polarised to be identified and shows how that viewpoint is polarised 
relative to other factors.  The aim is not to isolate individual items, but to identify the 
items that make the most important contributions to the viewpoint displayed by the 
particular factor. 
It is important not to immediately discount items that have been scored in the 
neutral zero position.  A previous Q-study (Watts and Stenner, 2005b), which 
focused on the punishment of youth offending, identified that whilst one factor 
scored the statement “parents of young offenders should be punished for their 
child’s crime” at zero, the remaining factors scored the same statement negatively.  
Thus the authors claimed that the opinion of the factor scoring the statement at zero 
was cautious agreement with the statement, which was supported by participants’ 
comments.  In Study 2, this inclusive nature of analysis has been employed, with all 
statements and factor scores interpreted where possible. 
Abductive logic: This element of the interpretative technique requires the 
researcher to consider the ranking of each statement by asking: why is it ranked 
where it is?; what does it mean?; what is it trying to tell me?  This creates a 
preliminary hypothesis, which can be considered to see whether it is sustained or 
disproved by the ranking of other items, participant comments or demographic data.  
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Thus the researcher’s attention continually moves between the individual items and 
the overall viewpoint.  Each statement is considered in terms of whether it confirms 
or changes the current understanding of the viewpoint and in this way the 
researcher continually confirms or adjusts the understanding of each factor 
viewpoint.  The researcher attempted to apply abductive logic to the interpretation of 
Study 2. 
Demographic data and comments booklet: It is advised (Watts and Stenner, 
2012) that these are related to the factors after interpretation to ensure that each 
factor is approached on its own terms, without being influenced by pre-conceived 
ideas that the researcher may hold.  The demographic data and participants’ 
comments can therefore confirm ideas arising from the factor interpretations and 
provide clarity and insight into who holds the beliefs represented by the factor.  The 
interpretation was carried out in this order for Study 2. 
Bi-polar factors: These are defined by having both positively and negatively 
loading Q-sorts.  An explanation of the negative viewpoint is achieved through 
interpretation of the exemplifying Q-sort that is the direct opposite of the 
exemplifying Q-sort created for the positive viewpoint.  Thus a statement ranked at 
+4 by the positive viewpoint would be ranked as -4 by the negative viewpoint or a 
statement ranked as -2 by the positive viewpoint would be ranked as +2 by the 
negative viewpoint.  This reversal of the factor exemplifying Q-sort is performed 
manually and the negative factor exemplifying Q-sort is then subjected to 
interpretation in its own right (Watts and Stenner, 2012).  This was necessary in 
Study 2 as one of the daily life Q-study factors was bi-polar (Results: Table 8.9 
shows the positive exemplifying Q-sort and Table 8.10 shows the negative 
exemplifying Q-sort).  Further, one of the daily life factors and one of the flare help-
seeking factors had only negative loadings, thus this manual reversal was used to 
produce their factor exemplifying Q-sorts (Results: Tables 8.12 and 8.19). 
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5.6 Understanding daily life and flare help-seeking (Exploratory and 
feasibility survey) 
5.6.1 Aims and objectives for Study 3 
The aims of Study 3 were: 
1. To explore the range, variation and level of patients’ symptoms over time 
2. To explore patients’ tipping points for seeking help 
3. To explore the feasibility of collecting daily data 
4. To explore the feasibility of collecting data from patients in a flare 
Thus the objectives of Study 3 were: 
1. To assess the recruitment and attrition rates 
2. To assess the acceptability of the questions and the rate of completion 
3. To assess the effect of missing data and how to handle this 
4. To provide pilot data on the range and variation of experiences over time 
5.6.2 Methods for Study 3: Daily life and flare help-seeking survey 
To establish the range and variation of patients’ symptoms over time 
symptoms were measured using a variety of patient reported outcome measures 
(PROMs).  To contextualise this daily data, weekly measures of impact and self-
management were used.  The symptoms and issues to be measured were 
developed from Studies 1 and 2 and where possible validated PROMs were used 
(Chapter 9: Tables 9.1 and 9.2).  Daily assessments were chosen to capture 
fluctuations in symptoms between individual days and to reduce retrospective bias.  
However, although data were collected daily, they were not real-time assessments 
of patients’ symptoms, but immediate retrospective measures in which patients 
rated their symptoms at the end of each day. 
Once a day assessments were chosen to reduce the burden on participants 
of having to complete PROMs more than once a day for three months.  However, it 
is noted that a study comparing the real-time and retrospective reported pain of 
people that had undergone painful medical treatment (Redelmeier and Kahneman, 
1996) found that retrospective reports of pain focus on either the peak pain (intensity 
of pain at the worst moment) or the end pain (intensity of pain at the final moment).  
Thus it is possible that these assessments could be capturing patients’ worst point 
throughout the day, or the way their symptoms are at the point of completing the 
PROMs. 
As symptoms were being measured for only three months, the researcher 
was concerned that this would not capture patients in an RA flare and thus flare 
symptoms may not be addressed.  Further, the daily assessments would not provide 
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information on patients’ decision-making processes for seeking help due to an RA 
flare.  Thus a second survey was developed using items from Studies 1 and 2 and 
with validated PROMs where possible (Chapter 9: Table 9.3) to target patients who 
contacted the rheumatology helpline in an RA flare. 
5.6.3 Identification and sampling of patients 
Ethics approval was granted by the South West 5 REC (11/SW/0103). 
Different recruitment criteria were used for Studies 3a and 3b.   
5.6.3.1 Study 3a: Daily life: Identification and sampling 
Patients were invited to participate if they had had a confirmed diagnosis of 
RA (Arnett et al, 1988) for a minimum of two years, and if they had experienced a 
flare during their disease trajectory.  Patients were purposely sampled to reflect a 
range of age, gender, disease duration, disability and drug treatment.  Patients were 
identified as relevant to the study by a member of their care team when they 
attended a clinic appointment at the BRI, UHBT, Cossham Hospital, NBT and St 
Peter’s Hospital, ASPH and were then introduced to the researcher.  The researcher 
then explained the research to the patient and gave them a patient information sheet 
including a sample of the daily measures, with a reply slip to take away with them 
(Appendix I1 and I2).  The researcher phoned all patients who returned the reply slip 
to arrange a mutually convenient date to begin completing the daily PROMs. 
5.6.3.2 Study 3b: Flare help-seeking survey: Identification and sampling 
Patients were invited to participate if they had a confirmed diagnosis of RA 
(Arnett et al, 1988) and had contacted the UHBT or ASPH rheumatology helpline 
(on which patients leave a message and a rheumatology specialist nurse calls them 
back) in a self-defined RA flare to seek help.  Patients were identified as relevant to 
the study by the nurse who returned the patient’s phone call.  The nurse asked the 
patient if they would be willing to be contacted by a researcher about their 
motivations for seeking help for their flare.  The contact details of patients who 
agreed were then passed to the researcher, who phoned the patient to further 
explain the study and arrange to meet them prior to their clinic appointment for their 
RA flare.   The researcher put a patient information sheet in the post to patients who 
had agreed to meet her prior to their clinical appointment (Appendix J).  Thus 
patients were able to opt out of the study prior to meeting the researcher. 
5.6.4 Study 3a: Daily life process 
A daily life questionnaire comprising 8 items relating to patients’ symptoms 
(Appendix K1) and a weekly questionnaire comprising 12 questions related to 
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patients’ self-management techniques and the impact of RA (Appendix K2) were 
developed by the researcher (based on Study 2: Section 5.6.2).  Patients who 
agreed to take part were contacted by phone to arrange a date to begin completing 
the questionnaires and given the option of completing with pen and paper, online or 
for the researcher to phone them daily for their responses. 
The paper versions of the daily questionnaires were printed on coloured 
paper, stapled into ‘one week’ packs, with the weekly self-management 
questionnaire at the end of the pack.  Different coloured paper was used for each 
week to provide diversity and retain patients’ interest.  The online versions were 
created using Qualtrics (Qualtrics Labs Inc, 2012), which enabled the PROMs to be 
easily replicated online.  Participants had their own secure link to complete the 
questionnaire, which was designated as invitation-only, which removed any chance 
of a non-participant finding and completing the questionnaire online.  Further, the 
online version of the questionnaire was secure, with only the researcher having 
access to all participants’ responses.  
Patients gave informed consent (Appendix L) at their respective hospitals 
and were sent the same pre-study questionnaire that was used in Studies 1 and 2 
(Appendices C1 and C2), this questionnaire was not made available online.  Then 
patients who chose the pen and paper option were sent one month’s worth of 
questionnaire packs with one return envelope for every week of data entry.  Patients 
who chose the online option were sent their own personal link to the online 
questionnaire with instructions of how to complete and their own personal reference 
number.  No patients chose the telephone option. 
It was explained to participants that if they forgot to complete the 
questionnaire for a day it would be better to leave it blank than to complete in 
retrospect.  Further, patients were reassured to continue with the rest of the study, 
even if they missed a day.  When there was a delay in the questionnaires being 
returned or online data were incomplete, the researcher contacted the participant to 
discuss any problems and to encourage them to continue with the study. 
After each month of data collection all patients were sent a hand-written 
note-card thanking them for their participation in the study so far and encouraging 
them to continue.  Patients who chose the pen and paper option were also sent their 
next month of questionnaire packs at this point.  Patients who remained in the study 
over the Christmas period were also sent a Christmas card, which thanked them for 
continuing with the study at that time.  At the end of the three month data collection 
period, patients were contacted to advise that the study had ended and to thank 
them for their time. 
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5.6.5 Study 3b: Flare help-seeking survey process 
To establish the level of patients' symptoms when they are in a self-reported 
flare and their motivations for seeking help, a Study 3b pack of questionnaires 
(Appendices M1-3) were developed by the researcher.  This comprised the same 
daily questionnaire given to patients in Study 3a; a flare help-seeking questionnaire, 
comprising PROMs relating to the impact of RA on patients’ lives, their self-
management and tipping points for seeking help.  The specific domains to be 
measured in the flare help-seeking questionnaire were developed from Studies 1 
and 2 and where possible validated PROMs were used (Chapter 9: Table 9.3); and 
a flare early warning signs questionnaire, comprising 11 items relating to early 
warning signs of a flare (Bartlett et al, 2012).  The individual questionnaires were 
printed on different coloured paper to distinguish them and stapled together in one 
questionnaire pack. 
Patients who agreed to take part were met in clinic prior to their urgent 
appointment.  Patients gave informed consent (Appendix N), completed the pre-
study questionnaire used in Studies 1, 2, and 3a (Appendix C) and then completed 
the flare help-seeking questionnaire pack (Appendices M1-3).  Four weeks after 
their clinic appointment, when it was anticipated that patients would no longer be in 
a flare, they were sent the daily measures questionnaire to complete again with a 
pre-paid envelope to return it, enabling symptom comparison between Time 1: in 
flare and Time 2: not in flare.  Participants’ data were anonymised with their own 
personal reference number. 
5.6.6 Patient partner involvement 
The questionnaires used in both Study 3a and 3b were reviewed by a PRP 
(PR) to assess them for content and comprehension.  The burden of completing 
measures daily was discussed with this PRP, and a maximum of one A4 page of 
questions to complete daily was thought reasonable.  The options for completing the 
daily measures were also discussed with this PRP and a range of response method 
options were provided to participants based on this discussion. 
5.6.7 Data analysis  
Study 3 was an exploratory and feasibility study and was not powered for 
statistical significance.  The data were therefore analysed for descriptive statistics: 
mean; standard deviation; range; frequency.  The daily questionnaire data from 
Study 3 were also visually analysed to identify patterns.  The researcher created 
individual graphs of each patient’s symptoms in order to visually identify patterns or 
similarities between patients’ experiences of RA.  Patients were clustered together 
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in groups according to whether they had experienced a flare or not during the data 
collection period and patterns within these groups were identified.  
5.7 Summary 
Three studies have been designed to qualitatively explore patients’ 
experiences of daily life and flare with RA and how they self-manage these, to 
identify clusters of experiences and to quantitatively address patients’ variation and 
fluctuation of symptoms.  The results of these studies will be presented in Chapters 
6 to 9. 
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Chapter 6: Study 1: Understanding the patient perspective 
(Interviews) 
This chapter presents the results for Study 1, in which the patient 
perspective of daily life, flare and self-management have been explored through 
semi-structured interviews.  
6.1 Summary of background information 
Rheumatoid Arthritis (RA) is a systemic, inflammatory condition causing 
synovitis and pain in multiple joints, which can result in permanent disability.  RA is 
also accompanied by fatigue, which is an invisible yet debilitating symptom.  The 
fluctuation and uncertainty of RA and a non-compliant body can impact on patients’ 
abilities to continue doing activities that they consider necessary or pleasurable.  
However, current research does not address how patients experience RA, in terms 
of either symptoms or impact, since the use of modern more intensive treatment 
regimes. 
RA is characterised by disease flares, which often prompt patients’ decisions 
to seek medical help.  However, there is currently no agreed definition of flare, with 
clinicians and patients prioritising different outcomes.  It is also unknown how 
patients distinguish a flare from daily symptom fluctuation and at what point a ‘bad 
day’ becomes a flare. 
There is a range of self-management and coping strategies recommended to 
patients to minimise the impact that RA has on their lives.  However, there is 
currently a lack of research that addresses which strategies patients use, how bad 
their symptoms have to be before they use these techniques and how long they self-
manage and/or cope for before seeking medical help for an RA flare. 
6.2 Objectives for Study 1 
1. To investigate patients’ perceptions of the range and characteristics of daily 
symptoms, normal variation, episodic patterns of disease activity and flare 
2. To investigate clustering of symptoms and early warning signs of flare 
3. To investigate how symptoms are managed and how the decision to seek 
help is reached 
4. To explore a visual representation of disease patterns 
6.3 Summary of Study 1 methods 
One to one semi-structured interviews were conducted with 15 RA patients, 
who had been diagnosed for at two least years.  Prior to the interviews patients were 
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asked to complete a questionnaire (Appendix C) comprising demographic questions 
and the Health Assessment Questionnaire (Fries et al, 1980).  Inductive Thematic 
Analysis (Braun and Clarke, 2006) was used to analyse the data from the 
interviews.  At the end of each interview patients were asked to complete two blank 
graphs, one to describe how their symptoms fluctuate in daily life (Appendix D1) and 
the other to show how their symptoms behave during an RA flare (Appendix D2).  
Patients have been given pseudonyms to protect their anonymity.  For the full study 
methods and interview topic guide see Chapter 5.4 and Fig 5.1. 
6.4 Results 
6.4.1 Participants 
65 people with RA from UHBT and NBT were invited to participate and 15 
(23%) agreed to take part.  Reasons for declining to take part included being busy 
with other commitments and having recently taken part in another research study.  
Data saturation was reached by interview 13.  The majority of the participants were 
female and ages ranged from 35 to 77 years (mean: 51.13yrs; SD: 11.78) (Table 
6.1).  Patients were on a range of treatment regimes and had a disease duration of 
3 to 30 years (mean: 14.8yrs; SD: 8.57), and a wide range of self-reported disease 
activity (DAS global) and disability (HAQ).  Three participants considered they were 
in a flare at the time of their interview.  Three men were successfully recruited, 
although they all came from the same NHS trust and had a small age range (47 to 
56 yrs: Mean = 50.3yrs).  Whilst three men agreed to participate, others expressed a 
reluctance to take part in an interview study.  A fourth man did agree to participate, 
but cancelled the appointment twice at short notice due to other commitments, after 
which he could not be contacted again.  All the patients in this study were White 
British in ethnic origin.  Patients from other ethnic groups were approached during 
recruitment, but declined to take part with the most frequent reason being either the 
language barrier or that they felt they would get too emotional when talking about 
their RA.  This may not be due to their ethnic origin; it could be that these particular 
patients were still reasonably early in their disease trajectory (data not 
systematically collected). 
                               Table 6.1 continued overleaf 
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Table 6.1: Study 1: Individual interviewees’ demographic and disease-related data (n=15) 
 
Patient ID Gender Age (Yr) Dis Dur (Yrs) HAQ Pt Global Current 
medication 
NHS  Trust*  In 
Flare? 
Work status Help at home Dependents 
Amelia Female 67 9 2.38 7.8 DMARDs 1 Yes Retired Husband None 
Charlotte Female 37 19 0.63 2.4 DMARDs 
NSAIDs 
2 No Employed None None 
Chloe Female 42 17 1.75 4.8 DMARDs 
Steroids 
1 No House-wife Husband 2 children 
Debbie Female 44 23 2.75 3.8 Anti-TNF 
DMARDs 
NSAIDs 
2 No House-wife Parents (not living with) 3 children 
Emma Female 42 20 1.00 3.3 DMARDs 2 No Employed None None 
Isabelle Female 45 25 2.38 4.0 NSAIDs 1 No Incapacity None None 
James Male 47 5 0.00 0.9 DMARDs 1 No Employed Wife 1 child 
Jane Female 65 16 2.75 2.8 Anti-TNF 
NSAIDs 
2 No Retired Husband None 
Kate Female 35 4 1.50 1.7 DMARDs 2 Yes Employed None None 
Linda Female 52 23 1.88 1.9 DMARDs 
NSAIDs 
2 No Employed Husband None 
Liz Female 59 3 0.88 3.1 DMARDs 1 No Retired Husband** Husband** 
Mary Female 77 30 Incomplete 4.6 Anti-TNF 
DMARDs 
2 No Retired Husband** Husband** 
Michael Male 48 10 0.25 3.0 Anti-TNF 
DMARDs 
Steroids 
1 No Employed Wife Wife*** 
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*Nb: NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
**Nb: These patients both care for and depend on their spouse 
***Nb: In contrast to the other patients who listed their spouse as a dependent, Michael considers his wife as a dependent as she relies on him for financial support rather than care 
 
Key: 
Dis dur = Disease duration 
HAQ = Health Assessment Score 0 – 3 (3 is most disabled) 
Pt Global = Disease activity score patient global measure (0 = doing very well, 10 = doing very badly 
Medication:          Anti-TNF = Anti-tumour necrosis factor;  DMARDs = Disease modifying anti-rheumatic drugs; NSAIDs = Non-steroidal anti-inflammatory drugs; Steroids = Glucocortico steroids 
Roger Male 56 13 0.25 3.5 Anti-TNF 
DMARDs 
1 Yes Employed Wife 1 child 
Sophie Female 51 5 0.13 1.1 DMARDs 1 No Employed Husband None 
Mean  51.1 14.8 1.30 3.3       
Stan Dev  11.8 8.6 1.00 1.7       
Range  42 27 2.75 6.9       
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The results from the pre-interview questionnaire indicate a diverse sample of 
participants (Table 6.1).  The majority of participants were employed rather than 
retired or on incapacity benefits.  This was unexpected due to the research 
population and may indicate increased RA control.  This is further supported by the 
low HAQ and DAS patient global scores by the majority of participants. The majority 
of participants had support at home, generally from their spouse or partner and very 
few participants had anyone that depended on them. Three participants were in an 
RA flare at the time of the interviews, but had not been in flare at recruitment.  
Patients who were in a flare at the time of recruitment were often not interested in 
participating due to their flare, or were no longer in a flare by the time of the 
interview, whilst others who had agreed to participate later cancelled due to an 
unexpected flare.  This indicates the unpredictable nature of RA and highlights the 
difficulty of including an unpredictable variable (flare) in the recruitment criteria.  Two 
female patients (Amelia and Jane) asked for their husbands to be present during the 
interview.  The decision was made to allow the husbands to be present, as it was 
felt this was preferable to losing the interview.  However, it should be noted that a 
spouse present in an interview may mean that a shared story is presented to the 
interviewer that protects the image of a harmonious marriage, rather than the 
patient’s individual experience (Boeije, 2004). 
6.4.2 Free-form graphs 
The free form graphs were completed by 8 of the 15 participants.  The 
remaining 7 participants did not have time (due to other commitments) to complete 
the graphs at the end of their interview.  One of the 8 participants who completed 
the graphs was unable to grasp the concept of the axes, despite the researcher’s 
attempts to explain.  This participant drew a line made up of different colours to 
indicate the fluctuations of her RA that did not correspond to the y-axis and RA flare 
that did not correspond to the x-axis, which made it difficult to interpret variation (Fig 
6.1 and Fig 6.2).  One participant incorporated daily life and flare into a single graph 
(Fig 6.9), which will be discussed below. 
6.4.2.1  “How does your RA change?”  
This graph aimed to capture the patterns of daily fluctuations and was 
successfully completed by 6 participants.  One participant (Liz) drew a straight line, 
to indicate that her RA does not change on a daily basis (Fig 6.3).  The other 5 
participants all drew a fluctuating line that changes within individual days as well as 
across time (Figs 6.4 to 6.8).  One participant incorporated daily life into the “What 
does a single flare look like?” graph (Fig 6.9), this also identified a fluctuating pattern 
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of symptoms. Whilst the majority of the graphs depict a fluctuating condition, it is 
impossible to pinpoint any common patterns to the graphs, particularly in this small 
sample. 
6.4.2.2 “What does a single flare look like?”  
This graph aimed to capture how patients’ symptoms change during a single 
episode of flare and what happens to patients’ symptoms following a flare.  This 
graph was successfully completed by 7 participants and 3 different experiences of 
flare could be identified.  One participant (Fig 6.10) identified a flare as coming on 
instantly without any warning.  This participant described that symptoms go from ‘no 
symptoms at all’ to ‘worst symptoms imaginable’ instantly, and then within 2 days 
return to ‘no symptoms at all’.  The second type of flare (n=2; Fig 6.11 and 6.12) is 
one which gradually gets worse, building from low or no symptoms and eventually 
reaching worst symptoms imaginable.  Participants report that this flare will not go 
away until they receive a steroid injection, at which point they report the symptoms 
instantly drop back to their original pre-flare level.  The final type of flare identified 
(n=4 Fig 6.9 and 6.13 to 6.15) begins with a moderate baseline level of symptoms, 
which gradually increases (over days and weeks) to a much higher symptom state.  
These patients do not report their flares ever reaching the worst symptoms 
imaginable as they experienced much worse symptoms at the time of diagnosis, 
when their disease was uncontrolled and they remain hopeful that “it’s never going 
to be that bad again” (Charlotte, 37).  These participants report the need for a 
steroid injection, which does begin to alleviate the symptoms.  However, it is only 
with self-management and time that these participants’ symptoms return to their 
baseline state, but never back to an absence of symptoms.
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Figure 6.1: How does your RA change? 
Free form graph completed by Jane 
 
Key: Brown = Worst symptoms 
         Green = In pain, but better than brown 
         Grey =   In pain, but better than green 
         Pink =   Best possible symptoms  
                      (still not pain free) 
 
 
 
Figure 6.3: How does your RA change?  
Free form graph completed by Liz 
 
 
 
 
 
 
 
 
Figure 6.2: What does a single flare look 
like? Free form graph completed by Jane 
 
Key: Brown = Worst symptoms 
         Green = In pain, but better than brown 
         Grey =   In pain, but better than green 
         Pink =   Best possible symptoms  
                      (still not pain free) 
 
 
 
Figure 6.4: How does your RA change? 
Free form graph completed by Linda 
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Figure 6.5: How does your RA change? 
Free form graph completed by Kate 
 Nb: The timescale that Kate added to this 
graph is end of 2006 to April 2010. 
 
 
 
 
 
 
Figure 6.7: How does your RA change? 
Free form graph completed by Isabelle 
 
 
 
 
 
 
 
Figure 6.6: How does your RA change? 
Free form graph completed by Charlotte 
 
 
 
 
 
 
 
 
Figure 6.8: How does your RA change? 
Free form graph completed by Mary 
 
Nb. The spike in symptoms relates to the cold 
weather 
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Figure 6.9: What does a single flare look 
like?  Free form graph completed by Sophie 
 
Sophie has incorporated both daily life and 
flare onto one graph.  The blue line represents 
daily life and the red line represents the flare. 
 
 
 
Figure 6.11: What does a single flare look 
like?  Free form graph completed by 
Isabelle 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10: What does a single flare look 
like?  Free form graph completed by Liz 
 
 
 
 
 
 
 
Figure 6.12: What does a single flare look 
like?  Free form graph completed by Kate 
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Figure 6.13: What does a single flare look 
like?  Free form graph completed by 
Charlotte 
 
 
 
 
 
Figure 6.15: What does a single flare look 
like?  Free form graph completed by Linda 
 
 
 
 
 
Figure 6.14: What does a single flare look 
like?  Free form graph completed by Mary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These graphs provide a summary of how patients perceive their daily life 
with RA and experience of flare.  The individual characteristics of patients’ 
experiences of living with RA will now be presented. 
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6.5 Thematic analysis of the qualitative interviews 
Three overarching or global themes were identified that related to the 
experience of living with RA, with an underpinning theme of Balance across all of 
them (Fig 6.16).  Within each of the three overarching themes there are sub-themes, 
which are summarised below.  
Theme 1: Living with RA in the background 
 Mediating the impact of RA on daily life 
o “It’s not going to get the better of me”: Physical impact and its 
mediation 
o “It just makes you snap”: Emotional impact and its mediation 
 Re-defining ‘me’ 
o “I am really fiercely independent”: Retaining independence  
o “You just accept it as normal”: Adapting normalities  
o “It’s just part of me”: Incorporating RA into identity  
o “You need to be positive”: Cognitive adjustment 
Theme 2: RA moving into the foreground 
 Unwelcome reminders 
o  “I’d forgotten about that RA”: The unpredictable nature of RA 
o “It’s hard for other people to understand”: Perceptions 
 Trying to make sense of fluctuation 
o “It’s always playing it by ear”: Uncertainty  
o “It might go away”: Avoiding seeking medical help  
Theme 3: Dealing with RA in the foreground 
 Trying to regain control 
o “Just keeping my fingers crossed: Attributing fluctuations to luck 
o “I just try anything”:  Crisis management of a flare 
o “You just go into hibernation mode”:  Social withdrawal 
 Losing Control 
o “It’s like a ‘Game Over’”: Unmanageable impact 
o “I was in agony and I couldn’t do anything”:  Seeking medical help 
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Figure 6.16: Overview of the overarching and underpinning themes 
 
6.6 Underpinning theme: “It’s like a juggling act”: Trying to maintain 
a balance 
An important part of managing RA is trying to maintain a balance, which 
patients reported being aware of in every aspect of their lives.  The main issues 
relating to balance are covered in this section, but the concept of balance is woven 
throughout the results as an underlying theme.  Patients spoke of the need to 
balance various aspects of their management strategies, as neither extreme 
episodes of rest nor of persevering with activities is helpful to them.  Patients 
reported the need to keep a healthy balance between resting and staying active; “it’s 
like a juggling act” (Charlotte, 37).  If a patient does too much activity and pushes 
themselves too hard, they are risking over doing things and causing a flare.  
However, if a patient rests too much their joints may stiffen, causing decreased 
mobility and function.  Patients also worry that not enough exercise will cause them 
to put on weight, putting extra stress on their joints: 
“It’s sort of a balancing job really.  If I use more than my share of energy for one 
day, it will affect the next” (Debbie, 44) 
 “I do like to eat well and drink well, but you know you burn it off by running or you 
know doing exercise, that keeps the balance sheet in check really, but now that’s 
gone and you can’t do that....and that adds weight then to your joints and um, 
you know that sort of compounds things a little bit.  So you know I try to sort of 
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watch my diet a little bit and exercise, do what I can, you know walking, which is, 
you know, what I try to do to compensate for that” (Michael, 48) 
Patients reported the need to find a balance in activities of daily living such 
as doing chores or something pleasurable.  This was a particularly salient topic for 
women with young children who consider it more important to spend time with their 
children than making sure the house looks perfect: 
“It’s just a balancing thing.  There’s some things that have to be done and those 
things that don’t have to be done sometimes aren’t done.  So, and there will be 
things around the house rather than, you know, where I concentrate on the 
children rather than the house” (Debbie, 44) 
“I plan that [cleaning] over the week ’cos I find I’d be, I’d be so worn out by the 
end of the day that I wouldn’t have time for the children when they came home 
from school and cooking tea and stuff like that” (Chloe, 42) 
When patients have to ask for help they are reminded of their RA, as this 
threatens their independence.  However, if patients do not ask for help when they 
need to they may bring their RA into the foreground by aggravating their symptoms.  
Thus patients need to find a balance between asking for help and remaining 
independent: 
“I think it’s trying to find that happy even isn’t it, between off-loading stuff to other 
people, yet remaining independent” (Linda, 52) 
Some patients do not find that they are able to maintain a balance in their 
daily life, although they are aware of the need for it.  For some patients this is due to 
being unable to discipline themselves into taking a period of rest.  However, for 
other patients this can be due to a deliberate decision not to give in to their RA and 
although they have weighed up the consequences, they choose to reject the idea of 
balance.  This is one way of keeping RA in the background, although by rejecting 
the idea of balance, RA may only be kept there temporarily: 
“I think ‘Oh I can wash up and I can go and do a bit of tidying up’ and then I think 
‘I’ll have to go and sit down in a minute’, but I don’t sit down I’ll go fussing with 
something else you know, and then course after that well, yes I’ve got to go and 
sit down you know, and that’s the end of it” (Mary, 77)   
“I’m going to have it for the rest of me life so I might as well have the most fun as 
I can for as long as I can and screw the consequences” (Kate, 35) 
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Patients who value the importance of balance in their lives find that it is not 
always possible to maintain this when they are in a flare.  Fulfilling responsibilities 
and staying mobile can lead to exacerbated symptoms:  
“If you rest too much then you, you sometimes, you’ve got to push yourself 
because otherwise you’re going to lose what mobility that you have got, so it’s 
just, even when I’m really bad, you know, I’ve still got to get the kids to and from 
school and all their activities and running around after them so, um, in a way that 
keeps me going I suspect in a way...You know sometimes it feels like there’s 
nothing left for me, you know there’s no energy left for me” (Debbie, 44) 
6.7 Theme 1: Living with RA in the background 
In normal daily life patients experience RA as a constant background reality.  
They are aware of a level of symptoms that, most of the time, can be put to the back 
of their mind.  However, in order to keep their RA in the background patients seem 
to micromanage both their symptoms and their daily lives to accommodate their RA. 
6.7.1 Mediating the impact of RA on daily life 
Patients discussed the impact of RA on their daily lives in terms of the 
restrictions that it imposes on them and the way this can make them feel.  Many 
patients are able to mediate this impact by overcoming or working around the 
restrictions, or cognitively reappraising their expectations of their abilities. These 
sub-themes are presented with data on impact initially, followed by data on the 
strategies patients used to mediate that impact. 
6.7.1.1 “It’s not going to get the better of me”: Physical impact and its mediation 
Patients experience a number of physical restrictions on their daily life due to 
their RA symptoms, which they often find ways of overcoming. These restrictions 
can include every day tasks that the general population would take for granted, such 
as getting dressed and choosing clothes according to style rather than practicality: 
“I mean clothes-wise I’ve adjusted the way that I um, that I dress.  I can’t do little 
buttons and things like that or zips at the back, so everything has to be sort of 
pulled on” (Linda, 52) 
RA can prevent patients from doing things in the way that they would choose 
or are used to, which is particularly unwelcome when RA interferes with personal 
preference.  Kate was forced to replace her motorbike with a car when she was no 
longer able to change the gears on the motorbike:  
“Not even with wanting to climb up a mountain and do er, outdoor stuff. Just what 
car, what transport I’ve got is dictated by the fact that I’ve got arthritis” (Kate, 35) 
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It is possible that this decision was especially difficult due to motorcycling 
being seen as a way of life and an identity, rather than just a mode of transport.  
Many patients experience physical restrictions on the activities that they 
consider valued or pleasurable.  Some patients feel that they have had to stop 
certain activities altogether.  This can be due to not feeling able to keep up with 
others any more or due to bad experiences during their early RA, when their disease 
was less well-controlled: 
 “I used to do a lot of walking with the local rambling club, um I’ve had to stop 
doing that” (Roger, 56) 
“I used to go running.  I could go out road running, nothing drastic, with friends or 
walking and we’d play badminton, but when I first had RA that all went out the 
window, I couldn’t do anything.  I couldn’t even hold the racquet, so um I stopped 
doing any sport like that” (James, 47) 
Although patients experience restrictions on their abilities, they are often 
determined to reduce the impact that RA has on their lives.  Some patients deal with 
this by pushing through their pain and other symptoms in order to carry on with their 
normal lives.  By managing in this way it is possible that patients are causing 
themselves more long-term damage to ligaments and tendons.  However, pushing 
through may allow them to maintain or regain perceived control of the situation and 
to fight back:   
“For the kids’ sake as well, I try and do as much, even if it’s really really painful 
and it’s really sort of ‘Ohhh’,  you know I do it and I think ‘No, it’s not going to get 
the better of me’” (Chloe, 42) 
“I just couldn’t be kept in the house so it would still be agony and I would try and 
drive [demonstrates steering with elbows]” (Isabelle, 45) 
Other patients will find alternative ways to do the things they want to do.  
They are aware that their RA can restrict their abilities, but are able to employ 
strategies to ensure that RA does not change the activities that make up their 
normal everyday life: 
“I think even when I’ve had a swollen knee I’ve got on the bike and just pedalled 
more with one leg than the other” (Emma, 42) 
The idea that patients only need to manage their RA when their symptoms 
are exacerbated is a misconception.  Of particular note is that even with new 
treatment regimes, which are deemed more effective, patients feel the need to 
micro-manage their symptoms and activities on a daily basis.  Patients take this 
proactive, preventative approach to ensure that their symptoms are kept at bay.  
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Charlotte described how she incorporates a level of micro-management into her 
working day: 
“If I was just printing something I will get up and go to the printer I won’t just wait 
and print a whole load and then go up at one point or get someone else to get it 
for me, I will get up and move around and go for a coffee and yeah have a little 
wander round the office or something.  I just find it helps a lot because otherwise 
you do seize up and that causes a lot more pain, a lot more trouble” (Charlotte, 
37) 
Patients use self-management techniques such as planning, pacing and 
delegating tasks, to try and ensure that they can maintain the equilibrium between 
‘life’ and RA:   
 “I knew that I’d be doing a lot of walking so I made sure that the next day was 
empty” (Debbie, 44) 
“So it is pacing your day so that you can do that little bit of work and then the 
household things that you have to do um, and then just trying to hand over things 
that perhaps you don’t need to do yourself” (Linda, 52) 
Self-managing RA on a daily basis becomes normal for patients and 
therefore many patients are automatically employing these self-management 
techniques.  It is possible that there is a subconscious element to self-management, 
with some people (e.g. Kate) reporting that they do not self-manage when directly 
asked in interview, but going on later to describe their self-management techniques.  
This indicates that although Kate is aware of the need to plan and pace, she 
considers this a part of her life with RA, rather than a conscious way of managing 
her symptoms: 
On direct questioning:  “I don’t really know what I do to manage it and I think 
that’s part of the problem, is I’m really bad at managing it” (Kate, 35) 
Later spontaneous comment: “I do burn the candle at both ends.  I absolutely 
know that.   The difference is, is I do know that once I’ve done that for a while I 
then need to have like a weekend where I just don’t do anything” (Kate, 35) 
Due to their refusal to allow RA to impact on their lives, many patients are 
able to carry on with activities that are important to them, such as spending time with 
their family:  
 “We go swimming and take her [daughter] out and do things and like I say, when 
the snow was around we went sledging” (James, 47) 
Some patients are even able to take part in more physically demanding 
activities, as they are determined that their RA will not stop them doing what they 
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want to do.  These patients are aware of the consequences of overdoing things, but 
make a conscious decision that the rewards outweigh the costs: 
 “If I want to go white-water rafting I’ll go white-water rafting and believe me I 
have.  I did pay for it the next day but you know, I enjoyed it at the time” 
(Charlotte, 37) 
6.7.1.2 “It just makes you snap”: Emotional impact and its mediation 
RA has not only a physical, but an emotional impact on patients’ daily lives.  
Many patients reported frustration due to being unable to do the things that they 
used to be able to do: 
 “I do get frustrated, ‘cos I’ve always been active.  I mean I was post-lady for the 
last sixteen years of me working life; running up and down steps in roads I mean 
and we’ve always gone cycling, swimming, walking, haven’t we [to husband], I 
can’t do cycling.”  (Amelia, 67) 
Patients with RA begin to accept a slower pace of life, but they still 
experience frustration due to their body not being able to keep up with their mind: 
“You just have to slow right down you know so, but it’s really frustrating when 
your brain’s going zzzzz you know you’re working ten to the dozen and you just 
want your body to follow and it just doesn’t” (Isabelle, 45) 
One patient, an ex-rugby player, explained how he has learnt to change the 
way he deals with his frustration.  More masculine ways of coping now have 
potential physical consequences for him and so this patient reported the need to 
adopt a more female-oriented coping strategy: 
“Talking is a way of taking that frustration out of your body when you can’t go and 
thump a wall because you end up with a flare so, and you can’t go and kick a 
football around or anything like that you know, so you need to find an outlet and 
talking is the outlet I suppose” (James, 47) 
However, James still finds current offered support unhelpful due to the focus 
on emotional support: 
“The self help groups don’t confront it enough, it might be all lovey-dovey but 
sometimes you have got to be quite hard about it” (James, 47) 
Some patients explained that they experience more than mere frustration 
due to their RA and the way it impacts on their lives.  A small number of patients 
reported feelings of anger, which seem to arise from their frustration and is 
exacerbated by their symptoms such as pain and fatigue: 
“It, I don’t know, it just makes you snap sometimes, it just makes you, I think it’s 
the frustration because you want to do it and you can’t do it and the frustration 
and the tiredness and everything” (Chloe, 42) 
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“No room for self pity at all or anything, no, just anger really” (Michael, 48) 
As well as frustration and anger, the impact of RA on their lives can cause 
patients to worry.  One source of worry for patients in employment is how their 
employer will react, particularly when they are unwell or need time off work due to 
their RA:  
“I’m quite worried about how work are going to react to that [operation].  Um, 
because I just see it as er, it’ll be an opportunity for them to fill my position while 
I’m away and, and I’m not so sure it’ll still be there when I get back” (Linda, 52) 
Patients also worry about their RA causing them embarrassment in public.  It 
is possible that the prospect of having to depend on others, particularly strangers, 
makes patients feel vulnerable: 
“I worry a lot about falling over um, because with my knee being replaced, I find it 
hard if I’m down on the floor, I cannot get up on my own, I cannot get, I have to 
literally physically have someone help me up.  If I fall over somewhere and 
there’s no-one I know, I’m so embarrassed, I’m like ‘Oh my God’, you know, 
‘Open the floor up and let me in’, because I just can’t get up” (Chloe, 42) 
Some patients experience feelings of guilt when they believe that they are 
holding people back or letting them down, particularly friends and family.  This can 
be due to cancelling plans or being unable to keep up with them: 
“I do sometimes feel that when we go on holiday I’m holding them [husband and 
teenage children] back from doing things that they’d enjoy doing” (Linda, 52) 
 “We do manage to take holidays don’t we [to husband]? But I can’t carry cases 
or bags, so it’s all left to him, and he ain’t getting no younger [laugh].  It’s like 
carting a nuisance about isn’t it?  But he’s ever so good though.  Without him 
mind, I’d be lost” (Amelia, 67) 
Amelia seemed to be aware of a certain level of dependence on her 
husband, which may challenge her sense of worth, thus causing her to feel like a 
burden. 
Patients use a number of strategies to minimise and rationalise the impact 
that RA has on their daily life and to keep their illness firmly in the background.  A 
number of patients reported using supportive family and friends in order to cope with 
difficult periods, such as exacerbated symptoms or low mood: 
 “I think you’re able to have a much more positive attitude if you’ve got a lot of 
support behind you” (Linda, 52) 
 “I find sometimes um if you go out and you socialise it does take your mind off of 
it a bit” (Jane, 65) 
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Some patients also find it helpful to talk to other patients about their 
experiences.  However, they feel it is important to speak to someone who is of a 
similar age and who has a similar outlook.  In contrast, other patients reported being 
reluctant to speak to other patients due to previous bad experiences:  
 “I didn’t realise how, you know, useful that was, or how nice that was to speak to 
other people sort of in the same age group” (Emma, 42) 
 “She’s [friend with RA] put me off talking to patients or other sufferers I will say 
that and the fact that every time I talk to her and say how is this ‘Oh yeah, yeah I 
am really down’” (James, 47) 
Patients also reported using the clinical rheumatology team for support.  
Those who receive good support feel grateful for it, whilst those who don’t feel 
supported are impacted by its absence: 
“You just feel safe I can’t explain it, it just feels like a safety net. You are not on 
your own, so it’s massive your relationship [with the medical team]” (Isabelle, 45) 
“The problem is, is that I’ve never really had anybody support me with this at all.  
Even at rheumatology, it just, it’s been an absolute mess, the support that I’ve 
been offered” (Kate, 35) 
Another way in which patients attempt to minimise the impact of their RA is 
by using humour to discuss it: 
 “Because I do a lot of typing at work, recently I have been given some gloves to 
put on my hands that seem to support the hands when you are typing, although I 
look a little bit like Michael Jackson [laughs].  It’s not a good look but you know I 
get all sorts of yeah people taking the p**s out of me for that” (Charlotte, 37) 
“I mean I get called ‘an old crip’ you know but I [laughs] because my toe has 
gone funny and my friend calls me a 3-toed sloth and all that but it’s all in fun, 
you know” (Jane, 65) 
Using humour to talk about RA may be a way for patients to avoid 
addressing their underlying concerns.  However, it is of note that the jokes have 
originated from people other than the patients.  Thus the humour may be an attempt 
to help others cope with the reality of RA.  
6.7.2 Re-defining ‘me’ 
Due to the restrictions it imposes on valued and daily activities, RA has the 
potential to pose a severe threat to patients’ identities.  In order to deal with this, 
patients begin to accept changes and report the need to “learn about your own body 
again” (Charlotte, 37).  They also re-evaluate their abilities, the way others see 
them, and how they see themselves, redefining themselves as someone with RA. 
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6.7.2.1 “I am really fiercely independent”: Retaining independence 
Patients discussed the importance of independence and reported that they 
will fight to be as independent as possible.  This can sometimes mean standing up 
to friends or family who are trying to help and who may not realise that they are 
posing a threat to the patient’s independence: 
“I am quite independent so I tend to sort of do things by myself and doing things 
by myself  I get a bit you know ‘no, no, I will do it’ yeah a little bit bolshie about it” 
(Charlotte, 37) 
“He [Husband] says ‘You won’t listen!’ I says ‘Well I do listen but I’ve always been 
active and independent and then all of a sudden that’s taken away isn’t it?’  You 
know, that I think that’s a big issue for people that um, have never wanted people 
to do things for them” (Amelia, 67) 
Some patients feel as though the choice to be independent has been taken 
away due to their RA.  One patient (Isabelle) explained that she has decided to get a 
wheelchair to be able to go out more and therefore increase her independence.  
Isabelle seems to be choosing to compromise one aspect of her identity, where she 
portrays herself as a young, healthy woman in order to retain another aspect of her 
identity; an independent woman: 
“I don’t wanna be in it [wheelchair] trust me I really don’t because I’m too vain, 
but I have got to, I’m just too restricted now and I wanna do things, I wanna see 
places and go places you know and now these places are so much more 
accessible, I need to just get over myself and get on with it, you know?” (Isabelle, 
45) 
6.7.2.2 “You just accept it as normal”: Adapting normalities 
Patients find the need to accept and adjust to a new level of ‘normal’ in terms 
of a body that has fluctuating levels of symptoms on a daily basis.  Some patients 
explained that the pain is always there and you have to learn to push through the 
pain and accept it, whilst others say that they don’t always notice the pain as they 
are so used to it being there.  The latter patients have incorporated this background 
level of pain into what is ‘normal’ for them: 
“It’s just the way of life now, you are just used to it” (Roger, 56) 
“Sometimes you’ve gotta kind of work through the pain, but you know, it doesn’t 
tend to sort of intrude, you know, sort of too much, you just sort of accept it as 
normal really” (Michael, 48) 
In terms of altered abilities, some patients do not find it so easy to accept a 
‘new normal’.  One patient describes a change in her abilities that challenges her 
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identity as she is no longer able to make a favourable comparison between herself 
and her friend: 
”There was um something that I just couldn’t carry that was too heavy for me, and 
my friend just picked it up and I know I’ve always been much stronger than her” 
(Emma, 42) 
Emma used this single event to create a negative belief about her physical 
abilities as it challenged her identity as a strong, capable woman. This demonstrates 
how one event that highlights a decline in abilities can have a negative impact on a 
person’s identity: 
“That’s something that I find quite hard to deal with really, that I’m a weakling” 
(Emma, 42) 
Other patients are able to be more pragmatic and rationalise their declining 
abilities.  One patient compares her change in activities to the general population 
who change as they get older, thus normalising the changes that she is adjusting to: 
“What I do in sort of my personal life has changed because I can’t do what I used 
to do ten years ago.  I mean that’s normal for people as they get older anyway” 
(Kate, 35) 
It is important to note that it is also possible that Kate is attempting to 
minimise the impact of her symptoms by trying to convince herself that it is normal to 
have reduced abilities at 35 years old. 
6.7.2.3 “It’s just part of me”: Incorporating RA into identity 
The majority of patients in this study spoke about their RA as though they 
have incorporated it into their identity: 
“It’s just part of me” (Debbie, 44) 
“It’s just like, you know, it’s kind of that’s who you are.  You just, it’s just, it’s that 
you have it [RA] and you just deal with it” (Charlotte, 37) 
Whether they have incorporated RA into their identity or not, patients are 
determined not to be defined by their RA or to be treated any differently because of 
it.  It is possible that if they allowed themselves to be treated as an ‘RA patient’ they 
may feel that they are losing their identity.  It seems that RA can become part of 
patients’ identities whilst still allowing them to retain their sense of self: 
“Yeah, it doesn’t define me” (Charlotte, 37) 
“So they are trying to sympathise and empathise, but when you’re young you 
don’t want that, you just want to be treated like everyone else” (Isabelle, 45) 
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In contrast, one patient (Kate) discussed RA as separate from her personal 
identity, she makes a clear distinction between ‘the body’ and ‘me’.  Kate previously 
resisted taking her medication due to worries about side effects, although she is 
aware that medication is the most effective way to keep on top of her RA.  In order 
to reconcile this difference and accept taking her medication, Kate thinks of her ‘RA 
body’ as separate to her personal identity:   
“I just think actually my body’s been pretty s**t to me so if I can get my own back 
on it a little bit by filling it full of toxins, then so be it, if it don’t behave that’s what it 
gets...If it chooses to behave then I’ll be a bit nicer to it and I’ll come off some of 
the drugs” (Kate, 35) 
6.7.2.4 “You need to be positive”: Cognitive adjustment 
Patients in this study seemed to be trying to minimise the effect that RA has 
on them by trying not to acknowledge it: 
“On the whole I tend to convince myself that actually everything’s fine and I’m 
completely normal” (Kate, 35) 
“Well I could still say it doesn’t really affect me that much, but you know, I know 
that’s not really true but it does seem right to say that” (Emma, 42) 
Patients also attempt to minimise the impact of their RA by having a positive 
attitude towards it, although not all patients find it easy to stay consistently positive: 
“You need to be positive the whole time and think well no, the pain’s there, yes, 
but the pain will go eventually” (Chloe, 42) 
“You have to just try and stay positive because for me it is really, and I get really 
tired of trying to be positive” (Isabelle, 45) 
Some patients tried to see the best of their situation by making comparisons 
to how they used to be or thought they would be. Patients also made downward 
comparisons between themselves and other patients, and with people with life-
threatening illnesses. Such downward comparisons enabled them to feel better 
about their own situation, even though they are unable to change it:  
“I’m in a much better position than I thought I probably would be” (Michael, 48) 
  “I see some people that can hardly walk, you know and I am thinking ‘No, I’m 
not going to let it get to that stage’” (Liz, 59) 
“This is an inconvenience, it’s not life threatening, there’s lots and lots of life 
threatening diseases out there you know, put you in perspective where you are” 
(James, 47) 
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“ I mean there’s so much going on in the world isn’t there at the moment, and like 
I say, you know, these poor soldiers coming back from Afghanistan and you 
know, and you think well you’ve got so much to be grateful for haven’t you?” 
(Linda, 52) 
Occasionally patients made comparisons with someone who is less disabled 
than they are such as friends or family who do not have RA.  However, upward 
comparisons such as these were unhelpful and largely negative: 
“I should think even my Mum can touch her toes and she’s 75” (Emma, 42) 
6.7.3 Theme 1: Summary 
In normal everyday life, patients’ RA is in the background, while their 
wellness is in the foreground.  This simple explanation may indicate that patients do 
not have any concerns about daily life with RA.  However, even when patients’ RA is 
in the background, there is a complex set of beliefs, expectations, impact and 
management surrounding the patient, which they have to learn to balance.  All of the 
sub-themes discussed above have an impact not only on the patient but also on 
each other (Fig 6.17), for example the physical impact of RA can reduce a patient’s 
independence, which in turn reduces how close they feel to ‘normal’ for them.  The 
physical impact can be mediated with self-management, which would in turn 
increase a patient’s independence and sense of normality (Fig 6.17).  Theme 1 has 
been used as the beginnings of a conceptual model to explain life with RA (Fig 
6.18).   
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Figure 6.17: Living with RA in the background 
 
 
 
 
Figure 6.18: Beginning of a conceptual model to explain life with RA  
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6.8 Theme 2: RA moving into the foreground 
Patients have strong coping and self-management strategies that allow them 
to keep their RA in the background most of the time.  However, the unpredictable 
and uncertain nature of life with RA can mean that despite their best efforts, RA can 
move into the foreground and begin to intrude on patients’ lives. 
6.8.1 Unwelcome reminders 
Living with RA, patients can experience unwelcome reminders about their 
condition.  This can be due to changes in RA disease activity leading to exacerbated 
symptoms, due to the clash between life and RA making people more aware of their 
limitations, or due to other people’s reactions to the person with RA. 
6.8.1.1 “I forgot that I’ve got this arthritis”: The unpredictable nature of RA 
Life with RA can be unpredictable as symptoms can fluctuate on a daily 
basis and patients are often unable to predict what each day might be like, which 
can mean they may need to cancel or change their plans.  Several patients 
discussed the fluctuating nature of their symptoms on a daily basis, the peaks 
referred to by Charlotte are not RA flares but a high level of daily symptoms: 
“You do sort of have peaks and troughs, yeah definitely” (Charlotte, 37) 
“There doesn’t feel like there’s been any pattern to it” (Kate, 35) 
Patients also discussed their inability to predict what the next day holds as 
there is no consistency between the way they feel in the morning and the way they 
felt the night before: 
“Um, God it’s really difficult, it’s so different, I never know what I’m going to feel 
like when I wake up” (Isabelle, 45) 
“Some days I can get up in the morning, and they’re [swollen joints] gone, that is 
gone, you know, down like this one [finger] that’s got a bit there and then another 
day it’s just up like that for nothing innit? I don’t know why it is really. I mean to 
me, if you’ve been resting all night, why should it go like that?” (Amelia, 67) 
Patients are also sometimes unable to predict or they forget what 
exacerbates their symptoms.  This causes an unwelcome reminder that their RA is a 
part of their life: 
“You might do something if you’re feeling good, you might do something then just 
go ‘Ooh I shouldn’t have done that, I forgot that you know, I’ve got this arthritis 
kind of thing’” (Charlotte, 37) 
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Due to unpredictable symptoms many patients find it difficult to make plans 
as these may have to be cancelled or altered depending on how they feel on the 
day.  This can be because of being physically unable to do something due to pain or 
stiffness, but it can also be due to the wipe-out feeling caused by fatigue. 
 “I do suffer quite a lot from fatigue, so it really depends how much energy I have 
to do that and then also if something’s quite sore I might not want to, you know, I 
might cancel a shopping trip if I’ve got a very sore knee or ankle or something, 
knowing that it’s going to aggravate it” (Debbie, 44) 
“There’s been a couple of times when we’ve been going to go somewhere and I 
just say I don’t feel like going, you know, I’d rather stay at home” (Mary, 77) 
Some patients felt it is better to keep plans vague and wait to see how they 
feel, becoming flexible around their RA, whilst others felt that the lack of ability to 
plan means they are unable to work: 
“Some days I can’t be bothered to go out at all and that’s that and I just sit with 
my feet up.  Another day I’ll think ‘Well I can go out today’” (Amelia, 67) 
“I did think if I could do that [charity work] maybe I could do a part-time job, but 
then that just confirmed that I just couldn’t sustain it, you couldn’t go in so many 
days a week or, because you never know what you’re going to be like” (Isabelle, 
45) 
One patient suggested that cancelling plans does not have a big effect on 
her.  However, it’s possible that cancelling or rearranging plans, particularly holidays 
as mentioned, does have an effect, but that she is choosing to minimise the impact it 
has on her: 
“Plans are plans you know, and if I phone up and say ‘Oh, I’m sorry I’ve got a bad 
day’ 90% of my friends say ‘that’s fine, we’ll leave it’ or you know, we will go on 
holiday a day later or whatever, no it doesn’t affect my life that much to be quite 
honest” (Liz, 59) 
RA is not only unpredictable in terms of symptoms on a daily basis, but also 
in terms of RA flares, with patients never knowing when their flare will come.  The 
phrase “out of the blue” was used numerous times by patients talking about their 
flares, indicating their unpredictable nature.  The majority of patients interviewed 
therefore experience no warning signs that they are about to have a flare: 
 “It comes out of the blue” (Sophie, 51) 
 “They just come from nowhere” (Roger, 56) 
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6.8.1.2 “It’s hard for other people to understand”: Perceptions  
Patients reported the ways in which they felt others perceived them due to 
their RA.  First, patients felt that arthritis is an ‘old person’s’ condition and they 
therefore worry that they might be seen as ‘old’ due to having RA.  They also find 
other people are less sympathetic to a young person with RA as they can’t 
understand why they might be slow or tired:   
“It is hard, the tiredness is the worst part of it.  People say ‘Oh you shouldn’t be 
tired you’re young’” (Chloe, 42) 
“It’s hard for people to understand, especially if you are quite young, why you 
can’t do things, why you can’t walk so fast and all that sort of stuff” (Charlotte, 37) 
One patient compared RA to multiple sclerosis (MS) in terms of the 
differences in public understanding.  The following quote indicates that RA has a 
large impact on this patient’s self-identity as she now thinks of herself as someone 
with an ‘old person’s’ condition.  It is possible that she is projecting these feelings 
onto other people as she is presuming that this is what they are thinking, rather that 
anyone having said anything to her specifically: 
“I wish I had MS, because you could say to somebody ‘I’ve got MS’ and they 
automatically think of a younger person and how difficult that is to manage work 
and relationships and everyday life because it’s a younger person’s disease.  I 
have to say ‘I’ve got arthritis’ and straight away they think ‘Oh she don’t look 
eighty, I wonder if she’s incontinent’” (Kate, 35) 
Patients also felt that other people do not always believe that they are as 
unwell as they say.  The unpredictable and fluctuating nature of RA means that 
patients can have periods of feeling ill and of feeling well within the same day.  As 
the full impact of RA on patients is not visible to others (fatigue and pain are invisible 
symptoms), it may be hard for other people to legitimise these symptoms and thus 
believe the patient.  Patients may therefore feel as though their symptoms are not 
validated by others. It is particularly important in a work situation for an employer to 
understand the fluctuating nature of RA and to believe patients, but also for other 
colleagues to understand in order to prevent resentment: 
“I mean, just sitting down for long periods at work, I then, you know,  get up and 
then I sort of find it difficult to get going again, which I’m sure people find really 
funny, that you know, I’m limping one minute and then I’m not the next” (Emma, 
42) 
Linda felt that she should not have to educate her employer about what is 
wrong with her and that she deserves to be believed.  Kate on the other hand will 
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seize opportunities to show colleagues the visible aspect of her RA in order to 
increase their understanding: 
“I don’t want to educate, do you know what I mean, really.  I mean I suppose I 
just want them to accept me as I am, and if I say I can’t do something, then I’m 
not trying to sort of opt out of doing it.  It really is because, you know, I can’t do it” 
(Linda, 52) 
“I’ll actually show her [colleague] all the bits that are swollen, because that 
actually helps.  Because it’s something that people can see that is easy to 
identify and for me that is actually better because it can be seen” (Kate, 35) 
Patients’ perceptions of a disbelieving attitude held by others are not 
confined to the work-place.  As Isabelle described, the general public can be just as 
doubting, making patients feel uncomfortable, which is a further reminder that RA is 
a part of their life: 
“It’s hard work when you are not, when you don’t look like there is anything wrong 
with you and especially like when I get out of the car, even though I might be 
limping a little bit, I get out of the car and the looks and the people I’ve had come 
up and say to me, ‘Why have you got a blue badge then?’ even the wardens and 
that, they’ll lean and I’m sat in my car with the badge up just about to get out or 
get in and they’re literally leaning across looking and they’ll sort of look me up 
and down and they’ll look at my badge” (Isabelle, 45) 
Some patients also find that their family and friends are not particularly 
understanding.  As Jane mentioned this is possibly because patients are good at 
hiding their symptoms and do not complain:   
 “You know they [friends] all say ‘Don’t you look... oh you do look well’ [laughs] I 
think they think you are swinging the lead but they don’t really understand how 
bad you feel because I am good at hiding it you know, I don’t want to give in to it 
do you know what I mean?” (Jane, 65) 
Life with RA therefore may not always be what it seems.  Patients often put 
on a brave face and appear to manage well despite the daily impact of RA.  This, 
coupled with invisible symptoms can make it difficult for friends, relatives or 
employers to tell whether patients are really affected by their RA or not.  In order to 
live with RA in the background and to protect their personal identities, patients would 
choose to think and talk about their RA as little as possible.  However, this may not 
be an option for patients for whom it’s important that other people understand their 
situation and believe them: 
“You either have it one way or the other I suppose; that you’re constantly going 
on about it and you let it rule your life; or you don’t let it rule your life and then 
people don’t really understand” (Emma, 42) 
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6.8.2 Trying to make sense of fluctuation  
Patients discussed feelings of uncertainty surrounding various aspects of 
their life with RA, often due to its unpredictability, which can leave people wondering 
whether there is anything they can do to make a difference.  Patients try a variety of 
self-management techniques, but they are unsure as to whether any of these 
methods are working as at times there seems to be inconsistency between the self-
management technique and the way the disease responds.  Patients are often 
unsure as to whether they are experiencing a flare or not, which may lead to a delay 
in help-seeking behaviours. 
6.8.2.1 “It’s always playing it by ear”: Uncertainty 
Patients reported that despite the uncertainty surrounding whether a self-
management technique is working, they are reluctant to avoid trying or continuing 
something in case it does work. Thus they feel it is better to do something that 
doesn’t work, than not do it and later regret that decision: 
 “I mean I do think that whatever you do, it [RA] does what it wants, I still think 
that. ’Cos I used to do hand exercises, I wouldn’t have not liked to have done 
them because they might have been so much worse, you know. I mean, it’s 
something you will never know, but you do wonder how much good they’ve done, 
because your hands still end up, you know, becoming inflamed and fusing and all 
these things happening to them.” (Linda, 52)  
Some patients monitor their food in order to manage their RA.  This can be 
for two reasons, the first is that they worry about gaining weight and therefore 
putting extra stress on their joints, therefore these patients eat as healthily as they 
can.  In contrast, other patients believe that certain foods have the potential to cause 
a flare, they therefore cut these foods out of their diet.  Patients still seem to remain 
uncertain about whether this is truly making a difference or not: 
 “And things like oranges, where there’s acid in it.  Anything with um...a big 
amount...if I have an orange I only have about three slices of the orange” 
(Amelia, 67) 
“But I can’t say that it [special diet] made any difference, but it’s really hard 
sometimes to know whether something is making a difference” (Emma, 42) 
Some techniques for self-management have their pros and cons and this can 
lead to patients feeling uncertain regards their priorities:  
“Figure out whether drinking more helps because it deadens the pain or actually 
not drinking is going to help because it won’t make me so ill, that tends to be a bit 
of a judgement call” (Kate, 35) 
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This uncertainty about whether a particular technique for managing 
symptoms does more harm than good in the long term affects patients’ concerns 
about medication. Some patients are unsure whether the medication is causing 
side-effects, or whether those symptoms are part of the RA, whether it’s due to them 
overdoing things, or whether they have had a bad day due to an external factor such 
as the weather:   
 “I was wondering sometimes if it’s because of the tablets you are taking that 
makes you tired” (Jane, 65) 
“I do feel, when it’s damp, I do feel it sort of, it does get a little bit worse I would 
definitely say that, um but it’s hard to sort of work out because you are in Bristol 
and it rains quite a lot” (Charlotte, 37) 
The unpredictable nature of RA makes it difficult to isolate a cause to 
patients’ symptoms as the disease may respond differently at different times: 
“I mean I feel that sometimes I am tired, but then I do get active and do lots of, 
you know, things and, you know, I might be doing something every night, but 
then other times I might not be doing something every night and I don’t think I 
necessarily notice that it gets any worse” (Emma, 42) 
Other patients are concerned about the long-term effects of medication, 
while for others there is an uncertainty about whether their body will get used to the 
medication and therefore lose its effectiveness. In contrast Sophie has concerns that 
the medication is working so well, it might be masking symptoms that should be 
warning her to take things more gently: 
“He [doctor] said ‘You 50 now’ and I said ‘Yeah’, he said ‘You could live ‘til you 80 
but tablets probably kill you first’” (Jane, 65) 
 “It’s like a lot of tablets isn’t it? Once you get used to them they don’t do you no 
good, but, so I’m hoping you know” (Mary, 77) 
 “If I’m taking Diclofenac and it’s making me not hurt, am I going to be damaging 
something by thinking it’s not hurting when really it should be hurting and I should 
be not using it, you know?” (Sophie, 51) 
Patients try to make sense of how their disease might progress, they wonder 
about whether the disease will get any worse and what the long term damage to 
their joints will be.  This is an unknown quantity to both patients and professionals 
and so patients report that all they can do is ‘wait and see’ (Roger, 56).  Some 
patients such as Linda see the positive side of this:   
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 “When they do me feet I can probably get some flat sandals and stuff like that 
hopefully, unless something else crops up. The other hip goes or the other knee 
goes.  That’s the only trouble, you don’t know where it’s gonna go” (Amelia, 67) 
“You don’t ever know what’s round the corner with it really. It’s just unpredictable 
but I mean it’s no use worrying about it is it? It’s just, I mean I’m not the bravest of 
people and um, I don’t think I’d want to know what was round the corner anyway, 
do you know what I mean?” (Linda, 52) 
As discussed in Section 6.8.1.1, flares are unpredictable, coming with very 
little notice, there are no certainties with a flare and so “it’s always playing it by ear” 
(Chloe, 42).  However, a few patients do report getting an early warning of their flare 
developing, although this is shrouded in uncertainty.  One patient explained how she 
experiences tiredness prior to a flare, although she was uncertain as to whether it is 
a flare developing or a cold coming on.  Early warnings seem to be unusual and 
even if they are experienced, they seem to be only recognised with hindsight: 
“[Before a Flare] I tend to get a bit tireder.  Especially I might even be a bit tireder 
the day before sort of like some things, you know, like am I coming down with a 
cold, or am I? You know, that type of thing” (Debbie, 44) 
Another patient who experiences early warnings before her flares is Isabelle: 
“Believe it or not I tend to feel really well before a flare-up, it’s almost like 
euphoric” (Isabelle, 45) 
It is possible that the euphoric feeling is not necessarily an early warning 
sign of a flare, but rather a period of respite from the disease activity.  In the face of 
this improvement, the patient may overdo things due to feeling so well, and 
therefore trigger a self-induced flare, leading to the perception of the calm before the 
storm: 
“I realise the warning signs now is when I feel like that it’s time to just ‘Whoa’ just 
not, it’s always when you feel really good you wanna do more because you 
physically feel you can do more but then when you do that, it bites you in the 
backside” (Isabelle, 45) 
Whilst the flare is developing, patients experience a period of uncertainty as 
to whether they are experiencing a flare or not.  Sophie made the distinction 
between symptoms from a flare (which she defines as the immune system being 
attacked), and from having overdone things (which she does not class as a flare).  
This reinforces the difficulties (see Chapter 2) in gaining consensus as to what a 
flare is and what causes it: 
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“It’s not clear enough to actually determine for me whether it, I’m fighting 
something off, an infection, or I’m, or my body’s fighting itself, basically. So it’s 
hard to tell” (Debbie, 44) 
“Whether that’s my immune system being attacked or a, I don’t know, or whether 
I’ve done too much with that arm in the day or walked too far on the previous day, 
I don’t know” (Sophie, 51) 
Patients are unsure as to what has caused the flare, how long it will last and 
even whether it definitely is a flare or not.  They therefore try to make sense of what 
they are experiencing:  
“It’s a human thing isn’t it, to try and connect it with something, like if you’re sick 
you think ‘Oh, that must have been some food that I ate’” (Sophie, 51) 
In trying to make sense of the cause or length of their flares there doesn’t 
seem to be much consensus between patients, or much certainty in their 
explanations.  Flares can be attributed to eating particular foods, to the weather, to 
stress or to overdoing things, which can include repetitive actions.  However, there 
is often confusion surrounding these causes due to lack of consistency or, as Amelia 
mentions, because the rheumatologist has not validated the patient’s opinion: 
“I mean they say food don’t give you flare-ups, I believe it do. It don’t matter 
which doctor you speak to, they say it’s a load of rubbish, there’s research have 
found there’s nothing, but if they, I don’t think it’s a load of rubbish” (Amelia, 67) 
 “Cold damp weather seems to bring out all the aches and pains and you feel 
absolutely dreadful” (Roger, 56) 
“Stress can cause it, you know something that’s worrying.  I mean, when my 
son’s marriage broke up that caused a flare-up” (Jane, 65) 
The following quote demonstrates how patients try to make sense of the 
cause of a flare, but however strong their conviction, they are still not certain: 
“This time I am fairly convinced, this is possibly the clearest I’ve ever been, that 
I’m fairly convinced it’s weather orientated” (Emma, 35) 
6.8.2.2 “It might go away”: Avoiding seeking medical help 
Although some patients will contact the medical team almost immediately for 
help with their RA flare, many more will try everything they can first.  Due to the 
uncertainty about whether they are in a flare (Section 6.8.2.1), patients experience a 
period of wishful thinking and hope that the flare might go away on its own. 
 “I am just one of those that thinks it might go away, you know” (Jane, 65) 
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Some patients have beliefs that cause them to avoid seeking medical help.  
These include the idea that the medical team would be unable to help them; that 
there is a limit on the number of steroid injections that they can have in a year and 
so they try to ‘save’ them up; or they feel like a fraud when making a downward 
comparison (Section 6.7.2.4) between themselves and other patients:   
 “I couldn’t get out of bed, yeah I had the doctor then, not that she could do much 
because, just because I knew what it was all about you know” (Mary, 77) 
“They can give me a depo [Depomedrone injection] and I can have up to 4 but I 
really try not to, I only try and have them when I’m going on holiday um, which is 
about twice a year” (Isabelle, 45) 
“I am just conscious that, you know, you go to sit in a waiting room and there’s 
loads of people with walking sticks and all sorts in all sorts of trouble so I just 
want to, I don’t feel like I am that bad” (Charlotte, 37) 
There is a point at which some patients are aware that they need to seek 
help from the medical team, but continue to avoid help-seeking.  This can be due to 
feeling as though the flare has been self-induced, not wishing to see other patients 
in clinic, or not wishing to take drugs: 
“If I’d done something stupid or you know been dancing ‘til 5am in the morning 
and wondering why my knees were hurting the next day, I wouldn’t go in, I would 
feel embarrassed” (Charlotte, 37) 
“Not wanting to come in here as well, to be fair, ‘cos whenever you come in, you 
look around and you just think, I’m a generation below, if not two.  Everybody’s 
sat in this room, you know, and it’s just like, you just don’t want to see it” (Kate, 
35) 
“I wouldn’t get on the phone straight away because I’m a bit of a, I don’t really 
want to take drugs to be honest” (Emma, 42) 
 
In general, patients see seeking medical help as a last resort and they will 
wait until they are really desperate before contacting the medical team: 
“I’m the type of person that I would do it [ask for help] as a last resort and I don’t 
like feeling like I am wasting anyone’s time” (Charlotte, 37) 
 “Dr X [rheumatologist] knows I’ll wait until I am sort of pretty desperate really” 
(Isabelle, 45) 
 
 
 Chapter 6: Study 1: Interviews 
 
142 
 
6.8.3 Theme 2: Summary 
Fluctuating symptoms mean life with RA is unpredictable, which can cause 
patients to question how other people perceive them.  The unpredictable nature of 
RA also leaves patients uncertain as to what is causing their symptoms and how 
long they will last, which is one of the reasons that patients will avoid help-seeking at 
this point. The impact of these fluctuating symptoms cause the delicate balance that 
patients maintain in daily life, to begin to tip towards RA being in the foreground of 
their lives (Fig 6.19).  Theme 2 has been incorporated into the developing 
conceptual model of life with RA (Fig 6.20).  
 
 
 
 
Figure 6.19: RA moving into the foreground 
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Figure 6.20: Developing conceptual model to explain life with RA 
 
6.9 Theme 3: Dealing with RA in the foreground 
When patients experience an RA flare, their RA can no longer be ignored or 
pushed into the background.  Patients attempt to regain control of their RA and their 
lives, but once their self-management strategies can no longer contain their 
increasing symptoms, patients decide that they have no choice but to seek medical 
help.  At this point, patients are experiencing their RA in the foreground as an 
unwelcome reality and have to deal with their wellness disappearing into the 
background. 
6.9.1 Trying to regain control 
When patients are in a flare, they can feel like they are losing control of their 
lives and will employ a number of strategies in an attempt to regain that control.  
Patients increase their self-management strategies to try and control the flare 
symptoms.  Some patients withdraw socially to control the effect that their symptoms 
and emotions might have on others, whilst others withdraw in order to control the 
amount that they have to acknowledge the effect the flare is having on them.  All 
patients involve luck when talking about their RA, which seems to be an attempt to 
manage the loss of control they experience. 
 Chapter 6: Study 1: Interviews 
 
144 
 
6.9.1.1 “I just try anything”: Crisis management of a flare 
When in a flare patients are more likely to use crisis management 
techniques.  This differs from patients’ day-to-day management of their symptoms 
as they are no longer using preventative measures and have moved into damage 
control in an attempt to reduce their symptoms and the impact those are having on 
their lives.  When the situation and their emotions become overwhelming, patients 
experience desperation and report being prepared to try anything: 
“I mean I just try anything to, you know, try and defeat it really” (Emma, 42) 
In terms of trying anything, some patients resort to extreme measures in an 
attempt to control their symptoms, such as fasting: 
“If I feel really bad, I do fast for a day.  I’ll drink [fluids] but I do fast and that does 
help” (Isabelle, 45) 
Patients use tried and tested techniques such as using hot and cold packs 
on their swollen or aching joints in an attempt to alleviate symptoms: 
“If I got really achy joints I tend to use sort of like heat therapy on those and it just 
kind of relaxes you a bit more and I have also got gel packs that you can put in 
the freezer and then if they are really swollen I will use those” (Charlotte, 37) 
“I would actually sit down and see if I can either rest it or get some ice on it 
depending on you know, which joint it was and how easy that was to do” (Debbie, 
44) 
Patients recognised the importance of resting and relaxing whilst they are in 
a flare.  They also discussed the need to slow down and pace themselves and may 
therefore either leave a task unfinished or delegate to others: 
“When I have had them [flares] I’ve always gone and sat down and tried to rest to 
see and very often I do feel a lot, feel a lot better after I’ve rested” (Mary, 77) 
“So I had to make sure that I had enough ‘sick time’ and that, that when I had a 
flare-up I could take it [sick-leave] rather than just overdoing it” (Kate, 35) 
Some patients like to keep themselves busy when they are in a flare in an 
attempt to distract themselves from their symptoms, or possibly in an attempt to 
deny to themselves that they are in a flare.  However, this cannot be sustained and 
patients find themselves needing to rest and relax: 
“That’s what I found is when I’m, because you are on almost automatic pilot and 
you’ve got something else to think about but it’s as soon as you relax it’s like it’s, 
you know ‘Remember, remember me?’ and it [RA] raises its ugly head” (Isabelle, 
45) 
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Patients also use medication to control their flare symptoms by increasing 
the frequency and amount of their analgesics:   
“I get out of bed and walk around and I think ‘I’ll go and take Diclofenac, or 
whatever, an aspirin’, whatever I can take” (Sophie, 51) 
“I’ve got Tramadol which is another strong pain killer that I take sometimes and 
um it gets rid of the pain” (Chloe, 42) 
6.9.1.2 “You just go into hibernation mode”:  Social Withdrawal 
When they are in a flare, some patients retreat into themselves, choosing to 
close themselves off from friends and family. This seems to be due to patients either 
trying to protect themselves from the reality of their flare or to protect other people 
from their frustrations.  Isabelle says “You just go into ‘hibernation mode’”.  She 
explained the reasons for not wishing to see anyone as not wanting them to see her 
struggling, she also does not seem to want any sympathy.  This could be part of 
keeping up a public identity as a ‘well person’ and letting herself be seen in a flare 
would challenge her sense of self: 
“I can’t stand being around my friends thinking that I’m, not that they would but 
think that I’m like ‘Ooh’ or moaning or when I get up it’s like hobbling and they go 
‘Are you all right?’ and they are so good and I am like ‘Ooh just’, so I just retreat I 
do, I don’t want to see anybody” (Isabelle, 45) 
Kate also discussed why she avoids seeing other people when she’s in a 
flare.  She explains how in previous flares, her denial that RA was affecting her, 
could not continue if other people saw her.  There is a need for other people to 
validate the way we feel about ourselves, if they are unable to do this our beliefs 
about ourselves are challenged.  In order to protect herself from this, Kate chose to 
keep friends and family away as a defence mechanism: 
“I don’t think it’s necessarily the denial, it’s the fact that I couldn’t carry on my 
denial when I was in those flare-ups, because if people had come round they 
would actually see how bad it was and I couldn’t process that at that point” (Kate, 
35) 
As well as not wanting to see anyone, patients can also experience apathy 
and a loss of motivation to do any of the activities they would normally do.  Patients 
often don’t want to leave the house and many need their bed either due to tiredness 
or low mood: 
“I just feel that I’m not interested in anything really” (Mary, 77) 
“I don’t know really but I mean when you’re feeling, when you are in a flare-up 
then you do, it’s just everything is an effort” (Jane, 65) 
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“I just feel so tired I just want to sit down and go asleep, you know it feels like you 
want to hibernate as well, you know” (Emma, 42) 
Kate described how she would stay in bed during her flares due to tiredness 
and pain, but this became a problem as her low mood caused her to remain in bed: 
“I would then just get stuck in bed and I think the cycle would just feed into itself 
that on the days that I possibly was feeling a bit better physically, mentally I 
wouldn’t be so then that would bring it all down. Because not getting out of bed 
and not moving makes everything hurt more because you’re not using anything” 
(Kate, 35) 
6.9.1.3 “Just keeping my fingers crossed”: Attributing fluctuations to luck 
The unpredictable and fluctuating nature of RA means that despite expert 
self-management strategies, patients are not always able to control their own 
outcomes.  Thus in order to manage the release of this control, patients attribute the 
fluctuating nature of RA to luck.  Every patient mentioned luck in some form: 
“I’ve been lucky [he touches wood] that it’s usually a couple of days, two or 
three days it’s settled and I just come up to a stable point again” (James, 47) 
“So a normal day is pretty normal life really, I’m quite lucky, you know, I’ve only 
got it mildly” (Roger, 56) 
Patients use lucky actions such as keeping their fingers crossed and 
touching wood when they talk about future outcomes with their RA.  This may be an 
attempt to maintain an illusion of control over their outcomes: 
 “They upped the Methotrexate, which I do have to say, touch wood, um, has 
actually begun to settle things down” (Linda, 56) 
“I’m just keeping my fingers crossed” (Mary, 77) 
6.9.2 Losing control 
When patients are in a flare, their RA is firmly in the foreground, and they 
seem to be fighting a losing battle; they are severely restricted, start to lose control 
of their symptoms and eventually have to ask for help.   
6.9.2.1 “It’s like a ‘Game Over’”:  Unmanageable Impact 
When they are in a flare, patients experience further restrictions on their day-
to-day abilities.  This level of impact of RA is more than patients have learnt to adapt 
and adjust to in their daily lives.  Thus even patients who have accepted a new 
normality in their lives are unable to tolerate this new level of restriction.  Whilst 
patients experience a slower pace of daily life due to RA limiting their mobility, in a 
flare this restriction is dramatically increased with some patients reporting that they 
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lose their mobility completely and with some even finding themselves confined to 
their bed: 
“It isn’t the pain really it’s the immobility, what it makes you feel is, it’s just on top 
of the restriction you’ve got, it’s like a ‘Game Over’” (Isabelle, 45) 
 “At times I could not get out of bed” (Mary, 77) 
Other patients find that a flare means having to deal with restrictions on 
practical tasks, which can cause frustration or embarrassment.  The flare draws 
attention to patients, meaning they are unable to preserve their public identity as a 
‘normal’ person: 
“If I‘ve got a flare and my hands hurt, I find that I drop things easily um and it’s 
difficult to open things and sort of like anything that’s fiddly” (Debbie, 44) 
“Awkward things and things more embarrassing than um, than uncomfortable or 
painful just in a social way, in a shop when you’re like picking stuff up and you 
drop it. Like, I’m trying to get my credit card out and she’s giving me a receipt and 
then she says ‘Have you got a Nectar card?’ and I throw it at her” (Sophie, 51) 
Patients describe feelings of frustration and irritation due to the extreme 
limitations that an RA flare can impose on them.  This can be made worse by the 
flare symptoms such as pain and fatigue causing patients to have a shorter temper 
than usual: 
“You just put up with it, it’s very very frustrating, extremely frustrating” (James, 
47) 
“I do tend to get irritable when I’m tired and in pain” (Debbie, 44) 
Chloe described how she was unable to pick up her new born baby, showing 
the impact a flare can have on even her most valued role.  She went on to describe 
how the intense effort needed to overcome these restrictions is reserved for truly 
extreme circumstances.  This demonstrates how an RA flare can cause patients to 
lose control of their situation and they may be unable to fulfil even the most 
important of their responsibilities, through no choice of their own: 
“I’d just had my second child and she was only six weeks old and I couldn’t even 
lift her out of the cot. I just could not lift her up, I just couldn’t physically, I was so 
bad with a flare-up that I just couldn’t move.  I couldn’t even get out the chair, I 
couldn’t walk, I couldn’t do anything” (Chloe, 42) 
“The little one’s just about to go out the door and you’re thinking ‘who left the stair 
gate open?’ and he’s gone and you’re thinking ‘oh I can’t run after him’, I just, you 
know. I do if I have to, I will have to put my head on and say ‘Right, you have got 
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to do it’, it might hurt, but you’ve got to get to him before he gets to the gate and 
he tries to go out into the road” (Chloe, 42) 
When they are in a flare, patients often feel that they have no choice but to 
ask for help from friends or family.  Independence is important to patients with RA 
(Section 6.7.2.1) and having to ask for help may not only cause them to feel 
dependent on others, but may also challenge their self-identity as capable, 
independent people: 
“I have to [ask for help] when, I really have to when it’s a flare-up because I can’t 
pick things up, I can’t even dress myself um, so then I do have to ask for help” 
(Liz, 59) 
The feeling of having no control over their flare is also expressed by patients 
in terms of when it comes, or how long it lasts.  Patients attempt to regain control 
over their symptoms through their normal self-management and coping strategies 
(section 6.7.1).  However, when these strategies are no longer sufficient, patients 
become even more aware of their loss of control as they are unable to help 
themselves: 
 “Don’t know what to do about it [flare].  Don’t know how to alleviate it” (Sophie, 
51) 
“There are times when, it just seems whatever you do, um it doesn’t prevent the 
flare going any further” (Linda, 52) 
During an RA flare, patients not only experience restrictions on their lives, 
but they can also lose both their control and independence.  Due to this, many 
patients report experiencing low mood during a flare, which some patients say is 
harder to deal with than the physical RA symptoms: 
 “It’s not so much the pain because you can take tablets for that but, you know, 
you can’t take tablets for what’s in your brain [negative thoughts], I don’t think” 
(Isabelle, 45) 
“It affects you in other ways, you know I think it does get you down and things like 
that, so it’s more than just the wrist pain” (Emma, 42) 
6.9.2.2 “I was in agony and I couldn’t do anything”:  Seeking medical help 
Patients will eventually seek help from the medical team for their flare.  An 
important tipping point for this seems to be when a patient feels they are no longer 
in control.  This can include a combination of: being unable to cope with the pain; 
being unable to control their symptoms; or the RA affecting their quality of life.  
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 “I went into one [flare] and I was in agony and I couldn’t do anything and um, I 
contacted them” (Chloe, 42) 
“It depends whether it’s really affecting what I’m able to do” (Debbie, 44) 
Another tipping point for seeking help is when patients feel that the flare is 
severe enough and it’s more than normal symptom fluctuation or when it has lasted 
longer than expected: 
 “I think you get a feeling as to what is just general activity and what is the 
medicine starting not to work and it’s getting a bit more out of control” (Debbie, 
44) 
“If I do have a flare, yeah I would contact them if it’s prolonged” (Charlotte, 37) 
When patients’ flare symptoms and the impact of these on their lives become 
noticeable, friends and family will often recognise that the patient needs to seek 
help.  Being prompted by friends or family is the tipping point for many patients 
when they are seeking help. This may be because patients are able to maintain their 
stoic, self-sufficient identity by being able to claim that they were pushed into 
seeking help: 
 “I do leave it quite a long time.  My daughter and my husband always say ‘You 
ought to go and see somebody’ and I think, ‘Oh, just give it a little bit longer, it’ll 
probably be ok’, but usually when it gets as bad as that I do need to um, see 
somebody” (Linda, 52) 
Previous experiences also encourage patients to seek help.  This can 
include knowing how bad the disease can get and not wishing to let it get that bad 
again, knowing that the medical team can help and knowing that there is easy 
access to the medical team. 
“I’m having a flare-up now, and it’s ok because I’m still managing, and that’s why 
I won’t ever let it get to the point that I can’t get out of bed again”  (Kate, 35) 
“At which point then you have got to come in and have injections and I wouldn’t 
want anybody to have fluid drained off your knees because it’s one of the most 
painful things I have ever had done in my life” (James, 47) 
 “I think that’s a huge, a massive thing for me is the accessibility to them [medical 
team]” (Isabelle, 45) 
Although patients will eventually seek help from the medical team when they 
are unable to manage their symptoms themselves, this is seen as a last resort for 
some patients, which they will only use when they feel desperate and unable to 
cope alone: 
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“I know last time I did everything I could to sort of prevent it, but it’s always the 
last port of call coming to see the rheumatologist.  I go through absolutely 
everything at home before I come and see them” (Linda, 52) 
6.9.3 Theme 3: Summary 
The unmanageable impact of RA that patients experience when they are in a 
flare, and the social withdrawal that this can lead to, tip the balance of life to RA 
being firmly in the foreground.  Patients try to balance the release of control over 
their symptoms with crisis management and attributing the flare to luck.  In daily life, 
patients will try to maintain a balance between asking for help and remaining 
independent, but when they are sure they are in a flare, patients will restore the 
balance to their lives by seeking medical help (Fig 6.21).    This behaviour 
completes the model that describes daily life with RA; the Fluctuating Balances 
Model (Fig 6.22). 
 
 
 
Figure 6.21: Dealing with RA in the foreground 
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6.10 Discussion 
This study has enabled the development of the Fluctuating Balances Model 
of living with RA (Fig 6.22), which centres around the need for patients to balance 
their fluctuating condition, in order to retain a sense of normality, identity, 
independence and control in their lives.  The model depicts life with RA as the 
illness shifting between the background and foreground of patients’ lives depending 
on the impact on their lives, their self-management techniques and the severity of 
their symptoms.  The red line at the top of the model represents the fluctuating 
symptoms experienced by patients, whilst the triangle at the bottom represents 
patients’ ability to balance every aspect of their lives.   
In daily life, patients were aware of the need to balance self-management 
strategies, as neither extreme of rest nor exercise is beneficial.  Patients also try to 
maintain a healthy balance between asking for help and remaining independent.  
However, this balance can be tipped when patients avoid seeking medical help for 
an RA flare.  Thus the impact of RA is mediated by the patient’s ability to maintain a 
delicate balance in their lives. 
The current study identified that life with RA is characterised by a fluctuation 
of the condition between the background and foreground of patients’ lives.  This 
supports the Shifting Perspectives Model (Patterson, 2001), which depicted the 
experience of chronic illness as continually changing perspectives about the disease 
to enable people to make sense of their experience.  The illness-in-the-foreground 
perspective is characterised by a focus on the sickness, suffering, loss and burden 
of the disease, whereas the wellness-in-the-foreground perspective includes 
attempts to reconcile self-identity and the identity shaped by the disease. However, 
the data from this study suggest that people with RA differ from this model in that 
the fluctuating nature of RA means that patients’ symptoms as well as their attitudes 
drive this shift in perspective. 
The individual graphs indicate that patients are never symptom free in daily 
life and following a flare they return to a baseline level of symptoms rather than an 
absence of symptoms.  Patients mediate the impact that physical and emotional 
symptoms have on their lives through a variety of self-management strategies and 
coping techniques.  A finding of particular note is that patients develop a strategy of 
micromanaging their symptoms, putting small adjustments in place throughout their 
day to reduce the potential future impact of their symptoms.  Through self-managing 
their physical symptoms, patients are also able to reduce the impact that their RA 
has on their independence.  However, when patients’ symptoms begin to move into 
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the foreground, they step up their self-management techniques in an attempt to 
reduce the chance of them turning into a flare.  Once patients’ symptoms have 
developed into a flare, they step their self-management up yet again from 
preventative management to crisis management, or damage control, but when their 
flare becomes unmanageable the final step is to seek medical help.  Thus patients 
appear to employ a stepped approach to managing their RA, depending on their 
symptoms.  In this way, patients move between the various steps on a ‘Mediation 
Ladder’ (Figure 6.23), which has been developed from these study findings. 
 
Figure 6.23: Mediation Ladder: Increasing steps of self-management 
 
Further, the findings in this study suggest that the components comprising 
impact of RA on daily life are severity of symptoms, self-management/coping 
strategies and symptom importance. This supports the proposed Impact Triad 
(Sanderson et al, 2011b) in which symptom severity, coping and importance interact 
to create a sense of impact. Thus whilst patients’ symptom severity impacts on their 
lives, this can be mediated by their self-management and coping strategies.  
However, when patients are unable to participate in valued activities, which are 
important to them in terms of maintaining their sense of normality and identity, this 
increases the impact of RA on their lives.  
The importance of retaining normality was raised, which supports previous 
findings (Sanderson et al, 2011a) in which six different typologies of normality were 
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highlighted.  The current study identified some but not all of the normality typologies 
in the patients’ stories.  Patients seemed to reconcile their personal identity with 
their identity as an RA patient, either by acknowledging and defining the two 
identities as separate or by incorporating RA into their identity.  Patients that 
reconcile their identities fit into Sanderson’s ‘resetting normality’ typology (normal life 
includes my illness).  However, patients trying to keep the two identities separate 
seem to be trying to reconcile ‘disrupted normality’ (overwhelming symptoms, 
normal life impossible) with ‘struggling normality’ (presenting a normal life whatever 
the cost).  Sanderson’s ‘fluctuating normality’ (life isn’t normal when I’m in a flare) is 
supported by the Fluctuating Balances Model (Fig 6.22) in which patients struggle to 
maintain a balance of control, independence, identity and normality in their lives 
when they are in flare. 
Patients use cognitive adjustments in order to mediate the impact that RA 
has on their identity and normality.  This includes adjusting their expectations of 
themselves and their abilities and making social comparisons.  Social comparison is 
a coping strategy that is particularly useful when a person is unable to change their 
situation (Wills, 1981; 1987).  Downward comparisons, which the majority of the 
patients in this study use, involve comparing oneself to a less advantaged person, 
often another less fortunate, patient (DeVillis et al, 1990).  One patient in the study 
displayed upward comparison, but this is not a positive coping strategy as patients 
are comparing abilities with someone who does not have the same restrictions 
(Wills, 1981; 1987). 
All patients in this study referred to the involvement of luck on their RA 
outcomes.  Locus of Control Theory (Rotter, 1966) proposed that individuals with a 
strong internal locus of control believe that they control their own outcomes through 
their own abilities and efforts, whilst people with a strong external locus of control 
believe that outcomes are due to external causes, such as luck.  This may indicate 
that patients with RA apply cognitions of an external locus of control to their RA.  
However, there are two dimensions to the external locus of control; chance and 
powerful others, and people who subscribe to one belief, do not necessarily hold the 
other. Thus a multidimensional health locus of control typology was proposed 
(Wallston and Wallston, 1982) in which patients could score high or low on each of 
the three dimensions of internal health locus of control (IHLC), powerful others 
health locus of control (PHLC) and chance health locus of control (CHLC), meaning 
6 different locus of control typologies are possible.  Four typologies include high 
CHLC, three of which seem unlikely to apply to the study population.  These are 
‘pure chance’ (IHLC and PHLC scored low); ‘double health external’ (IHLC scored 
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low, PHLC scored high) and ‘Yea-sayer’ (IHLC and PHLC both scored high, 
indicating participant scored yes to every question).  The yea-sayer typology does 
not apply in this case as patients were not asked to complete a locus of control 
questionnaire.  Further, the other two CHLC options do not apply to the RA patients 
in this study as they all discussed self-management techniques and controlling their 
RA themselves.  Thus RA patients seem to fall into typology VI (high IHLC and 
CHLC, low PHLC), which has been left unnamed due to rarely being relevant.  This 
typology states that the individual has learnt that there are certain aspects of their 
health that they can control and other aspects that are totally unpredictable 
(Wallston and Wallston, 1982).  This describes the experience of living with RA and 
thus chance is used as a tool to enable the individual to manage relinquishing 
control when they no longer have a choice.   
The current study found that unpredictability and uncertainty are central to 
patients’ experiences of RA, which supports previous qualitative research 
(Stenström, Bergman and Dahlgren, 1993; Hewlett et al, 2005a).   Patients try to 
make sense of their symptoms in terms of cause, how long they will last, and 
whether they can be defined as a flare.  This supports the Self-Regulatory Model 
(Leventhal, Nerenz and Steele, 1984; Leventhal and Diefenbach, 1991), which 
proposed that patients’ illness representations are based around distinct 
components which, in turn, determine coping.  Thus according to the revised Self-
Regulatory Model (Leventhal et al, 1997) patients will base their coping strategies 
on their own beliefs about the identity, cause, time-line and consequences and 
curability/controllability of their illness.  This model is supported by a previous study 
in which patients managed their RA flare according to its perceived cause (Kett et al, 
2010) and by the current study, which found that patients use different types of 
management depending on how they define their symptoms (identity) (Fig 6.23).  
Further patients will seek medical help for an RA flare based on how long they 
perceive their symptoms will last (time-line), worrying about long-term joint damage 
(consequences) and whether they feel able to self-manage their symptoms 
(controllability).  
Previous research (Hewlett et al, 2012) suggested that patients will wait to 
seek help for their RA flare, but as their self-management increases and their 
uncertainty as to whether they are in a flare decreases, they will seek medical help.  
Although the current study supports these findings, it also highlights an additional 
stage that patients go through before seeking help.  When patients decide they are 
in a flare, they will continue to delay help-seeking, whilst employing crisis 
management techniques, and withdrawing socially.  The majority of patients report 
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leaving help-seeking until their self-management strategies no longer control their 
symptoms.  
6.10.1 Strengths and Limitations 
This study included 15 participants and therefore could be criticised for not 
being representative.  However, this study sampled for a range of age, disease 
duration and disability, and recruited from 6 different consultants across 2 NHS 
trusts, thereby accessing a range of different disease experiences and care 
pathways.   Although the aim was to sample for a range of gender, only 3 male 
patients were recruited (20%), which is slightly less than the percentage of men in 
the general RA population (30%: Crowson et al, 2011).  The research did not ask 
patients about the impact of RA on intimacy and this imformation was not freely 
offered by patients, thus this issue has been overlooked in this study. 
This study involved one to one interviews with RA patients rather than focus 
groups, which enabled patients’ individual experiences to be understood without the 
risk of conformity bias (Asch, 1958).  The researcher introduced herself as a 
researcher, separating herself from the clinical team, which allowed patients to 
speak openly about their experiences.   A proportion of the data were independently 
analysed by two researchers and a patient partner to ensure rigour and reduce the 
chance of researcher bias (Cohen and Crabtree, 2008). 
6.11 Summary 
Patients’ experiences of RA shift between RA being in the background and 
wellness being in the foreground and vice versa.  In daily life with RA, even on 
current treatment regimes, patients experience a complex mixture of symptoms, 
emotions and beliefs, which they mediate through self-management, coping 
strategies and cognitive adjustments in order for the patient to maintain a balance in 
their life.  Patients experience life with RA as full of uncertainty and unpredictability 
due to the fluctuating nature of the disease.  When patients are uncertain as to 
whether they are in a flare, they will avoid help-seeking, whilst hoping for the best.  
However, even when patients realise they are in a flare, they will often continue to 
put off seeking help, whilst engaging in crisis management and withdrawing socially.  
It is only when they can no longer control their symptoms, as a last resort, that 
patients will accept that they need to seek help from the medical team. 
It can be very difficult to articulate abstract illness concepts when patients 
have incorporated illness into everyday life and their sense of personal identity. 
Given that metaphors have been used in healthcare before, the issue of metaphors 
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to communicate the experience of living with RA was explored in depth, and will be 
presented in Chapter 7. 
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Chapter 7: Study 1b: Eliciting meanings from words 
(Metaphor analysis) 
At the end of the Study 1 interviews patients were asked ‘If your RA were an 
animal what would it be?’  The current chapter describes the rationale for asking this 
and presents the results for this question along with other metaphors used by 
participants. 
7.1  Literature Review: Metaphors 
The term metaphor has two different uses, both originating with Aristotle in 
4c BC.  A metaphor is a literary figure of speech that uses an image, story or 
tangible thing to represent a less tangible or intangible concept or quality.  The term 
metaphor can also be used for any rhetorical figures of speech that achieve their 
effects through association, comparison or resemblance.  Thus antithesis, 
hyperbole, metonymy and simile would all be considered types of metaphor 
(McArthur, 1992).  In this study, the latter meaning will be used, employing the 
broader definition of the term metaphor. 
7.1.1 Metaphors and the construction of reality 
It is suggested that a person’s conceptual system, which governs their 
thoughts and structures their perception of the world, is largely metaphorical (Lakoff 
and Johnson, 1980).  Since communication is based on the same conceptual 
system used in thinking and acting, language provides evidence for what that 
conceptual system is.  One example of a concept being a metaphor and that 
concept structuring everyday activity is the concept argument and the metaphor 
argument is war.  This metaphor is used in everyday language for example ‘that 
claim is indefensible’ or ‘my argument was shot down’.  Argument is not only talked 
about in terms of war, but arguments can also be won or lost and the person being 
argued with is considered an opponent (Lakoff and Johnson, 1980).  Thus 
metaphors may create social realities, and can be a guide for future actions that fit 
the metaphor reinforcing its power and making the experience coherent.  Lakoff and 
Johnson (1980) provide an example of this in the form of President Carter’s 
declaration that the energy crisis was “the moral equivalent of war”.  A more modern 
example of this is President Bush declaring ‘”War on Terror”, a metaphor that 
generated an ‘enemy’, and a ‘threat to national security’.  The acceptance of the 
metaphor forces one to focus only on those aspects of the experience that it 
highlights.  Thus the metaphor begins to define its own reality (Lakoff and Johnson, 
1980), in the example of President Bush this reality included the concept that terror 
Chapter 7: Study 1b: Metaphor analysis 
159 
 
could be personified as an enemy.  “War on Terror” was not merely a way of viewing 
reality, but led to policy change and political action. 
Metaphors therefore are conceptual in nature and can play a central role in 
the construction of social and political reality.  Exploring the way in which RA 
patients use metaphors may provide powerful insight into how they perceive their 
RA flares, daily life with RA and its daily management, how they experience the 
world within their wider life with RA and their socially constructed reality, including 
how they communicate this to health care professionals. 
7.1.2 Metaphors and the unconscious 
A child needs to understand what is going on within his conscious self so 
that he can cope with what is going on in his unconscious.  This can be achieved 
through daydreaming, fantasizing and story-telling (Bettelheim, 2010).  It is therefore 
possible that adults may also be able to uncover their unconscious concerns 
through the use of metaphors.  In fact, it is suggested that metaphor functions 
unconsciously as the interpreter of emotional memory (Modell, 2005).  
Metaphors have been part of psychotherapy since Freud (1900) referred to 
symbols in dreams and noted the metaphoric equivalent meanings that children may 
attribute to the sensations that arise from bodily openings, such as the mouth 
(Freud, 1933).  This ability of the infant to transfer perceptual experience from one 
sensory modality to another, indicates that abstract representations of perception 
are formed and acted upon from the earliest days of life (Stern, 1985).  Metaphorical 
process is an inborn readiness, independent of language and thus metaphors may 
lead directly to what is unconscious (Wurmser, 2011).  If metaphors are the 
“language of the soul [and] the discourse of the inner world” (Wurmser, 2011: 123) 
then looking at the metaphors used by RA patients has the potential to uncover a 
deeper, more meaningful understanding of patients’ individual experiences and 
perceptions of living with RA.   
7.1.3 Metaphors in the cancer discourse 
Metaphors are used in health and illness, and an example of this is the 
cancer discourse, where patients and physicians use metaphors to describe the 
experience of cancer. In addition, cancer itself is used as a metaphor in daily life. 
For both physicians and patients, war is a dominant metaphor for cancer 
(Reisfield and Wilson, 2004).  It is talked of in terms of a fight, which can be won or 
lost.  This war metaphor can be seen throughout the cancer literature including 
cancer charities and the media such as “Join the biggest fight against cancer” 
(Cancer Research UK, 2012); “Stamp out male cancer” (The Institute of Cancer 
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Research, 2012); and a story about an 11 year old boy describes him as “brave” 
during his “four-year battle” and reports that he “lost his fight against brain cancer” 
(Daily Mail online, 2011).  However, the use of war as a metaphor has its limitations.  
Firstly, it is inherently masculine, power-based, paternalistic and violent (Mitchell, 
Ferguson-Pare and Richards, 2003) and for some patients conflict and fighting are 
not the preferred ways of coping with illness (Bowker, 1996; Hawkins, 1999).  
Further, there is the suggestion that winning the war (defeating the cancer) is only a 
matter of fighting hard enough (Hawkins, 1999), and thus one is personally 
responsible for one’s death by failing to fight. 
Cancer is also used as a metaphor in daily life.  Cancer is associated with 
slow, agonising and disfiguring death (Fye, 1996), and regarded with dread as 
‘loathsome’, thus it is logical that cancer has emerged as an evocative metaphor 
(Clow, 2001). Sontag (1979) provides the example of the Nazis likening the Jewish 
community to a ‘cancerous lesion’.  She argues against the use of illness as 
metaphor, claiming that metaphors warp illness experiences by heightening the 
social and psychological anguish experienced by a cancer diagnosis, because 
metaphors insinuate that the disease is disgraceful and shameful.  Sontag wished to 
eliminate metaphors from the cancer discourse, believing that removing the 
symbolic associations would enable patients to see cancer as a biological 
phenomenon rather than a social or moral one.  However, neither shame nor silence 
have been found to be features of the experience of cancer (Clow, 2001).  
7.1.4 Metaphors in healthcare 
In a health care setting, metaphors can assist both the physician and the 
patient.  For the physician, metaphors can be time-efficient tools for helping patients 
understand biologic processes (Arroliga et al, 2002).  For patients, metaphors can 
increase empowerment (Harpham, 2010) and improve comprehension of health 
explanations and retention of illness explanation (Whaley, 2000).  Metaphors can 
also be used by family members to help make sense of their loved one’s experience 
(Mastergeorge, 1999).  The shared language of metaphors can therefore aid the 
therapeutic relationship by providing a shared understanding of clinical reality 
(Reisfield and Wilson, 2004).   
Metaphors have helped health researchers gain insight into a range of 
understandings and experiences including patients’ and caregivers’ experiences of 
palliative care (Richardson and Grose, 2009) and men’s experiences of fibromyalgia 
(Paulson et al, 2001).  Caregivers’ of dementia patients use the metaphor of a 
journey to describe their situation (Golden, Whaley and Stone, 2011).  They 
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describe themselves as “drifting along” and trying to “find a course”, whilst they 
describe the person with dementia as “going downhill”.  These caregivers also 
describe life using other metaphors such as a machine (“system is beginning to shut 
down”) or harm (they’re “falling apart”; “beating [themselves] up” and “banging [their 
heads] against a wall”).   
Children with asthma (Peterson and Sterling, 2009) describe their condition 
as “a boa constrictor squeezing the life out of you”; a “troll [that] sleeps all day in the 
dark…until I wake him up by the activities I do, [then] he climbs up the ladder to tell 
the air it has to pay to come into my chest” or “[a] guardian angel [that] helps me to 
be good.  However, if I mess up, I will get into trouble.  My guardian angel does not 
protect me and can even take the air away”.  These metaphors provide a powerful 
insight into the way in which these children perceive the cause and experience of 
asthma. 
Metaphors are currently used in both family therapy and cognitive 
behavioural therapy (CBT).  Family therapy uses a technique called the animal 
attribution story telling technique (AASTT), which is used with children with 
behavioural disorders.  AASTT involves asking children to assign animals to each of 
their family members and tell a story that includes all the animals.  This technique is 
fun, non-threatening and encourages participation.  It provides the clinician with 
material that begins to explain the relationships within the family and provides a 
‘safe’ way of discussing this (Arad, 2004).  Metaphors have been used in CBT as a 
tool to assist with information processing or to provide a model for the change that a 
patient is trying to undertake (Otto, 2000). 
The use of metaphors has therefore been shown to be used in many health 
conditions as a way of grasping emotionally difficult concepts and of finding meaning 
in intangible thoughts and ideas (Lakoff and Johnson, 1980).  However, the use of 
metaphors to understand patients’ experiences of RA has not yet been explored. 
7.1.5 Animals as metaphors 
Although it can be argued that metaphors are culturally specific and may 
therefore not be universally comprehended, it is precisely this culturally specific 
nature that makes them valuable in emphasising the degree of emotion in a situation 
(Richardson and Grose, 2009).  Thus in prompting RA patients to describe their 
experience in terms of metaphors it would be necessary to choose a prompt that 
could be universally relevant. 
The metaphor “humans are naked apes” (Morris, 2005) indicates that what 
humans share with animals is more important than what they don’t share (Goatly, 
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2006).  Animals as symbols exist in all cultures, they are in sayings such as ‘the 
early bird gets the worm’ and in myths, fairy tales and fables.  By relating to an 
image of an animal, one relates to its specific characteristics and symbolic meaning.  
This allows for a range of experiences, emotions and perceptions to be 
acknowledged in a single animal image.  The externalisation of thoughts and 
feelings through animal imagery can facilitate dialogue, inspire change and increase 
the sense of personal power (Arad, 2004). 
7.2 Methods 
In an attempt to capture either the most important aspects of living with RA 
or those concepts that patients may find difficult to express in a general 
conversation, patients in Study 1 were asked a question that allowed them to think 
in a more abstract way about their RA.  The two questions considered for this were 
“if your RA were an animal, what animal would it be?” and “if your RA were a 
person, what relationship would you have with them?” as both questions include 
universally relevant metaphors.  Following discussions with PRPs it was decided 
that the animal question would be the most appropriate.  The PRPs felt that trying to 
compare their RA to a person would be uncomfortable for them as the question felt 
too personal to answer.  The animal question was therefore chosen as it was a 
concept that could be universally understood, whilst allowing patients to think 
abstractly about their RA in a way that was removed from their personal 
relationships. 
Interviews were conducted with 15 RA patients as described in Chapter 5.4. 
At the end of each interview, participants were asked “If your rheumatoid arthritis 
were an animal, what animal would it be?”   The interviewer acknowledged that the 
question was unusual and that it was alright for them to think for a little about their 
answer.  The interviewer was also ready with examples to give in case patients 
struggled with the concept, but this was not needed.   
7.2.1 Analysis 
The use of animals as a metaphor caused the researcher to be sensitive to 
other unprompted metaphors used during the interviews, as patients explained their 
experiences of daily life.   There is no agreement on the best method for identifying 
metaphors and the boundary between literal and metaphorical can be ambiguous 
(Gibbs and Franks, 2002).  For the purpose of this study, as mentioned in Section 
7.1, metaphors included any rhetorical figures of speech that achieve their effects 
through association, comparison or resemblance.  Deductive Thematic Analysis 
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(Braun and Clarke, 2006) was used to search the data for both prompted and 
unprompted metaphors. 
7.3 Results 
This was the same participant sample as described in Chapter 6.4.1 and 
Table 6.1. Patients used a range of metaphors to describe living with RA without 
being prompted.  The animal question was asked at the end of the interview, 
therefore patients had not already been primed to think in abstract ways.  Three 
main themes were identified, underpinned by a sense of identity: 
7.3.1 Theme 1: Zombies and dragons: Experiencing rheumatoid arthritis 
Patients used metaphors to describe the wide range of physical symptoms of 
RA that they experience on a day to day basis.  One patient said “I walked around 
like a Zombie for half the day” (Liz, 59), describing her experience of fatigue.  This 
indicates that fatigue can make patients feel as though they are not themselves; 
they may be unable to think straight or function as normal.  Fatigue is a concept that 
patients found particularly difficult to describe as it is not a visual symptom and 
cannot truly be understood by people who have never experienced it themselves.  
Metaphors used to describe this symptom involve large objects creating a barrier for 
patients:  
“I can wake up sometimes and feel like I’ve got a lead weight on me...It’s just like 
walking into a brick wall” (Roger, 56) 
The swelling in their hands and feet were compared to “sausages” (Mary, 77) 
and “great big plates of swollen meat” (Chloe, 42).  Using everyday objects makes it 
easy to visualise the symptoms being described as it puts it into a context that a lay-
person can understand.  Their descriptions make their hands and feet sound 
unattractive, the comparison to pieces of meat may indicate that patients see the 
swollen parts of their body as objects rather than a part of them.  
RA pain was likened to common types of pain that other people will have 
experienced and will understand.  The use of a familiar sensation enables friends 
and family to have a better understanding of patients’ symptoms: 
“I was constantly in toothache in my knee” (Chloe, 42) 
One patient described the pain she has experienced as “a lot of knives going 
into you” (Mary, 77).  Although unlikely that friends and family have experienced 
this, it is still a concept that can be recognised as painful and traumatic.  It conjures 
up a powerful mental image, providing insight into this patient’s experience, which 
may not have been achieved without the analogy.  Patients described pain and 
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discomfort in their feet, again using sensations that most people will be able to relate 
to.  Whilst these are less disturbing than the knife metaphor, they provide a clear 
picture of the discomfort: 
“If you walk on gravel in bare feet, it’s like that all the time even when you’ve got 
shoes on” (Linda, 52) 
 “Like walking on pebbles on a pebbly beach, that’s how it feels, that you can do 
it and it’s not gonna do you any harm but it’s not comfortable” (Sophie, 51) 
The periodic flares of RA characterised by hot, swollen joints, were likened to 
a fiery dragon or other examples of heat: 
“A Dragon comes to mind because it’s breathing my heat...that nasty fire that 
keeps attacking” (Liz, 59) 
 “a burning knotted flame” (Liz, 59) 
“as though you’re boiling, like it’s [blood] bubbling” (Amelia, 67) 
  Living with RA can also be an emotional experience, patients reported 
feelings of anger and frustration (Chapter 6.7.1.2).  One patient described this as:  
“Being in a pressure cooker, it bubbles and bubbles and bubbles and then it just 
goes” (Chloe, 42) 
Patients with RA have many symptoms that are difficult to describe, 
particularly those that are invisible such as pain and fatigue.  Using metaphors, 
patients are able to paint vivid pictures of concepts that would not otherwise be 
understood.  As a tool for communication, they enable patients to explain to friends 
and family how they experience life as a person with RA. 
7.3.2 Theme 2: Snakes and tigers: Unpredictable and uncertain 
Patients chose animals that attack from out of the blue, that are sneaky and 
that stalk their prey.  One patient compares his RA to a snake, highlighting its 
unpredictable nature:  
“Snakes, because they are horrible and sinister and sneaky and you know you 
don’t know when they are going to come and attack you” (James, 47) 
Another described a Tiger: an animal that is potentially dangerous due to its 
speed and sharp teeth.  However this patient describes her RA in terms of a tiger 
because of its unpredictability, rather than its ferocity: 
“I just envision a tiger creeping up through the undergrowth and you don’t know 
when it’s going to hit and then it does” (Charlotte, 37) 
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Another patient chose a Hyena, again highlighting the unpredictable aspect 
of this animal’s nature: 
“Snarly and laughing at you one minute and then snapping at your heels the 
next” (Isabelle, 45) 
When asked to think of an animal that represents their RA, many patients 
were drawn to vicious animals: 
“I’m thinking about the deadly 60 now” (James, 47) 
This quote refers to a children’s television programme in which a wildlife 
presenter attempts to find 60 of the world’s deadliest animals (CBBC, 2012).  These 
animals represent not only the aggressive nature of RA, but also its unpredictable 
nature.  In contrast, other patients chose tamer animals to describe the 
unpredictable and uncertain nature of living with RA.  One patient compared his RA 
to a domestic cat, indicating the lack of control that patients can feel due to 
unpredictability: 
“It [Cat] can be friendly when it wants to be but when it doesn’t want to be, you 
know, you can talk to the tail, as they say” (James, 47) 
Another patient used an unprompted metaphor to describe how her 
symptoms change daily: 
“You’re sort of up and down like the Weston donkeys” (Jane, 65) 
This refers to the donkeys on Weston-Super-Mare beach that walk up and 
down the beach giving rides to children, it is an expression used by people local to 
the Bristol area.  It suggests fluctuation, another aspect of the unpredictable nature 
of RA. 
One patient provided such a powerful description when asked “If your RA 
were an animal, what would it be?” that his story is highlighted in full.  Michael was 
angry with the way his RA was handled at the point of diagnosis, and although he 
had been diagnosed for 10 years it does not appear that he has been able to accept 
his RA.  He did not like the idea of comparing his RA to an animal, he came up with 
his own solution and provided his reasons for this: 
“Well, comparing it to say to someone in the animal kingdom, which are natural 
creatures in their natural environment, doing their natural things, I am not sure 
that’s a good analogy to be honest with you.  Um, you know because an animal 
doesn’t attack you for no reason...because you are normally threatening it you 
know.  If it’s people that would be different” (Michael, 48) 
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Michael was then invited to answer the question any way he would like to.  
His response provides a vivid metaphor for the helplessness patients can feel due to 
the unpredictable and aggressive nature of RA: 
“Someone like Hannibal Lecter [notorious fictional psychopath and cannibal: 
Harris 1981; 1988]... Um, it’s going to attack you at your lowest point and um 
where it hurts and um with malice in their heart really.  Whereas animals, you 
see, they don’t do that they will just react instinctively and you know if it is 
attacking you, you have got a chance of defending yourself and shooting it and 
removing it as a threat you know.  But if you have got someone that’s cleverer 
than you are and it’s on your case it’s stalking you um, no you are not looking at 
an animal, which is just doing its own thing so no I’m sorry I am not sure I can 
think of any animal even the most venomous you know they are in their own 
element.  As I say for me it’s Hannibal Lector as a person...there is only one 
creature that does things out of malice and nastiness and that’s your fellow 
human being really, and that is what your arthritis is really, it’s attacking, it’s 
turning your defences against you, your vulnerable points, your weak points in a 
way that hurts and you know catches you at your most awkward and most 
vulnerable and that’s what your psychiatrist turned serial killer does isn’t it really 
that’s their raison d’être really that’s their theme” (Michael, 48) 
Michael used metaphors throughout his interview to make sense of his 
situation.  One modern metaphor he used highlights the uncertainty surrounding RA 
as he attempted to make sense of the cause of RA and went on to hypothesise a 
cure: 
“It’s almost like a computer virus...it’s got an endless loop that won’t stop.  So the 
question then is how do you solve that on a computer? Well you can, well you 
pull the plug out and put it back in.  So maybe with that analogy...the logical sort 
of follow-on from that maybe is um you know whether the body would redo that, 
you know, reboot its immune system, would it default back to the original factory 
setting?” (Michael, 48) 
Patients often chose unpleasant metaphors to describe their RA, 
concentrating on the unpredictability and aggression.  Patients were also uncertain 
about how bad their symptoms will be from day to day, about the cause of their 
symptoms and many patients spoke of the hope for a cure.   
7.3.3 Theme 3: My ugly sister: Living together 
Many patients develop the skills to adapt to and cope with their RA (Chapter 
6.7) and are therefore used to living with their condition, although it remains an 
unwelcome presence in their lives: 
 “It’s almost like an ugly sister [laughs] it’s like almost, not the devil, but it lives 
with me” (Isabelle, 45) 
“An angry cat [laughs], it’s sort of like a, it’s my companion, but it can be quite 
vicious sometimes” (Debbie, 44) 
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Patients also used metaphors to describe the restrictions they experience 
due to their RA, this includes having to adjust to a slower pace of life and dealing 
with the barriers that RA can create: 
“It [elephant] can’t really run as fast as it used to, it can’t pick anything up, it could 
with its trunk but not with its hands, um, yeah an elephant” (Sophie, 51) 
“You’re there trying to fight your way through it and it [spider] keeps putting its 
web up to keep tracking you and stop you doing things that you want to do” 
(James, 47) 
There is also an awareness of the background reality that RA is gradually 
causing further joint damage, coupled with the fear of disease progression: 
“I thought of a rat...it’s just gnawing away quietly” (Linda, 52) 
Patients used less aggressive metaphors to explain what it is like to live with 
RA in general, as opposed to metaphors that specifically encompassed their 
symptoms or RA flares.  Despite the softer metaphors, patients still discussed living 
with their RA in terms of a battle.  A pathetic fallacy (McArthur, 1992) is similar to 
personification but more abstract, referring to the inclination to attribute human 
qualities to nature.  The term pathetic refers to ‘pathos’ or ‘empathy’, the capability 
of feeling and is therefore not intended as a derogatory term.  Thus by describing 
RA as something/someone capable of winning, these patients employed the 
‘pathetic fallacy’ that RA has the human capacity of wanting to beat them: 
“I have to feel really really, that it’s beaten me to [have to] go to bed” (Linda, 52) 
“Then obviously when it’s a flare-up it feels like it’s won” (Isabelle, 45) 
Although patients learn to adapt to their RA and to self-manage their 
symptoms on a daily basis, it is possible that patients never truly accept their RA.  
Through the metaphors in this theme patients indicate that whilst RA is part of their 
lives, it is an unwelcome inconvenience. 
7.3.4 Underpinning Theme: My yellow brick road: Identity 
Retaining identity is important to patients; some tackle this by incorporating 
RA into their identity, whilst others are determined to keep their pre-RA identity in 
spite of their RA.  One patient, Kate, explained that she feels other people have 
negative perceptions of her as an RA patient (Chapter 6.8.1.2). Kate went on to 
highlight this issue when she was asked to describe an animal: 
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“It’s [Sloth] big, it’s cumbersome, it looks horrible, it looks like it can’t do anything, 
but it actually is still able to get up and down a tree... even though it might look 
quite bad, on a good day you can actually be completely normal and you are 
completely normal ...but they can still climb up trees, and there’s nothing in 
nature that says they should be able to climb up trees, because they’re great big 
hairy mammals, but they can” (Kate, 35) 
The metaphor of the sloth shows the need for patients to defy the negative 
perceptions that others may have of them.  It is of note that Kate slipped between 
talking about the sloth and herself in the above quote, indicating how personal the 
metaphor is to her.  It is important to Kate that despite having RA, she is able to 
retain her identity of being a strong, self-sufficient woman. 
As discussed in Section 7.3.2 patients often chose aggressive, unpleasant 
animals as metaphors for their RA.  However, many patients mentioned softer 
options for the animals. It is possible that the fluffier choice of animal is because 
these patients have incorporated their RA into their identity.  These patients may 
find it difficult to think of themselves and their RA as truly separate, and thus not 
wish to associate themselves with an ugly or unpleasant animal: 
“I suppose you could equally say a shark but no something furry would be better 
[Tiger], nice and furry at least it’s a little bit furry and cuter” (Charlotte, 37) 
“I think anyone would say that they’d rather be a sloth than a snail, less likely to 
get squashed under-foot” (Emma, 42) 
Many patients also felt it was important to note that they were only able to 
give their own account of living with RA and that patients all experience very 
different journeys: 
“This is the path I took, this is my yellow brick road” (James, 47) 
7.4 Discussion 
The secondary analysis of these data indicates that patients use metaphors 
in a descriptive way, to improve their explanations of their symptoms to others.  
Patients used these descriptive metaphors throughout the interviews without any 
prompting, which indicates that this is a technique that they use with their friends or 
family.  One of the descriptive metaphors used by patients is that their fingers are 
like sausages.  This is a comparison that is also made by professionals in relation to 
psoriatic arthritis, with “sausage fingers” being an accepted term used in the 
diagnostic literature (Mease and Goffe, 2005; Taylor et al, 2006) and in patient 
information leaflets (Arthritis Research UK, 2011c).  It is possible that patients 
recognise this term from hearing professionals use it, although it is also plausible 
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that patients have come up with the term themselves due to the appearance of their 
fingers when swollen.  In slang, ‘sausage fingers’ is a derogatory term to describe a 
person with fat fingers and it is therefore also possible that this is the root of 
patients’ use of the term.   
A further explanation is that patients are using pieces of meat to describe 
parts of their body as this may allow them to think of their body parts as objects that 
they are able to dissociate themselves from.  This idea resonates with the psychic 
defence mechanism of ‘splitting’ (Klein, 1952), which is the separation of one item 
into two, such that they can be handled separately.  When a person holds two 
thoughts in their mind that are contradictory or uncomfortable, the person will 
cognitively separate them, not thinking of the separate thoughts at the same time. 
This is a process of 'psychic economy' whereby a complex situation is simplified by 
separation rather than resolution.  This can be in the form of visual appearance, 
concepts or ideas, commonly split into ‘good’ and ‘bad’.  In this way people can split 
‘whole objects’ (a whole person) into ‘part objects’ (part of a person), which can be 
‘good’ or ‘bad’.  The ‘good part objects’ can then be retained, loved and admired 
whilst the ‘bad part object’ is externalised and attacked or repressed.  This allows 
people to like themselves, while still recognising some unlikeable qualities.  Thus 
patients may be unconsciously separating the ‘part objects’ of their body that they 
consider ‘bad’ (due to visible RA e.g. sausage fingers) from their ‘self’.  
Patients also used a battle or war metaphor when discussing their RA, which 
can be compared to the use of this metaphor in the cancer discourse (Hawkins, 
1999) and may indicate that patients attempt to counter-act the powerlessness they 
feel due to their RA with a power-based metaphor.  Whilst the media use the battle 
metaphor in reference to cancer, the same cannot be found in the public literature 
for RA.  However, similar terms have been found in the media in relation to the 
common cold (NHS Choices, 2010; Daily Mail, 2010).  As the common cold does not 
have a long-term impact on people’s lives, it is possible that the battle metaphor now 
exists in society as a metaphor for illness in general, which may have removed 
some of the power that these fighting terms once carried.  
The machine metaphor that was used by RA patients has been seen in both 
the cancer and dementia literature (Gibbs and Franks, 2002; Golden, Whaley and 
Stone, 2011). One patient compared his RA to a “computer virus” and hopes it will 
“default back to factory settings”.  It is possible that through using a metaphor of a 
machine, patients or care-givers are able to dissociate themselves from the body or 
mind, thus making it easier to cope with an altered body or mind.  The concept of 
dissociation was also mentioned in relation to patients describing their bodies as 
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pieces of meat.  It is possible that patients use metaphors as a way of explaining 
their disease, whilst still being able to emotionally distance themselves. 
Very few studies include comparisons of health conditions to animals.  In a 
previous qualitative study one young patient compares his asthma to a boa-
constrictor (Peterson and Sterling, 2009).  This enables comparisons to be drawn 
with the current study as one patient used a snake as a metaphor for his RA.  
However, the reasons that the snakes were chosen for the two conditions differ; in 
asthma the snake metaphor represents the crushing, restricting feeling of being 
unable to breathe; whereas in RA the snake metaphor represents the sneaky, 
unpredictable nature of the disease.  This demonstrates that the same animal can 
be used to typify two different concepts and therefore the reason that patients are 
using particular metaphors should be listened to and assumptions should not be 
made.  One similarity between the asthma metaphor of the boa constrictor and the 
RA metaphor of the snake is that both types of attack result in the patient losing 
control.  The feeling of losing control is exemplified by a number of the animal 
metaphors chosen by RA patients in terms of not being able to control or predict 
when a flare will come (e.g. tiger), loss of control over everyday symptoms (e.g. 
domestic cat) and loss of control over the pace of life (e.g. elephant). 
When patients were asked to describe their RA in terms of an animal, some 
found it a strange or abstract concept and asked the researcher why she was asking 
them, whilst other patients immediately took to the question and gave an instant 
answer.  Those patients who thought the question slightly strange were satisfied 
with the answer that the question was there to add some light relief to the end of the 
interviews and that it may uncover issues that they had not previously thought of.  
All participants were able to give an answer to the question without any difficulty, in 
fact many enjoyed this task, reporting that it allowed them to think about their RA in 
a different way.  Some patients even expressed intentions to ask friends who have 
RA the same question. 
The majority of patients seemed to choose animals that reflected the overall 
tone of the interview and the concepts that were emerging as most salient to them.  
The most pertinent of these was Kate, who focussed in her interview on how other 
people have negative perceptions of her due to her RA. Kate wanted to show that 
she is still a strong young woman and thus used the metaphor of the sloth as it is 
able to do more than its appearance suggests.  Other examples include; Michael, 
who was angry about his RA and the lack of control he felt and compared his RA to 
Hannibal Lecter; and James who was unhappy at having had to give up playing 
Rugby due to his RA and described his RA as a spider’s web putting up obstacles to 
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stop him doing what he wants to.  It is possible that these issues are only what was 
most important to patients at the time of the interview rather than in general about 
their RA.  However, the use of metaphors to illustrate the most important aspects of 
RA, even if only at that moment, would enable clinicians to gain more insight into the 
issues that matter most to RA patients.  The large use of metaphors to highlight the 
unpredictable nature of RA indicates that this is an aspect of RA that is highly salient 
to patients. 
7.4.1 Strengths and limitations 
Secondary analysis can be criticised on epistemological grounds (Mauthner, 
Parry and Milburn, 1998; Blommaert, 2001) suggesting that only through a personal 
involvement in data collection and the reflexive relationship between the researcher 
and the researched, can the researcher interpret the interviews and recommending 
that secondary analysis is limited to ‘methodological exploration’.  However, this 
secondary analysis was done shortly after the initial analysis.  The researcher 
conducted the interviews herself and had audio versions of the interviews as well as 
the transcripts in order to give the patients as much of a voice in the secondary 
analysis as in the first. 
Whilst metaphors have been used in a number of other health conditions to 
explore the patient experience, the use of metaphors in RA is still a novel concept.  
Patients in this study were asked to describe their RA in terms of an animal at the 
end of the interviews, and therefore patients were not primed to think in terms of 
metaphors for the duration of the interview.  This demonstrates that the metaphors 
used by patients prior to the animal question were all naturally occurring.  Further, 
patients were asked to expand on their reasons for choosing these animals, so that 
no assumptions could be made as to the reasons patients chose a particular animal.   
7.5 Summary 
Patients used a range of metaphors to explain their experiences of living with 
RA, which seems to be a method of communication familiar to them.  Patients use 
aggressive, unpleasant metaphors to describe fluctuating symptoms or flares, but 
gentler metaphors to describe daily living.  The use of metaphors to explain life with 
RA is underpinned by patients’ sense of identity.  Further, when asked to summarise 
their RA under one metaphor, patients will pick the aspect of their RA that is most 
important to them, thus providing a valuable insight into their experience.   
Chapters 6 and 7 have presented the patients’ experiences of RA as a 
balancing act between living with it in the background, seeing it creeping back into 
the picture, and then dealing with flare in the foreground, vividly encapsulated by the 
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use of metaphors. The variation in these experiences and decisions on seeking help 
will now be explored for clusters or patterns, using Q-Methodology on data from 
these 15 patients, presented to a fresh cohort of patients.
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Chapter 8: Study 2: Elucidating clusters of experience          
(Q-Methodology) 
Chapters 6 and 7 highlight that life with RA comprises a diverse range of 
experiences, which patients can find difficult to express. The current chapter 
therefore presents the results for the Q-methodology study (Study 2), which aims to 
obtain consensus of these diverse experiences, using statements generated in 
Study 1. 
8.1  Objectives for Study 2 
1. To obtain consensus on the experience of living with RA from day-to-day 
2. To obtain consensus on patients’ decision-making surrounding help-
seeking behaviours when in a flare 
8.2 Summary of Study 2 methods 
Q-methodology is the scientific study of subjectivity and aims to explore the 
subjective dimension of any issue towards which different points of view can be 
expressed (Brown, 1996).  First, the range of opinions, or concourse (Brown, 1993) 
on both daily life with RA and help-seeking for RA flares needed to be sampled.  
This was done through interviews with 15 RA patients (Study 1, Chapter 6) and a 
literature review.  The statements taken from this wide concourse were refined 
through discussions with a PRP and put onto cards.  The statements were divided 
into two Q-sorts, one for daily life and one for flare help-seeking.  Prior to the Q-sorts 
patients were asked to complete a questionnaire (Appendix C) comprising 
demographic questions and the HAQ (Fries et al, 1980).  Then, each patient sorted 
(ranked) all of the Q-statements across a normal distribution grid into the order that 
they agreed with them (daily life; +5 to -5 and flare help-seeking +4 to -4).  Patients 
were invited to complete comments booklets about why they decided to sort the 
statements in this way and any other thoughts and feelings they had about individual 
statements (Appendices O1 and O2).  Patients were particularly encouraged to 
comment on the three top and three bottom sorted statements.  Q-analysis was 
used to analyse these data using PCQ for Windows software (Stricklin and Almeida, 
2010).  For the full study methods see Chapter 5.5. 
8.3 Deciding on the Q-set 
The statements (Q-set) used in the daily life Q-sort were gathered from 
Study 1 (Chapter 6), which produced 68 statements (Appendix P1).  21 of these 
statements were removed due to being related to a long-term rather than daily 
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consequence of RA (e.g. “I have had to give up something important to me because 
of my RA”) and 12 statements were removed due to being duplicates or polar 
opposites of the remaining statements.  Four individual statements were added 
based on patients’ experience of their symptoms in the qualitative interviews 
(statements D35 to D38).  This produced 39 daily life statements. 
The flare help-seeking Q-set were gathered from Study 1, which produced 
50 flare statements (Appendix P2), 30 of which were removed due to being related 
to the experience of flare rather than specifically to help-seeking (e.g. “A flare affects 
your entire body”).  Further, a literature review produced three flare statements that 
had not already been raised in the interviews, and were included to ensure a full 
range of beliefs (Table 8.1), producing 23 flare help-seeking Q-statements. 
 
Table 8.1: Sources of statements taken from the literature review 
 
 
 8.4  Factor extraction 
In Q-methodology it is necessary for the researcher to decide how many 
factors to extract for interpretation, and there are a range of criteria that can be used 
to decide this.  For the purpose of this study Watts and Stenner’s (2012) method 
was used, which combines the Kaiser-Guttman criteria (Guttman, 1954; Kaiser, 
1960; 1970), Brown’s (1980) ‘magic number seven’ (Chapter 5.5.9.2) and the ability 
of the researcher to override these criterion when experience, logic and the data 
dictate otherwise.   
As discussed previously (Chapter 5.5.9.1) the percentage variance accounts 
for a certain percent of the common variance present in the study.  For example, 
daily life Factor A accounts for 11% of the study variance and therefore accounts for 
11% of everything that the Q-sorts have in common (Watts and Stenner, 2012).  An 
Eigenvalue (EV) is indicative of a factor’s statistical strength and explanatory power.  
Low factor EVs, specifically those less than 1.00 are generally disregarded in Q due 
to the factor accounting for less study variance than a single Q-sort (Watts and 
Stenner, 2005a).  This is known as the Kaiser-Guttman criteria (Guttman, 1954; 
Statement Source 
 
F13: I am reluctant to seek medical help as I don’t get on well with my 
rheumatology team 
Kett et al (2010) 
F18: I am reluctant to seek medical help as I don’t want to waste my own time 
Sheppard et al 
(2008) 
F23: I wait until I have more than one flare symptom before seeking medical 
help 
Hewlett et al 
(2012) 
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Kaiser, 1960; 1970).  Thus high EVs and variances are considered worthy of 
attention (Kline, 1994). 
The statements were analysed using PCQ for Windows software (Stricklin 
and Almeida, 2010).  The factors were extracted and rotated using the orthogonal 
varimax procedure.  The researcher began with the daily life Q-study, by extracting 
five factors, based on Watts and Stenner’s (2012) rule of thumb of starting with one 
factor for every 6-8 participants, a variation of Brown’s (1980) ‘magic number seven’.  
This five-factor solution (Appendix Q1) explained 45% of the study variance and the 
EVs on all five factors exceeded 1.00, which complied with the Kaiser-Guttman 
criteria (Guttman, 1954; Kaiser, 1960; 1970). However, three of the factors had no 
statements that distinguished them from the other factors and thus this solution was 
rejected due to not providing sufficiently diverse experiences of living with RA to 
justify a five factor solution.   Four factors were then extracted (Appendix Q2), which 
explained 40% of the study variance and the EVs on all four factors again complied 
with the Kaiser-Guttman criteria.  However, with the four-factor solution, two of the 
Q-sorts were confounded (i.e. significantly loading on more than one of the 
presented factors) and one factor contained no statements that distinguished it from 
the other factors and thus this solution was rejected and a three-factor solution was 
extracted.  The three-factor solution (Appendix Q3) explained 33% of the study 
variance and the EVs of all factors complied with the Kaiser-Guttman criteria.  
Further, none of the Q-sorts were confounded and all factors contained 
distinguishing statements.  In order to ensure that the three-factor solution was the 
most appropriate the researcher extracted a two-factor solution (Appendix Q4).  This 
explained 26% of the study variance, the EVs of both factors far exceeded 1.00 and 
both factors contained distinguishing statements.  However, with a two-factor 
solution 12 of the individual Q-sorts did not significantly load onto either of the 
factors, in comparison to only 7 that did not significantly load onto the three-factor 
solution.  Thus the three-factor solution was chosen as presenting sufficiently 
diverse experiences of living with RA, which included the greatest number of 
individual Q-sorts.  Table 8.2 summarises the findings from the various factor 
extractions.  
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Table 8.2: Results from factor extraction of the Daily Life Q-sorts 
 
Factor 
Solution 
Factor Eigenvalue Study 
variance 
Confounded 
sorts 
Non-
significant 
sorts 
Distinguishing 
statements 
5-factor Factor A 
Factor B 
Factor C 
Factor D 
Factor E 
Total 
 
2.97 
3.39 
2.59 
1.98 
2.47 
13.40 
10 
11 
9 
7 
8 
45 
 
 
 
 
 
1 
 
 
 
 
 
6 
3 
0 
0 
0 
2 
 
4-factor Factor A 
Factor B 
Factor C 
Factor D 
Total 
 
3.01 
3.25 
2.58 
3.05 
11.89 
10 
11 
9 
10 
40 
 
 
 
 
2 
 
 
 
 
5 
3 
3 
2 
0 
3-factor Factor A 
Factor B 
Factor C 
Total 
 
3.29 
3.97 
2.67 
9.92 
11 
13 
9 
33 
 
 
 
0 
 
 
 
7 
7 
4 
5 
 
2-factor Factor A 
Factor B 
Total 
3.83 
3.97 
7.80 
13 
13 
26 
 
 
0 
 
 
12 
11 
11 
 
Then, based on the findings from the daily life Q-sort, the researcher 
extracted a four-factor solution for the flare help-seeking Q-sort.  This solution 
(Appendix R1) explained 63% of the study variance and the EVs on all four factors 
exceeded 1.00, which complied with the Kaiser-Guttman criteria, but three of the 
factors had no statements that distinguished them from the other factors and thus 
this solution was rejected due to not providing sufficiently diverse explanations of 
seeking help for RA flares to require a four-factor solution.  Three factors were then 
extracted (Appendix R2), which explained 57% of the study variance and the EVs on 
all three factors again exceeded 1.00.  However, there were no statements that 
distinguished Factor A from the other two factors and thus a two-factor solution was 
extracted.  The two-factor solution (Appendix R3) explained 51% of the study 
variance and the EVs far exceeded 1.00.  Further, none of the Q-sorts were 
confounded and all factors contained distinguishing statements.  Thus the two-factor 
solution was chosen as presenting sufficiently diverse explanations for help-seeking, 
which included the greatest number of individual Q-sorts.  Table 8.3 summarises the 
findings from the various factor extractions.  
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Table 8.3: Results from factor extraction of the Flare Help-Seeking Q-sorts 
 
Factor 
Solution 
Factor Eigenvalue Study 
variance 
Confounded 
sorts 
Non-
significant 
sorts 
Distinguishing 
statements 
4-factor Factor A 
Factor B 
Factor C 
Factor D 
Total 
 
9.29 
4.01 
2.95 
1.93 
18.19 
32 
14 
10 
7 
63 
 
 
 
 
1 
 
 
 
 
8 
0 
1 
0 
0 
 
 
3-factor Factor A 
Factor B 
Factor C 
Total 
 
8.83 
3.30 
4.63 
16.77 
30 
11 
16 
57 
 
 
 
2 
 
 
 
9 
0 
3 
1 
2-factor Factor A 
Factor B 
Total 
10.18 
4.58 
14.76 
35 
16 
51 
 
 
0 
 
 
7 
7 
7 
 
8.5 Presentation of results for individual Q-studies 
The daily life and flare help-seeking Q-sort results will be presented in 
sections 8.6 and 8.7 respectively.  The participant demographics for the two Q-sorts 
differs slightly, therefore each section begins with a table of participant 
characteristics.  Q-methodology is a quasi-quantitative method (Stenner and 
Stainton-Rogers, 2004), thus the quantitative analyses are presented first.  This will 
include the Q-study description, including the level of significance and the study 
variation.  First a table displaying the statements included in the Q-sort and the 
ranking assigned to each statement by each factor will be presented, followed by the 
statements that achieved consensus for all of the factors produced. 
Each factor will then be presented individually, describing the percentage 
variance and the EV.  An exemplifying Q-sort will be displayed for each factor that is 
produced by averaging the participant Q-sorts that loaded significantly on that factor 
alone.  This will be contextualised by a table displaying the demographic information 
of each participant loading on to the given factor.  In addition, a narrative or 
qualitative account will also be presented for each factor.  The qualitative 
explanation will treat these configurations as Gestalt entities (Watts and Stenner, 
2005b), they are constructed by considering the relative rankings and overall 
configuration or distribution of the statements in each factor exemplifying Q-sort.  
The rankings (daily life: +5 most agree to -5 most disagree; flare help-seeking +4 
most agree to -4 most disagree), which inform the construction of the account at 
each point are included in the text: (D6: +4) for example, indicates that statement D6 
was ranked in the +4 position and that this ranking is relevant to the account being 
offered.  This account is further enriched by the comments of participants whose 
individual Q-sorts have loaded significantly on the relevant factor.  
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8.6 Results: Q-methodology: “Living with RA day-by-day means….” 
8.6.1 Daily life Q-sort: Participants 
72 people with RA were invited to participate from UHBT, NBT and ASPH 
and 32 (44%) agreed to take part.  Data from two participants were excluded: a 73 
year old man was unable to understand the task and a 68 year old man asked his 
wife to make the decisions regarding the sorting of the cards.  The majority of the 
participants (n=30) were female (73%) and participants’ ages ranged from 30 to 79 
years (Table 8.4).  The majority were not currently working, these were either retired 
or unemployed.  There was a range of treatment regimes including one patient 
taking no medication.  There was also a range of disease duration (1-40 years), self-
reported disease activity (using the DAS global) and disability (HAQ score).  Six 
participants reported being in a flare at the time of the study. 
 
Table 8.4: Characteristics of participants in the Daily Life Q-study 
 
  Frequency Percentage 
Gender Female 22 73.3 
 Male 8 26.7 
    
Age (years) Under  40 4 13.3 
 40 – 49 4 13.3 
 50 – 59 8 26.7 
 60 – 69 11 36.7 
 70+ 3 10.0 
    
Employment Employed 12 40.0 
 Unemployed 9 30.0 
 Retired 9 30.0 
    
Medication Anti-TNF 13 43.3 
 DMARD 12 40.0 
 Steroids 4 13.3 
 No Medication 1 3.3 
    
Disease Duration > 2yrs < 5 yrs 8 26.7 
 > 5 yrs 3 10.0 
 > 10 yrs 9 30.0 
 > 20 yrs 9 30.0 
 Unknown 1 3.3 
    
Pt Global 0 ≤ 4 (mild) 19 63.4 
 > 4 ≤ 7 10 33.3 
 > 7 ≤ 10 (severe) 1 3.3 
    
Disability Score 0 ≤ 1 13 43.3 
 >1 ≤ 2 8 26.7 
 > 2 ≤ 3 9 30.0 
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8.6.2 Daily life Q-sort: Quantitative results 
Three factors were extracted and rotated using the orthogonal varimax 
procedure, which explained 33% of the variance and accounted for 23 of the 30 
participants.  Factor A comprised all positive loadings (A+), Factor B had both 
positive and negative loadings (B+, B-) and Factor C comprised only negative 
loadings (C-).  None of the sorts were confounded (i.e. significantly loading on more 
than one of the presented factors).  A participant loading of 0.41 reached 
significance at p < .01 in this study. 
Table 8.5 shows the ranking assigned to each of the 39 statements in each 
of the factor-exemplifying Q-sorts (Section 8.5).  Reading the table first by column 
shows the comparative ranking of statements that characterise a particular factor, 
for example Factor A+ scored statement D3: “Struggling to do certain things” at 
+1 and statement D13: “Not letting my RA get me down” at +3.  Then, reading 
the table by row shows the comparative ranking of a particular statement across 
factors, for example statement D1: “I sometimes have to cancel plans due to my 
RA” was scored at 0 by Factor A+, Factor B+ and Factor B-, and was scored at -1 
by Factor C-.  The highest and lowest rankings assigned to each of the statements 
are indicated, for example statement D16: “Using alternative medicines/therapies 
to manage my RA symptoms” received the highest score from Factor B+ (+3) and 
the lowest score from Factor A+ (-4).
  
   
1
8
0
 
     Table 8.5: By-Factor rankings of statements given in the Daily Life Q-Sort 
 
 Factor Scores 
Statement Factor A+ Factor B+ Factor B- Factor C- 
D1: I sometimes have to cancel plans due to my RA 0 0 0 -1 
D2: Being more spontaneous with life -1 +3 -3 +1 
D3: Struggling to do certain things +1 -2 +2 0 
D4: Choosing my clothes according to how easy they will be to put on and take off +1 +2 -2 -4 
D5: I am unable to predict how bad my symptoms will be each day -1 -3 +3 +1 
D6: Taking longer to get things done than I think it should +2 -2 +2 -2 
D7: Finding different ways of doing the things I want to +4 0 0 +2 
D8: Giving myself permission to leave a task half finished +1 0 0 -1 
D9: Using tools or devices to aid me in daily tasks +3 +1 -1 -5 
D10: Finding a balance between asking for help and remaining independent +2 -1 +1 0 
D11: Doing what I want to do regardless of the consequences -3 +2 -2 -1 
D12: Choosing to prioritise pleasurable activities against chores 0 +2 -2 -2 
D13: Not letting my RA get me down +3 +3 -3 +4 
D14: Relying on support from my family/friends/others 0 0 0 -3 
D15: Talking to other people with RA who are similar to me helps -1 +1 -1 -1 
D16: Using alternative medicines/therapies to manage my RA symptoms -4 +3 -3 0 
D17: Distracting myself from my symptoms +2 +1 -1 0 
D18: Trying not to eat certain foods -4 +4 -4 -3 
D19: I am cautious of gaining weight and putting extra stress on my joints -1 0 0 +3 
D20: Exercising as much as I can 
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D21: Making small adjustments to my day or activities constantly because of my RA +5 -1 +1 0 
D22: Taking my medication exactly as prescribed +3 +1 -1 +2 
D23: Planning rest time into my week +2 +1 -1 -3 
D24: Feeling lucky in comparison to other people -1 +2 -2 +5 
D25: I have periods of being completely symptom free -3 +4 -4 -2 
D26: Dealing with the severity of my symptoms going up and down +1 0 0 +1 
D27: Getting frustrated due to my RA -2 -3 +3 +2 
D28: Feeling guilty about holding others back due to my RA -2 -1 +1 -4 
D29: Feeling that my body has let me down -2 -1 +1 0 
D30: Trying to forget that I have RA 0 +1 -1 +3 
D31: Worrying because of my RA -2 -3 +3 0 
D32: Repetitive tasks make my RA symptoms worse 0 -2 +2 -1 
D33: Being determined not to allow my RA to interfere with my responsibilities +4 0 0 +4 
    All statements include the prefix “Living with Rheumatoid Arthritis day-by-day means...” Text highlighted in blue indicates  
    the highest ranking assigned to each statement.  Text highlighted in yellow indicates the lowest ranking.
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8.6.3 Daily life Q-sort: Qualitative results: Consensus items 
There are three consensus items in the daily life Q-study, meaning that all 
three factors sorted the statements into a similar place on the grid (Table 8.6). 
 
Table 8.6: Consensus items from Daily Life Q-sort 
 
Statement Factor Score 
 A+ B+ B- C- 
D1: I sometimes have to cancel plans due to my RA 0 0 0 -1 
D8: Giving myself permission to leave a task half finished +1 0 0 -1 
D15: Talking to other people with RA who are similar to me helps -1 +1 -1 -1 
 
The consensus items are all sorted close to the neutral zero score placement 
on the grid, which could be due to participants considering them as less important.  
However, the comments booklets provide more information regarding the positioning 
of the statements. 
The comments indicate that the statement “I sometimes have to cancel 
plans due to my RA” may be placed in a neutral position as patients are reluctant 
to cancel their plans, but know that this is something that they should do.  They 
therefore do not feel that they are able to place this statement more negatively: 
 “I don’t but probably should, as I often end up in more pain the next day” (P15) 
The statement “I give myself permission to leave a task half-finished” 
received one comment, which suggests it has been sorted neutrally as patients don’t 
feel that they need to give themselves permission: 
“I don’t give myself permission, I do it anyway” (P12) 
The comments associated with the statement “Talking to people with RA 
who are similar to me helps” suggest their lack of experience of talking to other 
patients may have forced a neutral stance.  Others have had both positive and 
negative experiences of interacting with other patients and still sorted the 
statements neutrally: 
“I haven’t really had chance, I think it would help though” (P12) 
“I’ve never done it, RA is not a big enough part of my life for me to go to a 
support group” (P20) 
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 “I’ve got a friend with RA who’s younger than me and working.  It really helps to 
talk to her and hear something positive.  I went to a support group at the hospital 
when I was newly diagnosed.  It was full of people moaning and made me more 
depressed, so I never went back” (P21) 
Each factor will now be explored in depth, contextualising the quantitative 
data with demographic and qualitative data.   
8.6.4 Factor A+: Taking active control: “Just a fact of life” 
Factor A+ has seven significantly loading participants, it has an eigenvalue 
of 3.29 and it explains 11% of the Q-study variance.  The exemplifying Q-sort for this 
factor (Table 8.7) shows how each statement (1-39) loads across negative to 
positive opinion (-5 to +5).  Summaries of the statements, as well as the statement 
numbers have been included to aid interpretation. For example, the average score 
for patients loading onto Factor A for statement D21: “Making small adjustments 
to my day or activities constantly because of my RA” is +5, therefore these 
patients strongly agree with this statement. 
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Table 8.7: Exemplifying Q-sort for Daily Life Factor A: Taking active control: “Just a fact of life” 
Negative         Neutral            Positive 
-5 -4 -3 -2 -1 0 +1 +2 +3 +4 +5 
34: 
Being 
angry 
because 
of my RA 
16: 
Using alt 
medicines 
/therapies 
to manage 
my RA 
11: 
Doing what I 
want regardless 
of the 
consequences 
27: 
Getting 
frustrated due 
to my RA 
2: 
Being more 
spontaneous 
with life 
1: 
I sometimes 
have to cancel 
plans due to 
my RA 
3: 
Struggling to do 
certain things 
6: 
Taking longer to 
do things than I 
think it should 
9: 
Using 
tools/devices 
to aid me in 
daily tasks 
7: 
Finding different 
ways of doing 
the things I want 
to 
21: 
Making small 
adjustments to 
my day or 
activities 
constantly 
 18: 
Trying not 
to eat 
certain 
foods 
25: 
I have periods of 
being completely 
symptom free 
28: 
Feeling guilty 
about holding 
others back 
due to my RA 
5: 
I am unable to 
predict how bad 
my symptoms 
will be 
12: 
Choosing to 
prioritise 
pleasurable 
activities 
against chores 
4: 
Choosing 
Clothes 
according to how 
easy they will be 
to put on 
10: 
Finding a 
balance between 
asking for help 
and remaining  
independent 
13: 
Not letting 
my RA get 
me down 
33: 
Being 
determined not 
to allow RA to 
interfere with 
responsibilities 
 
  39: 
Struggling to 
explain to family 
and friends what 
life is like 
29: 
Feeling that 
my body has 
let me down 
15: 
Talking to other 
people with RA 
who are similar 
to me helps 
14: 
Relying on 
support from 
family/friends/o
thers 
8: 
Giving myself 
permission to 
leave a task half 
finished 
17: 
Distracting 
myself from my 
symptoms 
22: 
Taking my 
medication 
exactly as 
prescribed 
  
   31: 
Worrying 
because of my 
RA 
19: 
Cautious of 
gaining weight 
and putting extra 
stress on joints 
30: 
Trying to forget 
that I have RA 
20: 
Exercising as 
much as I can 
23: 
Planning rest 
time into my 
week 
   
    24: 
Feeling lucky in 
comparison to 
other people 
32: 
Repetitive 
tasks make my 
RA symptoms 
worse 
26: 
Dealing with 
severity of 
symptoms going 
up and down 
    
    37: 
Experiencing 
swelling daily 
36: 
Experiencing 
pain daily 
 
35: 
Experiencing 
unexplainable 
fatigue / 
exhaustion daily 
    
     38: 
Experiencing 
stiffness daily 
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8.6.4.1 Daily Life Factor A+: Taking active control: “Just a fact of life”: Demographic 
information:  
Of the seven participants loading onto this factor, six were female (Table 
8.8).  They had an age range of 46 to 72 years with a mean average age of 61.7 
years (SD 10.3).    The disease duration ranged from 7 to 36 years with a mean 
average of 22.7 years (SD 10.8).  The mean disability (HAQ) score was 2.0 (SD 0.6) 
and mean disease activity (Pt Global) was 3.1 (SD 1.7).  Five patients were on anti-
TNF therapies, one used steroids and two used NSAIDs.  One participant was in a 
self-defined RA flare at the time of completing the Q-sort.  None of the participants 
had dependent children.
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Table 8.8: Demographic information for patients loading onto Daily Life Factor A+ 
 
ID Gender Age  
(yrs) 
Dis Dur  
(yrs) 
HAQ Pt 
Global  
Med NHS 
Trust* 
In Flare? Work status Help at home Dependents Factor Load 
P1 F 67 7 1.38 2.2 Anti-TNF 2 No Retired Husband** Husband** 0.48 
P2 F 72 36 2.38 6.7 NSAIDs 3 No Retired Husband None 0.70 
P3 F 46 23 2.63 2.6 Anti-TNF 3 Yes Incapacity Husband None 0.55 
P4 F 65 16 2.63 2.3 Anti-TNF 3 No Retired None None 0.52 
P5 M 72 32 2.25 2.6 Steroids  3 No Retired Wife None 0.51 
P6 F 50 31 1.50 4.0 Anti-TNF 2 No Employed Husband None 0.59 
P7 F 60 14 1.38 1.5 Anti-TNF 2 No Retired Grown-up child None 0.52 
Mean  61.7 22.7 2.0 3.1        
SD 
 
 10.3 10.8 0.6 1.7        
Range 
 
 26 29 1.3 5.2        
*Nb NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
**Nb patient and husband both care for and depend on each other  
 
Key:  
Dis Dur =  Disease Duration 
HAQ = Health Assessment Questionnaire score 0-3, high bad 
Pt Global = Disease activity score patient global measure  0-10, high bad 
Medication:    Anti-TNF = Anti-Tumour Necrosis Factor,   NSAIDs = Non-steroidal anti-inflammatory 
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8.6.4.2 Factor A+: Taking active control “Just a fact of life”: Interpretation    
The patients loading onto this factor are predominantly female, of retirement 
age and have been diagnosed with RA longer, on average, than the patients loading 
onto the other two daily life factors.  These patients also have more disability in 
comparison to the other factors.  However, their rating of the statements suggests 
that they reduce the impact that RA has on them by “taking active control” through 
effective self-management techniques. 
The statements in this factor indicate that patients make small adjustments 
to their day or activities constantly because of their RA (Table 8.7, statement D21: 
opinion +5), and the patient comments clarified this ranking further; “this is important 
as you need to be able to do this to manage your RA effectively” (P1).  The 
discourse suggests that patients find different ways of doing the things they want to 
(D7: +4) and are determined not to let their RA interfere with their responsibilities 
(D33: +4).  However, they will acknowledge that they struggle to do certain things 
(D3: +1) and that it can sometimes take longer to get things done than they think it 
should (D6: +2). 
In this factor patients take responsibility for managing their disease within 
their daily lives; they take their medication exactly as prescribed (D22: +3) as “it’s 
important and part of my routine” (P5) and will not do what they like regardless of 
the consequences (D11: -3): 
“You can’t just do this, people that do this make me angry.  You can’t expect the 
doctors to help you if you don’t help yourself” (P4) 
They adopt a practical approach to dealing with their RA, which includes 
using tools and devices to aid with daily tasks (D9: +3).  They also find a balance 
between asking for help and remaining independent (D10 +2) and will use 
pleasurable activities to distract them from their symptoms: “paint and draw, 
anything relaxing takes my mind off of it” (P5). 
These patients will not avoid foods that have the potential to trigger a flare 
(D18: -4) as they “don’t find they make a difference” (P2), and are also unlikely to try 
alternative medicines or therapies (D16: -4) as they generally “don’t believe in them” 
(P5).  One patient explains how she might be more inclined to use something if she 
felt desperate: 
“I tried acupuncture, but it didn’t work and was too expensive.  I do think some 
alternative medicines may help, but I’m well enough controlled not to need to try 
them.  If my back was against the wall I might try” (P7) 
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They do not feel guilty about holding others back due to their RA (D28: -2) as 
“they should understand by now” (P1).  They also do not struggle to explain to family 
and friends what daily life is like for them (D39: -3).  This seems to apply to 
experienced RA patients; they either no longer need to explain as their friends and 
family understand or alternatively they have given up trying to explain: 
“They’re understanding as I’ve had it a while now” (P2) 
“I don’t bother trying any more, other people just don’t understand.  I don’t think 
they should call it arthritis – people with osteoarthritis in one finger think they 
know how you feel” (P4) 
The discourse suggests that patients never experience periods of being 
symptom free (D25: -3), “you get used to your symptoms, but because of the 
disability you’re never symptom free” (P7).  However, the daily experience of pain 
(D36: 0), joint swelling (D37: -1), joint stiffness (D38: 0) and dealing with the severity 
of their symptoms going up and down (D26: +1) have all been sorted in the more 
neutral placements.  The comments suggest this is because patients are so used to 
dealing with these symptoms that they are no longer salient to them: 
“Just a fact of life, they’re sorted lower as they’re not as interesting as the other 
statements” (P2) 
This even includes the experience of fatigue (D35: +1), of which one patient 
says: 
 “This is a biggy.  People assume that it’s just because I’m getting older, but 
there’s a big difference between that and fatigue” (P4) 
These patients don’t worry (D31: -2) or get angry (D34: -5) because of their 
RA.  They do not feel as though their body has let them down (D29: -2) as “that’s a 
negative way of thinking” (P7) and they are determined not to let their RA get them 
down (D13: +3). 
In summary, patients in this factor ‘take active control’, they use effective 
self-management strategies, which they have developed through experience, they 
have become experts in managing their RA and they know what works for them.  
They take a practical approach to managing their RA, using preventative rather than 
crisis management techniques. 
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8.6.5 Factor B:  Feeling good: “Anti-TNF has kept me working” (B+) versus 
Constant struggle: “It gets me down every single day” (B-) 
Factor B is a ‘bipolar’ factor, meaning that two opposed viewpoints are being 
expressed by the participants who load on to this factor, each viewpoint having a 
factor exemplifying Q-sort that is the ‘mirror-image’ of the other.  It is therefore 
necessary to present two narrative accounts for Factor B. 
Factor B has nine significantly loading participants (one on Factor B+, eight 
on Factor B-), it has an eigenvalue of 3.97 and it explains 13% of the Q-study 
variance.   The exemplifying Q-Sorts for both the positive and negative loadings of 
this factor are displayed in Tables 8.9 and 8.10, respectively.
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Table 8.9: Exemplifying Q-sort for Factor B+: Feeling good: “Anti-TNF has kept me working”
 
Negative 
              
        Neutral 
     
    Positive 
-5 -4 -3 -2 -1 0 +1 +2 +3 +4 +5 
34: 
Being 
angry 
because 
of my RA 
35: 
Experiencing 
unexplainable 
fatigue / 
exhaustion 
daily 
5: 
I am unable 
to predict 
how bad my 
symptoms 
will be 
3: 
Struggling to 
do certain 
things 
10: 
Finding a balance 
between asking 
for help and 
remaining  
independent 
1: 
I sometimes have to 
cancel plans due to 
my RA 
9: 
Using 
tools/devices 
to aid me in 
daily tasks 
4: 
Choosing 
clothes 
according to 
how easy they 
will be to put 
on 
2: 
Being more 
spontaneous 
with life 
18: 
Trying not to eat 
certain foods 
20:  
Exercising as 
much as I 
can 
 36: 
Experiencing 
pain daily 
 
27: 
Getting 
frustrated 
due to my 
RA 
6: 
Taking 
longer to do 
things than I 
think it 
should 
21: 
Making small 
adjustments to my 
day or activities 
constantly 
7: 
Finding different 
ways of doing the 
things I want to 
15: 
Talking to 
other people 
with RA who 
are similar to 
me helps 
11: 
Doing what I 
want 
regardless of 
the 
consequences 
13: 
Not letting my 
RA get me down 
25: 
I have periods of 
being completely 
symptom free 
 
  31: 
Worrying 
because of 
my RA 
32: 
Repetitive 
tasks make 
my RA 
symptoms 
worse 
28: 
Feeling guilty 
about holding 
others back due to 
my RA 
8: 
Giving myself 
permission to leave a 
task half finished 
17: 
Distracting 
myself from 
my symptoms 
12: 
Choosing to 
prioritise 
pleasurable 
activities 
against chores 
16: 
Using alt 
medicines 
/therapies to 
manage my RA 
  
   38: 
Experiencin
g stiffness 
daily 
29: 
Feeling that my 
body has let me 
down 
14: 
Relying on support 
from 
family/friends/others 
22: 
Taking my 
medication 
exactly as 
prescribed 
24: 
Feeling lucky 
in comparison 
to other 
people 
   
    37: 
Experiencing 
swelling daily 
19: 
Cautious of gaining 
weight and putting 
extra stress on joints 
23: 
Planning rest 
time into my 
week 
    
    39: 
Struggling to 
explain to family 
and friends what 
life is like 
26: 
Dealing with severity 
of symptoms going 
up and down 
30: 
Trying to 
forget that I 
have RA 
    
     33: 
Being determined 
not to allow RA to 
interfere with 
responsibilities 
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Table 8.10: Exemplifying Q-sort for Factor B-: Constant struggle: “It gets me down every single day” 
Negative     Neutral    Positive 
-5 -4 -3 -2 -1 0 +1 +2 +3 +4 +5 
20: 
Exercising as 
much as I can 
18: 
Trying not to eat 
certain foods 
2: 
Being 
more 
spontaneo
us with life 
4: 
Choosing 
Clothes 
according to 
how easy they 
will be to put on 
9: 
Using 
tools/devices to 
aid me in daily 
tasks 
1: 
I sometimes 
have to cancel 
plans due to my 
RA 
10: 
Finding a balance 
between asking for 
help and 
remaining  
independent 
3: 
Struggling to do 
certain things 
5: 
I am unable 
to predict 
how bad my 
symptoms 
will be 
35: 
Experiencing 
unexplainable 
fatigue / 
exhaustion 
daily 
34: 
Being 
angry 
because 
of my 
RA 
 25: 
I have periods of 
being completely 
symptom free 
13: 
Not letting 
my RA get 
me down 
11: 
Doing what I 
want regardless 
of the 
consequences 
15: 
Talking to other 
people with RA 
who are similar 
to me helps 
7: 
Finding different 
ways of doing 
the things I want 
to 
21: 
Making small 
adjustments to my 
day or activities 
constantly 
6: 
Taking longer to 
do things than I 
think it should 
27: 
Getting 
frustrated 
due to my 
RA 
36: 
Experiencing 
pain daily 
 
 
  16: 
Using alt 
medicines/
therapies 
to manage 
my RA 
12: 
Choosing to 
prioritise 
pleasurable 
activities against 
chores 
17: 
Distracting 
myself from my 
symptoms 
8: 
Giving myself 
permission to 
leave a task half 
finished 
28: 
Feeling guilty 
about holding 
others back due to 
my RA 
32: 
Repetitive tasks 
make my RA 
symptoms worse 
31: 
Worrying 
because of 
my RA 
  
   24: 
Feeling lucky in 
comparison to 
other people 
22: 
Taking my 
medication 
exactly as 
prescribed 
14: 
Relying on 
support from 
family/friends/ot
hers 
29: 
Feeling that my 
body has let me 
down 
38: 
Experiencing 
stiffness daily 
   
    23: 
Planning rest 
time into my 
week 
19: 
Cautious of 
gaining weight 
and putting extra 
stress on joints 
37: 
Experiencing 
swelling daily 
    
    30: 
Trying to forget 
that I have RA 
26: 
Dealing with 
severity of 
symptoms going 
up and down 
39: 
Struggling to 
explain to family 
and friends what 
life is like 
    
     33: 
Being 
determined not 
to allow RA to 
interfere with 
responsibilities 
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8.6.5.1  Factor B: Demographic information  
Of the eight participants loading negatively onto this factor five were male 
(Table 8.11).  Patients in Factor B- had an age range of 41 to 63 years with a mean 
average of 55.5 years (SD 7.4).  Disease duration ranged from 2 to 40 years with a 
mean average of 15.3 years (SD 14.3).  The mean disability (HAQ) score was 1.5 
(SD 0.8) and mean disease activity (Pt Global) was 5.3 (SD 2.1).  Three participants 
were on anti-TNF therapies, four were taking DMARDs and one was taking only 
steroids due to trying for a baby.  One patient was in a self-defined RA flare at the 
time of completing the Q-sort and one participant had one dependent child.  The 
patient who loaded positively onto this factor was a 50 year old man.  His disease 
duration is unknown but he had a disability score of 0, disease activity of 0.5 and 
was on anti-TNF therapy. 
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Table 8.11: Demographic information for patients loading onto Daily Life Factor B 
 
ID Gender Age  
(yrs) 
Dis Dur  
(yrs) 
HAQ Pt 
Global 
Med NHS 
Trust* 
In Flare? Work status Help at home Dependents Factor Load 
P8 M 50 Unknown 0.00 0.5 Anti-TNF 
DMARDs 
3 No Self-employed Wife Wife 0.70 
P9 M 61 40 2.25 6.9 DMARDs 2 No Retired Wife None -0.50 
P10 F 63 27 0.50 4.3 DMARDs 3 No Retired None None -0.46 
P11 F 51 4 1.63 4.7 DMARDs 
Steroids 
1 No Employed Grown-up child 1 child -0.70 
P12 M 55 2 2.00 5.4 Anti TNF 
DMARDs 
2 No Incapacity Wife & 
Grown-up child 
None -0.54 
P13 M 52 5 0.63 6.7 DMARDs 2 Yes Self-employed None None -0.46 
P14 M 61 25 2.13 5.5 Anti-TNF 
Steroids 
3 No Incapacity Wife Mother -0.54 
P15 F 41 2 0.75 7.9 Steroids 2 No Employed Partner 1 child -0.85 
P16 M 60 17 2.14 1.0 Anti-TNF 
DMARDs 
2 No Unemployed Wife None -0.42 
Mean  54.9 15.3 1.3 4.8        
Stan Dev  7.1 14.3 0.9 2.5        
Range  22.0 38.0 2.3 7.4        
*Nb NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
 
Key:  
Dis Dur =  Disease Duration 
HAQ = Health Assessment Questionnaire score 
Pt Global = Disease activity score patient global measure 
Medication: Anti-TNF = Anti-Tumour Necrosis Factor,  DMARDs = Disease Modifying Anti-Rheumatic Drugs
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8.6.5.2  Factor B- : Constant struggle: “It gets me down every single day”: 
Interpretation 
The majority of participants loaded negatively onto this factor and will 
therefore be presented first.  These patients are predominantly male (5: 71%), which 
is of particular note when compared to the other two factors and to the study 
population (26% male), which reflects the RA population.  These participants appear 
to struggle with their RA, reporting negative experiences and thoughts associated 
with their RA. 
This factor describes patients who never experience periods of being 
completely symptom free (D25: -4).  They experience daily pain (D36: +4), fatigue 
(35: +4), swelling (D37: +1) and stiffness (D38: +2).  Patients describe fatigue as 
“the worst symptom” (P11): 
“This is worse than pain.  I have lost my enthusiasm and ‘get up and go’.  It’s like 
feeling ill all the time” (P15) 
However, despite the daily symptoms, the statements indicate that they are 
unable to predict how bad their symptoms will be each day (D5: +3).  
The discourse in this factor suggests that patients get frustrated (D27: +3) 
and angry (D34: +5) because of their daily life with RA.  They also worry because of 
it (D31: +3) and it gets them down (D13: -3): 
“I get very frustrated with it, the problem is then I get irritated and take it out on 
the wife” (P9) 
“It [RA] gets me down every single day” (P15) 
 These patients feel unlucky in comparison to other people (D24: -2), the 
thought of being lucky is “ridiculous” (P16). 
These patients are unable to exercise (D20: -5) or to be spontaneous (D2: -
3). They will not prioritise pleasurable activities against chores (D12: -2) and find 
that repetitive tasks make their RA symptoms worse (D32: +2).  They also struggle 
to do certain things (D3: +2) and find it takes longer to get things done than they 
think it should (D6: +2), which they find frustrating: 
“Very frustrating for me as I used to do things quickly” (P11) 
“I always did things quickly, I didn’t ever sit around.  I find the less I do, the less I 
want to do and I don’t want that.  I find it very frustrating” (P14) 
These patients would not do what they like regardless of the consequences 
(D11: -2).  They will not try to avoid certain foods (D18: -4) as they “don’t know what 
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to avoid” (P12) nor will they will try alternative medicines (D16: -3): “they’re a waste 
of time and money” (P14): 
“None of it works.  People often suggest things to me, but I just tell them I’ve 
already tried it – it shuts them up” (P16) 
In summary, these patients seem to prioritise the physical symptoms they 
experience, reporting negative thoughts and emotions associated with their RA, and 
they do not seem to have found self-management or coping strategies that work for 
them.  They may therefore be experiencing a sense of hopelessness about their 
lives with RA.  Despite having less disability than patients in Factor A+, these 
patients seem to be in a ‘constant struggle’ with their RA. 
8.6.5.3  Factor B+: Feeling good: “Anti-TNF has kept me working”: Interpretation 
Factor B+ represents a direct reversal of the configuration of statements that 
was characteristic of Factor B-.  This single patient, loading positively onto this 
factor, appears to have little or no disability or disease activity (patient global 0) and 
may even be considered to be in remission, he is therefore feeling good, which he 
attributes to anti-TNF therapy. 
This factor describes periods of being completely symptom free (D25: +4) 
and not experiencing pain (D36: -4), fatigue (D35: -4), swelling (D37: -1) nor 
stiffness (D38: -2) daily.  This patient suggests this has improved “since I’ve been on 
anti-TNF” (P8).  It is hard for him to predict the severity of symptoms (D5: -3), 
perhaps because they no longer occur daily. 
The discourse in this factor suggests that this patient does not get frustrated 
by his RA (D27: -3) or worry because of it (D31: -3).  He definitely does not get 
angry due to his RA (D34: -5) as this is a “negative emotion” (P8) nor does he allow 
his RA to get him down (D13: +3).  In fact, he feels reasonably lucky in comparison 
to other patients (D24: +2): 
“I know I’m lucky in comparison to others, especially people with young children 
or who are trying to carry on working – anti-TNF has kept me working”  (P8) 
This patient exercises as much as he can (D20: +5) and tries to be more 
spontaneous (D2: +3) as “being diagnosed was a wake-up call” (P8) and will 
prioritise pleasurable activities against chores (D12: +2).  He does not find that 
repetitive tasks make his RA symptoms worse (D32: -2), does not take longer to get 
things done than he thinks it should (D6: -2) nor does he struggle to do things (D3: -
2).  To manage his RA, this patient will try to avoid certain foods that have the 
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potential to trigger a flare (D18: +4) and will try alternative medicines (D16: +3).  
However, he will still do what he likes regardless of the consequences (D11: +2). 
In summary, this patient is ‘feeling good’ and RA does not have a great 
impact on his life.  It is possible that this is due to effective management through 
anti-TNF therapy. 
8.6.6 Factor C- : Keeping RA in its place: “It’s a very small part of you” 
Factor C- has seven significantly loading participants, it has an eigenvalue of 
2.67 and it explains 9% of the study variance.  All seven participants load negatively 
onto this factor, therefore the negative viewpoint will be presented.  The 
exemplifying Q-sort for the negative loading of this factor is displayed in Table 8.12 
  
  
1
9
7
 
 
Table 8.12: Exemplifying Q-sort for Daily Life Factor C-: Keeping RA in its Place: “It’s a very small part of you” 
Negative            Neutral           Positive 
-5 -4 -3 -2 -1 0 +1 +2 +3 +4 +5 
24: 
Feeling lucky 
in comparison 
to other 
people 
13: 
Not letting my 
RA get me down 
19: 
Cautious of 
gaining weight 
and putting 
extra stress on 
joints 
7: 
Finding 
different ways 
of doing the 
things I want 
to 
2: 
Being more 
spontaneous 
with life 
3: 
Struggling to do 
certain things 
1: 
I sometimes 
have to cancel 
plans due to my 
RA 
6: 
Taking longer 
to do things 
14: 
Relying on 
support from 
family/friend 
/others 
4: 
Choosing 
Clothes 
according to 
how easy they 
will be to put on 
9: 
Using 
tools/device
s to aid me 
in daily tasks 
 33: 
Being 
determined not 
to allow RA to 
interfere with 
responsibilities 
30: 
Trying to 
forget that I 
have RA 
20: 
Exercising as 
much as I can 
5: 
I am unable to 
predict how bad 
my symptoms 
will be 
10: 
Finding a balance 
between asking 
for help and 
remaining  
independent 
8: 
Giving myself 
permission to 
leave a task half 
finished 
12: 
Choosing 
pleasurable 
activities over 
chores 
18: 
Trying not to 
eat certain 
foods 
28: 
Feeling guilty 
about holding 
others back due 
to my RA 
 
  35: 
Experiencing 
unexplainable 
fatigue / 
exhaustion 
daily 
22: 
Taking my 
medication 
exactly as 
prescribed 
11: 
Doing what I 
want regardless 
of the 
consequences 
16: 
Using alt 
medicines/therapie
s to manage my 
RA 
15: 
Talking to other 
people with RA 
who are similar 
to me helps 
25: 
Periods of 
being 
symptom free 
23: 
Planning 
rest time into 
my week 
  
   27: 
Getting 
frustrated due 
to my RA 
26: 
Dealing with 
symptoms going 
up and down 
17: 
Distracting myself 
from my 
symptoms 
32: 
Repetitive tasks 
make my RA 
symptoms worse 
34: 
Being angry 
because of 
my RA 
   
    36: 
Experiencing 
pain daily 
 
21: 
Making small 
adjustments to my 
day or activities 
constantly 
37: 
Experiencing 
swelling daily 
    
    38: 
Experiencing 
stiffness daily 
29: 
Feeling that my 
body has let me 
down 
39: 
Explaining to  
friends and 
family 
    
     31: 
Worrying because 
of my RA 
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8.6.6.1  Factor C-: Keeping RA in its place: “It’s a very small part of you”: 
Demographic information:  
All seven of the loading participants are female (Table 8.13).  They had an 
age range of 30 to 63 years with a mean average of 42.4 years (SD 11.2).  The 
disease duration ranged from 1 year to 30 years with an average of 9.9 years (SD 
10.2).  The mean disability (HAQ) score was 0.5 (SD 0.5) and mean disease activity 
(Pt Global) was 1.7 (SD 1.0).  Three patients were on anti-TNF therapies, two were 
taking DMARDs, one was taking only steroids due to being pregnant and one was 
taking no medication due to having recently had a baby.  One patient was in a self-
defined RA flare at the time of completing the Q-sort.  Three participants had three 
dependent children, one participant had two dependent children and another was 
pregnant with her second child, two participants did not have dependent children.   
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Table 8.13: Demographic information for patients loading onto Daily Life Factor C- 
 
ID Gender Age  
(yrs) 
Dis Dur  
(yrs) 
HAQ Pt 
Global  
Med NHS 
Trust* 
In Flare? Work status Help at home Dependents Factor Load 
P17 F 63 9 0.38 1.2 Anti-TNF 2 Yes Employed None None -0.52 
P18 F 30 6 0.00 0.3 Steroids 1 No Maternity leave Husband 1 child -0.42 
P19 F 50 1 0.13 1.3 DMARDs 3 No Employed Husband & 
Grown-up child 
None -0.67 
P20 F 39 16 0.88 3.4 Anti-TNF 3 No Employed Husband 2 children -0.44 
P21 F 33 30 0.63 2.3 No 
medication 
1 No House-wife Husband 3 children -0.63 
P22 F 39 3 0.00 1.9 DMARDs 1 No Employed Husband & 
Grown-up child 
3 children -0.48 
P23 F 43 4 1.25 1.5 Anti-TNF 3 No Housewife Husband 3 children -0.59 
Mean  
42.4 9.9 0.5 1.7 
       
St Dev  
11.2 10.2 0.5 1.0 
       
Range  33.0 29.0 1.3 3.1        
*Nb NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
 
Key:  
Dis Dur =  Disease Duration 
HAQ = Health Assessment Questionnaire score 
Pt Global = Disease activity score patient global measure 
Medication:     Anti-TNF = Anti-Tumour Necrosis Factor,  DMARDs = Disease Modifying Anti-Rheumatic Drugs 
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8.6.6.2 Factor C- : Keeping RA in its place: “It’s a very small part of you”: 
Interpretation:   
This factor comprises all female patients, younger on average than those 
loading onto the other two daily life factors.  These patients are all either working, 
have young children or both.  These patients seem to have responsibilities that they 
place above their own well-being and therefore find it necessary to keep RA in its 
place.  The discourse in this factor suggests that patients are determined not to let 
their RA interfere with their responsibilities (D33: +4): 
“I’ve lived with it for a long time now, I’m not going to allow it to ruin my life, it’s 
not fair on the children.  I’ll do what I can for the children, even if I suffer for it” 
(P20) 
They find different ways of doing the things they want to (D7: +2) and they 
will prioritise chores over pleasurable activities (D12: -2).  They also do not find that 
it takes longer to get things done than they think it should (D6: -2).  These patients 
therefore do not feel guilty about holding others back (D28: -4) as they “don’t hold 
others back” (P23) and they are often able to forget that they have RA (D30: +3): 
“This works.  I am able to forget about it a lot of the time.  My Consultant said to 
me ‘This is you [draws a circle] and this is your RA [draws a much smaller circle]’.  
It’s a very small part of you, and I believe that” (P22) 
The discourse also indicates that patients do not plan rest time into the week         
(D23: -3) as they consider themselves too busy for this: 
“Not going to happen.  I run my own business and have two small children” (P20) 
These patients are cautious of gaining weight and putting extra stress on 
their joints (D19: +3); it’s “a constant worry” (P19).  They therefore try to exercise as 
much as they can (D20: +2): 
 “Staying active is important to me, I’ve got a dog for this reason” (P22) 
They do not struggle to explain what life is like for them to family and friends 
(D39: -1), and they do not rely on support from family and friends (D14: -3) as they 
“don’t ask for help” (P19).  They do not find the need to use tools or devices to aid 
with daily tasks (D9: -5), they do not avoid certain foods that have the potential to 
trigger a flare (D18: -3) and nor do they worry about choosing clothes according to 
how easy they are to put on and take off (D4: -4): 
 “I never think of my RA when I’m shopping for clothes, I just wear what I like” 
(P18) 
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These patients will take their medication as prescribed (22: +2) as “this is 
really important” (P22). 
The discourse suggests that patients do not get angry due to their RA (D34: -
2) and will not allow their RA to get them down (D13: +4).  They feel particularly 
lucky in comparison to other people (D24: +5): 
 “Definitely – most important [statement].  RA runs in the family, so I’ve seen 
relatives in wheelchairs and very unwell with it and you see other people in clinic.  
I look and feel so well with it.” (P17) 
In summary, the female patients loading onto this factor do not allow RA to 
impact on their lives, which may be due to their lower disability and disease activity, 
but also seems to be due to them putting other people first.  Either way, these 
patients ‘keep RA in its place’ and carry on with their lives despite the presence of 
their RA. 
8.6.7 Daily life summary 
This Q-study indicates that daily life with RA can be experienced in at least 4 
ways (Fig 8.1).  Some patients (Factor B+) may have such well-controlled RA that 
they feel good and experience little impact of RA, whilst other patients lessen the 
impact that RA has on their lives through taking active control of their RA with self-
management strategies perfected through experience (Factor A+) or by putting RA 
in its place and putting responsibilities first (Factor C-).  However, some patients, the 
majority of whom appear to be male, struggle through, they seem unable to identify 
effective self-management or coping strategies and experience negative thoughts 
and beliefs about their RA. 
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Figure 8.1: Different ways of experiencing daily life with RA 
 
Having explored patients’ views on daily life with RA, their views on help-
seeking when in an RA flare will now be presented. 
 
8.7 Results: Q-methodology: “When I am in a flare…” 
8.7.1 Flare help-seeking Q-sort: Participants 
The same 72 patients were invited to participate and 30 (42%) agreed to 
take part.  Two participants who completed the daily-life Q-sort did not complete this 
flare help-seeking Q-sort: a 72 year old man (daily life patient P5) who did not have 
time to complete it and a 60 year old woman (daily life patient P7) who explained 
she had not experienced an RA flare since starting anti-TNF therapy and therefore 
felt she could not comment on her help-seeking behaviour.  Data from a 73 year old 
man who was unable to understand the task was excluded.  Data from the man who 
was excluded from the daily life study due to help from his wife was included in this 
flare help-seeking Q-study as this Q-sort was conducted whilst his wife was not in 
the room.   The majority of the participants (n=29) were female (72%) and 
participants’ ages ranged from 30 to 79 years (Table 8.14).  The majority were not 
currently working, these were either retired or unemployed.  There was a range of 
treatment regimes including one patient taking no medication.  There was also a 
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range of disease duration (1-40 years), self-reported disease activity (using the DAS 
global) and disability (HAQ score).  Six participants reported being in a flare at the 
time of the study.  
 
Table 8.14: Characteristics of participants in the Flare Help-Seeking Q-methodology study 
 
  Frequency Percentage 
Gender Female 21 72.4 
 Male 8 27.6 
    
Age (years) Under  40 4 13.8 
 40 – 49 4 13.8 
 50 – 59 8 27.6 
 60 – 69 11 37.9 
 70+ 2 6.9 
    
Employment Employed 12 41.4 
 Unemployed 9 31.0 
 Retired 8 27.6 
    
Medication Anti-TNF 12 41.4 
 DMARD 13 44.8 
 Steroids 3 10.3 
 No Medication 1 3.5 
    
Disease Duration > 2yrs < 5 yrs 8 27.6 
 > 5 yrs 3 10.3 
 > 10 yrs 8 
 
9 
27.6 
 > 20 yrs 9 31.0 
 Unknown 1 3.5 
    
DAS Global 0 ≤ 4 (mild) 17 58.6 
 > 4 ≤ 7 11 37.9 
 > 7 ≤ 10 (severe) 1 3.5 
    
Disability Score 0 ≤ 1 13 44.8 
 >1 ≤ 2 7 24.2 
 > 2 ≤ 3 9 31.0 
 
8.7.2 Flare help-seeking Q-sort: Quantitative results 
Two factors were extracted and rotated using the orthogonal varimax 
procedure, which explained 51% of the variance and accounted for 22 of the 29 
participants.  None of the sorts were confounded (i.e. significantly loading on more 
than one of the presented factors).  A participant loading of 0.54 reached 
significance at p < .01 in this study. 
Table 8.15 shows the ranking assigned to each of the 23 statements in each 
of the factor exemplifying Q-sorts.  Reading the table by column shows the 
comparative ranking of statements which characterise a particular factor.  Reading 
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the table by row shows the comparative ranking of a particular statement across 
factors.  The highest and lowest rankings assigned to each of the statements are 
indicated. 
  
2
0
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Table 8.15: By-Factor rankings of statements given in the Flare Help-Seeking Q-Sort 
 
 
All statements include the prefix “When I am in a flare...” Text highlighted in blue indicates the highest ranking assigned to each statement.   
Text highlighted in yellow indicates the lowest ranking.
 Factor Scores 
Statement Factor A Factor B- 
F1: I feel the flare will last until I seek medical help 0 -3 
F2: I will contact the medical team as soon as possible +1 -3 
F3: I am reluctant to seek medical help as I worry about wasting the rheumatology team’s time -3 0 
F4: I am more reluctant to seek medical help when I think I’ve caused the flare -1 -2 
F5: I am reluctant to seek medical help as I don’t think the Dr can do anything to help -3 -1 
F6: I am reluctant to seek medical help as I hope it’ll go away on its own -1 +4 
F7: I avoid seeking medical help as I don’t like taking drugs -2 -2 
F8: I seek help from the medical team once flare starts to affect my quality of life too much +4 +1 
F9: I know I don’t have to manage my flare alone +2 +1 
F10: Easy access to the medical team is part of my decision to seek help for my flare +1 0 
F11: A loved one tells me I ought to seek medical help 0 +2 
F12: I don’t like admitting that I need to ask for help -1 +2 
F13: I am reluctant to seek medical help as I don’t get on well with my rheumatology team -4 -4 
F14: I manage my symptoms  until the flare stops 0 +1 
F15: I seek help from the medical team as I worry about long term damage to my joints +1 -1 
F16: I seek help from the medical team when the pain becomes too intense +3 +3 
F17: I wait until my next scheduled appointment with the rheumatologist before seeking help -2 -1 
F18: I am reluctant to seek medical help as I don’t want to waste my own time -2 0 
F19: I seek help from the medical team when I know my flare needs to be controlled by new medication +2 -2 
F20: I control my flare symptoms with medication before contacting the medical team 0 0 
F21: I seek help from the medical team when my symptoms become uncontrollable +3 +3 
F22: I seek help from the medical team when the flare has gone on longer than I expected +2 +2 
F23: I wait until I have more than one flare symptom before seeking medical help 0 0 
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8.7.3 Flare help-seeking consensus items 
There are nine consensus items in this study, meaning that both factors 
sorted the statements into a similar place on the grid (Table 8.16). 
 
Table 8.16: Consensus items from Flare Help-Seeking Q-sort 
 
     
There is a large amount of consensus in terms of patients’ decision-making 
and help-seeking behaviours.  There is agreement that patients know they don’t 
have to manage their flare alone due to “supportive family and friends” (P8).  The 
discourse also suggests agreement that patients do get on well with their 
rheumatology team and would not avoid seeking help due to the team: 
“They know my name and say ‘Hi’ to me, even when they haven’t seen me in 
months.  Completely different experience to [another department]” (P17) 
There is also consensus that patients would not avoid seeking help due to 
having caused the flare themselves.  However, the two justifications provided for this 
are very different to each other: 
“No, how would I have caused a flare? It’s the disease that causes it” (P13) 
“Most flares are self-inflicted, so you can’t avoid coming in just for that reason” 
(P14) 
Patients also disagree that they avoid seeking help due to not wanting to 
take medication, explaining that if they are bad enough they will “do what I need to” 
(P26).  Both Factors score the statement “I control my flare symptoms with 
 Factor 
Score 
Statement A B- 
F4: I am more reluctant to seek medical help when I think I’ve caused the flare -1 -2 
F7: I avoid seeking medical help as I don’t like taking drugs -2 -2 
F9: I know I don’t have to manage my flare alone +2 +1 
F13: I am reluctant to seek medical help as I don’t get on well with my rheumatology team -4 -4 
F16: I seek help from the medical team when the pain becomes too intense +3 +3 
F20: I control my flare symptoms with medication before contacting the medical team 0 0 
F21: I seek help from the medical team when my symptoms become uncontrollable  +3 +3 
F22: I seek help from the medical team when the flare has gone on longer than I expected +2 +2 
F23: I wait until I have more than one flare symptom before seeking medical help 0 0 
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medication before contacting the medical team” in the neutral zero space.  The 
comments made by the patients suggest that they try to control their symptoms with 
medication, but it does not always work: 
“I try steroids first, it usually doesn’t work, but it’s worth trying” (P20) 
Both Factors also score the statement “I wait until I have more than one 
flare symptom before seeking medical help” in the neutral zero position.  The 
comments suggest that this can depend on the type of flare that is being 
experienced: 
“No, sometimes just my thumb or just my knee hurts” (P1) 
Of particular note are the tipping points for help-seeking that received 
consensus.  These are the flare going on longer than expected, the pain becoming 
too intense and when patients are no longer able to control their symptoms: 
“When I just don’t know what to do anymore” (P25) 
8.7.4 Factor A: Definite decisions: “It won’t go away, so I won’t wait” 
Factor A has sixteen patients significantly loading, it has an eigenvalue of 
10.18 and it explains 35% of the study variance.  The exemplifying Q-sort for this 
factor is displayed in Table 8.17. 
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Table 8.17: Exemplifying Q-sort for Flare Help-Seeking Factor A: Definite decisions: “It won’t go away, so I won’t wait” 
Negative           Neutral              Positive 
-4 -3 -2 -1 0 +1 +2 +3 +4 
13: 
I don’t get on with 
my Rheumatology 
team 
3: 
I worry about 
wasting the 
Rheumatology 
team’s time 
7: 
I don’t like taking 
drugs 
4: 
More reluctant to 
seek help when I 
think I’ve caused the 
flare 
1: 
I feel the flare will 
last until I seek 
medical help 
2: 
I will contact the 
medical team as 
soon as possible 
9: 
I know I don’t have to 
manage my flare 
alone 
16: 
I seek help when the 
pain becomes too 
intense 
8: 
I seek help when 
flare affects my 
quality of life 
 5: 
I don’t think the 
doctor can do 
anything to help 
17: 
I wait until my next 
scheduled 
appointment 
6: 
I hope it’ll go away 
on its own 
11: 
A loved one tells 
me I ought to seek 
medical help 
10: 
Easy access to 
the team is part 
of my decision 
19 
I seek help when my 
flare needs to be 
controlled by new 
medication 
21: 
I seek help when my 
symptoms become 
uncontrollable 
 
  18: 
I don’t want to 
waste my own 
time 
12: 
I don’t like admitting 
that I need to ask for 
help 
14: 
I manage my 
symptoms until 
the flare stops 
15: 
I worry about 
long term 
damage to my 
joints 
22: 
I seek help when the 
flare has gone on 
longer than expected 
  
    20: 
Control flare 
symptoms with 
medication 
 
    
    23: 
I wait until I have 
more than one 
flare symptom 
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8.7.4.1 Factor A: Definite decisions: “It won’t go away, so I won’t wait”: Demographic 
information 
Of the sixteen participants loading onto this factor eleven were female (Table 
8.18).  They had an age range of 39 to 68 years with an average age of 54.8 years 
(SD 10.7).  The disease duration ranged from 2 to 31 years with an average of 15.2 
years (SD 10.9).  The mean disability (HAQ) score was 1.2 (SD 0.8) and mean 
disease activity (Pt Global) was 3.3 (SD 2.5).  Eleven patients were on anti-TNF 
therapies, one used NSAIDs and four used DMARDs.  Three participants were in a 
self-defined RA flare at the time of completing the Q-sort.  Four participants had 
dependent children, one had a parent who depended on them and two patients had 
spouses who depended on them for care.   
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Table 8.18: Demographic information for patients loading onto Flare Help-Seeking Factor A 
 
ID Sex Age  
(yrs) 
Dis Dur  
(yrs) 
HAQ Pt 
Global  
Med NHS 
Trust* 
In Flare? Work status Help at home Dependents Factor Load 
P17 F 63 9 0.38 1.2 Anti-TNF 2 Yes Employed None None 0.90 
P8 M 50 Unknown 0.00 0.5 Anti-TNF 3 Yes Self-employed Wife Wife 0.86 
P20 F 39 16 0.88 3.4 Anti-TNF 3 No Employed Husband 2 children 0.78 
P14 M 61 25 2.13 5.5 Anti-TNF 3 No Incapacity Wife Mother 0.60 
P1 F 67 7 1.38 2.2 Anti-TNF 2 No Retired Husband Husband 0.86 
P15 F 41 2 0.75 7.9 NSAIDs 1 No Employed Partner 1 child 0.76 
P6 F 50 31 1.50 4.0 Anti-TNF 2 No Employed Husband None 0.62 
P24 M 68 20 2.50 5.0 DMARDs 2 No Retired Wife Wife 0.81 
P25 F 53 30 0.88 0.3 Anti-TNF 3 No Employed Husband & 
Grown-up child 
None 0.55 
P23 F 43 4 1.25 1.5 Anti-TNF 3 No Housewife Husband 3 children 0.67 
P10 F 63 27 0.50 4.3 DMARDs 3 No Retired None None 0.78 
P26 M 62 12 0.75 2.0 DMARDs 1 No Retired None None 0.76 
P11 F 51 4 1.62 4.7 DMARDs 1 No Employed Grown-up child 1 child 0.58 
P12 M 55 2 2.00 5.4 Anti-TNF 2 No Incapacity Wife & 
Grown-up child 
None 0.57 
P3 F 46 23 2.63 2.6 Anti-TNF 2 Yes Incapacity Husband None 0.70 
P4 F 65 16 2.63 2.3 Anti-TNF 2 No Retired None None 0.89 
Mean  54.8 15.2 1.4 3.3        
St Dev  9.6 10.4 0.8 2.1        
Range  29.0 29.0 2.6 7.6        
*Nb: NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
Key:  
Dis Dur =  Disease Duration 
HAQ = Health Assessment Questionnaire score 
Pt Global = Disease activity score patient global measure 
Medication: Anti-TNF = Anti-tumour necrosis factor,  DMARDs = Disease modifying anti-rheumatic drugs,  NSAIDs = Non-steroidal anti-inflammatory drugs 
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8.7.4.2 Factor A: Definite decisions: “It won’t go away, so I won’t wait”: Interpretation  
 The patients in this factor, the majority of whom are using anti-TNF 
therapies, make a definite decision to seek help from the medical team.  These 
patients will contact the medical team as soon as possible when they are in a flare 
(F2: +1).  This statement only received one comment explaining how quickly these 
patients will seek help: 
“I’ll contact the next day and I get seen very quickly” (P11) 
The discourse suggests that patients know from previous experience that the 
medical team are able to help them (F5: -3) and they don’t think that their flare will 
go away on its own (F6: -1): 
“Minor aches and pains go away on their own, flare-ups don’t” (P8) 
These patients will ask for help if they need it (F12: -1) and don’t worry about 
wasting their own time (F18: -2) or the rheumatology team’s time (F03: -3) because 
“that’s what they’re there for” (P17).  They wouldn’t wait until their next scheduled 
rheumatologist appointment before seeking help (F17: -2) as “it won’t go away, so I 
won’t wait” (P10) and easy access to the medical team is part of their decision to 
seek help (F10: +1). 
Tipping points for seeking help specific to patients in this factor are worries 
about long term damage to their joints (F15: +1), knowing their flare needs to be 
controlled by new medication (F19: +2) and when flare begins to affect their quality 
of life (F8: +4).  These patients make a definite decision that their symptoms 
constitute a flare and that the medical team are there to help them. 
8.7.5 Factor B- : Cautious indecision: “Lying down and not moving until it 
goes” 
Factor B- has six patients significantly loading, it has an eigenvalue of 4.58 
and it explains 16% of the study variance.   All six participants load negatively onto 
this factor therefore the negative viewpoint will be presented.  The exemplifying Q-
sort for the negative loading of this factor is displayed in Table 8.19. 
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Table 8.19: Exemplifying Q-sort for Flare Help-Seeking Factor B- : Cautious indecision: “Lying down and not moving until it goes”
Negative          Neutral              Positive 
-4 -3 -2 -1 0 +1 +2 +3 +4 
13: 
I don’t get on with 
my Rheumatology 
team 
1: 
I feel the flare will 
last until I seek 
medical help 
4: 
More reluctant to 
seek help when I 
think I’ve caused the 
flare 
5: 
I don’t think the 
doctor can do 
anything to help 
3: 
I worry about 
wasting the 
Rheumatology 
team’s time 
8: 
I seek help when 
flare affects my 
quality of life 
11: 
A loved one tells 
me I ought to seek 
medical help 
16: 
I seek help when the 
pain becomes too 
intense 
6: 
I hope it’ll go 
away on its own 
 2: 
I will contact the 
medical team as 
soon as possible 
7: 
I don’t like taking 
drugs 
15: 
I worry about long 
term damage to 
my joints 
10: 
Easy access to 
the team is part of 
my decision 
9: 
I know I don’t 
have to manage 
my flare alone 
12: 
I don’t like 
admitting that I 
need to ask for 
help 
21: 
I seek help when my 
symptoms become 
uncontrollable 
 
  19 
I seek help when my 
flare needs to be 
controlled by new 
medication 
17: 
I wait until my 
next scheduled 
appointment 
18: 
I don’t want to 
waste my own 
time 
14: 
I manage my 
symptoms until 
the flare stops 
22: 
I seek help when 
the flare has gone 
on longer than 
expected 
  
  
 
 
 
  20: 
Control flare 
symptoms with 
medication 
 
    
    23: 
I wait until I have 
more than one 
flare symptom 
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8.7.5.1 Factor B- : Cautious indecision: “Lying down and not moving until it goes”: 
Demographic information 
Of the six participants loading onto this factor four were female (Table 8.20).  
They had an age range of 30 to 66 years with an average age of 50.5 years (SD 
15.4).  The disease duration ranged from 5 to 40 years with an average of 18.7 
years (SD 13.9).  The mean disability (HAQ) score was 1.2 (SD 1.0) and mean 
disease activity (DAS Global) was 4.1 (SD 2.6).  Four patients used DMARDs, one 
used steroids and one was on no medication.  None of the participants loading onto 
this factor used anti-TNF therapy.  Two participants were in a self-defined RA flare 
at the time of completing the Q-sort.  Two participants had dependent children.   
  
 
2
1
4
 
 
Table 8.20: Demographic information for patients loading onto Flare Help-Seeking Factor B- 
 
ID Sex Age  
(yrs) 
Dis Dur  
(yrs) 
HAQ Pt 
Global  
Med NHS 
Trust* 
In Flare? Work status Help at home Dependents Factor Load 
P21 F 33 30 0.63 2.3 None 1 No House-wife Husband 3 children -0.60 
P18 F 30 6 0.00 0.3 Steroids 1 No Maternity leave Husband  1 child -0.71 
P13 M 52 5 0.63 6.7 DMARDs 2 Yes Self-employed None None -0.63 
P27 F 66 18 1.57 3.6 DMARDs 3 Yes Retired None None -0.70 
P9 M 61 40 2.25 6.9 DMARDs 2 No Retired Wife None -0.72 
P28 F 61 13 2.30 5.0 DMARDs 2 Yes Retired Grown-up child None -0.59 
Mean  50.5 18.7 1.2 4.1        
St Dev  15.4 13.9 1.0 2.6 
       
Range  36.0 35.0 2.3 6.6        
*Nb: NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
  
Key:  
Dis Dur =  Disease Duration 
HAQ = Health Assessment Questionnaire score 
Pt Global = Disease activity score patient global measure 
Medication:    DMARDs = Disease Modifying Anti-Rheumatic Drugs 
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8.7.5.2 Factor B- : Cautious indecision: “Lying down and not moving until it goes”: 
Interpretation 
These patients are similar to patients in Factor A in terms of both clinical and 
demographic data.  However, in contrast to Factor A, none of the patients loading 
onto this factor use anti-TNF therapies.  These patients appear to be both cautious 
and indecisive in seeking help for their flares.  The statements in this factor indicate 
that patients will not contact the medical team as soon as possible when they are in 
a flare (F2: -3).  These patients are reluctant to seek help as they hope the flare will 
go away on its own (F6: +4) and do not believe that the flare will last until they seek 
medical help (F1: -3).  One comment suggests that this idea has been reinforced by 
their previous experiences: 
“It does sometimes go away on its own after 3 or 4 days” (P9) 
These patients don’t like admitting that they need to ask for help (F12: +2) 
and they worry about wasting the rheumatology team’s time (F3: 0), which the 
comments suggest are due to beliefs that they should manage alone: 
“I was brought up to be self sufficient and not run for help, I know that I should 
know better, but it’s ingrained” (P27) 
These patients scored the statement “I am reluctant to seek medical help 
as I worry about wasting the rheumatology team’s time” in the neutral ‘0’ 
position, which may indicate that the statement is less important to them.  However, 
Q-methodology looks at not only the statement relationships within each factor, but 
also between each factor.  Thus in contrast to Factor A, which scored this statement 
at -3, the patients in Factor B- are more aware of wasting the rheumatology team’s 
time, making this finding more robust that it initially appears.  Patients in this factor 
may be scoring this statement neutrally due to cautious agreement.  The comments 
suggest that patients do worry about wasting the rheumatology team’s time, but feel 
they shouldn’t worry about this, which may be causing a conflict in sorting the 
statement: 
“I do worry about this [wasting the rheumatology team’s time], even though I 
shouldn’t.  I went to the Dr and had to keep going back for help and it wasn’t 
getting any better – but it wasn’t getting any worse.  So I thought, they know how 
bad it is, they don’t need to see me unless it gets worse, so I left it” (P9) 
These patients are also more reluctant to seek help than patients in Factor A 
due to worries about wasting their own time (F18: 0).  They may wait until their next 
scheduled appointment before seeking help (F17: +1) and will try and manage their 
symptoms until the flare stops (F14: +1).  This statement received one comment, 
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which suggests that this can involve “just lying down and not moving until it goes” 
(P9). 
These patients are not prompted to seek help by the feeling that their flare 
needs to be controlled by new medication: (F19: -2).  There were no comments 
made relating to this statement and so it is unclear as to whether this is because 
patients are unable to recognise the signs of a flare that needs to be controlled by a 
medication change.  The tipping point for seeking help specific to patients in this 
factor is being prompted by a loved one (F11: +2).   
In summary, these patients will wait to seek help whilst they are indecisive 
about whether they are in a flare, they are cautious of contacting the medical team 
until they are sure of this (“cautious indecision”) due to worries about wasting the 
rheumatology team’s time and beliefs that they should manage alone and often wait 
until prompted by someone else. 
8.7.6 Flare help-seeking summary 
This Q-study suggests that patients will seek help for their RA flares due to 
the intensity of the pain, longevity of the flare and no longer being able to control 
their symptoms.  Although this appears to be a succinct explanation of why patients 
seek help, this study finds that there are at least two ways in which patients differ in 
how they reach the decision to seek help (Fig 8.2).  Some patients will quickly define 
their symptoms as a flare and make a definite decision to seek help, believing that 
the medical team are there to help them.  However, other patients are indecisive as 
to whether their symptoms constitute a flare, hoping that it will go away, and are 
cautious of seeking help due to worries about wasting the rheumatology team’s time 
and beliefs that they should manage alone. 
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Figure 8.2: Decisions about seeking help in a flare  
 
8.8 Comparing patients across both Q-sorts 
To see whether any relationships exist between patients’ experience of daily 
life and their help-seeking behaviours, patients have been compared according to 
the factors they loaded onto across the two Q-sorts (Fig 8.3).  Two patients did not 
load onto any factors on either of the two Q-sorts (one of whom did not take part in 
the flare help-seeking Q-sort) 11 patients did not load onto any factors on one of the 
two Q-sorts and therefore cannot be compared across the two studies.  Of the 
patients who loaded onto both Q-sorts; all the patients who loaded onto daily life 
Factor A+ (‘taking active control’) and the man who loaded onto daily life Factor B+ 
(‘feeling good’) also loaded onto flare help-seeking Factor A (‘definite decision’).  
Patients who loaded onto one of the two flare help-seeking factors were not split 
evenly (Factor A: 72.7%; Factor B-: 27.3%).  Thus the patients who loaded onto 
daily life Factor B- (‘constant struggle’) were divided between the flare help-seeking 
factors in a similar proportion to the overall study (Factor A: 71.4%; Factor B-: 
28.6%).  However, patients who loaded onto daily life Factor C- (‘keeping RA in its 
place’) were also divided between the flare help-seeking factors, but with a higher 
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proportion loading onto flare help-seeking Factor B- (‘cautious indecision’) than the 
study proportion (Factor A: 60%; Factor B-: 40%). 
 
 
 
 
Figure 8.3: Graph showing the comparison of patient loading across both Q-studies  
 
8.9 Discussion 
The findings from both the daily life and flare help-seeking Q-methodology 
studies have been incorporated into the Fluctuating Balances Model (Fig 6.22, 
Chapter 6) to further expand and clarify the conceptual model (Fig 8.4).  In terms of 
help-seeking, the tipping points have been incorporated into this model, along with 
additional arrows to indicate patients who will skip the trying to regain control stage 
(‘definite decision’ makers) and patients who fluctuate between trying to make sense 
of fluctuations and trying to regain control before finally seeking help (‘cautious 
indecision’).  The findings from the daily life Q-sort suggest that patients experience 
varying degrees of impact on their lives, which they can balance with expert self-
management techniques and allowing RA to have less importance in their lives.  
Although balance seems to be necessary to reduce the impact of RA, not all 
patients are able to achieve this. Thus the four experiences of daily life with RA have 
been incorporated into the model through their link with the underpinning theme of 
‘trying to maintain a balance’. 
.   
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         Figure 8.4: Final fluctuating balances model
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This idea of patients balancing the impact that RA has on their lives supports 
the impact triad (Sanderson et al, 2011b), which claims that disease severity, 
importance and self-management affect the level of impact on a patient’s life and 
these can mediate each other.  An example of both the Impact Triad and Fluctuating 
Balances Model is daily life Factor A+ (‘taking active control’), in which despite 
having greater disease severity, patients experience less impact on their lives due to 
their expertise in self-management and placing less importance on their symptoms.  
They have therefore balanced their fluctuating disease with self-management and 
attributing less importance, thus placing their RA in the background of their lives.  In 
contrast, patients in Factor B- (‘constant struggle’) experience greater impact on 
their lives, despite having less disease severity, due to placing high importance on 
their symptoms and rejecting self-management techniques.  These patients seem 
unable to maintain the balance of RA and therefore regularly experience RA in the 
foreground of their lives (Fig 8.4). 
The factors from the two Q-studies were compared to see whether there was 
any relationship between the way patients experience daily life and their help-
seeking behaviours.  The only relationship of particular note is that none of the 
patients loading onto daily life Factor A+ (‘taking  active control’) loaded onto flare 
help-seeking Factor B- (“cautious indecision’) This clearly supports that there are 
two separate constructs, and that the patients in Factor A+ take a practical approach 
to their RA, knowing when and how to seek help. 
This daily life study indicates that men may be struggling to cope with their 
RA and experiencing negative emotions and a greater impact on their lives because 
of this.  This is supported by Study 1 (Chapter 6) in which James discusses having 
to relinquish male coping strategies and Michael reports feeling angry: 
“You can’t go and thump a wall because you end up with a flare so, and you can’t 
go and kick a football around or anything like that” (James, 47) 
“No room for self pity at all or anything, no, just anger really” (Michael, 48) 
The finding that men struggle to cope with their RA supports a previous small 
qualitative study in RA (Hale et al, 2006), which found that men and women 
displayed different coping needs.  It also supports the proposal that a new health 
strategy is needed, which takes into consideration the specific needs of men (White 
et al, 2011).  The experiences of men with RA have not previously been explored in 
depth and this needs further investigation. 
The younger women in the daily life Q-study reported not allowing RA to 
impact on their lives.  As these women were more recently diagnosed, they had less 
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disability than the other patients in this study, which may be why they seem to 
experience less impact of RA.  However, the discourse also suggests that these 
young women will prioritize their responsibilities over their well-being, they may 
therefore be playing down the impact of their RA as a coping strategy.  This idea is 
supported by Study 1 (Chapter 6) in which Emma says: 
“Well I could still say it doesn’t really affect me that much, but you know, I know 
that’s not really true but it does seem right to say that” (Emma, 42) 
By putting their RA in its place these patients seem to be trying to maintain 
normality in their lives.  This would support findings in Study 1 (Chapter 6) and 
previous research that suggested six distinct typologies of normality exist in RA, 
which show how patients respond differently to the challenges of RA (Sanderson et 
al, 2011a).  The current study did not identify these six different typologies of 
normality, but the concept of normality appears to be important, particularly to 
younger patients. 
The flare help-seeking Q-study suggests that patients will be prompted to 
seek help for an RA flare due to pain intensity, longevity of the flare and no longer 
being able to control their symptoms (statements which achieved consensus).  This 
supports previous research (Hewlett et al, 2012), which found that patients will seek 
help from the medical team once they are certain they are in a flare and have 
increased their self-management.  Patients in this study reached consensus that 
they will not avoid help-seeking due to not getting on with their rheumatology team.  
This contrasts to the study from which this statement originated (Kett et al, 2010), 
which was carried out with an ethnically diverse population, whilst the current study 
was conducted with White British patients.  Thus White British patients may have a 
very different experience of care in comparison to patients from different cultural and 
ethnic backgrounds. 
 Whilst some patients will seek help quickly for their RA flare, others will wait, 
potentially causing further joint damage, due to beliefs that they should manage 
alone.  The only difference that could be identified between these patients is that the 
majority of the patients who would seek help quickly were taking anti-TNF therapies, 
whereas those patients who will wait were not.  This difference could be attributed to 
a number of reasons.  It is possible that patients on anti-TNF therapies have a 
different experience of care due to regular contact with the team because of 
repeated medication reviews.  Patients who have not been prescribed anti-TNF 
therapies may feel as though their symptoms are not validated, due to not having 
been offered this desirable, expensive treatment, which would support previous 
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qualitative research that found patients perceive anti-TNF therapies as expensive 
and worry about failing to ‘qualify’ for this treatment (Sanderson et al, 2009).  This 
may explain why they worry more about wasting the rheumatology team’s time and 
feel they should manage alone.  This study does not establish the cause and effect 
of the relationship between help-seeking and drug treatment, and so it is also 
possible that some patients have been prescribed anti-TNF therapies due to their 
help-seeking behaviours, therefore enabling the rheumatology team to treat their 
symptoms effectively. 
A further reason for the difference between the two types of help-seeking 
behaviour could be due to the definition of flare that patients were using.  The 
researcher did explain that flare was thought of as the type of flare that causes 
patients to seek medical help, but patients seemed to be using more than one 
definition of flare, such as one painful, swollen joint: 
“Sometimes just my thumb or just my knee hurts” (P1) 
The use of more than one definition of flare by patients supports previous 
qualitative research in RA, which found that patients use five different definitions of 
the word flare (Hewlett et al, 2012).  These different types of flare may create 
different help-seeking behaviours due to differences in severity and perceived cause 
and therefore differences in the impact the flare has on patients’ lives.  
8.7.1 Strengths and limitations 
This study may be criticised for lack of generalisability, due to the relatively 
small number of participants.  However, Q-methodology does not aim to be 
generalisable, it aims to sample the range of opinions and beliefs held about the 
subject.  As patients were sampled from three different NHS Trusts, all of which 
have different ways for patients to access care, it is likely that a wide range of 
opinions were represented. 
This study used patient-defined flare (patients were asked whether they felt 
they were in a flare or not at the time of participating), rather than an objective 
measure, it is therefore not possible to tell whether patients were in a clinical flare or 
not at the time of participating in the study.  Further, patients were not asked to 
provide their definition of flare, which would have aided interpretation in terms of 
why patients may delay help-seeking.  However, this was a pragmatic study, and the 
lack of consensus of a flare definition may pose a clinical problem, which was 
reflected in this study. 
Q-methodology can be criticised for imposing beliefs onto participants by 
giving them opinions to sort.  However, the statements patients sorted came from 
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interviews with 15 RA patients as well as the literature and should therefore 
represent a wide range of relevant opinions.  Further, the comments booklets 
allowed patients to expand on their sorting, thus reducing the influence of the 
researcher’s beliefs on the factor explanations. 
A strength of these Q-studies is that they were carried out on a one-to-one 
basis, thus removing conformity bias (Asch, 1958) in which people conform to the 
majority, which may occur with other consensus techniques (Chapter 5.5.4).  As 
patients were sorting cards across a grid they could not perceive the full story they 
were telling and were therefore able to be more open with their responses.  This 
was particularly important for the male participants, as men will tend to provide a 
discourse that protects their masculinity (Knight et al, 2012).   It has been proposed 
that men discuss their health in ways that draw on and reproduce idealised 
masculine expectations (what it means to be a ‘real’ man) (Knight et al, 2012) and it 
has been suggested that men need to be given explicit permission to break with the 
ideals of what men talk about (Oliffe and Mroz, 2005).  It is therefore possible that 
the finding that men appear to be struggling with their RA may not have been 
discovered through qualitative interviews, when they had to present a cohesive story 
to another person (female) and thus might have been tempted to preserve their 
masculinity by hiding certain feelings or thoughts, or editing their narrative.  
8.10 Summary 
Daily life with RA has less impact on some patients than others, which can 
be due to less disease severity, expert self-management or attaching less 
importance to their RA.  However, RA has a larger impact on other patients, the 
majority of whom seem to be male, due to concentrating on physical symptoms and 
rejecting self-management techniques. 
In an RA flare some patients will seek help quickly, whilst others will wait due 
to beliefs that they should manage alone.  Patients will seek help when their pain is 
too intense, their flare has gone on longer than expected and they are no longer 
able to control their flare.  Patients may therefore see medical help-seeking as a last 
resort, when they are no longer able to cope alone. 
Studies 1 and 2 explored daily life with RA and help-seeking behaviour in a 
flare, first through qualitative methods and then explored these further for clustering 
and by consensus, their importance.  In study 3 therefore, the daily symptoms and 
behaviours patients identified as most important will be examined in quantitative 
terms to understand the daily variation of symptoms and the levels that prompt help-
seeking.
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Chapter 9: Study 3: Understanding daily life and flare help-
seeking (Exploratory and feasibility survey)  
The current chapter presents the results of Study 3, which used items that 
were identified as important by patients in Study 2 to further understand daily 
variation and flare help-seeking. 
9.1 Aims and objectives for Study 3 
The aims of Study 3 were: 
1. To explore the range, variation and level of patients’ symptoms over time 
2. To explore patients’ tipping points for seeking help 
3. To explore the feasibility of collecting daily data 
4. To explore the feasibility of collecting data from patients in a flare 
Thus the objectives of Study 3 were: 
1. To assess the recruitment and attrition rates 
2. To assess the acceptability of the questions and the rate of completion 
3. To assess the effect of missing data and how to handle this 
4. To provide initial data on the range and variation of experiences over time 
9.2 Summary of Study 3 methods 
This study was divided into two parts, in both of which patients completed a 
baseline questionnaire (Appendix C) comprising demographic questions and the 
HAQ (Fries et al, 1980).  Patients in Study 3a (Daily Variation) then completed a 
Daily Symptoms Questionnaire for three months (Appendix L1) with an 
accompanying Weekly Impact and Management Questionnaire (Appendix L2).  
They had the option of completing the questionnaires online, or through traditional 
pen and paper responses, patients who chose the latter posted their responses 
back at the end of each week. 
Patients in Study 3b (Flare Help-Seeking) needed to be experiencing a flare, 
therefore Study 3b involved patients who phoned the rheumatology helpline (where 
patients leave a message for a rheumatology specialist nurse to call them back for 
help or to make an emergency appointment) in a self-defined RA flare.  Those who 
arranged an appointment to have their symptoms reviewed were invited to find out 
more about the study by the rheumatology specialist nurse who responded to their 
call.  Patients were then approached by the researcher to explain the study.  Those 
who agreed to take part completed a questionnaire pack in clinic that comprised the 
same Daily Symptoms Questionnaire (Appendix N1), a Flare Help-Seeking 
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Questionnaire (Appendix N2) to explore motivations for seeking help, and a Flare 
Early Warnings Questionnaire (Appendix N3); and were sent the Daily Symptoms 
Questionnaire to complete again four weeks after their appointment (when they 
should no longer be in a flare) in order to examine change in experienced 
symptoms.  For the full study methods see Chapter 5.6. 
9.3 Questionnaire development 
The Daily Symptoms Questionnaire items were developed from Study 2 (Q-
methodology) and comprised issues that either gained overall consensus in the Q-
methodology study, or were rated as important by one subset of participants 
(Factor).  Where possible a single validated item was used for each issue, but where 
this did not exist a single item was created based on the words used by patients in 
Studies 1 and 2, and with the advice of a patient partner and the study team. The 
Weekly Impact and Management Questionnaire was developed in the same 
manner. The justification and source for each item on each questionnaire are 
provided in Tables 9.1 and 9.2.   
Flare early warnings were not included as an item in Study 2 as few patients 
in Study 1 mentioned these.  However, a previous qualitative study across five 
countries found that RA patients could identify early warnings of their flares (Hewlett 
et al, 2012) and a questionnaire was developed to capture this (Bartlett et al, 2012) 
and a Flare Early Warnings Questionnaire was included in Study 3b to explore the 
issue further.  Items were informed by the previous publications (Hewlett et al, 2012, 
Bartlett et al, 2012) (Table 9.3). 
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Table 9.1:  Justification and sources for Daily Symptoms Questionnaire items 
 
Questionnaire item 0-10 Justification for inclusion Source 
1. How much pain do you have? Study 2: Factor B- scored +4 on the daily life 
item “Experiencing pain daily” 
Pain numerical rating scale (NRS)  
Farrar et al (2001) 
2. What is your average level of fatigue? Study 2: Factor B- scored +4 on the daily life 
item “Experiencing unexplainable 
fatigue/exhaustion daily” 
Bristol Rheumatoid Arthritis Fatigue (BRAF) scale 
Nicklin et al (2010a) 
3. How much joint swelling do you have? Study 2: Factor B- scored +1 on the daily life 
item “Experiencing swelling daily” 
Item created* 
4. How much joint stiffness do you have? Study 2: Factor B- scored +2 on the daily life 
item “Experiencing stiffness daily” 
Item created* 
5. How much time today did you spend being 
frustrated by your RA? 
Study 2: Factor B- scored +3 and Factor C 
score +2 on the daily life item “Getting 
frustrated due to my RA” 
Item created* 
6. How much time today did you spend being 
angry about your RA? 
Study 2: Factor B- scored +5 on the daily life 
item “Being angry because of my RA” 
Item created* 
7. How much time today was your RA a 
worry in your life? 
Study 2: Factor B- scored +3 on the daily life 
item “Worrying because of my RA” 
Item created* 
8. Is your rheumatoid arthritis in a flare 
condition today? 
To clarify whether current symptoms 
represent daily life or flare 
Item created* 
*Item created by the researcher as an existing item could not be found
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Table 9.2:  Justification and sources for Weekly Impact and Management Questionnaire items 
 
Questionnaire item Justification for inclusion Source 
1. How many times (if at all) have you had to 
cancel/change your plans due to your RA? 
Study 2: Consensus reached on the daily life item 
“I sometimes have to cancel plans due to my RA” 
Item created* 
2. Over the past week, what things have you 
tried to help you deal with your arthritis? (Tick) 
  
2a.   Avoided or altered doing the things that might 
cause pain 
Study 1: Identified as a self-management 
technique 
Rheumatoid Arthritis Self-Efficacy (RASE) scale 
Hewlett et al (2001) 
Modified to indicate what patients have done 
rather than believe they could do 
2b.   Gave myself permission to leave a task half-    
finished 
Study 2: Consensus reached on the daily life item 
“Giving myself permission to leave a task half 
finished” 
Item created* 
2c.    Distracted myself from my symptoms Study 2: Factor A scored +2 on the daily life item 
“Distracting myself from my symptoms” 
Item created* 
2d.   Asked for help with the difficulties of everyday 
tasks 
Study 2: Factor A scored +2 on the daily life item 
“Finding a balance between asking for help and 
remaining independent” 
Rheumatoid Arthritis Self-Efficacy (RASE) scale 
Hewlett et al (2001) 
Altered to indicate what patients have done rather 
than believe they could do 
2e.   Made small adjustments to my day to deal 
with the difficulties of everyday tasks  
Study 2: Factor A scored +5 on the daily life item 
“Making small adjustments to my day or activities 
constantly because of my RA” 
Item created* 
Table 9.2 continued overleaf 
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2f.   Made time for socialising Phase 1: Socialising identified as a self-
management technique 
Rheumatoid Arthritis Self-Efficacy (RASE) scale 
Hewlett et al (2001) 
Altered to indicate what patients have done rather 
than believe they could do 
2g.   Allocated time for relaxation Study 2: Factor A scored +2 and Factor B+ scored 
+1 on the daily life item “Planning rest time into my 
week” 
Rheumatoid Arthritis Self-Efficacy (RASE) scale 
Hewlett et al (2001) 
Altered to indicate what patients have done rather 
than believe they could do 
2h.   Managed my medication (knowing when and 
how to take it) 
Study 2: Factor A scored +3, Factor B+ scored +1 
and Factor C scored +2 on the daily life item 
“Taking my medication exactly as prescribed” 
Rheumatoid Arthritis Self-Efficacy (RASE) scale 
Hewlett et al (2001) 
Altered to indicate what patients have done rather 
than believe they could do 
2i.   Contacted my doctor or other health 
professional 
To understand patients help-seeking behaviours in 
relation to their daily symptoms 
Item created* 
3. Considering your arthritis overall, how would 
you rate your level of physical well-being 
during the past week? Circle the number that 
best describes your level of physical well-
being. 
To provide an overview of how patients view their 
physical well-being each week 
Rheumatoid Arthritis Impact of Disease (RAID) 
scale 
Gossec et al (2008) 
4. Considering your arthritis overall, how would 
you rate your level of emotional well-being 
during the past week? Circle the number that 
best describes your level of emotional well-
being. 
To provide an overview of how patients view their 
emotional; well-being each week 
Rheumatoid Arthritis Impact of Disease (RAID) 
scale 
Gossec et al (2008) 
*Item created by the researcher as an existing item could not be found 
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Table 9.3:  Justification and sources for Flare Help-Seeking Questionnaire items 
 
Questionnaire item Justification for inclusion Source 
1. Please circle the number that describes the 
severity of your RA flare 
 
Study 2: Consensus of +3 reached on the flare 
help-seeking item “I seek help from the medical 
team when the pain becomes too intense”.  Thus 
overall severity was measured in this study 
Rheumatoid arthritis flare evaluation 1.0 
OM RA Flare working group. Dec 2010 
 
2. Considering your normal ability to run or 
manage your life (at work or home), please 
circle the number that describes how you are 
currently managing 
 
Study 2: Factor B scored +4 on the flare help-
seeking item “I seek help from the medical team 
once flare starts to affect my quality of life too 
much”.  Divided into two separate questions for 
this study 
Rheumatoid arthritis flare evaluation 1.0 
OM RA Flare working group. Dec 2010 
(Question wording slightly modified.  One 
question divided between questions 2 and 3 to 
provide clarity) 
3. Considering your ability to take part in social 
and/or pleasurable activities that are normal for 
you, please circle the number that describes 
your current level of involvement 
Study 2: Factor B scored +4 on the flare help-
seeking item “I seek help from the medical team 
once flare starts to affect my quality of life too 
much”.  Divided into two separate questions for 
this study 
Rheumatoid arthritis flare evaluation 1.0 
OM RA Flare working group. Dec 2010 
(Question wording slightly modified.  One 
question divided between questions 2 and 3 to 
provide clarity) 
4. Considering your arthritis overall, please circle 
how well you coped with your disease during 
the last week? 
Study 2: Consensus of +3 reached on the flare 
help-seeking item “I seek help from the medical 
team when my symptoms become uncontrollable” 
Rheumatoid arthritis flare evaluation 1.0 
OM RA Flare working group. Dec 2010 
 
5. As a result of this flare, what did you do? (Tick 
as many boxes as apply): 
Study 1: Identified that patients will go through a 
period of crisis management prior to seeking help 
for an RA flare.  
Overall question:  Rheumatoid arthritis flare 
evaluation 1.0 
OM RA Flare working group. Dec 2010 
Some individual items have been altered  - see 
below 
Table 9.3 continued overleaf 
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5a.   I didn’t do anything different N/A Unaltered 
5b.   I reduced the amount of 
         activities I did 
Study 1: Identified patients cancel plans due to RA 
flares 
Unaltered 
5c.   I increased my rest time Study 1: Identified as a self-management 
technique 
Study 2: Factor A scored +2 on the daily life item 
“Planning rest time into my week” 
Item added by researcher, due to the lack of 
practical management items in the rheumatoid 
arthritis flare evaluation questionnaire 
5d.   I avoided doing activities I had  
        planned to do 
Study 1: Identified patients cancel plans due to RA 
flares 
Unaltered 
5e.   I asked for help with everyday 
        Tasks 
Study 1: Identified as a self-management 
technique 
Study 2: Factor A scored +2 on the daily life item 
“Finding a balance between asking for help and 
remaining independent” 
Item added by researcher, due to the lack of 
practical management items in the rheumatoid 
arthritis flare evaluation questionnaire 
5d.   I tried to distract myself from my    
        symptoms   
Study 1: Identified as a self-management 
technique 
Study 2: Factor A scored +2 on the daily life item 
“Distracting myself from my symptoms” 
Item added by researcher, due to the lack of 
practical management items in the rheumatoid 
arthritis flare evaluation questionnaire 
5e.   I took more painkillers or extra   
        anti-inflammatory medications   
        (NSAIDS) 
Study 1: Identified patients increase medication 
before seeking medical help for an RA flare 
Examples of medication removed from this item 
as the researcher felt this made the item 
confusing  
5f.   I took more steroid tablets Study 1: Identified patients increase medication 
before seeking medical help for an RA flare 
Examples of medication removed from this item 
as the researcher felt this made the item 
confusing 
6. What finally caused you to decide to contact 
the medical team? 
An open question to capture patients’ final tipping 
points and to highlight any issues not captured in 
Studies 1 and 2. 
Item created* 
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7. Do any of the following apply to you?   
7a.   I avoided seeking medical help  
        as I didn’t want to be given any  
        more medication 
 
Study 1: Identified as a reason for delaying help-
seeking 
 
Item created* 
7b.   I waited until the Flare had   
        lasted longer than I expected   
        before seeking help 
Consensus of +2 reached on the flare help-
seeking item “I seek help from the medical team 
when the flare has gone on longer than I 
expected” 
Item created* 
7c.   I waited until I had more than   
       one Flare symptom before  
       seeking medical help 
Consensus of 0 reached on the flare help-seeking 
item “I wait until I have more than one flare 
symptom before seeking help”.  Although only 
scored at 0, the comments suggest that this 
placing is because this depends on the type of 
flare patients are experiencing, thus this item has 
been included 
Item created* 
7d.   I was prompted by a family  
        member/friend to seek medical  
        help 
Study 2: Factor B scored +2 on the flare help-
seeking item “A loved one tells me I ought to seek 
medical help” 
Item created* 
 
*Item created by the researcher as an existing item could not be found 
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9.4 Results: Study 3a: Daily and weekly symptoms, impact and self-
management  
9.4.1 Study 3a participants 
45 people with RA were invited to participate from UHBT, NBT and ASPH 
and 28 (62%) agreed to take part.  One participant did not begin completing the 
daily measures, despite two reminders, thus 27 patients took part in Study 3a (Fig 
9.1).  7 participants (26%) chose to complete the measures online, 20 chose the pen 
and paper option and no patients chose the telephone option.  The majority of the 
participants were female (82%) and ages ranged from 24 to 83 years (mean: 
59.7yrs; SD: 14.4) (Table 9.4).  Patients were on a range of treatment regimes and 
had a disease duration of 1 to 57 years (mean: 16.2yrs; SD: 14.4), and a wide range 
of self-reported disease activity (DAS global) and disability (HAQ).   The majority of 
patients were retired and all were White British in ethnic origin (Table 9.4).  
 
 
Figure 9.1: Flow diagram of recruitment for Study 3a: Daily and weekly measure
  
 
2
3
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Table 9.4: Demographic information for participants in Study 3a: Daily and weekly symptoms, impact and self-management 
 
ID Gender Age 
(yrs) 
Dis Dur 
(yrs) 
HAQ DAS VAS Med NHS Trust* Work status Help at home Dependents 
P1 F 64 32 2.50 Unknown* DMARDs 1 Retired Husband None 
P2 F 78 21 1.13 2.0 Steroids 1 Retired Husband** Husband** 
P3 F 59 4 0.88 2.5 DMARDs 
Steroids 
1 Retired None None 
P4 M 55 12 2.25 5.1 DMARDs 
Steroids 
2 Employed Wife None 
P5 F 61 13 2.63 8.7 DMARDs 
Steroids 
2 Retired Grown-up 
children 
None 
P6 M 48 18 0.88 4.9 Anti-TNF 
DMARDs 
2 Employed Grown up 
children 
None 
P7 F 73 48 2.25 4.5 DMARDs 
Steroids 
2 Retired Grown-up 
children 
None 
P8 M 57 10 1.00 5.4 DMARDs 1 Employed Wife None 
P9 F 36 2 0.75 2.3 DMARDs 1 Employed Partner, Grown-
up child 
None 
P10 F 42 8 1.38 2.6 DMARDs 
Steroids 
1 Employed Husband 2 children 
P11 F 24 10 1.50 4.9 Anti-TNF 
DMARDs 
3 Employed Partner 1 child 
P12 M 62 1 0.00 1.3 DMARDs 3 Employed Wife None 
P13 F 49 10 1.38 7.8 DMARDs 3 On sick leave, 
job filled - 
?unemployed 
Child  (17yrs) 1 child 
P14 F 83 15 2.00 5.0 DMARDs 3 Retir  Husband None 
P15 M 68 57 2.63 7.6 DMARDs 
Steroids 
3 Retired Wife Wife 
P16 F 80 4 2.63 3.3 Anti-TNF 3 Retired Husband None 
P17 F 78 28 3.00 7.2 DMARDs 
Steroids 
1 Retired Husband None 
P18 F 60 10 1.13 4.1 DMARDs 1 Retired Husband** Husband** 
P19 F 61 11 2.38 4.7 Steroids 2 Retired Husband None 
P20 F 52 22 2.38 3.1 Anti-TNF 
DMARDs 
2 Incapacity Husband & 
home help 
None 
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P21 F 52 33 0.25 0.2 NSAIDs 2 Employed Partner None 
P22 F 64 15 1.75 1.3 Anti-TNF 
DMARDs 
2 Retired Husband None 
P23 F 74 8 2.75 6.1 DMARDs 
Steroids 
3 Retired Husband None 
P24 F 73 7 1.25 0.8 DMARDs 
Steroids 
1 Retired Husband None 
P25 F 60 4 2.75 8.4 Steroids 3 Retired Husband None 
P26 F 37 18 1.88 3.4 Anti-TNF 
DMARDs 
2 Self-employed Husband and 
young carer 
2 children 
P27 F 61 Unknown*** Unknown*** Unknown*** Unknown* 3 Retired Husband None 
Mean  59.7 16.2 1.7 4.3      
Stan dev  14.4 13.7 0.8 2.4      
*Nb NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
*Nb patient and husband both care for and depend on each other  
**Not completed by patient 
 
Key:  
Dis Dur =  Disease Duration 
HAQ = Health Assessment Questionnaire score 
DAS VAS = Disease activity score visual analogue scale (DAS global) 
Medication:    Anti-TNF = Anti-Tumour Necrosis Factor;    DMARDs = Disease Modifying Anti-Rheumatic Drugs;   NSAIDs = Non-steroidal anti-inflammatory;     Steroids = Glucocorticosteroids
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9.4.2 Missing data 
7 participants (26%) completed all 91 days of data collection, while 16 
participants (59%) had between 1 and 45 days of missing data due to forgetting to 
complete or illness.  Four participants (15%) withdrew from the study early, one due 
to illness; the others did not provide a reason (Table 9.5).  Seventeen patients (63%) 
returned at least 81/91 days data and were taken forward for further analysis.  
Patients with fewer completed days than this had too many gaps to analyse the data 
with any certainty. 
 
Table 9.5: Summary of missing data for participants in Study 3a: Daily and weekly measures   
 
Participant Missing 
days 
Reason 
P1 11 Consecutive days - Ill with flu couldn’t distinguish between symptoms so did not complete 
P2 1 1
st
 day – forgot to start 
P3 13 Individual days - forgot to complete 
P4 31 1 individual day – forgot to complete 
30 consecutive days – finished study early, no reason given 
P5 1 Forgot to complete 
P6 42 Completed sporadically with no explanation, despite reminders 
P7 2 Individual days – forgot to complete 
P8 1 Forgot to complete 
P9 56 All consecutive – finished study early, no reason given 
P10 1 Forgot to complete 
P11 4 Individual days - forgot to complete 
P12 55 13 Individual days - forgot to complete 
Finished 42 days early, no reason given 
P13 45 Completed sporadically with no explanation, despite reminders 
P14 0  
P15 3 Individual days - forgot to complete 
P16 42 3 individual days – forgot to complete 
Finished 39 days early due to severe flu  
P17 0  
P18 4 Individual days – forgot to complete 
P19 1 Forgot to complete 
P20 17 Individual days - forgot to complete 
P21 0  
P22 0  
P23 0  
P24 0  
P25 0  
P26 28 Individual days - forgot to complete 
P27 9 2 individual days - forgot to complete 
Finished 7 days early, no reason given 
Mean 
Stan Dev 
13.5 
18.8 
 
 
Nb: Patients highlighted in italic have more than 10 days of missing data 
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9.4.3 Symptom scores 
Every day for 3 months, patients recorded all symptoms from 0 to 10 on a 
numerical rating scale, with 10 being worst symptoms imaginable.  These data were 
not significantly skewed (Table 9.6), where significance was calculated as at least 
twice the standard error (SE): 
SE = √(6/n)  = √(6/17)  = 0.6 
2 x SE  = 0.6 x 2  = 1.2 
Thus the means rather than the medians have been reported.  The 17 
patients included in this analysis reported a mean pain score of 4.3 (SD 2.7), mean 
fatigue score of 4.7 (SD 2.7), mean joint stiffness score of 3.6 (SD 2.6), mean 
swollen joints score of 3.9 (SD 2.6), mean frustration score of 3.7 (SD 2.9), mean 
anger score of 3.1 (SD 3.3) and mean worry score of 3.7 (SD 3.1).  Thus pain and 
fatigue have the highest average severity and anger is the lowest.  Patient’s scores 
ranged from 0 to 10, and thus these overall means mask the range of symptoms 
experienced. 
Patients were asked daily whether they felt their symptoms constituted an 
RA flare (“Is your rheumatoid arthritis in a flare condition today?”), and examination 
of these data suggested that there were  three groups of patients with broadly 
common patterns: 1) those who did not report being in an RA flare for the entire 
three month data collection period, suggesting that these symptoms are how normal 
daily life can be experienced by people with RA (Daily Life patients, n=8); 2) those 
who reported one or more flares intermittently throughout the three months 
(Intermittent Flare patients, n=6); and 3) those who reported being in an RA flare for 
the entire three months (Constant Flare patients, n=3). For the purpose of analysis, 
patients have been separated into these three groups (Table 9.6). 
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Table 9.6: Summary of mean, standard deviation and range of symptoms 
Patients  Pain Fatigue Stiff 
Joints 
Swollen 
Joints 
Frustration Anger Worry 
Daily Life Mean 
SD 
Range 
 
Min score 
Max score 
3.1 
2.3 
10.0 
 
0.0 
10.0 
3.6 
2.6 
10.0 
 
0.0 
10.0 
2.4 
 1.5 
10.0 
 
0.0 
10.0 
2.7 
1.9 
10.0 
 
0.0 
10.0 
2.8 
2.9 
10.0 
 
0.0 
10.0 
2.2 
3.3 
10.0 
 
0.0 
10.0 
2,7 
3.1 
10.0 
 
0.0 
10.0 
Intermittent flare Mean 
SD 
Range 
 
Min score 
Max score 
 
4.8 
2.3 
9.0 
 
0.0 
9.0 
4.9 
2.0 
8.0 
 
1.0 
9.0 
4.0 
2.1 
9.0 
 
0.0 
9.0 
4.4 
2.1 
8.0 
 
1.0 
9.0 
4.1 
2.2 
9.0 
 
0.0 
9.0 
3.1 
2.6 
8.0 
 
0.0 
8.0 
4.3 
2.4 
9.0 
 
0.0 
9.0 
Constant flare Mean 
SD 
Range 
 
Min Score 
Max Score 
 
6.4 
3.1 
9.0 
 
1.0 
10.0 
7.0 
2.5 
9.0 
 
1.0 
10.0 
6.4 
3.3 
9.0 
 
1.0 
10.0 
6.3 
3.2 
9.0 
 
1.0 
10.0 
5.5 
3.5 
10.0 
 
0.0 
10.0 
5.2 
3.6 
10.0 
 
0.0 
10.0 
5.3 
3.6 
10.0 
 
0.0 
10.0 
Study Total Mean 
SD 
Range 
4.3 
2.7 
10.0 
4.7 
2.7 
10.0 
3.6 
2.6 
10.0 
3.9 
2.6 
10.0 
3.7 
2.9 
10.0 
3.1 
3.3 
10.0 
3.7 
3.1 
10.0 
 Skew 0.4 0.3 0.8 0.6 0.4 0.6 0.5 
 
9.4.3.1 Symptoms of Daily Life 
Daily Life patients reported a mean pain score of 3.1 (SD 2.3), mean fatigue 
score of 3.6 (SD 2.6), mean joint stiffness score of 2.4 (SD 1.5), mean swollen joints 
score of 2.7 (SD 1.9), mean frustration score of 2.8 (SD 2.9), mean anger score of 
2.2 (SD 3.3) and mean worry score of 2.7 (SD 3.1) (Table 9.7a).  Thus in daily life 
pain and fatigue are still the highest average scored symptoms and anger is still the 
lowest scored.  These scores are all lower than the respective overall study means, 
indicating that patients who do not report being in flare are experiencing lower than 
average symptoms.  However, it is of note that even in normal daily life, on average 
patients are not symptom free.  Patients’ individual daily scores ranged from 0 to 10 
for all symptoms and therefore despite being divided into a smaller group, reporting 
only the mean scores may still be masking individual differences.  For example, 
daily life patients’ mean pain scores ranged from 0.2 (SD 0.5) in patient P24 to 5.8 
(SD 2.2) in patient P19, and fatigue scores ranged from 0.4 (SD 0.9) to 7.6 (SD 2.0) 
(P24 and P23). This demonstrates the wide variation in symptoms experienced 
between patients who do not consider themselves to be in a flare.  However, a 
mean symptom score, even per patient, does not address the daily fluctuation of RA 
symptoms over the 3 months, which will be addressed in section 9.4.4. 
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9.4.3.2 Symptoms of Intermittent Flare 
Intermittent Flare patients reported a mean pain score of 4.8 (SD 2.3), mean 
fatigue score of 4.9 (SD 2.0), mean joint stiffness score of 4.0 (SD 2.1), mean 
swollen joints score of 4.4 (SD 2.1), mean frustration score of 4.1 (SD 2.2), mean 
anger score of 3.1 (SD 2.6) and mean worry score of 4.3 (SD 2.4) (Table 9.7b).  
Thus for patients experiencing intermittent flares, pain and swollen joints are the 
highest average scored symptoms and anger is still the lowest scored.  These 
scores are all higher than the respective overall study means, indicating that 
patients experience higher average symptoms when they are in and out of flare than 
in normal daily life.  Patients’ individual daily scores ranged from 0 to 9 and 
therefore, despite being divided into a smaller group, these mean scores may be 
masking individual differences.  Over the 91 days, intermittent flare patients’ mean 
pain scores ranged from 2.5 (SD 1.2) to 7.0 (SD 0.6) (P14 and P17), and swollen 
joint scores ranged from 2.3 (SD 0.8) to 6.5 (SD 1.6) (P21 and P17), again 
demonstrating the difference in symptoms experienced between patients.  It is of 
note that all the lowest mean symptom scores for these patients are lower than the 
highest mean symptom scores for daily life patients.  This indicates that some 
patients experience higher level of symptoms in daily life than others do when 
experiencing intermittent flares.  Individual fluctuations of symptoms will be 
addressed in Section 9.4.5. 
9.4.3.3 Symptoms of Constant Flare 
Constant Flare patients reported a mean pain score of 6.4 (SD 3.1), mean 
fatigue score of 7.0 (SD 2.5), mean joint stiffness score of 6.4 (SD 3.3), mean 
swollen joints score of 6.3 (SD 3.2), mean frustration score of 5.5 (SD 3.5), mean 
anger score of 5.2 (SD 3.6) and mean worry score of 5.3 (SD 3.6) (Table 9.7c).  
Thus for patients in a constant flare, pain and stiff joints are the highest average 
scored symptoms and anger is still the lowest scored.  These scores are all higher 
than the respective overall study means, indicating that patients experience higher 
average symptoms when they are in a flare than in normal daily life or experiencing 
intermittent flares.  Patients’ individual daily scores ranged from 0 to 10 and 
therefore despite being divided into a smaller group, these mean scores may be 
masking individual differences.  Constant flare patients’ mean pain scores ranged 
from 2.4 (SD 1.3) to 9.3 (SD 0.8) (P11 and P5) and stiff joint scores ranged from 2.3 
(SD 01.5) to 9.5 (SD 0.8) (P11 and P5), demonstrating the range of variation in 
symptoms experienced between patients.  It is again of note that all the lowest mean 
symptom scores for these patients are lower than the highest mean symptom scores 
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for daily life patients.  This indicates that some patients experience higher level of 
symptoms in daily life than others do when they consider themselves in a flare.  
Individual fluctuations of symptoms will be addressed in section 9.4.6. 
 
Table 9.7a: Mean, standard deviation and range of symptoms reported by Daily Life patients 
  
Patients  Pain Fatigue Stiff Joints Swollen 
Joints 
Frustration Anger Worry 
P2 Mean 
SD 
Range 
Min Score 
Max Score 
 
1.7 
0.8 
2.0 
1.0 
3.0 
1.9 
0.6 
3.0 
0.0 
3.0 
1.5 
0.7 
3.0 
0.0 
3.0 
1.4 
0.5 
2.0 
1.0 
3.0 
1.1 
0.7 
3.0 
0.0 
3.0 
0.0 
0.2 
1.0 
0.0 
1.0 
0.9 
0.5 
2.0 
0.0 
2.0 
P8 Mean 
SD 
Range 
Min Score 
Max Score 
 
 
3.6 
1.0 
4.0 
1.0 
5.0 
 
4.3 
0.9 
3.0 
2.0 
5.0 
3.5 
0.8 
2.0 
2.0 
4.0 
3.5 
0.8 
2.0 
2.0 
4.0 
3.8 
0.6 
3.0 
2.0 
5.0 
3.6 
0.8 
3.0 
2.0 
5.0 
3.7 
0.6 
2.0 
2.0 
4.0 
P10 Mean 
SD 
Range 
Min Score 
Max Score 
 
2.3 
0.5 
3.0 
1.0 
4.0 
3.0 
0.4 
2.0 
2.0 
4.0 
2.3 
0.5 
3.0 
1.0 
4.0 
2.4 
0.5 
3.0 
1.0 
4.0 
2.2 
0.5 
2.0 
1.0 
3.0 
0.0 
0.2 
1.0 
0.0 
1.0 
2.7 
0.6 
2.0 
1.0 
3.0 
P19 Mean 
SD 
Range 
Min Score 
Max Score 
 
5.8 
2.2 
8.0 
1.0 
9.0 
6.3 
2.5 
9.0 
1.0 
10.0 
4.8 
1.6 
8.0 
0.0 
8.0 
6.5 
1.6 
7.0 
2.0 
9.0 
4.5 
1.9 
8.0 
0.0 
8.0 
4.5 
2.1 
8.0 
0.0 
8.0 
3.9 
1.7 
7.0 
0.0 
7.0 
P22 Mean 
SD 
Range 
Min Score 
Max Score 
 
2.0 
0.6 
2.0 
1.0 
3.0 
2.8 
0.7 
1.0 
2.0 
3.0 
1.9 
0.7 
2.0 
1.0 
3.0 
2.2 
0.5 
2.0 
1.0 
3.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
1.0 
0.0 
1.0 
P23 Mean 
SD 
Range 
Min Score 
Max Score 
 
5.6 
2.2 
8.0 
2.0 
10.0 
7.6 
2.0 
8.0 
2.0 
10.0 
2.3 
0.8 
5.0 
0.0 
5.0 
2.8 
1.2 
7.0 
1.0 
8.0 
8.7 
0.7 
3.0 
7.0 
10.0 
9.2 
0.7 
2.0 
8.0 
10.0 
9.4 
0.6 
2.0 
8.0 
10.0 
P24 Mean 
SD 
Range 
Min Score 
Max Score 
 
0.2 
0.5 
3.0 
0.0 
3.0 
0.4 
0.9 
3.0 
0.0 
3.0 
0.3 
0.7 
2.0 
0.0 
2.0 
0.5 
0.9 
3.0 
0.0 
3.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
P27 Mean 
SD 
Range 
Min Score 
Max Score 
 
3.5 
1.2 
5.0 
1.0 
6.0 
2.6 
1.3 
5.0 
0.0 
5.0 
2.3 
0.9 
3.0 
1.0 
4.0 
2.3 
1.1 
4.0 
1.0 
5.0 
1.8 
0.9 
4.0 
0.0 
4.0 
0.1 
0.3 
1.0 
0.0 
1.0 
0.7 
0.6 
2.0 
0.0 
2.0 
Total Mean 
SD 
Range 
 
Min score 
Max score 
3.1 
2.3 
10.0 
 
0.0 
10.0 
3.6 
2.6 
10.0 
 
0.0 
10.0 
2.4 
 1.5 
10.00 
 
0.00 
10.00 
2.7 
1.9 
10.0 
 
0.0 
10.0 
2.8 
2.9 
10.0 
 
0.0 
10.0 
2.2 
3.3 
10.0 
 
0.0 
10.0 
2,7 
3.1 
10.0 
 
0.0 
10.0 
Nb. Highest mean scores for each patient group highlighted in blue, lowest mean scores for 
each patient group highlighted in yellow 
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Table 9.7b: Mean, standard deviation and range of symptoms reported by Intermittent Flare 
patients  
 
Patients  Pain Fatigue Stiff 
Joints 
Swollen 
Joints 
Frustration Anger Worry 
P7 Mean 
SD 
Range 
Min Score 
Max Score 
 
6.6 
1.0 
5.0 
4.0 
9.0 
7.4 
1.0 
4.0 
5.0 
9.0 
4.9 
1.0 
4.0 
3.0 
7.0 
5.4 
1.0 
3.0 
4.0 
7.0 
6.3 
1.2 
7.0 
2.0 
9.0 
5.7 
1.3 
6.0 
2.0 
8.0 
7.8 
1.2 
6.0 
3.0 
9.0 
P14 Mean 
SD 
Range 
Min Score 
Max Score 
 
2.5 
1.2 
6.0 
0.0 
6.0 
3.9 
0.8 
5.0 
2.0 
7.0 
1.7 
0.7 
3.0 
0.0 
3.0 
3.0 
0.8 
4.0 
1.0 
5.0 
2.1 
0.7 
4.0 
0.0 
4.0 
0.0 
0.3 
3.0 
0.0 
3.0 
1.9 
0.8 
4.0 
0.0 
4.0 
P15 Mean 
SD 
Range 
Min Score 
Max Score 
 
6.9 
0.8 
4.0 
5.0 
9.0 
5.8 
0.7 
4.0 
4.0 
8.0 
6.2 
1.1 
5.0 
3.0 
8.0 
6.5 
1.0 
4.0 
4.0 
8.0 
5.9 
0.9 
5.0 
3.0 
8.0 
5.1 
0.8 
4.0 
3.0 
7.0 
5.8 
0.8 
4.0 
3.0 
7.0 
P17 Mean 
SD 
Range 
Min Score 
Max Score 
 
7.0 
0.6 
3.0 
5.0 
8.0 
6.4 
0.9 
4.0 
4.0 
8.0 
6.1 
0.9 
4.0 
4.0 
8.0 
6.5 
0.9 
5.0 
4.0 
9.0 
6.0 
1.0 
6.0 
2.0 
8.0 
5.6 
1.2 
6.0 
2.0 
8.0 
5.6 
1.0 
4.0 
4.0 
8.0 
P18 Mean 
SD 
Range 
Min Score 
Max Score 
 
2.8 
1.4 
8.0 
1.0 
9.0 
2.7 
1.2 
8.0 
1.0 
9.0 
2.6 
1.5 
8.0 
1.0 
9.0 
2.8 
1.5 
8.0 
1.0 
9.0 
2.6 
1.4 
7.0 
1.0 
8.0 
2.3 
1.2 
6.0 
1.0 
7.0 
2.3 
1.1 
6.0 
1.0 
7.0 
P21 Mean 
SD 
Range 
Min Score 
Max Score 
 
3.2 
0.7 
3.0 
2.0 
5.0 
3.0 
0.9 
3.0 
1.0 
5.0 
2.3 
0.9 
3.0 
1.0 
4.0 
2.3 
0.8 
3.0 
1.0 
4.0 
2.1 
0.8 
4.0 
0.0 
4.0 
0.0 
0.1 
1.0 
0.0 
1.0 
2.4 
0.7 
3.0 
1.0 
4.0 
Total Mean 
SD 
Range 
 
Min score 
Max score 
4.8 
2.3 
9.0 
 
0.0 
9.0 
4.9 
2.0 
8.0 
 
1.0 
9.0 
4.0 
2.1 
9.0 
 
0.0 
9.0 
4.4 
2.1 
8.0 
 
1.0 
9.0 
4.1 
2.2 
9.0 
 
0.0 
9.0 
3.1 
2.6 
8.0 
 
0.0 
8.0 
4.3 
2.4 
9.0 
 
0.0 
9.0 
Nb. Highest mean scores for each patient group highlighted in blue, lowest mean scores for 
each patient group highlighted in yellow 
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Table 9.7c: Mean, standard deviation and range of symptoms reported by Constant Flare 
patients  
 
Patients  Pain Fatigue Stiff 
Joints 
Swollen 
Joints 
Frustration Anger Worry 
P5 Mean 
SD 
Range 
Min Score 
Max Score 
 
9.3 
0.8 
4.0 
6.0 
10.0 
9.3 
0.7 
3.0 
7.0 
10.0 
9.5 
0.8 
4.0 
6.0 
10.0 
9.5 
0.7 
4.0 
6.0 
10.0 
9.0 
0.7 
4.0 
6.0 
10.0 
 
8.9 
0.7 
4.0 
6.0 
10.0 
8.9 
0.7 
5.0 
5.0 
10.0 
P11 Mean 
SD 
Range 
Min Score 
Max Score 
 
2.4 
1.3 
6.0 
1.0 
7.0 
4.4 
2.1 
8.0 
1.0 
9.0 
2.3 
1.5 
6.0 
1.0 
7.0 
2.2 
1.4 
5.0 
1.0 
6.0 
1.1 
1.3 
7.0 
0.0 
7.0 
0.7 
0.9 
5.0 
0.0 
5.0 
0.6 
0.9 
5.0 
0.0 
5.0 
P25 Mean 
SD 
Range 
Min Score 
Max Score 
7.3 
1.4 
6.0 
4.0 
10.0 
7.3 
1.4 
6.0 
4.0 
10.0 
7.3 
1.1 
6.0 
4.0 
10.0 
7.2 
1.3 
6.0 
4.0 
10.0 
6.2 
1.4 
8.0 
2.0 
10.0 
5.9 
1.5 
9.0 
1.0 
10.0 
6.2 
1.2 
9.0 
1.0 
10.0 
 
Total Mean 
SD 
Range 
 
Min Score 
Max Score 
6.4 
3.1 
9.0 
 
1.0 
10.0 
7.0 
2.5 
9.0 
 
1.0 
10.0 
6.4 
3.3 
9.0 
 
1.0 
10.0 
6.3 
3.2 
9.0 
 
1.0 
10.0 
5.5 
3.5 
10.0 
 
0.0 
10.0 
5.2 
3.6 
10.0 
 
0.0 
10.0 
5.3 
3.6 
10.0 
 
0.0 
10.0 
Study 
total 
Mean 
SD 
Range 
 
Min Score 
Max Score 
4.3 
2.7 
10.0 
 
1.0 
10.0 
4.7 
2.7 
10.0 
 
1.0 
10.0 
3.6 
2.6 
10.0 
 
1.0 
10.0 
3.9 
2.6 
10.0 
 
1.0 
10.0 
3.7 
2.9 
10.0 
 
0.0 
10.0 
3.1 
3.3 
10.0 
 
0.0 
10.0 
3.7 
3.1 
10.0 
 
0.0 
10.0 
Nb. Highest mean scores for each patient group highlighted in blue, lowest mean scores for 
each patient group highlighted in yellow 
 
9.4.4 Symptom patterns 
Patients recorded the severity of four physical symptoms and three 
emotional symptoms, and these have been combined to produce overall physical 
and emotional scores for each patient in the form of the percentage of the total 
possible score.  For example on day 1 patient P18 scored 2 (out of a possible 10) 
for pain, 3 for fatigue, 2 for swollen joints and 2 for stiffness and thus scored 9 out of 
a possible 40 for physical symptoms, or 22.5% of the total possible physical 
symptoms score.  In order to visualise the fluctuation of symptoms across time and 
to identify patterns, these overall symptom scores have been displayed in a graph, 
per patient.  Whilst these graphs provide the overall patterns of physical and 
emotional symptoms per patient, they do not address the fluctuations of individual 
symptoms.  Thus graphs displaying individual symptoms for each patient were 
created and examples of these are used to exemplify patterns of symptoms.   
It was anticipated that patients would display a low level of fluctuating 
symptoms in daily life and simultaneous peak if they reported experiencing a flare.  
This belief was due to the researcher’s experience of observing how clinicians 
explain life with RA to newly diagnosed patients.  However, only one patient 
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displayed this ‘typical’ pattern of RA (Fig 9.2).  When this patient reported a flare, all 
physical and emotional symptoms peaked together (Figs 9.3 to 9.4).  Further, this 
patient increased the number of self-management strategies used when a flare was 
reported (Fig 9.5). 
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Figure 9.2: Graph showing total (%) physical and emotional symptoms for patient P18 (Intermittent flares underlined in red) 
 
 
 
Figure 9.3: Graph showing individual physical symptoms for patient P18 (Intermittent flares underlined in red) 
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Figure 9.4: Graph showing individual emotional symptoms for patient P18 (Intermittent flares underlined in red) 
 
 
Figure 9.5: Graph showing the number of self-management techniques used per week by patient P18 (Intermittent flare patients) 
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9.4.5 Symptom patterns in Daily Life 
Eight patients reported no flares at all in 3 months, suggesting that for them 
this is what everyday life is like with RA.  However, even in daily life individual 
patients appear to have a range of very different experiences of the fluctuations of 
RA symptoms. Three different potential daily patterns have been identified in these 
daily life patients 1) Low symptoms, little fluctuation; 2) Low symptoms, daily 
fluctuation; 3) High symptoms, daily fluctuation. 
9.4.5.1 Daily Life: Low symptoms, little fluctuation 
Two patients in this group (n=3) were female and one male, they had a 
mean age of 69.3 (SD 11.0), disease duration 12.7 years (SD 7.4), disability (HAQ) 
1.13 (SD 0.13), and disease severity (DAS global) 2.4 (SD 2.7).  Two patients were 
using DMARDs and one was using steroids, two patients were retired and one was 
working.  These patients experienced low symptoms (less than 50% of possible total 
symptoms) daily and experienced up to 30 consecutive days without any fluctuation 
in symptoms (Figs 9.6 to 9.8, P8, P22, P24).  Two patients reported none or very 
few emotional symptoms, whilst patient P8 reported her emotional and physical 
symptoms as tightly linked with each other (Fig 9.6). 
Graphs displaying patients’ individual physical and emotional symptoms 
show that pain and fatigue were generally, but not consistently, higher than the other 
reported symptoms. These patients reported no more than up to 2 points variation 
within individual symptoms each day.  Further, these patients used nearly all the 9 
measured self-management strategies weekly, which may indicate why they are 
able to maintain this level of RA symptoms.  These findings are exemplified by 
patient P8 (Figs 9.9 to 9.11). 
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Figure 9.6: Graph showing total (%) physical and emotional symptoms for patient P8 (daily life patient) 
 
  
 
 
Figure 9.7: Graph showing total (%) physical and emotional symptoms for patient P22 (daily life patient) 
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Figure 9.8: Graph showing total (%) physical and emotional symptoms for patient P24 (daily life patient) 
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Figure 9.9: Graph showing individual physical symptoms for patient P8 (daily life patient) 
 
 
 
 
Figure 9.10: Graph showing individual emotional symptoms for patient P8 (daily life patient) 
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Figure 9.11: Graph showing the number of self-management techniques used per week for patient P8 (daily life patient) 
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9.4.5.2 Daily Life: Low symptoms, daily fluctuation 
Patients in this group (n=3) were all female, had a mean age of 60 (SD 
25.5), disease duration 9.2 years (SD 14.5), disability (HAQ) 0.2 (SD 1.3), and 
disease severity (DAS global) 0.4 (SD 2.3).  One patient was using DMARDs, one 
was using steroids, one patient was retired and one was working.  One patient did 
not complete the baseline questionnaire and therefore this information is unknown. 
These patients experienced low symptoms (less than 50% of possible total 
symptoms) daily, with almost daily fluctuation of symptoms.  In 3 months, these 
patients did not have more than 3 consecutive days without fluctuations in physical 
symptoms, or 7 consecutive days without variation in emotional symptoms (Figs 
9.12 to 9.14, P2, 10, 27). They reported physical and emotional symptoms as similar 
in severity, with physical symptoms being consistently slightly higher than emotional.  
In general, as physical symptoms increase in severity, so do emotional symptoms.   
Graphs displaying patients’ individual physical and emotional symptoms 
show that these patients’ symptoms fluctuated by up to 4 points out of a possible 10 
difference between individual symptoms daily.  No physical symptom was 
consistently higher than any other, and frustration was often reported as more 
severe than the other emotional symptoms.  The fluctuations show that when pain 
increases, fatigue increases within a few days.  Swollen and stiff joints appear to 
follow a similar pattern to each other and increases follow increases in pain, but to a 
lesser extent.  These patients use the majority of the measured self-management 
strategies weekly, indicating that they may be able to manage the level of their 
symptoms, but not the amount of fluctuation.  This is exemplified by patient P27 
(Figs 9.15 to 9.17). 
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Figure 9.12: Graph showing total (%) physical and emotional symptoms for patient P2 (daily life patient) 
 
 
 
Figure 9.13: Graph showing total (%) physical and emotional symptoms for patient P10 (daily life patient) 
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Figure 9.14: Graph showing total (%) physical and emotional symptoms for patient P27 (daily life patient) 
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Figure 9.15: Graph showing individual physical symptoms for patient P27 (daily life patient) 
 
 
 
 
 
Figure 9.16: Graph showing individual emotional symptoms for patient P27 (daily life patient) 
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Figure 9.17: Graph showing the number of self-management techniques used per week for patient P27 (daily life patient) 
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9.4.5.3 Daily Life: High symptoms, daily fluctuation  
Patients in this group (n=2) were both female, had a mean age of 67.5 (SD 
9.2), disease duration 9.5 years (SD 2.1), disability (HAQ) 0.3 (SD 2.6), and disease 
severity (DAS global) 1.0 (SD 5.4).  Both patients were using DMARDs and were 
retired.  Despite not considering themselves in flare on any day for 3 months, both 
these patients reported symptoms that were higher than 70% of possible total 
symptoms. They reported daily fluctuations, with no more than 3 consecutive days 
without symptom variation (Figs 9.18 and 9.19, P19, P23).  One patient (P19) 
reported physical and emotional symptoms as similar in severity, with physical 
symptoms being consistently slightly higher than emotional, whilst the other (P23) 
reported a larger difference between the severity of physical and emotional 
symptoms, with emotional symptoms being consistently higher than physical. 
Graphs displaying patients’ individual physical and emotional symptoms 
show that one patient (P19) scored up to 6 points out of a possible 10 points 
variation within physical symptoms daily and 4 points variation within emotional 
symptoms daily with no symptom being consistently higher than any other.  It is of 
note that patient P19 uses less self-management strategies than patients with low 
average symptoms.  However, between weeks 2 and 5 this patient increased the 
number of self-management strategies used, which corresponded with a decrease 
in reported symptom severity.  Further, P19 reported some days with all physical 
symptoms scored 7 and above, yet did not consider herself to be in a flare.  It is 
therefore possible that this patient considers a flare to be at least 8/10 in all 
symptoms, or that she is using different criteria, other than these symptoms, to 
define flare.   
P23 scored greater fluctuation in daily physical symptoms (up to 8 points) 
and 3 points variation within emotional symptoms daily, with pain and fatigue being 
scored consistently higher than stiff and swollen joints. P23 used fewer self-
management strategies than patients with low symptom scores, although still used 
at least 5 different strategies every day.  This did not appear to correspond to 
changes in symptom scores.  Despite scoring pain and fatigue as 10 (worst 
symptoms imaginable) on some days, P23 does not consider herself in a flare at 
any time, thus it is possible that either swollen or stiff joints need to be perceived as 
higher for this patient to define herself as in flare.  As these patients display such 
differences in fluctuating symptoms, both patients’ graphs are presented (Figs 9.20 
to 9.25).
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Figure 9.18: Graph showing total (%) physical and emotional symptoms for patient P19 (daily life patient) 
 
 
 
Figure 9.19: Graph showing total (%) physical and emotional symptoms for patient P23 (daily life patient) 
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Figure 9.20: Graph showing individual physical symptoms for patient P19 (daily life patient) 
 
 
 
Figure 9.21: Graph showing individual emotional symptoms for patient P19 (daily life patient) 
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Figure 9.22: Graph showing the number of self-management techniques used per week for patient P19 (daily life patient) 
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Figure 9.23: Graph showing individual physical symptoms for patient P23 (daily life patient) 
 
 
 
Figure 9.24: Graph showing individual emotional symptoms for patient P23 (daily life patient) 
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Figure 9.25: Graph showing the number of self-management techniques used per week for patient P23 (daily life patient) 
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9.4.6 Symptom patterns in Intermittent Flare 
Patients in this group (n=6) were five women and one man, they had a mean 
age of 69 (SD 11.5), disease duration 31.8 years (SD 18.3), disability (HAQ) 1.9 (SD 
1.0), and disease severity (DAS global) 4.8 (SD 2.7).  Five patients were using 
DMARDs and one was using only NSAIDs.  All the patients in this group reported at 
least one episode of flare during the 3 month data collection period.  All these 
patients reported physical and emotional symptoms as similar in severity, with 
physical symptoms being consistently slightly higher than emotional.  It is notable 
that all but one patient reported higher symptoms on some of the days on which 
they did not report being in flare, than on days that they reported being in a flare 
(Figs 9.26 to 9.30, P7 P14, P15, P17, P21).  For example, patient P21 (Fig 9.30) 
reported higher symptoms on day 61 (non-flare) than all six instances when flare 
was reported. In contrast patient P18 reported a classic pattern of daily life and flare, 
in which she reported relatively low (yet not symptom free) symptoms in between 
flares and spikes of both physical and emotional symptoms during flares (Fig 9.2). 
Graphs displaying patients’ individual physical and emotional symptoms 
show that on days when patients considered themselves in a flare, their pain and 
fatigue symptoms were higher than most non-flare days (exemplified by P7 and 
P17, Figs 9.31-34). However, there were no symptoms that were reported as being 
consistently only higher when the patients were in flare.  Thus patients may be using 
different criteria other than their symptoms to decide whether they are in a flare or 
not.  It is of note that patients reported equal or higher swollen joint scores on some 
of the days on which they did not report being in flare, than on days that they 
reported being in a flare this is exemplified by patients P7 (Fig 9.31 days 16 - 19) 
and P17 (Fig 9.33 days 58 - 60).  These patients used less self-management 
strategies weekly than the daily life patients.  However, they all used at least five 
self-management strategies daily.  With these patients, the number of strategies 
used did not appear to relate to symptom scores.  Exemplified by P17 (Fig 9.35).
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Figure 9.26: Graph showing total (%) physical and emotional symptoms for patient P7 (Intermittent flares underlined in red) 
 
 
 
 
Figure 9.27: Graph showing total (%) physical and emotional symptoms for patient P14 (Intermittent flares underlined in red) 
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Figure 9.28: Graph showing total (%) physical and emotional symptoms for patient P15 (Intermittent flares underlined in red) 
 
 
 
 
Figure 9.29: Graph showing total (%) physical and emotional symptoms for patient P17 (Intermittent flares underlined in red) 
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Figure 9.30: Graph showing total (%) physical and emotional symptoms for patient P21 (Intermittent flares underlined in red) 
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Figure 9.31: Graph showing individual physical symptoms for patient P7 (Intermittent flares underlined in red) 
 
 
 
Figure 9.32: Graph showing individual emotional symptoms for patient P7 (Intermittent flares underlined in red) 
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Figure 9.33: Graph showing individual physical symptoms for patient P17 (Intermittent flares underlined in red) 
 
 
Figure 9.34: Graph showing individual emotional symptoms for patient P17 (Intermittent flares underlined in red) 
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Figure 9.35: Graph showing the number of self-management techniques used per week for patient P17 (intermittent flare patient) 
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9.4.7 Symptom patterns in Constant Flare 
Patients in this group (n=3) were all female with a mean age of 48.3 (SD 
21.1), disease duration 12 years (SD 1.7), disability (HAQ) 2.3 (SD 0.6), and 
disease severity (DAS global) 7.4 (SD 2.2).  One patient was using DMARDs, one 
was using steroids and one was using anti-TNF therapy.  All the patients in this 
group reported being in a flare for the entire 3 month period.  They all reported 
physical and emotional symptoms as similar in severity, with physical symptoms 
being consistently slightly higher than emotional.  However, these three patients 
reported very different experiences of being in a prolonged flare.  Whilst one patient 
(P5) reported consistently high symptoms, another (P25) reported symptoms that 
fluctuated between medium and high severity and the third patient (P11) reported 
low fluctuating symptoms that only spiked above 50% of total possible symptoms on 
3 occasions.  Thus patients reported a very wide range of experiences of symptoms 
that they considered to be an RA flare (Figs 9.36 to 9.38). 
Two patients reported the severity of physical and emotional symptoms as 
similar to each other, with no one symptom being consistently higher than the 
others.  This is exemplified by patient P25 (Figs 9.39 to 9.40).  However, patient P11 
reported high fatigue, whilst the other symptoms were reported as lower but still 
mirroring the fluctuations of fatigue.  This patient may therefore be using her fatigue 
to define herself as in a flare (Figs 9.41 to 9.42).  These patients also differed in the 
number of self-management strategies they used.  Two patients reported using less 
self-management strategies weekly than other patients, exemplified by P11 (Fig 
9.43).  This indicates they may need to increase their self-management to control 
their symptoms, whilst P25 reported using all self-management strategies nearly 
every week, indicating she was doing all she could to manage her flare (Fig 9.44).
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Figure 9.36: Graph showing total (%) physical and emotional symptoms for patient P5 (Constant flare patient) 
 
 
Figure 9.37: Graph showing total (%) physical and emotional symptoms for patient P11 (Constant flare patient) 
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Figure 9.38: Graph showing total (%) physical and emotional symptoms for patient P25 (Constant flare patient) 
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Figure 9.39: Graph showing individual physical symptoms for patient P25 (Constant flare patient) 
 
 
 
 
Figure 9.40: Graph showing individual emotional symptoms for patient P25 (Constant flare patient) 
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Figure 9.41: Graph showing individual physical symptoms for patient P11 (Constant flare patient) 
 
 
 
 
Figure 9.42: Graph showing individual emotional symptoms for patient P11 (Constant flare patient) 
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Figure 9.43: Graph showing the number of self-management techniques used per week for patient P11 (Constant flare patient) 
 
 
 
Figure 9.44: Graph showing the number of self-management techniques used per week for patient P25 (Constant flare patient)
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9.4.8 Impact and self-management 
Patients reported having to cancel plans due to their RA a total of 154 times 
across the three month data collection period, which is a mean of 1.4 cancellations 
per patient per week (Table 9.8).  Daily life patients reported the lowest total mean 
of 0.5 times per patient per week.   Even in daily life some of these patients reported 
cancelling their plans up to 4 times in one week.  However, this group is skewed by 
one patient who reported 42 cancelled plans in three months.  The remaining daily 
life patients reported cancelling a maximum of two plans in one week.  Intermittent 
flare patients reported only a slightly higher mean than daily life patients (0.6 times 
per patient per week); they did not consistently cancel their plans more when in a 
perceived flare.  Constant flare patients reported cancelling their plans a mean of 
1.5 times per patient per week, indicating that patients do have more disrupted lives 
when in a flare. 
 
Table 9.8: Number of times patients reported cancelling their plans due to their RA 
Nb: Scores highlighted in yellow indicate weeks in which patients reported a flare (they were not 
necessarily in a flare for the entire week) 
 
Patients reported using a variety of self-management techniques.  Those 
used by all the patients were ‘avoided or altered doing the things that might cause 
pain’ and ‘asking for help with the difficulties of daily tasks’ (Table 9.9).  All the 
management techniques, except contacting their doctor, were used frequently by at 
Patient Week Total 
Mean 
(per 
week) 
 1 2 3 4 5 6 7 8 9 10 11 12 13   
Daily life patients 
P2 1 0 1 0 0 0 0 0 1 0 0 0 0 3 0.2 
P8 2 4 2 2 4 4 4 4 4 4 4 2 2 42 3.2 
P10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 
P19 0 0 0 0 0 0 0 1 2 0 1 0 0 4 0.3 
P22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 
P23 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0.1 
P24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 
P27 0 0 1 0 0 0 0 0 0 0 0 1 1 3 0.2 
Total 3 4 4 2 5 4 4 5 7 4 5 3 3 53 0.5 
Intermittent flare patients  
P7 4 1 2 3 1 2 1 2 0 2 1 0 0 19 1.5 
P14 0 0 2 1 0 0 2 0 0 1 0 0 0 6 0.5 
P15 3 0 0 0 0 0 0 0 0 0 0 0 0 3 0.2 
P17 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0.1 
P18 0 0 2 1 2 4 0 2 0 0 3 0 0 14 1.1 
P21 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0.1 
Total 8 1 6 5 3 6 3 4 1 3 4 0 0 44 0.6 
Constant flare patients  
P5 4 4 3 3 4 3 3 8 2 0 0 0 0 34 2.6 
P11 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0.1 
P25 1 1 1 3 2 2 2 1 2 2 2 2 1 22 1.7 
Total 6 5 4 6 6 5 5 9 4 2 2 2 1 57 1.5 
Overall 
Total 
17 10 14 13 14 15 12 18 12 9 11 5 4 154 
1.4 
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least 14 of the patients a mean of between 8.3 and 10.5 weeks out of 13 weeks per 
patient (Table 9.9 and Fig 9.45).  8 patients contacted their doctor or other health 
professional.  Whilst the 3 Daily Life patients each called for help once, this may not 
have been for a flare as the question asked if they had “contacted [their] doctor or 
other health professional” without specifying the reason and these patients reported 
no flares in 3 months.  Of 6 the Intermittent Flare patients only 3 contacted the 
medical team, all of whom contacted within one week of first reporting being in flare.  
Of the 3 patients who considered themselves in a flare for the whole 3 months 
(Constant Flare patients), 2 contacted their medical team, one of whom waited at 
least 7 weeks from the start of data collection, but it is not known how long they had 
experienced flare prior to starting data collection (Table 9.10).  Thus some patients 
who consider themselves in a flare may not contact the medical team at all or will 
wait a long time, whilst other patients will contact the team as soon as they consider 
themselves in a flare.  It is of note that some patients contacted the team more than 
once during the data collection period. 
 
 Table 9.9: Frequency of self-management strategies used by patients in Study 3a 
 
 
 
Self-Management Technique 
No. of 
patients 
No.  of 
instances 
Mean 
per 
patient 
Avoided or altered doing the things that might cause pain 
17 158 9.3 
Gave myself permission to leave a task half-finished 
16 143 8.9 
Distracted myself from my symptoms 
14 128 9.2 
Asked for help with the difficulties of daily tasks 
17 159 9.4 
Made small adjustments to my day to deal with the difficulties of everyday tasks 
16 148 9.3 
Made time for socialising 
16 133 8.3 
Allocated time for relaxation 
16 158 10.5 
Managed my medication (knowing when and how to take it) 
15 147 9.8 
Contacted my doctor or other health professional 8 34 4.25 
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Figure 9.45: Graph showing self-management strategies used by patients in Study 3a 
 
 
Table 9.10: Frequency of help-seeking for Study 3a patients 
 
Patient Medical help 
sought? 
If yes, after how long?* 
Intermittent flare patients   
P7 Yes 0 
P14 No N/A 
P15 Yes 1 
P17 Yes 0 
P18 No N/A 
P21 No N/A 
Constant flare patients   
P5** Yes 7 
P11 No N/A 
P25 Yes 0 
*How long in weeks after first reporting flare, before seeking help. Patients were asked daily about flares and weekly 
about help-seeking.  Thus figures can only be accurate to within 1 week. 
**The researcher was concerned about this patient during data entry as all symptoms were scored consistently 
highly.  Thus the researcher contacted the patient (week 6) to remind her about the rheumatology helpline, which 
may have influenced this patient’s decision 
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9.5 Results: Study 3b: Flare help-seeking 
Study 3b used a different cohort of patients to Study 3a (Daily Variation).  
Following three months of recruitment at one NHS Trust for this study (Site 1), only 
2 patients had agreed to take part.  As patients were being recruited by the 
rheumatology specialist nurses through the rheumatology helpline, the researcher 
was unable to ascertain whether this low recruitment rate was due to a lack of 
patients calling the helpline in a flare, whether patients were declining to take part, 
or if they were not being asked.  Thus for the fourth month of recruitment an 
additional site was added (Site 2) and a prospective audit of the rheumatology 
helpline at Site 1 was carried out, in order to audit the recruitment procedures.  The 
NHS Trusts have been distinguished by numbers to preserve patients’ anonymity. 
9.5.1 Rheumatology helpline and recruitment audit 
Over a one month period (6th Feb to 5th March 2012) the records kept to 
identify the reasons patients were calling and the outcome of the call were 
examined.  During this one month period, 139 calls were made to the rheumatology 
helpline.  Of these, 123 (89%) were patients with RA, 20 (16%) of whom were 
calling due to an RA flare, all of whom had appointments made for them.  One of 
these patients was calling due to worsening symptoms, but made an appointment 
for an RA flare after a discussion with the rheumatology specialist nurse.  The other 
three patients calling with worsening symptoms had recently changed medication 
and were advised on how long this should take to make a difference to their 
symptoms.  Eight (40%) of the patients in an RA flare were not invited to participate, 
as when the nurse rang to give them their appointment date, they could only leave a 
message on the answer phone.  Of the 12 patients invited only 4 (33%) agreed to 
discuss participating in Study 3b with the researcher and only 1 of these patients 
agreed to participate.  RA patients phoned the rheumatology helpline for a range of 
reasons, which resulted in different outcomes of the call (Table 9.11). 
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Table 9.11: Summary of reasons and outcomes of patients contacting a rheumatology helpline 
 
  Frequency Percentage 
Gender Male 30 24.4 
 Female 93 75.6 
Reason for call Request appointment for RA flare 19 15.4 
 Request appointment for other reason 24 19.5 
 Cancel appointment 6 4.9 
 Discuss drug side effects 19 15.4 
 Results query 9 7.3 
 Worsening symptoms 4 3.3 
 Other advice* 33 26.9 
 Update the team** 7 5.7 
 Request IM depomedrone*** 2 1.6 
Outcome of call Verbal advice 64 52.0 
 Appointment made or cancelled 20 16.3 
 Appointment made for other reason 24 19.5 
 Appointment cancelled 6 4.9 
 IM depomedrone arranged 2 1.6 
 No action needed 7 5.7 
Applicable for study Not applicable 103 83.7 
 Accept study invitation**** 4 3.3 
 Decline study invitation 8 6.4 
 Not asked 8 6.4 
*Other advice included what patients could see their GP for, medication dose and physiotherapy advice 
**Patients called to update the team with how their medication  is working 
***IM depomedrone requested due to an up-coming holiday, rather than RA flare 
****Accepted study invitation from rheumatology specialist nurses (only 1 went on to participate) 
 
9.5.2 Study 3b participants 
The first three months recruitment rates are unknown, but 2 patients agreed 
to participate.  In the final month of recruitment 40 patients were invited to 
participate and 29 (72.5%) agreed to take part.  Thus 31 patients agreed to take part 
in this study, of whom 28 came from Site 2.  Differences in recruitment rates are 
discussed in Section 9.6. 
The majority of the participants were female (97%) and ages ranged from 27 
to 84 years (mean: 59.5yrs; SD: 15.2) (Table 9.12).  Patients were on a range of 
treatment regimes and had a disease duration of 2 months to 35 years (mean: 
11.3yrs; SD: 9.9), and a wide range of self-reported disease activity (DAS global) 
and disability (HAQ).   The majority of patients were retired and all were White 
British in ethnic origin. 
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Table 9.12: Summary of demographic information for participants in Study 3b: Flare help-seeking 
 
ID Gender Age 
(yrs) 
Dis Dur 
(yrs) 
HAQ DAS VAS Med NHS Trust* Work status Help at home Dependents 
P1 F 72 13 1.63 5.0 Unknown** 1 Retired None None 
P2 F 73 7 Unknown** 5.2 DMARDs 1 Retired None None 
P3 F 40 8 Unknown** 8.9 NSAIDs 1 Incapacity Husband, adult 
child, young 
carer 
2 children 
P4 F 84 2 2.63 9.6 DMARDs 2 Retired None None 
P5 F 55 2 0.25 1.1 DMARDs 2 Employed None None 
P6 M 58 13 1.88 4.5 Steroids 2 Retired Wife Mother 
P7 F 42 6 2.38 8.5 DMARDs 2 Employed Husband 3 children 
P8 F 68 35 2.38 9.1 Anti-TNF 2 Retired Husband None 
P9 F 47 5 1.75 3.0 Steroids 2 Employed Husband, young 
carer 
3 children 
P10 F 68 35 2.88 7.7 Regular Depo*** 2 Retired Husband None 
P11 F 60 9 Months 1.88 6.1 Regular Depo*** 2 Employed None None 
P12 F 79 5 2.38 1.5 Regular Depo*** 2 Retired Husband None 
P13 F 63 2 Months 2.75 10 Regular Depo*** 2 Retired Husband None 
P14 F 70 25 0.63 3.9 DMARDs 
Steroids 
2 Employed None None 
P15 F 51 5 2.00 4.6 Regular Depo*** 2 Employed None None 
P16 F 38 10 1.00 3.0 Steroids 2 Employed Husband 1 child 
P17 F 27 6 1.13 2.4 DMARDs 2 Employed None None 
P18 F 54 18 2.75 7.5 Anti-TNF 2 Unemployed Husband & adult 
child 
None 
Table 9.12 continued overleaf 
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P19 F 39 10 0.63 2.0 DMARDs 
Steroids 
2 Employed Husband & 
young carer 
3 children 
P20 F 44 4 1.63 4.9 DMARDs 2 Employed Husband 1 child 
P21 F 79 10 1.88 6.7 Regular Depo*** 2 Retired None None 
P22 F 50 9 2.38 8.1 DMARDs 
Steroids 
2 Incapacity Partner Partner 
P23 F 52 12 1.75 7.9 DMARDs 
Steroids 
2 Retired Husband**** Husband**** 
P24 F 42 8 1.50 8.7 DMARDs 
Steroids 
2 Employed Partner Children 
P25 F 55 18 2.25 6.6 DMARDs 2 Employed Husband & 
grown-up child 
Parents 
P26 F 60 5 2.63 7.6 Regular Depo*** 2 Employed Husband None 
P27 F 82 30 1.50 7.4 Anti-TNF 2 Retired None None 
P28 F 78 5 2.50 4.7 Regular Depo*** 2 Retired Grown-up child None 
P29 F 69 29 2.75 7.2 Anti-TNF 
DMARDs 
2 Retired Husband None 
P30 F 76 1 2.38 6.9 DMARDs 2 Retired Husband & 
grown-up child 
None 
P31 F 69 13 2.25 6.6 Anti-TNF 
DMARDs 
2 Retired Husband None 
 Mean  59.5 11.3 1.9 6.0      
Stan Dev  15.2 9.9 0.7 2.5      
*Nb NHS Trusts have been distinguished by numbers due to concerns about retaining patients’ anonymity 
**Not completed by patient 
***These patients are controlled with regular depomedrone injections 
**** Nb patient and husband both care for and depend on each other 
 
Key:  
Dis Dur =  Disease Duration; HAQ = Health Assessment Questionnaire score; DAS VAS = Disease activity score visual analogue scale (DAS global);  Med = Medication 
Medication:     Anti-TNF = Anti-Tumour Necrosis Factor;  DMARDs = Disease Modifying Anti-Rheumatic Drugs;  NSAIDs = Non-steroidal anti-inflammatory; Steroids = Glucocorticosteroids 
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9.5.3 Study completion 
Of the 31 patients who agreed to take part in Study 3b, 20 patients 
completed the Daily Symptoms questionnaire (Appendix N1) at Time 1, when they 
attended clinic for their emergency flare appointment.  Eleven patients from NHS 
Trust 2 were not given the symptom measures questionnaire due to a 
misunderstanding, and therefore were not sent the questionnaire at Time 2 (4 weeks 
after Time 1).  Of the 20 patients that completed symptom measures at Time 1, 12 
patients (60%) returned the questionnaire at Time 2.  Only three patients completed 
the early warning signs questionnaire (Appendix N3), all explaining that they were 
only able to comment on these with the benefit of hindsight.  Thus the results of this 
questionnaire have not been included.  All 31 patients completed the flare help-
seeking questionnaire (Appendix N2), which related to impact, self-management 
and tipping points for seeking help. 
9.5.4 Flare symptoms 
The 7 emotional and physical self-reported symptom scores were totalled (0-
70).  Patients reported a mean symptom score in flare of 41.7 (SD 14.0), with no 
one symptom being scored consistently higher than all other symptoms between 
patients (Table 9.13).  Patients reported a wide range of symptom scores with the 
lowest range being 7.0 for stiff joints (scores ranged from 3 to 10) indicating that 
between-patients, different levels of symptoms cause them to define themselves as 
in flare.   It is of note that patients’ self-reported severity scores for their flare (0-10) 
do not correspond to their total symptom score.  For example patient P8 scored their 
total symptoms as 36/70, but their single flare severity question as 8/10, whist P13 
scored their total symptoms at 65/70, with a flare severity of 5/10.  It was therefore 
decided to perform a correlational analysis between the individual reported symptom 
scores and the reported flare severity.  A Spearman’s rho correlation was chosen as 
the symptoms were self-reported scores and therefore may not have been normally 
distributed (Dancey and Reidy, 2008).  A significant positive correlation was found 
for the relationship between patients’ pain and their flare severity (Table 9.14: rho = 
0.666, p = 0.01), but no significant correlation was found for the relationship 
between patients’ flare severity and any of the other individually reported symptoms.  
Significant positive correlations were also found for the relationship between 
frustration and worry (rho = 0.855), anger and worry (rho = 0.728, p = 0.01), 
frustration and fatigue (rho = 0.632, p = 0.01) and stiff joints and fatigue (rho = 
0.589, p = 0.01). 
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All patients were given an IM depomedrome as treatment, except one who 
received an intra-articular injection (P3).  One patient (P4) also had their DMARDs 
changed.   At Time 2, 11 out of 12 patients reported their total symptom score had 
decreased and one patient’s score remained the same (P3), with a mean symptom 
score of 17.2 (SD 20.1).  It is of note that four weeks after their appointment, two 
patients (P3 and P4) still considered themselves to be in a flare (Table 9.14).   
 
Table 9.13:  Flare help-seeking patients’ symptom scores at Time 1 
 
Patient Pain Fatigue Swollen 
joints 
Stiff 
joints 
Frustration Anger Worry Total Flare severity 
P1 4 4 6 6 1 1 1 23 6 
P2 7 9 4 4 10 7 8 49 8 
P3 8 8 8 10 10 8 9 61 8 
P4 10 9 10 10 10 10 10 69 10 
P5 9 5 1 5 4 0 1 25 9 
P6 6 5 2 5 3 2 1 24 6 
P7 8 7 6 7 10 4 10 52 8 
P8 8 3 8 8 3 3 3 36 8 
P9 7 7 6 7 9 9 9 54 7 
P10 9 10 2 9 9 0 8 47 9 
P11 7 8 3 7 7 1 3 36 9 
P12 5 2 8 3 3 5 2 28 3 
P13 8 9 8 10 10 10 10 65 5 
P14 5 5 6 6 5 5 7 39 8 
P15 7 9 9 10 6 0 0 41 8 
P16 7 6 6 7 6 1 4 37 7 
P17 9 8 7 7 2 2 3 38 8 
P18 8 6 6 7 7 8 7 49 8 
P19 2 7 2 7 1 1 1 21 2 
P20 8 5 3 7 7 4 5 39 7 
Mean 7.1 6.6 5.55 7.1 6.2 4.1 5.1 41.7 7.2 
St Dev 1.9 2.2 2.6 2.0 3.2 3.5 3.6 14.0 2.0 
Range 8.0 8.0 9.0 7.0 9.0 10.0 10.0 48.0 8.0 
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Table 9.14: Spearman’s rank correlation co-efficients for patients’ self-reported symptom scores and flare severity  
 
   Pain Fatigue SwollenJoints StiffJoints Frustration Anger Worry FlareSeverity 
Spearman's rho Pain Correlation Coefficient 1.000        
Sig. (2-tailed) .        
N 20        
Fatigue Correlation Coefficient .406 1.000       
Sig. (2-tailed) .076 .       
N 20 20       
SwollenJoints Correlation Coefficient .155 .134 1.000      
Sig. (2-tailed) .515 .574 .      
N 20 20 20      
StiffJoints Correlation Coefficient .495* .589** .505* 1.000     
Sig. (2-tailed) .026 .006 .023 .     
N 20 20 20 20     
Frustration Correlation Coefficient .466* .632** .204 .440 1.000    
Sig. (2-tailed) .038 .003 .389 .052 .    
N 20 20 20 20 20    
Anger Correlation Coefficient .133 .091 .482* .144 .549* 1.000   
Sig. (2-tailed) .576 .704 .031 .544 .012 .   
N 20 20 20 20 20 20   
Worry Correlation Coefficient .460* .455* .268 .394 .855** .728** 1.000  
Sig. (2-tailed) .041 .044 .252 .085 .000 .000 .  
N 20 20 20 20 20 20 20  
FlareSeverity Correlation Coefficient .666** .410 .006 .278 .392 -.120 .251 1.000 
Sig. (2-tailed) .001 .073 .979 .236 .087 .615 .286 . 
N 20 20 20 20 20 20 20 20 
*. Correlation is significant at the 0.05 level (2-tailed) 
** Correlation is significant at the 0.01 level (2-tailed) 
Chapter 9: Study 3: Exploratory study 
284 
 
Table 9.15:  Flare help-seeking patients’ symptom scores at Time 2 
Patient Pain Fatigue Swollen 
joints 
Stiff 
joints 
Frustration Anger Worry Total In Flare? 
P3 9 10 9 8 10 8 7 61 Y 
P4 8 7 8 7 8 9 9 56 Y 
P6 2 2 0 2 1 0 0 7 N 
P9 3 5 1 3 6 7 4 29 N 
P11 1 2 1 2 1 0 0 7 N 
P13 7 8 7 9 7 5 7 50 N 
P14 3 4 4 4 1 1 3 20 N 
P15 3 2 2 2 0 0 0 9 N 
P16 2 2 2 3 2 0 2 13 N 
P17 1 5 2 1 0 0 0 9 N 
P18 2 4 6 3 4 4 3 26 N 
P20 4 5 1 3 4 2 4 23 N 
Mean 3.8 4.7 3.6 4.0 3.7 3.0 3.3 17.2  
St Dev 2.7 2.6 3.1 2.6 3.4 3.4 3.1 20.1  
Range 8.0 8.0 8.0 8.0 10.0 9.0 9.0 54.0  
 
9.5.5 Flare impact, self-management and help-seeking 
9.5.5.1 Flare impact 
Patients scored flare impact items from 0-10, with 10 relating to managing as 
normal, full involvement and coping very well (results displayed in a graph in 
Appendix S).  Patients scored highest on being able to manage whilst in an RA flare 
(mean 4.7, SD 2.5) and lowest on their current level of involvement in social or 
pleasurable activities (mean 4.1, SD 2.4).  It is of note that whilst some patients’ 
managing, coping and involvement scores were similar, some patients (e.g. P11, 
circled in blue) reported they were able to manage well, whilst not coping or being 
involved, and others (e.g. P6, circled in red) reported they were able to cope, but not 
to manage (Fig 9.46) 
9.5.5.2 Flare self-management 
Increasing rest time was the most common self-management strategy (25 
patients) and only 2 patients did not do anything differently when they realised they 
were in flare.  It is of note that 26 out of 31 (84%) patients increased their medication 
themselves, all of whom increased their analgesics or anti-inflammatory medication, 
3 of whom also increased their steroids (Table 9.16). 
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Table 9.16: Frequency of self-management strategies used by patient in Study 3b  
 
Self-management strategy Number of patients 
(n=31) 
I didn’t do anything different 2 
I reduced the amount of activities I did 23 
I increased my rest time 25 
I avoided doing activities I had planned to do 17 
I asked for help with everyday tasks 18 
I tried to distract myself from my symptoms 20 
I took more painkillers or extra anti-inflammatory medications 26 
I took more steroid tablets 3 
 
9.5.5.3 Delays and tipping points for flare help-seeking 
Four patients (7%) reported delaying help-seeking due to not wanting to be 
prescribed any more medication, 13 patients (42%) reported waiting until they had 
more than one symptom before seeking help and 21 (66%) reported waiting until the 
flare had lasted longer than expected before seeking help.  Further, 21 patients 
(66%) reported having been prompted to seek help by a family member or friend.  
Patients’ free-form responses regarding their final tipping points for seeking help 
have been grouped into symptoms, impact, coping/self-management strategies and 
other.  It is acknowledged that some overlap exists in the categories, for example 
mobility being affected could be placed within quality of life being affected.  
However, these data were separated in order to use participants’ own words and to 
show the diversity in the specific final tipping points, rather than masking this 
diversity under one overall ‘quality of life’ heading.   These results show that patients 
reported multiple tipping points with unbearable pain being the most common tipping 
point for patients, followed by being unable to sleep or rest (Table 9.17). 
 
Table 9.17: Frequency table of final tipping points for flare help-seeking 
 
 Tipping Points  Number of patients 
Symptoms Unbearable pain 23 
 Stiffness 2 
 Swelling 2 
 Fatigue 3 
 Dark thoughts/low mood 2 
Impact  Quality of life affected 2 
 Unable to rest/sleep 7 
 Mobility affected 3 
 Unable to do daily tasks  2 
 Paid work affected 3 
 Social withdrawal/isolation 2 
Coping/Self-management Not coping 2 
 Self-management not working 2 
 Painkillers not working 3 
Other Feeling desperate 2 
 Knew it would get worse without help 2 
 Family member phoned helpline (choice removed) 1 
 Prompted by rheumatology nurse when phoned helpline for other reason 1 
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9.6 Discussion 
This study produced novel data showing first that patients are never 
symptom free but experience a wide range of daily symptoms that vary between and 
within patients; second that self-management is a constant necessity; third that 
definitions of flare vary within and between people and may not be purely defined by 
symptom severity; fourth that help-seeking decisions vary widely; and fifth that few 
patients experience early warnings for flare. 
Study 3a identified that even on current, modern treatment regimes patients 
are never symptom free, even in daily life, which supports the findings from the free-
form graphs completed by patients in Study 1 (Chapter 6.4.2).  In fact some patients 
report higher symptoms in daily life than when they consider themselves in flare.  
The vast difference in reported symptom patterns by patients in daily life, intermittent 
flare and constant flares, highlight the individual nature of patients’ experiences of 
RA.  Only one patient reported symptoms that fit the expected pattern of RA, which 
anecdotal evidence suggests is used by clinicians as an illustration of RA to newly 
diagnosed patients (after sitting in on clinics, the researcher noted that all clinicians 
either draw a standard wavy line or wave their hands to indicate fluctuations, to 
explain to newly diagnosed patients what life will be like).  This demonstrates the 
problem with the flare illustration by Stone et al (2008), which displayed four types of 
flare to patients with AS and asked them to pick which best fit their experience.  
Clinicians may not have a true picture of how patients’ symptoms fluctuate daily and 
thus asking patients to pick one of four patterns produced by clinicians may not truly 
reflect how their disease fluctuates.  Further, four patterns of symptoms appears to 
be too reductionist to enable this complex phenomenon to be fully appreciated. 
Study 3 also found that patients use different levels of self-management, 
which do not necessarily relate to their level of symptoms. This supports the 
different patient groups identified in Study 2 (Q-methodology).  Patients in study 3a 
who experience daily life as low symptoms with varying fluctuations report using a 
high number of self-management strategies every week.  These patients seem to fit 
the Study 2 ‘taking active control’ group (Factor A+), as they are self-managing their 
symptoms to a manageable level.  Patients in Study 3a who reported daily life as 
high levels of symptoms and high fluctuation reported a moderate level of weekly 
self-management and appear to fit into the Study 2 ‘constant struggle’ group (Factor 
B-).  For some of these patients, their increase in self-management strategies did 
not relate to a drop in symptom severity and they therefore may not be identifying 
the correct types of self-management to control their symptoms, further supporting 
fit with the ‘constant struggle’ group.  However, for other patients, as they increased 
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the number of self-management strategies they used, their reported RA symptoms 
reduced.  Thus it is possible that these are the Study 2 ‘putting RA in its place’ group 
(Factor C-) and do not always have time to consider self-management strategies, 
but when they do use them, they work.  
Patients who experienced intermittent flares throughout the data collection 
period still used a moderate number of self-management strategies and some 
patients in a constant flare reported using all measured self-management strategies.  
Thus these patients appear to represent the Study 2 ‘constant struggle’ patients, 
being unable to self-manage their symptoms.  However, these patients report self-
managing as much as possible and thus could also be considered the Study 2 
‘taking active control’ group but who are no longer able to control their 
unmanageable flare symptoms.  Thus even patients that are able to take control of 
their RA and maintain a balance in normal daily life, may still lose control when flare 
symptoms become overwhelming.   
Study 3b identified that patients used a variety of self-management 
strategies before seeking medical help, including increasing their medication.  These 
prospective, quantitative data support previous qualitative research (Hewlett et al, 
2012), performed with patients who were asked to look back to a time when they 
were in a flare, and which proposed that failure of self-management strategies 
prompt patients’ help-seeking behaviours.  A previous qualitative study (Kett et al, 
2010), which addressed the self-management strategies used during flares in an 
ethnically diverse population had broadly similar findings, but with some specific 
cultural differences.  Further, this increasing level of self-management prior to 
seeking help for an RA flare supports the Mediation Ladder developed in qualitative 
Study 1 (Chapter 6 Figure 6.23), confirming patients do use an additional level of 
self-management prior to help-seeking. It therefore appears that some, but not all, of 
the previous flare proposals generated from qualitative studies with patients not in 
flare, are supported by these quantitative exploratory data collected prospectively in 
patients in flare. 
Study 3 identified that patients may all be using different criteria to define 
flare.  It is also possible that patients who reported high symptoms, yet did not 
consider themselves to be in a flare at those times, may have accepted this high 
level of symptoms as normal for them.  Nearly all patients who reported intermittent 
flares during the Study 3a data collection period reported days not in flare on which 
they recorded higher levels of symptoms than days in flare.  Further, although 
patients who reported flares cancelled more plans on average than those not in 
flare, individual patients did not necessarily cancel more plans on the days they 
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reported flares than the days they did not.  Thus it is possible that patients are using 
more than just physical symptoms, emotions and impact on their lives to define 
themselves as in an RA flare.  Patients may consider themselves in flare when they 
are no longer able to mediate the balance in their lives, with no single factor 
consistently contributing to this loss of balance.  This idea is supported by Jane in 
Study 1 (Interviews): 
“Stress can cause it, you know something that’s worrying.  I mean, when my 
son’s marriage broke up that caused a flare-up” (Jane, 65) 
It is possible that stressful events do not always cause flare-ups per se, it 
may be that the stressful event tips the balance in patients’ lives enough to cause 
them to reclassify their symptoms as a flare.  Indeed, patients in Study 3b (Help-
Seeking) did experience lower overall symptoms four weeks after their clinic 
appointment (when they were no longer in flare) indicating that seeking medical help 
for a flare does help to restore this balance, which supports the Fluctuating 
Balances Model developed in this thesis (Chapter 8, Figure 8.4). 
The finding that there is a significant positive correlation between patients’ 
self-reported pain and flare severity support findings from informal discussion 
groups with RA patients (Bingham et al, 2009b), which proposed that pain was a 
critical factor in patients’ definition of flare.  It is important to note that patients’ self-
reported flare severity did not significantly correlate with patients’ self-reported 
swollen joints, which is the only RA symptom that is explicitly visible to clinicians. 
These prospective, quantitative data from these patients at the time they 
consider they are in flare, suggest that they have a complex set of beliefs and 
tipping points that cause them to define their symptoms as an RA flare.  This 
supports previous research (Hewlett et al, 2012), which claimed that increased 
symptoms and failure of self-management strategies led to patients defining 
themselves as in flare.  However, the current study has demonstrated that even this 
may be too simplistic and the influence of inter-personal factors alongside socio-
cultural factors in relation to patients’ flare definitions need to be explored further, in 
order to better understand the individual context. 
The help-seeking behaviours of patients in Study 3a who reported a flare 
support the types of flare help-seeking identified in Study 2.  Some patients reported 
seeking help quickly (‘definite decision’: Factor A), whilst others waited up to seven 
weeks after identifying themselves as in a flare (‘cautious indecision’: Factor B).  It is 
of note that not all patients in Study 3a who reported being in a flare sought medical 
help.  Some of these were patients who reported being in flare for the 3 months of 
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the study and of unknown duration prior to the study commencing.  It is possible that 
these patients fit into the ‘cautious indecision’ type, and may eventually seek help.  
However, due to the length of time their flare has lasted without help-seeking, it is 
also possible that these patients form another group, who don’t ever seek help for 
their RA flares. 
The majority of patients in Study 3b (Help-Seeking) reported low scores on 
(at least one of) being able to manage, being able to cope and maintaining their 
level of involvement.  This supports the Fluctuating Balances Model (Chapter 8, Fig 
8.4) developed in this thesis, which identified losing control as a tipping point for 
help-seeking.  This prospective study with patients in flare identified that the most 
common tipping points for seeking help were unbearable pain and flare going on 
longer than expected.  This supports the consensus for flare help-seeking identified 
in Study 2, which were intense pain, longevity of flare and loss of control.  Further, 
these tipping points for help-seeking are similar to those identified in patients pre-
diagnosis (Sheppard et al, 2008), which were symptom severity, impact on daily life 
and the patient’s interpretation and evaluation of their symptoms.  The only tipping 
point not expressly measured was patients’ interpretation of their symptoms.  
However, all these patients considered themselves in a flare and thus had 
interpreted their symptoms in this way.   
A further tipping point of note is that the majority of patients reported being 
prompted by a friend or family member to seek help.  This could be due to patients 
needing external validation of their interpretation of their symptoms (Stoller et al, 
1998).  It is also possible that patients need this external permission to seek help, 
thus removing the responsibility of the patient possibly having made the wrong 
decision.  This supports a previous qualitative study in acute myocardial infarction, 
which found that people were more likely to seek help if a friend or family member 
phoned for help as the patient reported feeling less guilty about the possibility of 
wasting the doctor’s time (Pattenden et al, 2002).  Further, being prompted by a 
friend or family member to seek help may allow patients to retain their stoic identity, 
whilst still seeking help, by being able to claim they were coerced into seeking help.  
This indicates that patients are not alone in the decision-making process and thus 
family members of newly diagnosed patients may benefit from education along with 
patients.   
Patients who sought help were asked how well they were coping, managing 
and able to be involved in activities.  It was of note that these were not necessarily 
linked to each other, with some patients reporting being able to cope, but not to 
manage and vice versa.  This supports previous qualitative research (Nicklin et al, 
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2010b), which found that patients make a clear distinction between managing and 
coping, with managing being related to practical issues and coping being concerned 
with emotions.  This supports the psychological theory (Lazarus and Folkman, 1984) 
that claimed coping can be divided into problem-focused and emotion-focused.  
Thus some patients in this study may be able to cope emotionally, but not to 
manage in a practical way due to their symptoms, whilst others may be able to 
manage practical issues, but are not able to cope emotionally.  It is possible that 
these different experiences could point to different types of flare, with one being 
related to physical restriction and another being related to patients becoming 
overwhelmed and losing their daily life balance. 
In Study 3b (Flare Help-Seeking) only 3 out of 31 patients reported early 
warning signs of their flares and they reported that it was only with hindsight they 
were able to recognise these, thus these data were not reported.  This contrasts 
with findings from a previous qualitative study (Hewlett et al, 2012), which found that 
some patients experience early warning signs of a flare such as flu-like symptoms, 
fatigue or symptoms in particular joints; and an international patient and professional 
Delphi study (Bartlett et al, 2012), which found that 77/148 (62%) patients identified 
early warning signs of a flare.  It is possible that this difference is due to the small 
sample size in the current study and thus patients who experience early warning 
signs may not have been identified.  Another explanation is that in the current study, 
the researcher was in the same room as the patient when they completed the early 
warning signs questionnaire, the participants therefore had the option to express to 
the researcher their feelings that they were only experiencing these with hindsight, 
whereas in the Delphi study (Bartlett et al, 2012) patients were either posted or 
emailed the study, and thus did not provide additional comments.  It is of note that 
early warning signs were not retained in the Delphi study (Bartlett et al, 2012), which 
may indicate that whilst experienced by some patients, these are not essential for a 
definition of flare and thus the idea of early warning signs may need further 
exploration. 
This was also a feasibility study and thus the potential for a larger study will 
be addressed.  The recruitment rate for Study 3a indicates that patients are willing to 
complete daily questionnaires for three months and the low attrition rate (14.8%) 
indicates that once patients have started the study they are likely to complete it.  
The option for patients to complete the daily measures online increased the 
likelihood of recruitment.  However, there were a substantial proportion of missing 
data.  Some patients reported the reasons for this, which were forgetting to 
complete and illness.  The other participants may also have missed data for these 
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reasons, or perhaps due to no longer wishing to complete questionnaires daily, 
being busy over the Christmas period or going on holiday without advising the 
researcher.  Therefore this amount of missing data needs to be taken into account 
when calculating sample size for a larger study.   Analysing the data visually through 
individual graphs was time-consuming, therefore to conduct this study on a multi-
centre scale, a different method of analysis would be more practical (discussed in 
Chapter 10). 
The recruitment rate for Study 3b (Flare Help-Seeking) at Site 1 was so low 
that based on this site alone it would not be possible to run the study on a larger 
scale.  However, the 100% recruitment rate at site 2 indicates that this may be a 
local problem, potentially due to patients at Site 1 being over-researched.  It is also 
possible that the high recruitment rate at Site 2 may have been due to a different 
definition of flare being used by the team there.  Further, a number of the patients 
from Site 2 were managed with regular depomedrone injections, thus it is possible 
that these patients were calling for a routine injection and were incorrectly labelled 
as in flare by the person that recruited them from the Site 2 research team.  It would 
therefore be advisable to use a large number of sites to recruit the numbers needed 
for this study to be powered.  The Site 1 helpline audit identified that in a one month 
period only 16% of the callers with RA, were in a flare.  This can be compared to a 
previous audit that was carried out on an RA helpline at a different Trust (Hughes et 
al, 2002), which found that 32% of calls were from patients reporting worsening 
symptoms.  This study did not specify when patients were in flare, thus it is possible 
that not all patients who reported worsening symptoms were in flare.  However, in 
the audit conducted in the current study only 19% of patients reported either flare or 
worsening symptoms, thus it appears as though fewer patients are contacting the 
helpline in an RA flare than they did ten years ago.  This could be due to better 
control of RA or patients being better educated in how to self-manage and therefore 
having less need for crisis intervention.    
9.6.1 Strengths and limitations 
This study could be criticised for the small sample size, but it was an 
exploratory and feasibility study and therefore did not intend to be powered.  The 
majority of patients in Study 3b came from one NHS Trust and therefore may not 
have represented a wide range of patients’ experiences of flare when deciding to 
seek help.  However, patients in Study 3a were recruited from three NHS Trusts with 
a range of age, gender, disease duration, disability and current flare status, thus 
providing a range of experiences of RA.  Further, patients were offered both online 
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and pen and paper response options, which also provided a diverse sample of 
patients. 
This study did not define flare for patients, nor did it ask patients how they 
were defining flare, which means that all patients could have been using a different 
definition for flare.  Further, in Study 3b the criterion was to recruit patients in a self-
defined flare, but it is possible that the rheumatology specialist nurses made a 
judgement call and thus the definition of flare may have come from them.       
Further possible limitations relate to the scales used.  First, patients in Study 
3a were asked whether they cancelled their plans, but not whether they avoided 
making plans.  Thus patients may have been self-managing by not making plans 
when their RA symptoms were higher, which may indicate why there were not 
necessarily more plans cancelled when patients were in a flare.  Alternatively, 
patients may have been keeping their plans due to weighing up the consequences 
and deciding that they would rather put up with their symptoms to achieve or 
complete something more important to them.  For example, patients may decide that 
going shopping with friends provide more benefits, in terms of social support, than 
resting and withdrawing socially provides through minimising symptom severity, an 
interpretation supported by Study 1 (Interviews): 
“I find sometimes um if you go out and you socialise it does take your mind off of 
it a bit” (Jane, 65) 
Second, some patients reported seeking medical help for more than one 
week running.  It is unclear as to whether this is due to not being helped during their 
appointment, ticking the option weekly whilst waiting for an appointment, or study 
fatigue in which patients may have been ticking every self-management box by the 
end of the study.  Thus this question should have been clearer or more detailed in 
order to unpick this. 
The strengths of this study are that the content of the items used in the 
current study were developed from Study 1 and Study 2 and therefore reflected 
patients’ views rather than being imposed by the researcher.  Further, an open 
question was provided for patients in Study 3b in order to capture any tipping points 
that were not included in the other measures.  This open question only identified one 
tipping point that had not been covered, which was the rheumatology specialist 
nurse prompting the patient to seek help when she phoned for another reason.   
Study 3a was a prospective diary study, which captured symptoms daily and 
Study 3b captured patients whilst they were still in a flare.  Thus neither of these 
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studies were subject to retrospective bias.  Daily measures of symptoms have not 
been previously measured in RA, which makes this study novel.  
9.7 Summary 
Patients report varying levels of symptoms in both daily life (not in flare) and 
when they are in flare, and these overlap.  Patients therefore may be defining flare 
in very individual ways. Thus flare judgements made by patients may not always 
include the traditional professional views of high pain and swelling, this will be 
explored further in the discussion where all three Studies are considered together 
(Chapter 10).  However, when patients do seek help the tipping points used by the 
majority of patients are pain, longevity of symptoms, lack of control and being 
prompted by a friend or family member. 
The studies in this thesis have provided novel contributions to knowledge 
and have many implications for further research and clinical practice.  These larger 
concepts will be explored in depth in Chapter 10.
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Chapter 10: Discussion of the research findings, and the 
implications for research and clinical practice 
Chapters 6 to 9 presented the results and discussed the individual findings of 
the three studies in this thesis.  The current chapter discusses the combined 
findings of the three studies and considers the implications that these have for future 
research and clinical practice. 
10.1 Thesis aims 
The aims of this thesis were: 
 To explore the individual experience and impact of RA in daily life and flare 
and how patients self-manage these 
 To obtain consensus on patients’ experiences of daily life with RA 
 To obtain consensus on patients’ help-seeking behaviours in an RA flare 
 To characterise the level, variation and clustering of symptoms in daily life 
 
Three studies were used to address these aims: qualitative interviews (Study 
1), Q-methodology (Study 2) and two exploratory and feasibility surveys (Study 3).   
10.2 Contributions to knowledge 
The three studies used to meet the aims of this thesis have provided the 
following novel contributions to knowledge: 
1. In normal daily life, even on current more aggressive treatments, RA 
patients are not symptom-free 
2. Life with RA involves maintaining a delicate and fluctuating balance to 
mediate its impact 
3. Patients employ a stepped approach to self-management, which 
increases as their symptoms increase and includes a baseline level of 
daily micro-management 
4. Patients will seek help for their RA due to loss of control, longevity of the 
flare, pain severity, and feeling unable to cope or manage.  However, 
there are also tipping points and barriers specific to subsets of patients 
based on personal beliefs 
5. Patients may be using a definition of flare in a way that has not 
previously been identified. 
As well as meeting the aims of this thesis, two novel issues were discovered: 
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6. Male RA patients have a more negative experience of RA than female 
patients  
7. Patients use metaphors as a communication tool to express their RA 
symptoms and the impact it has on their lives 
These contributions to knowledge will be addressed individually. 
10.2.1 Daily life with RA 
The findings from this thesis suggest that patients experience life with RA as 
unpredictable and uncertain, with their fluctuating symptoms making it difficult to 
predict how they will feel: 
“Um, God it’s really difficult, it’s so different, I never know what I’m going to feel 
like when I wake up” (Isabelle, 45, Study 1) 
This supports previous qualitative research (Stenström, Bergman and 
Dahlgren, 1993), which reported uncertainty due to unpredictable exacerbations and 
remissions of RA, and its unpredictable long term course.  However, Stenström’s 
study is now 17 years old and therefore may not reflect experiences on current 
treatments.  Further, this study used only 9 patients all of whom were female, 
therefore saturation of ideas may not have been reached.   
Even on current more aggressive treatment regimes, which have been 
deemed more effective (Singh et al, 2010; Aaltonen et al, 2012) this thesis presents 
the novel finding that patients are never symptom-free, experiencing at least a 
baseline level of symptoms daily.  Some patients in Study 3 even reported symptom 
levels as high as 8/10 (10 being worst symptoms imaginable), yet did not feel these 
symptoms constituted a flare and nor did they seek help.  It is unclear as to why 
patients will accept these high levels of symptoms in daily life.  It is possible that 
patients have learnt to live with this level of symptoms, or that they are reluctant to 
define themselves as in a flare as this would mean they would have to acknowledge 
and deal with their symptoms. 
10.2.2 Fluctuating Balances 
This thesis has proposed that patients experience life with RA as a 
continually fluctuating balance between living with their RA in the background and 
living with it in the foreground (Fig 8.4).  Thus patients need to balance their physical 
and emotional RA symptoms with self-management techniques.  Patients’ RA 
symptoms are constantly fluctuating: even in normal daily life patients are rarely 
symptom free and report cancelling plans, and therefore employ self-management 
techniques to manage their RA even when they consider themselves to be doing 
well.  Patients also balance the impact that RA has on aspects of their lives such as 
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their identity and their independence, through making cognitive adjustments.  The 
unpredictable and uncertain nature of RA and negative perceptions of RA can cause 
the delicate balance to tip, but patients are sometimes able to control this impact 
and restore the balance.  However, at other times patients’ RA symptoms become 
too much for them to control, which can prompt them to seek medical help (Section 
10.2.4).  It should also be noted that some patients, predominantly men, do not 
seem able to achieve a balance in their lives with RA and therefore often experience 
RA in the foreground of their lives (Section 10.2.6). 
The Fluctuating Balances Model (Fig 8.4) builds on the Shifting Perspectives 
model of chronic illness (Paterson, 2001).  This model claimed that living with a long 
term condition is an ongoing and continually shifting process between an illness in 
the foreground or wellness in the foreground perspective.  A wellness in the 
foreground perspective includes an attempt to reconcile self-identity with the identity 
that is shaped by the illness, the construction of the illness by others and by life 
events (Fife, 1994).  In contrast an illness in the foreground perspective is the 
perspective of threats to control.  These can include signs of disease progression, 
lack of skill to manage the disease, disease-related stigma and interactions with 
others that emphasise dependence (Paterson, 2001). 
However, whilst this theory was developed through a metasynthesis of 
qualitative research studies and therefore was not based on primary data, the theory 
was not tested and refined through subsequent interviews.  The Shifting 
Perspectives model (Paterson, 2001) had not previously been applied to the specific 
experiences of patients with RA but this study demonstrates that the Shifting 
Perspectives model of illness being either in the foreground or background of 
patients’ lives may not adequately capture the experience of living with RA.  In 
contrast, the Fluctuating Balances Model proposes that the fluctuating nature of RA 
symptoms coupled with patients’ expert self-management techniques can mean that 
patients experience a third, dynamic stage in which their RA is moving into the 
foreground.  At this point, RA is a potential threat but crucially, patients often hold 
the skills to manage their symptoms and balance the impact of RA and move it back 
in the background.  Thus patients with RA seem to experience a fluctuation of their 
illness along a continuum of their RA being in the foreground or background, and 
one over which they can exert some control to regain balance, rather than 
Paterson’s either/or model in which control is quickly lost. 
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In addition, the Fluctuating Balances Model (FBM: Fig 8.4) has shown that 
RA in the background (wellness in the foreground) involves a more complex process 
than patients’ abilities to reconcile their self-identity with their RA identity, which was 
proposed by Paterson. To keep their RA in the background patients need to balance 
their needs not only for self-identity, but also for independence and normality by 
using self-management of their symptoms to reduce the impact rather than simply a 
shift of perspective. 
The finding that patients adapt their perspectives of normality in order to 
balance their lives with RA contributes to the existing literature.  One study using 
nominal group technique (Sanderson et al, 2011a) found six different typologies of 
normality, which provides depth to the concept of normality, which was not 
specifically explored in this thesis.  However, adapting normality is only one aspect 
of patients’ experience of RA.  It is therefore proposed that patients experience life 
with RA as a fluctuating condition, in which they need to employ constant but 
varying levels of self-management and coping in order to maintain the balance of 
their lives with RA.  However, when patients experience severe symptoms, they are 
not always able to maintain this balance and some patients seem to struggle to 
achieve this balance at all. 
The FBM has the potential to facilitate discussions between patients and 
health professionals.  It could be used in discussions with newly diagnosed patients 
about what life with RA might be like for them.  It could also be used in discussions 
with patients who need help coping with their RA, using the model to help patients 
understand where they fit within the model, where they would like to fit and how they 
could get to this point.  However, the sections of the FBM relate to the themes that 
were identified in Studies 1 and 2, and therefore the language used may not be 
understood by all RA patients.  The researcher has made an initial attempt at 
simplifying the language used in the FBM (Fig 10.1), but this needs testing with 
patients and clinicians to ensure the content can be easily understood and that none 
of the items  pose a threat to patients, before recommending its use in clinical 
practice.  
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   Figure 10.1: First attempt at Patient-Friendly Fluctuating Balances Model
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10.2.3 Mediation Ladder 
This thesis has proposed that patients use a stepped approach to manage 
their RA, or use a Mediation Ladder (Fig 6.23), whereby as patients’ symptom 
severity increases, their self-management strategies also increase.  This stepped 
approach to self-management means patients are often able to control their 
symptoms and can therefore step up or down depending on the impact and severity 
of their symptoms and their ability to manage them. 
 
Figure 6.23: Mediation Ladder: Increasing steps of self-management 
 
The RA literature reports that patients use pacing and planning, hot and cold 
packs, resting and exercise (Hammond, 1998) to control their RA.  However, this 
study found that in addition patients use a baseline level of micro-management in 
daily life, even when they consider themselves to be well, a novel finding of 
preventative strategies. Thus patients are constantly aware of their RA, employing 
strategies to minimise the risk of initiating or aggravating their symptoms: 
“If I was just printing something I will get up and go to the printer I won’t just wait 
and print a whole load and then go up at one point or get someone else to get it 
for me, I will get up and move around and go for a coffee and yeah have a little 
wander round the office or something.  I just find it helps a lot because otherwise 
you do seize up and that causes a lot more pain, a lot more trouble” (Charlotte, 
37, Study 1) 
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“This [making small adjustments to my day or activities constantly] is important as 
you need to be able to do this to manage your RA effectively” (P1, Study 2).   
When patients are in a flare, they step up their self-management strategies 
and employ crisis management in an attempt to reduce the physical symptoms and 
psychological factors associated with a flare.  In addition to increasing their use of 
hot and cold therapies and resting, patients begin to increase their analgesics, 
increase their steroids, withdraw socially, reduce their activities, increase fluids and 
fast: in short, patients report that when they are in a flare they would be prepared to 
try anything to reduce their symptoms: 
“I just try anything to, you know, try and defeat it really” (Emma, 42, Study 1) 
This contributes to the small body of previous literature that addresses 
patients’ self-management techniques when in an RA flare.  One qualitative study 
with an ethnically diverse population (Kett et al, 2010) identified that patients 
increase their rest time, apply heat to their joints, increase their analgesics, use 
distraction, use alternative therapies and avoid foods they believe will make their 
symptoms worse.  This study conducted interviews in Punjabi, Urdu and Hindi as 
well as English and as the researcher spoke those languages they stated there was 
no need for a translator in the interviews.  However, the authors do not explain how 
the interviews were translated for analysis: if they were translated by the researcher 
this has the potential for researcher-bias in terms of how they translated the data 
(Temple and Young, 2004) and there is no acknowledgement that the researcher 
may have paraphrased during interviewing.   
This stepped approach to self-management supports a number of aspects of 
Crisis Theory (Chapter 3.1.1; Moos, 1982; Moos and Shaefer, 1986).  Patients’ self-
management techniques increase (step up) as their symptoms increase and they 
perceive their RA as more threatening (Illness-related factors) and patients are more 
likely to seek help when they appraise their symptoms as constituting an RA flare 
(cognitive appraisal).  Further, patients alter their adaptive tasks based on this 
appraisal, for example patients in daily life are trying to maintain a baseline level of 
RA symptoms, whereas patients in a flare are trying to reduce their symptoms to a 
manageable level.  These different adaptive tasks would need different coping skills, 
which the Mediation Ladder (Fig 6.23) demonstrates.  The final mediation step 
patients use to manage their RA flare is to seek help from the medical team.   
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10.2.4 Flare help-seeking 
This thesis has identified consensus on tipping points for help-seeking in an RA flare 
as longevity of the flare, the pain becoming too intense and patients no longer 
feeling able to control their symptoms (Q methodology Study 2, Fig 8.2).  However, 
two different types of help-seeking behaviours have been identified.  One group 
(‘definite decision’) will seek help quickly, believing the medical team are there to 
help them.  These patients are prompted to seek help quickly by worries about long 
term damage to their joints, feeling their flare needs to be controlled by new 
medication and affects on their quality of life.  In contrast, another group of patients 
(‘cautious indecision’) will wait a long time as they hope the flare will go away and 
believe they should manage alone.  These patients also worry more about wasting 
the rheumatology team’s time and sometimes need to be prompted by a friend or 
family member to seek medical help.  A further group of patients was identified in 
the prospective data in Study 3, who whilst experiencing severe symptoms and 
defining themselves in a flare may never seek medical help. 
 
 
Figure 8.2: Decisions about seeking help in a flare  
 
The finding that patients seek medical help when they are no longer able to 
control their symptoms supports a previous qualitative study (Hewlett et al, 2012), 
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which claimed that patients seek help when their self-management strategies fail.  
However, this study did not identify patients’ barriers to or final tipping points for 
seeking help.  The finding that patients delay help-seeking due to worries about 
wasting the rheumatology team’s time supports findings from another qualitative 
study (Kett et al, 2010).  However, this study asked only one question about help-
seeking in a study addressing self-management strategies and therefore the issue 
was not explored in depth.  Thus help-seeking for RA flare has largely been 
overlooked in the literature and this thesis has explored this issue in depth through 
qualitative interviews (Study 1), identified typologies of help-seeking decision-
making (Study 2) and has tested these for the first time by applying them 
prospectively to patients’ behaviours when in a flare (Study 3).    
All the behaviour change theories discussed in Chapter 4 have the potential 
to partly explain patients’ help-seeking behaviours identified in this thesis.  However, 
as hypothesised the illness perceptions associated with the Self-Regulatory Model 
(Moss-Morris et al, 2002) (Chapter 4.3.5) seem to best fit the help-seeking findings 
identified in this thesis.  In terms of cause, patients who identified the cause of their 
flare as inflammation and therefore a need for a change in medication were more 
likely to seek help than those who could not identify a cause for their flare.  In terms 
of acute/chronic timeline, patients reached consensus on seeking help when their 
flare had gone on longer than expected.  In terms of cyclical timeline, the 
unpredictable nature of their RA left many patients uncertain as to whether their 
symptoms constituted a flare and therefore delayed help-seeking.  In terms of 
personal control, patients who felt able to control their symptoms are less likely to 
seek help, as consensus was reached on being unable to manage symptoms as a 
tipping point for seeking help.  In terms of treatment control, patients who felt the 
medical team were there to help them were more likely to seek help.  In terms of 
consequences patients reported seeking help when the pain became too intense, or 
started to affect their quality of life.  In terms of emotional representations patients 
who worry about the long term consequences are more likely to seek help.  Finally, 
in terms of Illness coherence, patients who define their symptoms as an RA flare are 
more likely to seek help, whereas those who are uncertain about the cause of their 
symptoms will wait, hoping that their flare will go away on its own.  Thus the revised 
illness perceptions (Moss-Morris et al, 2002) appear to effectively explain the 
decision-making process of patients in seeking help for an RA flare.  However, the 
finding that some patients need to be prompted by a friend or family member to seek 
help indicates that illness perceptions cannot explain all aspects of help-seeking 
behaviours.  This finding supports research in patients with pre-diagnosed RA that 
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has found patients used friends and family as ‘lay consultants’ to seek advice and 
validation from before seeking help (Shaul, 1995; Sakalys, 1997).  Patients may be 
waiting for friends or family to prompt them to seek help due to this removing the 
responsibility from them and thus causing them to worry less about wasting the 
rheumatology team’s time, which has previously been identified with acute 
myocardial infarction patients (Pattenden et al, 2002).  
 
10.2.5 Flare definition 
Patients in all three studies in this thesis use varying definitions of flare, 
which supports previous qualitative research that suggested patients use five 
different definitions of flare (Hewlett et al, 2012), all of which have been identified in 
this thesis: 1. Flare can be a single bad joint; 2. Flare can be self-induced; 3. Flare 
can be due to an external cause, such as food or the weather; 4. Flare can be a few 
bad days: 5. Flare that relates to uncontrollable symptoms prompting a request for 
medical help: 
“Sometimes just my thumb or just my knee hurts” (P1, Study 2) 
“Most flares are self-inflicted” (P14, Study 2) 
“I mean they say food don’t give you flare-ups, I believe it do” (Amelia, 67, Study 
1) 
“It does sometimes go away on its own after 3 or 4 days” (P9, Study 2) 
“I went into one [flare] and I was in agony and I couldn’t do anything and um, I 
contacted them [rheumatology team]” (Chloe, 42, Study 1) 
However, this thesis has identified an additional definition of flare, which 
relates to patients’ abilities to balance their lives with RA.  Patients in prospective 
Study 3 reported increased symptoms that did not always correspond to defining 
themselves as in an RA flare.  Further, some patients reported consistently high 
symptoms, yet still did not define themselves as in an RA flare.  Thus it appears that 
an additional flare definition exists, which does not relate specifically to patients’ 
symptoms.  It is therefore proposed that the type of flare that is uncontrollable and 
prompts a request for medical help (Hewlett et al, 2012) can be divided into 
‘Inflammatory Flare’, which relates to patients’ symptoms and their ability to control 
them, and ‘Avalanche Flare’.   
Avalanche flare occurs when patients feel they have lost control of all 
aspects of their lives and are no longer able to maintain a balance.  Thus patients’ 
Chapter 10: Discussion 
305 
 
tipping points for defining themselves in an Avalanche Flare could be unrelated to 
their RA inflammation, but may be an internal factor (e.g. feeling low) or an external 
factor (e.g. going through a divorce) that tips the balance in their lives sufficiently for 
them to feel that they are no longer in control.  This type of flare has been termed 
Avalanche Flare due to this cascading nature.  This novel definition of Avalanche 
Flare may explain the differences between patient and physician perspectives of 
flare described by Bingham et al (2009b). Patients may need different support for an 
Avalanche Flare and therefore it is important for both clinicians and patients to be 
able to recognise the difference between this and an Inflammatory Flare. 
One measure of Inflammatory Flare has been published since the studies in 
this thesis were conducted (Berthelot et al, 2012) and another is in the process of 
being developed, but only the flare domains have been selected so far (Bartlett et al, 
2012).  Both these studies used the Delphi method to identify items that patients and 
professionals deemed important enough to be included in a measure of flare.  
Domains that were consistent across both studies are joint swelling, stiffness, pain 
and participation, all of which were identified in Study 1 (Interviews).  However, pain 
was the only patient-reported symptom that significantly correlated with patients’ 
self-reported flare severity in Study 3b (Flare Help-Seeking survey).  Function and 
tender joints were identified as domains by Bartlett et al (2012) while increased need 
for help, social withdrawal and increase in medication were domains identified by 
Berthelot et al (2012), all of which were also identified in Study 1.  However, neither 
of these studies include a domain that relates to loss of control or feeling 
overwhelmed by issues other than RA, which has been identified in this thesis as an 
important element of Avalanche Flare.  The Flare Assessment in Rheumatoid 
Arthritis (FLARE: Berthelot et al, 2012) does include items related to depression and 
irritability, and the core domains identified by Bartlett et al (2012) also include 
emotions (general emotional distress item).  However, patients can experience loss 
of control without considering themselves depressed or irritable and emotional 
distress may be too vague to encompass such a complex process.  Thus these 
measures and domains appear to relate to Inflammatory Flare as they include items 
relating to patients’ symptom severity, but do not include items that might be 
important for a definition of Avalanche flare.   
Delphi techniques were used by both studies that attempted to measure or 
define flare (Bartlett et al, 2012; Berthelot et al, 2012).  Delphi is a technique that 
only considers items that reach a certain level of consensus (Jones and Hunter, 
1995) and can be criticised for losing items that whilst not important to the majority, 
may still be worthy of attention.  Further, both of these studies included patients who 
Chapter 10: Discussion 
306 
 
were not currently experiencing flare, which may affect how they perceive the 
experience of being in flare. 
10.2.6 Men’s experiences of RA 
This thesis found that male patients have a more negative experience of RA 
than female patients.  This raises the possibility that men could be less able to cope 
with their RA and do not find the current support that is offered useful: 
The self help groups don’t confront it enough, it might be all lovely-dovey but 
sometimes you have got to be quite hard about it” (James, 47, Study 1) 
  This contributes to the small body of research that exists concerning men’s 
experiences of RA.  One qualitative study (Lack, Noddings and Hewlett, 2011) 
identified that RA threatens men’s sense of power and control, which causes an 
impact on their masculinity.  However, this study did not identify the support needs 
of men or the self-management strategies they used.  Further, one small qualitative 
study (Hale et al, 2006) interviewed men and women with RA just before and one 
year after a self-management programme, and found that men sought practical 
coping skills in order to retain their masculinity.  The courses consisted of 
predominantly female patients, which was a barrier that prevented men from 
engaging in the emotional support element of the course.  The idea that men with 
RA have different support needs to women adds strength to these data suggesting 
that men are not coping as well with their RA as women. This is also supported by 
the wider masculinity literature, which shows that men have fewer social networks 
than women (Charmaz, 1994) and therefore do not experience the benefits of these.  
This indicates potential important gender differences in several coping strategies, 
which are not taken into consideration in current RA self-management programmes.   
Further, men are more likely to externalise their distress, such as anger directed at 
others (Branney and White, 2008), which supports the findings in this thesis: 
“I get very frustrated with it, the problem is then I get irritated and take it out on 
the wife” (P9, Study 2) 
  It is therefore possible that male RA patients have different support needs 
to women, which may not be taken into consideration by current self-management 
interventions.  Thus it is possible that men’s health needs may be better served by 
more tailored support.  The specific needs of male RA patients is an area that would 
benefit from further detailed research to ascertain whether an intervention targeting 
the specific needs of men is needed. 
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10.2.7 Metaphors as a communication tool 
One novel finding from qualitative Study 1 is that patients use metaphors to 
explain their experiences of RA, which has not previously been explored.  The 
naturally occurring use of metaphor in the interviews indicates that patients often 
use this method of communication, therefore the use or awareness of metaphors in 
clinic may enable better communication between patients and clinicians. This 
contributes to the wider  literature, not previously applied to RA, which suggests that 
the shared language of metaphors can aid the therapeutic relationship by providing 
understanding of clinical reality (Reisfield and Wilson, 2004, Whaley, 2000) and can 
also help family members understand patients’ experiences (Mastergeorge, 1999). 
 Further, patients in Study 1 used the question “If your RA were an animal 
what would it be?” to express ideas that they had not previously voiced in the 
interview or to summarise issues that were important to them, indicating this 
question could be a useful communication tool.  The animal attribution technique 
has been successfully used in family therapy to assist children with behavioural 
disorders (Arad, 2004), but has not previously been used with adults.  Patients in 
Study 1 enjoyed participating in the animal question and reported that it enabled 
them to think differently about their RA.  Thus this technique can be effective with 
adults, providing a way for them to discuss their thoughts and concerns about RA.  It 
is therefore proposed that metaphors are a valuable communication tool for patients 
with RA to use with their friends, family and clinicians. 
10.3 Implications for research 
10.3.1 The use of Q-methodology in rheumatology research 
Q-methodology has been used in a wide-range of health conditions including 
chronic pain (Eccleston et al, 1997) and irritable bowel syndrome (Stenner, Dancey 
and Watts, 2000), but only one study has previously used Q-methodology within 
rheumatology (Nikolaus et al, 2010), which explored patients’ perspectives of RA 
fatigue.  However, this study did not embrace the Gestalt nature of Q-methodology 
as only the statements sorted in the +6, +5, +4, -4, -5, -6 (highest and lowest) 
positions were included in the analysis, thus the full meaning of the statement 
configurations may have been overlooked (Watts and Stenner, 2012).  Further, this 
study did not invite patients to complete comments booklets, thus the intended 
meaning of the statement positions may not have been captured.   
Q-methodology is a practical task for participants as it requires them to move 
cards across a fixed grid.  This could be potentially problematic for RA patients due 
to not being able to reach across the grid or not being able to grip the cards to move 
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them.  In Study 2 the grid on which patients sorted the statements was A3 in size, 
which the majority of patients were able to reach across.  However, some patients 
found the continual reaching required by Q-methodology was strenuous.  Whilst 
some patients were happy for the researcher to place the cards for them, others 
preferred to walk around the table to place the cards themselves.  Thus it is 
recommended that future Q-studies with RA patients are conducted with the sorting 
grid placed on a table that has space to walk around it.  Further, in Study 2 Velcro 
was placed on the cards and on the grid.  This served two purposes: firstly, it 
ensured that the statements could not be knocked off the grid and secondly, the 
Velcro on the cards raised them up from the table, which enabled patients to grip 
them.  The use of Velcro would therefore be recommended for future Q-studies with 
RA patents. These issues highlight the usefulness of Q-methodology but identify 
that in RA patients a pilot run is critical, and patient partners would provide an ideal 
collaboration to test out practicalities. 
The majority of patients in Study 2 easily understood what was being asked 
of them and reported that they enjoyed the Q-sorting task, although one man did 
not.  Thus it should be noted that Q-methodology cannot be understood by 
everyone.  Further, sorting statements will exclude people who are illiterate, but Q-
methodology can be conducted with images instead of words (Fairweather and 
Swaffield, 2002), which would remove this limitation.   
The Study 2 Q-sorting task provided a discussion point between the 
participants and the researcher, with many providing powerful insights into their 
experiences of RA and reasons for sorting the cards.  Patients also completed 
comments booklets, which enabled more detailed analysis.  However, the patients in 
Study 2 did not record everything that they verbalised to the researcher, in their 
comments booklets.  Thus it is suggested that future Q-studies with RA patients are 
digitally-recorded to capture such informal discussions and further enrich the 
analysis. 
In Q-methodology participants concentrate on sorting individual cards in 
relation to other cards across a grid.  It is difficult for participants to perceive the 
overall story they are telling by looking at their statement configurations, thus people 
are able to be more open with their responses.  This was particularly important for 
male participants as men tend to provide a discourse that protects their masculinity, 
drawing on and reproducing idealised masculine expectations (Knight et al, 2012), 
but also for other patients who might be attempting to portray a particular identity.  
Further, patients are sorting statements that have been generated from interviews 
with other patients.  They may therefore feel able to agree with a statement due to 
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feeling it has been validated by being included in the study, which they may not 
have felt able to raise themselves in an interview (e.g. “I get angry due to my RA”).   
Q-methodology was chosen for Study 2 rather than a consensus method 
such as NGT or Delphi due to its ability to retain the individual context (Chapter 
5.5.2).  This was effective in Study 2, as four different experiences of daily life and 
two different ways in which people decide to seek help for their RA flares were 
discovered.  These experiences are so diverse it is difficult to see how they could 
have been combined into one consensus, which supports the argument that 
consensus techniques may produce a bland averaging of opinions or beliefs 
(Rennie, 1981).   
It is therefore suggested that Q-methodology is an under-used method in 
rheumatology research, which could provide insights and experiences that may not 
be reached by qualitative methods or consensus methods alone.  However, it would 
be important to analyse the entire configuration of sorted statements, along with 
comment booklets and digital-recording of the discussion to provide a full 
explanation of patients’ experiences. 
10.3.2 Future research 
There are many aspects of patients’ experiences of RA identified in these 
studies that deserve further exploration.  Three specific areas suggested for further 
research are detailed here. 
10.3.2.1 Daily variation and patterns 
This thesis identified that patients have very different experiences of their RA 
in daily life, although broad categories of experience could still be identified (Chapter 
9).  Study 3 identified that a multi-centre study measuring patients’ symptoms daily 
for three months would be possible.  This would enable detailed analysis of patients’ 
daily patterns of symptoms and a larger number of participants may enable the 
discovery of common patterns across patients.  Further, a larger number of 
participants may enable the statistical identification of differences in patients’ 
symptoms when they are in and out of both Inflammatory and Avalanche Flare.   
It is suggested that the scales used in Study 3 are tested for clarity of 
wording before applying them to a multi-centre study. The weekly self-management 
questions in Study 3 were potentially problematic as it was unclear why patients 
chose particular options, and cognitive interviewing would be an ideal methodology 
(Drennen, 2003). Reliability and sensitivity to change should also be established.  
Further, the method of visual analysis used in Study 3 would be time-consuming 
with a larger number of participants and statistical conclusions cannot be drawn.  It 
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is therefore suggested that time-series analysis (McCleary et al, 1980) is used with a 
larger version of this study, but this was beyond the remit of this thesis, which aimed 
to gather preliminary data and see whether a larger study would be possible.  Time-
series analysis is the analysis of quantitative data, recorded at successive time 
intervals, with a view to projecting this experience of the past to predict what will 
happen in the (uncertain) future (McCleary et al, 1980).  Thus time-series analysis 
has the potential to predict patterns of RA symptoms based on previous symptom 
patterns. 
10.3.2.2 Avalanche Flare 
The novel separation of patient-perceived flare into Inflammatory and 
Avalanche Flare was identified in Study 3 of this thesis. An Avalanche Flare seems 
to prompt patients to seek medical help, but does not necessarily involve patients’ 
highest reported symptoms.  Thus future research is needed to unpick the difference 
between an Avalanche Flare and an Inflammatory Flare in order to support patients 
effectively.  As Avalanche Flare was only identified through Study 3, which involved 
patients who were in flare, it is proposed that future research into this type of flare is 
conducted with patients who are in flare at the time of the study.  It is necessary to 
explore the differences at the time of flare, between Avalanche Flare and 
Inflammatory Flare in depth (qualitative research) and also to discover how 
frequently these different definitions occur (quantitative research).  Data on patients’ 
symptoms, emotions, life events and other items identified by qualitative research 
should be collected prospectively from patients who are in a self-defined flare and 
factor analysis could be used to see if the differences between Inflammatory Flare 
and Avalanche Flare could be explained differently by different factors (e.g. stronger 
emotions in an Avalanche Flare and stronger swollen joints in an Inflammatory 
Flare).  This could lead to developing and testing information or an education 
programme to educate patients or to train staff, as appropriate and to develop and 
test a measure or single item relating to Avalanche Flare to add to the developing 
flare questionnaires. Further, the difference between Avalanche Flare and 
Inflammatory Flare has the potential to explain the difference in flare definitions used 
by patients and professionals, which should be further explored.  
10.3.2.3 Men, masculinity and rheumatoid arthritis 
The finding that men have a more negative experience of RA than women 
has not previously been explored in detail.  There is a lack of understanding as to 
how men experience their RA, how it impacts on their lives and the types of support 
that they require from their medical team.  As more women (70%) than men have 
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RA, studies of support needs have been biased towards the female viewpoint.  Thus 
to provide care that meets men’s specific needs it is necessary to explore male 
patients’ needs in depth (qualitative research) and to discover how widespread the 
issues are (quantitative research) and then develop and test an appropriate 
intervention through collaboration with a male patient research partner. 
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10.4 Implications for clinical practice 
Clinicians should be aware that for the majority of RA patients, even on 
current medication regimes, normal daily life is never symptom free.  Patients must 
employ a constant level of micro-management to control their symptoms or prevent 
exacerbation, which they increase in steps as their symptoms increase.  Further, in 
normal daily life patients still report cancelling plans due to their RA.  These are 
important points to consider when informing newly diagnosed patients about what 
life with RA is likely to be like.  Clinicians should also be aware that there are at least 
four ways in which patients experience life with RA: ‘Feeling Good’, ‘Taking Active 
Control’, ‘Keeping RA in its Place’ and ‘Struggling Through’ and these patients 
would require different levels and types of support.  Some patients manage well due 
to low symptoms or expert self-management and therefore appear to need little 
intervention from the medical team.  The Patient-Friendly Fluctuating Balances 
Model and Mediation Ladder can be used in clinical discussions with patients and 
visually represented in patient information materials to help educate newly 
diagnosed patients. 
Clinicians need to be aware that patients use the word flare to explain a 
variety of different experiences.  Thus it may be necessary to further unpick the 
terminology that an individual patient is using in clinic in order to inform treatment 
discussions and improve understanding and concordant decisions.  Further, it is 
important to ensure patients feel that it is valid to ask for help in an Avalanche Flare, 
as patients may worry about seeking help for symptoms that do not specifically 
constitute an Inflammatory Flare.  In fact, whilst some patients will seek help quickly 
due to beliefs that the medical team are there to help them, other patients delay in 
help-seeking for their flares due to being uncertain as to whether they are in a flare, 
beliefs they should manage alone and worries about wasting the rheumatology 
team’s time.  These patients sometimes needed to be prompted by a friend or family 
member to seek help.   This indicates the need for patient education programmes to 
ensure patients are aware of when to seek help for their RA flares. 
Cognitive Behavioural Therapies (CBT) (Sheldon, 2011) are growing in 
application within the UK health care system.  In rheumatology, positive results have 
been found for tailored CBT interventions among patients with systemic lupus 
erythematosus (SLE) (Goodman et al, 2005) and RA.  In RA CBT interventions have 
facilitated the reduction of depression, helplessness, fatigue and enhanced the use 
of active coping strategies (Evers et al, 2002; Hewlett et al, 2011; Dures et al, 2012).  
Thus based on the findings of this thesis, one subset of patients may benefit from 
clinicians addressing psychological issues to empower them to seek help even if 
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they are uncertain of whether their symptoms constitute an Inflammatory or 
Avalanche Flare. A CBT intervention might be used to facilitate patients’ skills in 
self-managing an Avalanche Flare. 
One group of patients of particular note are male RA patients, who appear to 
have a more negative experience of RA than female patients.  These male patients 
focus on their symptoms, experience negative thoughts and feelings and do not 
seem able to identify effective self-management techniques.  This has an important 
clinical implication for the way in which men with RA are supported.  These male 
patients may benefit from a tailored intervention, but their specific support needs 
require further research before an effective intervention can be designed (Section 
10.3.2.1). 
A further consideration is that patients use metaphors to explain their RA, 
and thus adopting these metaphors in clinic may facilitate better communication 
between the patient and clinician.  Clinicians should listen for the metaphors patients 
are using and respond to these.  Asking patients “If your RA were an animal what 
would it be?” provided insight into the issues that appeared to be most salient to the 
patient (based on the content of the preceding interview) and issues that they had 
not previously voiced.  The use of metaphors in clinic may help clinicians and 
patients differentiate between Avalanche Flare and Inflammatory Flare. 
10.5  Strength and limitations 
The strengths and limitations relevant to the individual studies have been 
addressed in their respective results chapters.  The most important were the small 
number of male patients recruited in all three studies and the lack of validated 
scales.  The main strengths of these studies were the critical and careful approach 
with each study building on the previous, the use of mixed methodologies and 
support from patient research partners.  It is of particular note that the Partner (PR) 
who reviewed the Fluctuating Balances Model and Mediation Ladder could fully 
identify with these as encapsulating what her daily life is like, and helped make 
minor adjustments to the wording of the model.  The findings from this thesis have 
already begun to be disseminated (Appendix T: Flurey et al 2012a; 2012b; 2012c; In 
Press). 
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10.6 Thesis summary 
Patients with RA experience varying levels of symptoms in daily life even on 
the best available treatment regimes. They employ a stepped approach to self-
management (Mediation Ladder) in order to maintain a balance in their lives.  Thus 
patients experience a Fluctuating Balance of life with RA: 
“It’s sort of a balancing job really.  If I use more than my share of energy for one 
day, it will affect the next” (Debbie, 44, Study 1) 
Patients use many definitions of flare, one of which (Avalanche Flare) has 
not previously been acknowledged in the literature and involves tipping points for 
patients defining themselves as in flare that relate to more than their inflammatory 
symptoms: 
“Stress can cause it, you know something that’s worrying.  I mean, when my 
son’s marriage broke up that caused a flare-up” (Jane, 65, Study 1) 
Patients often see seeking help for their flares as a last resort, having tried 
everything they can think of first and prompted by loss of control.  However, 
clinicians should be aware that some patients will wait a long time before seeking 
help due to worries about wasting the rheumatology team’s time and beliefs they 
should manage alone.  When the balance has tipped and patients are no longer in 
control of their flare symptoms then it’s “Game over”:  
“It isn’t the pain really it’s the immobility, what it [flare] makes you feel is, it’s just 
on top of the restriction you’ve got, it’s like a ‘Game Over’” (Isabelle, 45, Study 1) 
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Appendix A1: Study 1 patient information sheet 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
Patients’ individual experiences of high disease activity in 
rheumatoid arthritis 
 
Patient information sheet 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will involve.  
Please read the following information carefully and discuss it with friends and relatives 
if you wish.  Ask us if anything is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
 
Who is asking you to take part? 
I am Caroline Flurey, a PhD student at the University of the West of England.  This 
research study is the first of three research studies which will form my PhD.  The 
results from this study will assist with the designing the next two research studies, as 
well as providing important information to help clinicians understand what daily life with 
RA is really like. 
 
What is the purpose of the study? 
The aim of medication in rheumatoid arthritis (RA) is to help control inflammation.  
From time to time, people with RA have episodes of inflammation or high disease 
activity.  Sometimes, this high disease activity makes the patient and the doctor 
wonder if the RA drugs are not working well enough, and should be changed.  Usually, 
the patient and the doctor decide this together.   
 
However, some early research suggests that patients and health professionals think 
about different symptoms when they discuss inflammation.  We don’t really know what 
it is that patients experience when they have inflammation.  We don’t even have a 
common term for this bad inflammation.  Some people call it a ‘flare’ but this may mean 
different things to different people.  It is important to understand more about what 
patients experience during these episodes of inflammation, and how they decide that it 
is time they discussed their medication with their doctors.  This research study aims to 
explore the patient’s experience of inflammation – what are the symptoms they get?  
How do patients decide their drugs may need changing?  If we knew this, it would help 
avoid misunderstandings when treatment decisions are made.   
Appendix A1 
 
 
348 
 
 
We would also like to find out what daily life is like with RA and how patients manage 
their symptoms.  At the moment doctors describe daily life with RA to newly diagnosed 
patients as unpredictable and will often either draw wavy lines to explain this or wave 
their hands to indicate ups and downs!  However, we don’t really know what makes a 
good day or a bad day with RA. Having a better understanding of daily life with RA 
would help doctors to give newly diagnosed patients a better understanding of RA, what 
life will be like and how to manage their symptoms.   
 
Why have I been chosen? 
You have been invited to take part because you have RA, and have experienced an 
episode of high disease activity at some point.  We are inviting about 20-25 patients to 
take part within Bristol from both the Bristol Royal Infirmary and Cossham Hospital. 
 
What will I be asked to do if I take part? 
You will be invited to take part in a one-on-one interview with a researcher.  In the 
interview you will be asked questions which will enable you to discuss what it feels like 
to have high disease activity – the symptoms, how you manage them and how you would 
decide that this is different from your daily symptoms.  You can say as much or as little 
as you like, and there’s no such thing as a wrong answer - we are looking for your own 
individual experience. The discussion will last between an hour and an hour and a half 
and will be held in the Rheumatology Outpatient Department at the Bristol Royal 
Infirmary.  We will offer you refreshments and will be happy to pay your travel costs 
to attend.   
 
We will tape record the discussion, type it up and then analyse it.  This means that we 
will examine the typed transcripts for different themes about inflammation and daily 
life.  To check our findings, we will ask two other project members to review several 
transcripts.  These project members include a patient representative.  As the 
discussions will be typed up they will be completely anonymous to the other project 
members.  The only person who will know who the interview transcript belongs to would 
be you and the researcher interviewing you.   
 
We will put the findings from these interviews together with findings from the other 
one-on-one interviews being conducted.  The findings from the interviews will also be 
put together with findings from focus groups (group discussions) conducted across 5 
countries (UK, the USA, Canada, Germany and Australia) and look at whether there are 
any differences between the individual and the group results.   
 
A report will be written on what it means to have high disease activity and we will be 
happy to send you a copy of the final report.  
 
The findings from the interviews will also be used in the second stage of the PhD 
research project. This will involve asking people to put the themes which came out of 
the interviews into the order of most importance to them. 
 
Do I have to take part? 
No, taking part is voluntary.  It is up to you to decide whether or not to take part.  If 
you do decide to take part we will ask you to sign a consent form and give you a copy to 
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keep.  If you take part you are still free to withdraw at any time. If you decide not to 
take part you do not have to give a reason, nobody will be upset and the care you 
receive will not be affected.   
 
What are my responsibilities? 
We would be grateful if you could attend the clinic for the interview if you agree to 
take part.  We would also like you to complete a brief questionnaire about your 
arthritis, so that we can make sure we have a wide range of patients taking part.   
 
What are the possible side effects of taking part? 
We do not believe that talking about your experience of high disease activity in an 
interview will have any side effects.  However, if it makes you feel worried about your 
arthritis, the researcher will be able to arrange for you to see a nurse or doctor from 
the Rheumatology team. 
 
What are the possible benefits in taking part? 
We do not expect there to be any benefits for you in taking part.  However the 
information you give us will help us understand more about a common problem and how 
patients and doctors can discuss it better.  Once we understand what high disease 
activity really means to patients, we will develop a definition that both patients and 
doctors can agree on.  This should be useful in everyday clinical practice, in clinical 
research trials, and in helping educate people about how to manage their RA.   
 
Will my taking part in this study be kept confidential? 
Yes.  When the tape is typed up, your name will be replaced with a code.  No one will be 
able to identify you from the typed discussion.  Although the report will include 
quotations from the interviews, no names will be used.  The tapes will be kept securely 
for 6 years and then destroyed, in accordance with good practice guidelines. 
The analysis of the transcripts will be led by Caroline Flurey in the University of the 
West of England, Bristol. 
 
Will my GP be informed that I am taking part in this study? 
That is up to you.  The researchers will be happy to send a letter to your GP to explain 
this study if you require. 
 
What will happen to the results of the research study? 
The research will take about one year.   The results will be reported in professional 
publications and conferences (but patients will not be identified by name).   The results 
will also be reported in the PhD thesis produced by Caroline Flurey.  The results will 
help inform the design of the following two stages of the PhD research project which in 
total will take three years to complete. 
 
Who is funding the study and who has reviewed the research? 
The research has been funded by Arthritis Research Campaign (arc).  The study has 
been peer reviewed by the UWE Research Degrees Committee and has been approved 
by the North Somerset and South Bristol Research Ethics Committee and the Research 
Department of the Bristol Royal Infirmary.  The University of the West of England will 
take responsibility for the conduct of the study. 
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What do I do now? 
Thank you for considering taking part in this research.  Please complete the slip if you 
are interested and either hand it to the clinic nurse, or return it in the reply-paid 
envelope.  A researcher will then contact you with further information.   
 
If you have any concerns about participating in this study and would like to receive free 
independent advice please contact PALS (Patient Advise and Liaison Service) on 0800 
0851 067. 
 
 
Researcher details: 
 
Caroline Flurey MSc 
University of the West of England, Bristol, UK 
PhD Student, Bristol Royal Infirmary 
0117 928 4972 
Caroline2.Flurey@uwe.ac.uk 
 
 
Study Team 
Caroline Flurey MSc, PhD Student, UWE Bristol 
Sarah Hewlett PhD MA RN, arc Professor of Rheumatology Nursing, UWE Bristol 
Marianne Morris PhD MSc, Principal Lecturer in Health Psychology, UWE Bristol 
John Pollock, PhD, Reader in Epidemiology, UWE Bristol 
Rod Hughes MD, Rheumatologist, Chertsey 
Pam Richards – Patient Partner 
Angela Knight – Patient Partner 
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Appendix A2: Study 1 reply slip 
 
 
 
 
Patients’ individual experiences of high disease 
activity in rheumatoid arthritis 
 
Please complete the following and return this sheet of paper in the envelope 
provided. The researcher will contact you in the next few days to talk about 
the study and arrange a time to meet up. 
 
I agree to be contacted by the researcher to discuss the research study 
 
 
Signature .................................................................................................... 
 
 
Name  .................................................................................................... 
 
 
Address .................................................................................................... 
 
 
  .................................................................................................... 
 
 
Preferred contact telephone Number ......................................................... 
 
 
Preferred contact time .................................................................................. 
 
 
 
Many Thanks 
 
Caroline Flurey, Research PhD Student 
University of the West of England 
Tel No: 0117 3424972 
Email: Caroline2.Flurey@uwe.ac.uk
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Appendix B: Study 1 participant consent form 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
Patients’ individual experiences of high disease activity in 
rheumatoid arthritis 
 
Consent form for research study 
 
Please initial each box 
 
1 I confirm that I have read and understand the information sheet  
 dated 17th March 2010 for the above study 
 
2          I understand that my participation is voluntary and that I am free to  
 withdraw at any time without my medical care or legal rights being  
affected 
 
3 I understand that relevant sections of my medical notes will be looked at  
by a member of the clinical team.  I give permission for these individuals  
to have access to my records. 
 
4 I am willing for the interview to be audio-recorded 
 
5 I understand that anonymised quotes from the interview may be  
used in publications, conference presentations and a PhD thesis. 
 
6 I agree to take part in the above study 
 
 
 
                     _______________ 
 Name of patient  Date   Signature 
 
 
                                                                                                                      
 Name of researcher                Date             Signature 
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Appendix C1: Demographic and clinical questionnaire 
Participant No.____________ 
 
Pre-Interview Questionnaire 
 
 
 
1. Please state your age:  years 
 
 
2. Are you employed?  If so, what is your current role? 
 
............................................................................................................................. 
 
............................................................................................................................. 
 
3. Do you have anyone at home who helps you? Please delete as applicable: 
Husband / Wife / Partner / Grown-up child / Young Carer / No-one / Other 
If other, please state: 
…………………………………………………………………......................... 
 
4. Do you have anyone at home who relies on you?  If so, what is their relationship to you?  
e.g. Child / Parent 
............................................................................................................................. ......... 
 
5. How long ago was your RA diagnosed?...................................................................... 
 
6. What medication are you currently taking for your RA? ............................................ 
 
……………………………………………………………………………………….. 
 
...................................................................................................................................... 
 
7. If any of these are new in the last 6 months, please say which and what you were previously 
        taking in its place 
 
............................................................................................................................. .......... 
 
....................................................................................................................................... 
 
 
8. Have you experienced a period of high disease activity whilst having RA? 
 
   Yes               No     
 
9.   How often, would you say, that you experience bad patches with your RA? 
 
............................................................................................................................. ......... 
 
10. Considering all the ways your arthritis affects you, please mark on the line below how well 
you are doing: 
 
 
    VERY WELL       VERY BADLY 
 
              ______________________________________________
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Appendix C2: Health Assessment Questionnaire 
 
Please tick the one response which best describes your usual ABILITIES over the 
PAST WEEK 
 
  
Without 
ANY  
difficulty 
 
 
With 
SOME 
difficulty 
 
With 
MUCH 
difficulty 
 
Unable  
to do 
1  DRESSING AND GROOMING 
    Are you able to: 
  - Dress yourself, including tying 
    shoelaces and doing buttons? 
 
  - Shampoo your hair? 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
2  RISING 
    Are you able to: 
  - Stand up from an armless    
straight chair?  
 
  -Get in and out of bed? 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
3  EATING 
    Are you able to: 
  - Cut your meat? 
 
  - Lift a full cup or glass to your 
mouth? 
 
  - Open a new carton of milk (or 
soap powder)? 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
4  WALKING 
    Are you able to: 
  - Walk outdoors on flat ground?  
 
  - Climb up five steps? 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
 
Please tick any aids or devices that you usually use for any of these activities: 
 
........... Cane    ........... Devices used for dressing (button 
........... Walking Frame                           hook, zipper pull, long handled shoe horn etc 
 ........... Crutches   ........... Built-up or special utensils 
 ........... Wheelchair   ........... Special or built-up chair 
   
Other(specify): ........................................................................................................................... 
 
 
Please tick any categories for which you usually need help from another person:  
 
 ........... Dressing and   ........... Eating 
  grooming 
 ........... Rising    ........... Walking 
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5  HYGIENE     Are you able 
to: 
 
  - Wash and dry your entire 
body? 
 
  - Take a bath? 
 
  - Get on and off the toilet? 
 
 
 
 
 
Without 
ANY 
difficulty 
 
 
_________ 
 
_________ 
 
_________ 
 
 
 
 
With SOME 
difficulty 
 
 
 
_________ 
 
_________ 
 
_________ 
 
 
 
 
With 
MUCH 
difficulty 
 
 
_________ 
 
_________ 
 
_________ 
 
 
 
 
Unable  
to do 
 
 
 
_________ 
 
_________ 
 
_________ 
 
6  REACH     Are you able 
to: 
 
  - Reach and get down a 5lb 
object (eg a bag of potatoes) 
from just above your head? 
 
  - Bend down to pick up 
clothing from the floor? 
 
 
 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
 
_________ 
 
7  GRIP     Are you able to: 
 
  - Open car doors? 
 
  - Open jars which have 
been  
     previously opened? 
 
  - Turn taps on and off? 
 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
_________ 
 
8  ACTIVITIES     Are you 
able to: 
 
  - Run errands and shop? 
 
  - Get in and out of a car? 
 
  - Do chores such as 
vacuuming, housework or 
light gardening? 
 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
Please tick any aids or devices that you usually use for any of these activities: 
 
 ........... Raised toilet seat ........... Bath rail  
 ........... Bath seat  ........... Long handled appliances for reach 
 ........... Jar opener (for jars   
  previously opened)  
 
Other (specify)............................................................................ 
  
Please tick any categories for which you usually need help from another person:  
 
 ........... Hygiene  ........... Gripping and opening things 
 ........... Reach   ........... Errands and housework
  
 
 
3
5
6
 
  
How does your RA change? 
Worst 
symptoms 
imaginable 
 
No symptoms 
at all 
Time-scale? 
A
p
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1
 
A
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3
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Time-scale? 
What does a single flare look like? 
Worst 
symptoms 
imaginable 
 
No symptoms 
at all 
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Appendix E: List of rheumatoid arthritis drug names 
 
 
NSAIDs 
 
Ibuprofen 
Nabumetone 
Meloxicam 
Diclofenac 
Clelbrex 
 
 
DMARDs 
 
Methotrexate 
Gold 
Lefunomide 
Sulphasalazine 
Hydroxychloriquine 
Cyclosporin 
 
Anti-TNF / Biologics 
 
Rituximab 
Adulimamab 
Infliximab 
Remicide 
Embrel 
 
Steroids 
 
Prednisolone 
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Appendix F1: Study 2 patient information sheet 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
 
A Q-methodology research study.  What is life like with 
rheumatoid arthritis? 
 
Patient information sheet 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will involve.  
Please read the following information carefully and discuss it with friends and relatives 
if you wish.  Ask us if anything is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
 
Who is asking you to take part? 
I am Caroline Flurey, a PhD student at the University of the West of England.  This 
research study is the second of three research studies which will form my PhD. 
 
What is the purpose of the study? 
We would like to find out what daily life is like with Rheumatoid Arthritis (RA) and how 
patients manage their symptoms.  At the moment doctors describe daily life with RA to 
newly diagnosed patients as unpredictable and will often either draw wavy lines to 
explain this or wave their hands to indicate ups and downs!  However, we don’t really 
know what makes a good day or a bad day with RA. Having a better understanding of 
daily life with RA would help doctors to give newly diagnosed patients a better 
understanding of RA, what life will be like and how to manage their symptoms.   
 
In addition to this, some early research suggests that patients and health professionals 
think about different symptoms when they discuss periods of high disease activity.  It 
is important to understand more about what patients experience during these episodes 
of high disease activity, and how they decide that it is time to discuss their medication 
with their doctors.  We would like to explore your experience of high disease activity – 
what symptoms do you get? And how do you decide your drugs may need changing?  If 
we knew this, it might help avoid misunderstandings when treatment decisions are 
made.   
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Why have I been chosen? 
You have been invited to take part because you have RA, and have experienced an 
episode of high disease activity at some point.  We are inviting between 20 and 50 
patients to take part from Bristol hospitals and from Ashford and St. Peter’s Hospital, 
Cherstey. 
 
What will I be asked to do if I take part? 
You will be invited to take part in a study called a Q-sort.  This means you will be given 
cards with statements on them, which may or may not relate to your experience of 
living with RA. The statements will cover aspects of your daily life and how you manage 
when you have high disease activity (when your RA is particularly bad). You will be 
invited to sort the statements according to how much you agree or disagree with them. 
 
There is no right or wrong way of sorting these statements - we are looking for your 
own individual understanding of high disease activity and normal daily life. The study 
will last about an hour and you will have the choice of coming to the Rheumatology 
Outpatient Department at the Bristol Royal Infirmary, or for the researcher to visit 
you at home.  If you choose to come to the Bristol Royal Infirmary we will offer you 
refreshments and will be happy to pay your travel costs to attend.   
 
The way that you sort the statements will be recorded and then your method of sorting 
will be compared with other patients.  In doing this we will be able to show a number of 
ways in which patients experience and manage their RA.  To check our findings, we will 
ask two other project members to review our analysis.  These project members include 
a patient representative. 
 
Do I have to take part? 
No, taking part is voluntary.  It is up to you to decide whether or not to take part.  If 
you do decide to take part we will ask you to sign a consent form and give you a copy to 
keep.  If you take part you are still free to withdraw at any time. If you decide not to 
take part you do not have to give a reason, nobody will be upset and the care you 
receive will not be affected.   
 
What are the possible side effects of taking part?  
Talking about your experience of high disease activity in an interview should not 
produce any side effects.  However if it makes you feel worried about your arthritis 
the researcher will arrange for you to see a member of the clinical team. 
 
What are the possible benefits in taking part?  
We do not expect there to be any benefits for you in taking part.  However the 
information you give us will help us understand more about a common problem and how 
patients and doctors can discuss it better. 
 
Will my taking part in this study be kept confidential? 
Yes.  When the card sort is typed up your name will be replaced with a code.  No one 
will be able to identify you from your card-sort.  The anonymised data will be kept 
securely for 6 years and then destroyed, in accordance with good practice guidelines. 
The analysis will be led by Caroline Flurey in the University of the West of England, 
Bristol. 
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What will happen to the results of the research study? 
The research will take about one year.   The results will be reported in professional 
publications and conferences (but patients will not be identified by name).   The results 
will also be reported in the PhD thesis produced by Caroline Flurey.  A summary of the 
results will be sent to you once the study is complete.  The results will help inform the 
design of the final stage of the PhD research project which in total will take three 
years to complete. 
 
Who is funding the study and who has reviewed the research? 
The research has been funded by Arthritis Research UK.  The study has been peer 
reviewed by the UWE Research Degrees Committee and has been approved by South 
West 4 Research Ethics Committee and the Research Department of the Bristol Royal 
Infirmary.  The University of the West of England will take responsibility for the 
conduct of the study. 
 
What do I do now? 
Thank you for considering taking part in this research.  Please complete the slip if you 
are interested and either hand it to the clinic nurse, or return it in the reply-paid 
envelope.  A researcher will then contact you with further information.   
 
If you have any concerns about participating in this study and would like to receive free 
independent advice please contact PALS (Patient Advise and Liaison Service) on 0800 
0851 067. 
 
 
Researcher details: 
 
Caroline Flurey MSc 
University of the West of England, Bristol, UK 
PhD Student, Bristol Royal Infirmary 
0117 342 4972 
Caroline2.Flurey@uwe.ac.uk 
 
 
Study Team 
Caroline Flurey MSc, PhD Student, UWE Bristol 
Sarah Hewlett PhD MA RN, Arthritis Research UK, Professor of Rheumatology Nursing, 
UWE Bristol 
Marianne Morris PhD MSc, Principal Lecturer in Health Psychology, UWE Bristol 
Jon Pollock, PhD, Reader in Epidemiology, UWE Bristol 
Rod Hughes MD, Rheumatologist, Chertsey 
Pam Richards – Patient Partner 
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Appendix F2: Study 2 reply slip 
 
 
 
 
 
A Q-methodology research study. What is life like 
with rheumatoid arthritis? 
 
Please complete the following and return this sheet of paper in the envelope 
provided. The researcher will contact you in the next few days to talk about 
the study and arrange a time to meet up. 
 
I agree to be contacted by the researcher to discuss the research study 
 
 
Signature ....................................................................................... 
 
 
Name  ........................................................................................ 
 
 
Address .......................................................................................... 
 
 
  ........................................................................................... 
 
 
Preferred contact telephone Number ................................................. 
 
 
Preferred contact time .................................................................................. 
 
 
 
Many Thanks 
 
Caroline Flurey, Research PhD Student 
University of the West of England 
Tel No: 0117 3424972 
Email: Caroline2.Flurey@uwe.ac.uk 
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Appendix H: Study 2 participant consent form 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
A Q-methodology study. What is life like with  
rheumatoid arthritis? 
 
Consent form for research study 
 
Please initial each box 
 
1 I confirm that I have read and understand the information sheet  
 dated 26th Oct 2010 for the above study 
 
2          I understand that my participation is voluntary and that I am free to  
 withdraw at any time without my medical care or legal rights being  
affected 
 
3 I understand that relevant sections of my medical notes may be looked at  
by a member of the clinical team.  I give permission for these individuals  
to have access to my records. 
 
4 I understand that anonymised card sort data collected during the study may 
 be used in publications, conference presentations and a PhD thesis. 
 
5 I agree to take part in the above study 
 
 
 
            
Name of patient   Date   Signature 
 
 
                                                                                                                                      
Name of researcher             Date   Signature 
 
 
1 Copy to Participant    1 Copy to Researcher    1 Copy for Notes 
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Appendix I1: Study 3a patient information sheet 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
Capturing Daily Fluctuations in Rheumatoid Arthritis 
 
Patient information sheet 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will involve.  
Please read the following information carefully and discuss it with friends and relatives 
if you wish.  Ask us if anything is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
 
Who is asking you to take part? 
I am Caroline Flurey, a PhD student at the University of the West of England.  This 
research study is the third of three research studies which will form my PhD. 
 
What is the purpose of the study? 
We would like to find out what daily life is like with Rheumatoid Arthritis (RA) and how 
patients manage their symptoms.  At the moment doctors describe daily life with RA to 
newly diagnosed patients as unpredictable and will often either draw wavy lines to 
explain this or wave their hands to indicate ups and downs!  However, we don’t really 
know what makes a good day or a bad day with RA. Having a better understanding of 
daily life with RA would help doctors to give newly diagnosed patients a better 
understanding of RA, what life will be like and how to manage their symptoms.   
 
Why have I been chosen? 
You have been invited to take part because you have RA, and have experienced a Flare of your RA at 
some point.  We are inviting 30 patients to take part from Bristol hospitals and from Ashford and St. 
Peter’s Hospital, Cherstey. 
 
What will I be asked to do if I take part? 
You will be invited to take part in a daily diary study.  This will involve completing 10 
simple questions about your RA symptoms every day and 10 short questions about your 
experiences weekly (a copy of each questionnaire is attached).  You will be asked to do 
this for 3 months. 
 
You can choose how to answer the questions.  You can complete them on paper and post 
this back to the researcher each week, or the researcher could phone you daily for 
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your responses (which should take about 10 minutes), or you can complete your 
responses daily online on a secure website.  It’s up to you! 
 
There are no right or wrong answers, we would like to know how your individual 
symptoms vary from day to day. 
 
Do I have to take part? 
No, taking part is voluntary.  It is up to you to decide whether or not to take part.  If 
you do decide to take part we will ask you to sign a consent form and give you a copy to 
keep.  If you take part you are still free to withdraw at any time.  If you decide not to 
take part you do not have to give a reason, nobody will be upset and the care you 
receive will not be affected.   
 
What are the possible side effects of taking part?  
Recording your daily symptoms should not produce any side effects.  However if it 
makes you feel worried about your arthritis the researcher will arrange for you to see 
a member of the clinical team. 
 
What are the possible benefits in taking part?  
We do not expect there to be any benefits for you in taking part.  However, the 
information you give us will help us understand more about a common problem and how 
patients and doctors can discuss it better.  If you would like a copy of your daily 
scores, to assist in discussions with your doctor, the researcher will provide this for 
you. 
 
Will my taking part in this study be kept confidential? 
Yes.  When your responses are input into the computer your name will be replaced with 
a code.  No one will be able to identify you from your responses.  The anonymised data 
will be kept securely for 6 years and then destroyed, in accordance with good practice 
guidelines. 
The analysis will be led by Caroline Flurey in the University of the West of England, 
Bristol. 
 
What will happen to the results of the research study? 
The research will take about one year.   The results will be reported in professional 
publications and conferences (but patients will not be identified by name).   The results 
will also be reported in the PhD thesis produced by Caroline Flurey.  A summary of the 
results will be sent to you once the study is complete. 
 
Who is funding the study and who has reviewed the research? 
The research has been funded by Arthritis Research UK.  The study has been peer 
reviewed by the UWE Research Degrees Committee and has been approved by South 
West 5 Research Ethics Committee and the Research Department of the Bristol Royal 
Infirmary.  The University of the West of England will take responsibility for the 
conduct of the study. 
 
What do I do now? 
Thank you for considering taking part in this research.  Please complete the attached 
reply slip if you are interested and either hand it to the clinic nurse, or return it in the 
pre-paid reply envelope.  A researcher will then contact you with further information.   
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Helpful Contact Numbers: 
If you have any concerns about participating in this study and would like to receive free 
independent advice please contact PALS (Patient Advise and Liaison Service) on 0117 
342 3571.  If you have any complaints about this research please contact the Patient 
Complaints Manager on 0117 342 3604. 
 
Researcher details: 
 
Caroline Flurey MSc 
University of the West of England, Bristol, UK 
PhD Student, Bristol Royal Infirmary 
0117 342 4972 
Caroline2.Flurey@uwe.ac.uk 
 
 
Study Team 
Caroline Flurey MSc, PhD Student, UWE Bristol 
Sarah Hewlett PhD MA RN, Arthritis Research UK, Professor of Rheumatology Nursing, 
UWE  
Marianne Morris PhD MSc, Principal Lecturer in Health Psychology, UWE Bristol 
Jon Pollock, PhD, Reader in Epidemiology, UWE Bristol 
Rod Hughes MD, Rheumatologist, Chertsey 
Pam Richards – Patient Partner 
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Appendix I2: Study 3a reply slip 
 
 
 
 
 
Capturing Daily Fluctuations in Rheumatoid Arthritis 
 
Please complete the following and return this sheet of paper in the envelope 
provided. The researcher will contact you in the next few days to talk about 
the study and arrange a time to meet up. 
 
I agree to be contacted by the researcher to discuss the research study 
 
 
Signature ........................................................................................................................... 
 
 
Name  ........................................................................................................................... 
 
 
Address ........................................................................................................................ 
 
 
  ....................................................................................................................... 
 
 
Preferred contact telephone Number ............................................................................ 
 
 
Preferred contact time .................................................................................................. 
 
 
 
Many Thanks 
 
Caroline Flurey, Research PhD Student 
University of the West of England 
Tel No: 0117 3424972 
Email: Caroline2.Flurey@uwe.ac.uk 
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Apendix J: Study 3b patient information sheet 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
 
Seeking Help for Flares in Rheumatoid Arthritis 
 
Patient information sheet 
 
You are being invited to take part in a research study.  Before you decide it is 
important for you to understand why the research is being done and what it will involve.  
Please read the following information carefully and discuss it with friends and relatives 
if you wish.  Ask us if anything is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
 
Who is asking you to take part? 
I am Caroline Flurey, a PhD student at the University of the West of England.  This 
research study is the third of three research studies which will form my PhD. 
 
What is the purpose of the study? 
It is important to understand more about what people with Rheumatoid Arthritis (RA) 
experience during a Flare, and how they decide that it is time to seek help or discuss 
their medication with their doctors.  We would like to explore your current experience 
Flare – what symptoms do you have? And how did you decide to come to the 
Rheumatology team for help?  We would also like to understand the differences 
between a Flare and normal daily symptoms.   
 
Why have I been chosen? 
You have been invited to take part because you have RA, and have contacted the Direct 
Access helpline to make an appointment due to currently experiencing a Flare.  We are 
inviting 15 patients to take part from the Bristol Royal Infirmary and 15 patients from 
Ashford & St Peter’s Hospital, Chertsey. 
 
What will I be asked to do if I take part? 
You will be invited to complete a short questionnaire when you come to the clinic for 
your appointment.  The questionnaire is about your current symptoms and the period 
that led up to you contacting the helpline.  You will also be sent a further short 
questionnaire about your symptoms, which will be sent to you four weeks after your 
appointment and you will be asked to return this in a pre-paid envelope.   
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The information you provide will be used to help us understand what motivates people 
to seek help, or what causes them to wait.  The symptoms scores will provide useful 
information about the severity of your symptoms when you are experiencing a Flare 
 
Do I have to take part? 
No, taking part is voluntary.  It is up to you to decide whether or not to take part.  If 
you do decide to take part we will ask you to sign a consent form and give you a copy to 
keep.  If you take part you are still free to withdraw at any time.  If you decide not to 
take part you do not have to give a reason, nobody will be upset and the care you 
receive will not be affected.   
 
What are the possible side effects of taking part?  
Filling in a questionnaire about your symptoms and motivations for seeking help should 
not produce any adverse effects.  However, if it makes you feel worried about your 
arthritis the researcher will arrange for you to see a member of the clinical team. 
 
What are the possible benefits in taking part?  
We do not expect there to be any benefits for you in taking part.  However, the 
information you give us will help us understand more about a common problem and how 
patients and doctors can discuss it better. 
 
Will my taking part in this study be kept confidential? 
Yes.  When the questionnaires are input into the computer your name will be replaced 
with a code.  No one will be able to identify you from your responses. The anonymised 
data will be kept securely for 6 years and then destroyed, in accordance with good 
practice guidelines. 
The analysis will be led by Caroline Flurey in the University of the West of England, 
Bristol. 
 
What will happen to the results of the research study? 
The research will take about one year.   The results will be reported in professional 
publications and conferences (but patients will not be identified by name).   The results 
will also be reported in the PhD thesis produced by Caroline Flurey.  A summary of the 
results will be sent to you once the study is complete.  
 
Who is funding the study and who has reviewed the research? 
The research has been funded by Arthritis Research UK.  The study has been peer 
reviewed by the UWE Research Degrees Committee and has been approved by South 
West 5 Research Ethics Committee and the Research Department of the Bristol Royal 
Infirmary.  The University of the West of England will take responsibility for the 
conduct of the study. 
 
What do I do now? 
Thank you for considering taking part in this research.  If you are interested in taking 
part, please hand the attached slip into reception when you attend clinic for your 
appointment.  If you are no longer interested in taking part, there’s nothing more you 
need to do. 
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Helpful Contact Numbers: 
If you have any concerns about participating in this study and would like to receive free 
independent advice please contact PALS (Patient Advise and Liaison Service) on 0117 
342 3571.  If you have any complaints about this research please contact the Patient 
Complaints Manager on 0117 342 3604. 
 
 
Researcher details: 
 
Caroline Flurey MSc 
University of the West of England, Bristol, UK 
PhD Student, Bristol Royal Infirmary 
0117 342 4972 
Caroline2.Flurey@uwe.ac.uk 
 
 
Study Team 
Caroline Flurey MSc, PhD Student, UWE Bristol 
Sarah Hewlett PhD MA RN, Arthritis Research UK, Professor of Rheumatology Nursing, 
UWE  
Marianne Morris PhD MSc, Principal Lecturer in Health Psychology, UWE Bristol 
Jon Pollock, PhD, Reader in Epidemiology, UWE Bristol 
Rod Hughes MD, Rheumatologist, Chertsey 
Pam Richards – Patient Partner
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Appendix K1: Daily symptoms questionnaire 
 
 
 
 
Today’s date: ________________________________ 
 
 
Please circle the appropriate number from 0-10 (none to worst) for each item,  
based on your RA symptoms for THE PAST 24 HOURS 
 
 
1)   How much pain do you have?                        0    1    2    3    4    5    6    7    8    9    10 
 
               No pain at all                      Worst possible pain 
 
 
2)   What is your average level of fatigue?        0    1    2    3    4    5    6    7    8    9    10 
 
             No Fatigue   Totally Exhausted 
 
 
3)   How much joint swelling do you have?       0    1    2    3    4    5    6    7    8    9    10 
 
          No swelling at all                      Worst possible swelling 
 
 
4)   How much joint stiffness do you have?      0    1    2    3    4    5    6    7    8    9    10 
 
            No stiffness at all              Worst possible stiffness 
 
 
5)   How much time today did you spend being frustrated by your RA?   
        
             0    1    2    3    4    5    6    7    8    9    10 
  
                   None of the time                               All of the time 
 
 
6)   How much time today did you spend being angry about your RA?   
        
             0    1    2    3    4    5    6    7    8    9    10 
  
                 None of the time                All of the time 
 
 
7)   How much time today was your RA a worry in your life?  
  
               0    1    2    3    4    5    6    7    8    9    10 
  
                   None of the time                              All of the time 
 
 
 
8)  Is your Rheumatoid Arthritis in a Flare condition today? Yes  No 
 
ID …………………………. 
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Appendix K2: Weekly impact and management questionnaire 
 
 
 
 
Today’s date: ________________________________ 
 
 
Self-Management 
 
Please answer these questions in relation to the PAST WEEK 
 
1) How many times (if at all) have you had to cancel/change your plans due to 
your RA? 
 
 
 
2) Over the past week, what things have you tried to help you deal with your 
arthritis? 
 
Please  if you have used this 
 Activity       in the last week 
 
a) Avoided or altered doing the things that might cause pain  ________
  
b) Gave myself permission to leave a task half-finished   ________ 
 
c) Distracted myself from my symptoms     ________ 
 
d) Asked for help with the difficulties of everyday tasks   ________ 
 
e) Made small adjustments to my day to deal with the difficulties of  
 everyday tasks                    ________ 
                  
f)  Made time for socialising      ________ 
 
g) Allocated time for relaxation      ________ 
 
h) Managed my medication (knowing when and how to take it)              ________ 
 
i)  Contacted my doctor or other health professional   ________ 
 
 
 
 
 
 
 
 
 
Please see overleaf for 2 questions relating to your overall feelings 
 
 
 
 
 
 
 
 
ID …………………………. 
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Overall Feelings 
3) Considering your arthritis overall, how would you rate your level of physical 
well-being during the past week? Circle the number that best describes your level of 
physical well-being. 
0 1 2 3 4 5 6 7 8 9 10 
Very Good           Very Bad 
 
4) Considering your arthritis overall, how would you rate your level of emotional 
well-being during the past week? Circle the number that best describes your level of 
emotional well-being. 
0 1 2 3 4 5 6 7 8 9 10 
Very Good           Very Bad 
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Appendix L: Study 3a participant consent form 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
Capturing Daily Fluctuations in Rheumatoid Arthritis 
 
Consent form for research study 
 
Please initial each box 
 
1 I confirm that I have read and understand the information sheet  
 dated 27th May 2011 for the above study 
 
2          I understand that my participation is voluntary and that I am free to  
 withdraw at any time without my medical care or legal rights being  
affected 
 
3 I understand that relevant sections of my medical notes may be looked at  
by a member of the clinical team.  I give permission for these individuals  
to have access to my records. 
 
4 I understand that anonymised data collected during the study may 
 be used in publications, conference presentations and a PhD thesis. 
 
5 I agree to take part in the above study 
 
 
 
            
 Name of patient  Date   Signature 
 
 
                                                                                                                          
 Name of researcher  Date    Signature 
 
 
 
1 Copy to Participant    1 Copy to Researcher    1 Copy for Notes 
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Appendix M1: Daily symptoms questionnaire 
 
 
 
Today’s date: ________________________________ 
 
 
Please circle the appropriate number from 0-10 (none to worst) for each item,  
based on your RA symptoms for THE PAST 24 HOURS 
 
 
1)   How much pain do you have?                        0    1    2    3    4    5    6    7    8    9    10 
 
               No pain at all                      Worst possible pain 
 
 
2)   What is your average level of fatigue?        0    1    2    3    4    5    6    7    8    9    10 
 
             No Fatigue   Totally Exhausted 
 
 
 
3)   How much joint swelling do you have?       0    1    2    3    4    5    6    7    8    9    10 
 
          No swelling at all                      Worst possible swelling 
 
 
 
4)   How much joint stiffness do you have?      0    1    2    3    4    5    6    7    8    9    10 
 
            No stiffness at all              Worst possible stiffness 
 
 
 
5)   How much time today did you spend being frustrated by your RA?   
        
             0    1    2    3    4    5    6    7    8    9    10 
  
                   None of the time                               All of the time 
 
 
 
6)   How much time today did you spend being angry about your RA?   
        
             0    1    2    3    4    5    6    7    8    9    10 
  
                 None of the time                All of the time 
 
 
7)   How much time today was your RA a worry in your life?  
  
               0    1    2    3    4    5    6    7    8    9    10 
  
                   None of the time                              All of the time 
 
 
 
8)  Is your Rheumatoid Arthritis in a Flare condition today? Yes  No 
 
ID …………………………. 
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Appendix M2: Flare help-seeking questionnaire 
 
 
 
        
Today’s date: ________________________________ 
 
 
1) Please circle the number that describes the severity of your RA flare: 
 
0 1 2 3 4 5 6 7 8 9 10 
Usual RA symptoms             Extremely bad 
 
2) Considering your normal ability to run or manage your life (at work or home), 
please circle the number that describes how you are currently managing: 
 
   0  1 2 3 4 5 6 7 8 9 10 
Unable to manage                 Able to manage as normal
      
3) Considering your ability to take part in social and/or pleasurable activities 
that are normal for you, please circle the number that describes your current level of 
involvement: 
 
0 1 2 3 4 5 6 7 8 9 10 
No Involvement          Full Involvement
                  
4) Considering your arthritis overall, please circle how well you coped with your 
disease during the last week? 
 
0 1 2 3 4 5 6 7 8 9 10 
Coped Not At All Well                      Coped Very Well
                    
5) As a result of this flare, what did you do? (Tick as many boxes as apply) 
 
  I didn’t do anything different 
  I reduced the amount of activities I did  
  I increased my rest time 
  I avoided doing activities I had planned to do  
  I asked for help with everyday tasks 
  I tried to distract myself from my symptoms   
  I took more painkillers or extra anti-inflammatory medications (NSAIDS) 
  I took more steroid tablets 
 
6) What finally caused you to decide to contact the medical team? 
 
 
 
 
 
 
 
 
 
 
 
 
Please see overleaf for final question 
 
 
ID …………………………. 
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7) Do any of the following apply to you? (Tick as many boxes as apply) 
 
  I avoided seeking medical help as I didn’t want to be given any more medication 
   I waited until the Flare had lasted longer than I expected before seeking help 
  I waited until I had more than one Flare symptom before seeking medical help 
  I was prompted by a family member/friend to seek medical help 
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Appendix M3: Flare early warning signs questionnaire 
 
 
 
 
 
       Today’s date: ________________________________ 
 
 
1) Did you get any early warning signs that this flare was about to start? 
Yes   No 
 
 
 
2) Thinking back to when your flare started, did you experience any of the 
following early warning signs? 
 
 
 
Early Warnings of a Flare Yes No 
‘Flu-like’ symptoms   
Increased pain   
Symptoms in a single joint that warned you about a flare starting   
Increased fatigue   
Became more aware of your physical body   
Realised that you needed to ask for help   
Realised that you had been taking extra painkillers   
Realised that you had been using more self-management 
strategies than usual   
People close to you noticed warning signs of the flare   
Just ‘knew’ that a flare was coming   
Didn’t want to be touched because everything is so tender   
 
ID …………………………. 
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Appendix N: Study 3b participant consent form 
 
 
 
Rheumatology Research 
Faculty of Health and Life Sciences 
Based at: 
Academic Rheumatology 
Bristol Royal Infirmary 
BRISTOL BS2 8HW 
 
Seeking Help for Flares in Rheumatoid Arthritis 
 
Consent form for research study 
 
Please initial each box 
 
1 I confirm that I have read and understand the information sheet  
 dated 27th May 2011 for the above study 
 
2          I understand that my participation is voluntary and that I am free to  
 withdraw at any time without my medical care or legal rights being  
affected 
 
3 I understand that relevant sections of my medical notes may be looked at  
by a member of the clinical team.  I give permission for these individuals  
to have access to my records. 
 
4 I understand that anonymised data collected during the study may 
 be used in publications, conference presentations and a PhD thesis. 
 
5 I agree to take part in the above study 
 
 
 
                          
 Name of patient  Date   Signature 
 
 
                                                                                                                          
 Name of researcher  Date   Signature 
 
 
 
1 Copy to Participant    1 Copy to Researcher    1 Copy for Notes
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Appendix O1: Daily life comments booklet 
 
 
Living with RA day by day means........ 
 
 
Number Statement Comment 
 
 
1 
 
I sometimes 
have to cancel 
plans due to my 
RA 
 
 
 
 
 
2 
 
Being more 
spontaneous 
with life 
 
 
 
 
 
3 
 
 
Struggling to do 
certain things 
 
 
 
 
 
4 
 
Choosing my 
clothes 
according to 
how easy they 
are to put on 
and take off 
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5 
 
I am able to 
predict how bad 
my symptoms 
will be each day 
 
 
 
 
6 
 
Taking longer to 
get things done 
than I think it 
should 
 
 
 
 
7 
Finding different 
ways of doing 
the things I want 
to 
 
 
 
 
8 
 
Giving myself 
permission to 
leave a task half 
finished 
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9 
 
Using tools or 
devices to aid 
me in daily tasks 
 
 
 
 
10 
 
Finding a 
balance 
between asking 
for help and 
remaining 
independent 
 
 
 
 
11 
 
Doing what I 
want to do 
regardless of the 
consequences 
 
 
 
 
 
12 
 
Choosing to 
prioritise 
pleasurable 
activities against 
chores 
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13 
 
Not letting my 
RA get me down 
 
 
 
 
14 
 
Relying on 
support from my 
family / friends / 
other 
 
 
 
 
15 
 
Talking to other 
people with RA 
who are similar 
to me helps 
 
 
 
 
16 
 
Using alternative 
medicines / 
therapies to 
manage my RA 
symptoms 
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17 
 
Distracting 
myself from my 
symptoms 
 
 
 
 
18 
  
Trying not to eat 
certain foods 
 
 
 
 
19 
 
I am cautious of 
gaining weight 
and putting extra 
stress on my 
joints 
 
 
 
 
20 
 
Exercising as 
much as I can 
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21 
 
Making small 
adjustments to 
my day or 
activities 
constantly 
because of my 
RA 
 
 
 
 
22 
 
Taking my 
medication 
exactly as 
prescribed 
 
 
 
 
23 
 
Planning rest 
time into my 
week 
 
 
 
 
24 
 
Feeling lucky in 
comparison to 
others 
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25 
 
 I have periods 
of being 
completely 
symptom free 
 
 
 
 
26 
 
Dealing with the 
severity of my 
symptoms going 
up and down 
 
 
 
 
27 
 
Getting 
frustrated due to 
my RA 
 
 
 
 
28 
 
Feeling guilty 
about holding 
others back due 
to my RA 
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29 
 
Feeling that my 
body has let me 
down 
 
 
 
 
30 
 
Trying to forget 
that I have RA 
 
 
 
 
 
 
 
31 
 
Worrying 
because of my 
RA 
 
 
 
 
32 
 Repetitive tasks 
make my RA 
symptoms worse 
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33 
  
Being 
determined not 
to allow my RA 
to interfere with 
my 
responsibilities 
 
 
 
 
34 
 
Being angry 
because of my 
RA 
 
 
 
 
35 
 Experiencing 
unexplainable 
fatigue / 
exhaustion daily 
 
 
 
 
36 
 
Experiencing 
pain daily 
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37 
 
Experiencing 
swelling daily 
 
 
 
 
38 
 
Experiencing 
stiffness daily 
 
 
 
 
39 
 
Struggling to 
explain to family 
and friends what 
life is like for me 
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Appendix O2: Flare comments booklet 
 
When I am in a Flare..... 
 
Number Statement Comment 
 
 
1 
 
I feel the Flare 
will last until I 
seek medical 
help 
 
 
 
 
 
2 
 
I will contact the 
medical team as 
soon as possible 
 
 
 
 
3 
I am reluctant to 
seek medical 
help as I worry 
about wasting the 
Rheumatology 
Team’s time 
 
 
 
 
 
4 
I am more 
reluctant to seek 
medical help 
when I think I’ve 
caused the Flare 
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5 
I am reluctant to 
seek medical 
help as I don’t 
think the Dr can 
do anything to 
help 
 
 
 
 
6 
 
I am reluctant to 
seek medical 
help as I hope it’ll 
go away on its 
own 
 
 
 
 
7 
 
I avoid seeking 
medical help as I 
don’t like taking 
drugs 
 
 
 
 
8 
I seek help from 
the medical team 
once flare starts 
to affect my 
quality of life too 
much 
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9 
 
I know I don’t 
have to manage 
my flare alone 
 
 
 
 
10 
Easy access to 
the medical team 
is part of my 
decision to seek 
help for my flare 
 
 
 
 
11 
 
A loved one tells 
me I ought to 
seek help 
 
 
 
 
12 
 
I don’t like 
admitting that I 
need to ask for 
help 
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13 
I am reluctant to 
seek medical 
help as I don’t get 
on well with my 
Rheumatology 
Team 
 
 
 
 
14 
 
I manage my 
symptoms until 
the flare stops 
 
 
 
 
15 
I seek help from 
the medical team 
as I worry about 
long term 
damage to my 
joints 
 
 
 
 
16 
 
I seek help from 
the medical team 
when the pain 
becomes too 
intense 
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17 
I wait until my 
next scheduled 
appointment with 
the 
Rheumatologist 
before seeking 
help 
 
 
 
 
18 
I am reluctant to 
seek medical 
help as I don’t 
want to waste my 
own time 
 
 
 
 
19 
I seek help from 
the medical team 
when I know my 
Flare needs to be 
controlled by new 
medication 
 
 
 
 
20 
I control my Flare 
symptoms with 
medication before 
contacting the 
medical team 
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21 
I seek help from 
the medical team 
when my 
symptoms 
become 
uncontrollable 
 
 
 
 
22 
I seek help from 
the medical team 
when the Flare 
has gone on 
longer than I 
expected 
 
 
 
 
23 
I wait until I have 
more than one 
Flare symptoms 
before seeking 
medical help 
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Appendix P1: Initial list of Daily Life Q-statements 
 
1. I often have to cancel my plans due to my RA 
2. I have had to become more spontaneous 
3. There are certain things I always struggle with 
4. I choose my clothes according to how easy they will be to take on and off 
5. I have adapted my home to fit my needs 
6. Sometimes I can do daily chores on my own, but at other times I need help 
7. It takes me longer to get things done than I think it should 
8. I’ve lost confidence in my ability to do the things I want to  
9. I have had to give up something important to me because of my RA 
10. It’s important to me that I keep working despite having RA 
11. I modify my life around my RA 
12. I often have to ask for help from my friends and/or family 
13. I like to remain as independent as possible 
14. I find different ways of doing things so that my RA doesn’t stop me  
15. I give myself permission to leave a task half finished 
16. I use tools or devices to aid me in daily life 
17. I find other things to do to replace the activities that I can no longer manage 
18. I try to find a balance between asking for help and remaining independent 
19. I try to find a balance between being active and resting  
20. Before I act I always consider the consequences of how I will feel the next day 
21. I prioritise pleasurable activities over household chores 
22. If I want to do something, I do it.  Even if that means I’m pain in the next day. 
23. I have to work hard not to let my RA get me down 
24. Having RA has turned my life upside down 
25. I feel lucky compared with other people who have RA 
26. I think my Rheumatologist knows best about how to manage my RA 
27. Having control over my RA is important to me 
28. Having RA is part of my identity now 
29. I have to work hard to remain positive 
30. My family and/or friends are understanding and support me 
31. I think a supportive medical team is important 
32. Talking to other people with RA who are similar to me helps 
33. It gets me down to talk to other people who have RA 
34. I use alternative medicines/therapies to manage my RA symptoms 
35. I try to distract myself when I am having a bad day 
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36. I try to rest as much as possible throughout a normal day 
37. I try not to eat certain foods in case they trigger a Flare 
38. I am careful of what I eat as I don’t want to put on weight 
39. I exercise as much as I can 
40. I build small tasks into my working day to keep my symptoms at bay 
41. I do my best to avoid any activity that may lead to a Flare 
42. I plan a ‘rest-day’ into my week 
43. When I have a task to do I pace myself; I do a little bit then stop for a rest, then do 
a bit more 
44. On a normal day I would consider myself to be completely symptom free 
45. Throughout a normal day, the severity of my symptoms go up and down 
46. I consider myself unlucky to have RA 
47. The medication I take controls my symptoms well 
48. I am reluctant to take medication for my RA 
49. I always take my medication as it has been prescribed 
50. I often get frustrated due to my RA 
51. I feel guilty when I feel that I am holding others back due to my RA 
52. I feel that my body has let me down 
53. I now have a new definition of ‘normal’ for me 
54. Other people can’t understand what it’s like to have RA 
55. If I want to do something I will push through the pain 
56. I won’t let my RA stop me doing anything 
57. I want people to believe I have a disability.  I don’t want to have to explain myself. 
58. I want to be treated the same as everyone else 
59. I try to forget that I have RA 
60. I avoid telling people that I have RA 
61. My RA symptoms are completely unpredictable 
62. I have no idea how I will feel when I wake up in the morning 
63. I can’t work because of my RA 
64. I worry that I can’t keep up with my colleagues at work 
65. I find that repetitive tasks make my RA symptoms worse 
66. I don’t like to have time off work due to my RA 
67. I won’t allow my RA to interfere with my responsibilities 
68. I am angry that I have RA 
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Appendix P2: Initial list of Flare Q-statements 
 
1. A ‘flare’ means having a couple of swollen joints 
2. I find that a ‘flare’ that I can’t explain is worse than one I can explain 
3. A ‘flare’ can be pain that lasts no more than a few minutes 
4. A ‘flare’ effects your entire body 
5. A ‘flare’ is when my symptoms are out of my control 
6. When I am in a ‘flare’ I worry that the disease is getting worse 
7. I get irritable when I’m in a ‘flare’ 
8. The emotional aspect of a ‘flare’ is worse than the physical symptoms 
9. If I do a repetitive task I will end up in a ‘flare’ 
10. Overdoing it can cause a ‘Flare’ 
11. Stress causes a ‘flare’ 
12. I have ‘flares’ regularly 
13. I increase my medication to control a ‘flare’ 
14. I try to distract myself from ‘flare’ symptoms 
15.  I rest as much as possible when I’m in a ‘flare’ 
16. If I have a ‘flare’ I will have to cancel any plans I have 
17. I slow down if I feel a ‘flare’ up coming to try and prevent it developing 
18. When I have a ‘flare’ I struggle to move 
19. When I have a ‘flare’ my symptoms are similar to having the Flu 
20. When I am in a ‘flare’ I can’t get comfortable as I am in so much pain 
21. My joints get swollen and hot when I am in a ‘flare’ 
22. When I am in a ‘flare’ I have no energy 
23. My ‘flare’ will last until I seek medical help 
24. When I have a ‘flare’ I just want to hibernate 
25. When I have a ‘flare’ I have no choice but to ask for help 
26. When I have a ‘flare’ it feels like the RA is winning 
27. I don’t have any motivation when I’m in a ‘flare’ 
28. When I am in a ‘flare’ I wait as long as possible before contacting the medical team 
29. I wait to contact the medical team for assistance as I worry that I will be wasting 
their time 
30. I am more reluctant to seek medical help for a ‘flare’ if I think I’ve caused it 
31. I don’t like to see other patients with RA, so I avoid coming to clinic 
32. I don’t come for medical help when I am in a ‘flare’ as I don’t think the Dr can do 
anything to help 
33. I don’t seek help for a ‘flare’ straight away as I hope it’ll go away on its own 
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34. I’m not always certain that my symptoms are related to RA 
35. I don’t like taking drugs, so I avoid seeking medical help when I am in a ‘flare’ 
36. I seek help from the medical team for a ‘flare’ when it starts to effect my quality of 
life 
37. I know I don’t have to manage alone when I am in a ‘flare’ 
38. If my clinic appointment’s coming up I will wait to seek help for my ‘flare’ 
39. I can tell the difference between daily fluctuation and a ‘flare’ 
40. I can tell whether my ‘flare’ needs to be controlled by medication or not 
41. When I am in a flare I worry about long term damage to my joints 
42. Easy access to the medical team is important to me 
43. I always try to think of a reason for my ‘flare’ 
44. I don’t like admitting that I need to ask for help 
45. A ‘flare’ comes out of the blue 
46. Having a ‘flare’ means game-over 
47. I can sometimes manage my ‘flare’ myself 
48. I have to be encouraged to seek help for my ‘flare’ by a family member 
49. I seek help from the medical team when my ‘flare’ has gone on too long 
50. I increase my medication before contacting the medical team when I am in a ‘flare’
  
4
0
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Appendix Q1: Daily life Q-study 5-factor solution 
 
=============================================================================================================== 
Factor scores                            Living with RA day by day means.sty  
=============================================================================================================== 
Living with RA day by day means.sty file name 
30 sorts 
39 items 
11 piles 
5 centroids 
1 2 3 4 6 7 6 4 3 2 1  frequencies 
5.43589743589744 variance 
  
scores edited scores edited     4:01:02 PM,7/6/2012 
factored factored          4:02:00 PM,7/6/2012 
varimax  
last opened at last opened at     4:00:49 PM,7/6/2012 
  
=============================================================================================================== 
Summary (varimax)                         
=============================================================================================================== 
23 sorts have been accounted for in 5 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[ 8]  A  |  3  7 16 18 21 23 25 28   
[ 4]  B  | 12 17 19 20   
[ 6]  C  |  1  2  5  8  9 14   
[ 2]  D  | 10 30   
[ 3]  E  |  4 26 29   
--------------------------------------------------------------------------------------------------------------- 
A
p
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e
n
d
ix
 Q
1
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Factors  
 have no loadings greater or equal to 41 
--------------------------------------------------------------------------------------------------------------- 
[ 1]      Confounded: 13,  
[ 6] Not significant:  6,11,15,22,24,27,  
=============================================================================================================== 
Factor A for Living with RA day by day means.sty (varimax)  
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 18  15  16   1   4   5   8  13   3   6  33   
     19  25   2   9  14  10  27   7  35       
         39  12  20  26  11  28  36           
             24  22  29  17  38               
                 23  30  21                   
                 31  32  37                   
                     34                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI61MBL                     3  0.48          COSS79FGK                    7  0.44 
CH72FEH                     16  0.70          CH61MSB                     18  0.58 
BRI55MAA                    21  0.46          COSS55FDH                   23  0.43 
BRI52MMH                    25  0.63          BRI46FGB                    28  0.49 
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=============================================================================================================== 
Factor B for Living with RA day by day means.sty (varimax) 
 
 
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 34  35  31   5   3   1   7   4   2  11  20   
     36  32  27   6   8  12  16  18  13       
         38  29  15   9  26  17  25           
             39  19  10  28  24               
                 21  14  30                   
                 37  22  33                   
                     23                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
CH50MLC                     12  0.62          CH63FMN                     17 -0.59 
COSS51FKP                   19 -0.78          COSS41FCS                   20 -0.83 
  
  
=============================================================================================================== 
Factor C for Living with RA day by day means.sty (varimax) 
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 33  13  19  11   7   2   1   6  12   4   9   
     24  20  22  16   3  15   8  23  14       
         30  27  17   5  21  18  28           
             35  26  10  31  34               
                 36  25  32                   
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                 38  29  39                   
                     37                      
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1 -0.50          COSS33FHJ                    2 -0.63 
COSS30FSB                    5 -0.48          COSS39FKK                    8 -0.41 
CH50FJM                      9 -0.69          CH39FDV                     14 -0.46 
  
  
===============================================================================================================
Factor D for Living with RA day by day means.sty (varimax)   
=============================================================================================================== 
 
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 22   6   4  19   1  12   3   2  16  11  25   
     13   7  24   5  17   8  18  36  34       
         33  27   9  21  10  30  37           
             29  15  31  14  32               
                 20  35  23                   
                 26  38  28                   
                     39                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
CH66FOM                     10 -0.68          BRI65FVV                    30 -0.52 
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=============================================================================================================== 
Factor E for Living with RA day by day means.sty (varimax)                                             
=============================================================================================================== 
 
 
 
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 29  11  16  18   3   1   4   7   8  12  22   
     28  31  25   6   2   5   9  10  21       
         34  27  33  13  14  20  23           
             39  35  15  17  26               
                 37  19  24                   
                 38  30  32                   
                     36                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI67FJF                     4  0.77          BRI50BD                     26  0.42 
BRI60FSY                    29  0.66            
  
  
=============================================================================================================== 
Item scores  (varimax)                         
=============================================================================================================== 
                                                Factors  A    B    C    D    E     
                                                        ---- ---- ---- ---- ----   
  1.I sometimes have to cancel plans due to my RA         -2    0    1   -1    0   
  2.Being more spontaneous with life                      -2    3    0    2    0   
  3.Struggling to do certain things                        3   -1    0    1   -1   
  4.Choosing my clothes according to how easy they        -1    2    4   -3    1   
    are to put on and take off                            
  5.I am able to predict how bad my symptoms will be       0   -2    0   -1    1   
    each day                                              
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  6.Taking longer to get things done than I think it       4   -1    2   -4   -1   
    should                                                
  7.Finding different ways of doing things                 3    1   -1   -3    2   
  8.Giving myself permission to leave a task half          1    0    2    1    3   
    finished                                              
  9.Using tools or devices to aid me in daily tasks       -1    0    5   -1    2   
 10.Finding a balance between asking for help and          1    0    0    1    3   
    remaining independent                                 
 11.Doing what I want to do regardless of the              1    4   -2    4   -4   
    consequences                                          
 12.Choosing to prioritise pleasurable activities         -2    1    3    0    4   
    against chores                                        
 13.Not letting my RA get me down                          2    4   -4   -4    0   
 14.Relying on support from my family / friends /          0    0    4    1    1   
    other                                                 
 15.Talking to other people with RA who are similar       -4   -1    1   -1    0   
    to me helps                                           
 16.Using alternative medicines / therapies to manage     -3    2   -1    3   -3   
    my RA symptoms                                        
 17.Distracting myself from my symptoms                    1    2   -1    0    1   
 18.Trying not to eat certain foods                       -5    3    2    2   -2   
 19.I am cautious of gaining weight and putting extra     -4   -1   -3   -2    0   
    stress on my joints                                   
 20.Exercising as much as I can                           -1    5   -3   -1    2   
 21.Making small adjustments to my day or activities       1   -1    1    0    4   
    constantly because of my RA                           
 22.Taking my medication exactly as prescribed            -1    0   -2   -5    5   
 23.Planning rest time into my week                       -1    0    3    1    3   
 24.Feeling lucky in comparison to others                 -2    2   -4   -2    1   
 25.I have periods of being completely symptom free       -3    3    0    5   -2   
 26.Dealing with the severity of my symptoms going up      0    1   -1   -1    2   
    and down                                              
 27.Getting frustrated due to my RA                        2   -2   -2   -2   -2   
 28.Feeling guilty about holding others back due to        2    1    3    1   -4   
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    my RA                                                 
 29.Feeling that my body has let me down                   0   -2    0   -2   -5   
 30.Trying to forget that I have RA                        0    1   -3    2    0   
 31.Worrying because of my RA                             -1   -3    1    0   -3   
 32.Repetitive tasks make my RA symptoms worse             0   -3    1    2    1   
 33.Being determined not to allow my RA to interfere       5    1   -5   -3   -1   
    with my responsibilities                              
 34.Being angry because of my RA                           0   -5    2    4   -3   
 35.Experiencing unexplainable fatigue / exhaustion        4   -4   -2    0   -1   
    daily                                                 
 36.Experiencing pain daily                                3   -4   -1    3    0   
 37.Experiencing swelling daily                            1   -1    0    3   -1   
 38.Experiencing stiffness daily                           2   -3   -1    0   -1   
 39.Struggling to explain to family and friends what      -3   -2    1    0   -2   
    life is like for me                                   
  
=============================================================================================================== 
Consensus statements  (varimax)                                                                         
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
          There are no consensus item for Living with RA day by day means.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
  
===============================================================================================================
Differentiating statements   (varimax)                                                                 
=============================================================================================================== 
  3 items distinguish Factor A from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D   E    
                                                        --- --- --- --- ---   
 27.Getting frustrated due to my RA                       2  -2  -2  -2  -2   
 33.Being determined not to allow my RA to interfere      5   1  -5  -3  -1   
 35.Experiencing unexplainable fatigue / exhaustion       4  -4  -2   0  -1   
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--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor B 
--------------------------------------------------------------------------------------------------------------- 
  
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor C 
--------------------------------------------------------------------------------------------------------------- 
  
---------------------------------------------------------------------------------------------------------------  
No items distinguish Factor D 
--------------------------------------------------------------------------------------------------------------- 
  
--------------------------------------------------------------------------------------------------------------- 
  2 items distinguish Factor E from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D   E    
                                                        --- --- --- --- ---   
 22.Taking my medication exactly as prescribed           -1   0  -2  -5   5   
 28.Feeling guilty about holding others back due to       2   1   3   1  -4   
  
  
=============================================================================================================== 
Factor correlations   (varimax)                                                                         
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
        Factors  A   B   C   D   E    
--------------------------------------------------------------------------------------------------------------- 
             A   0 -26 -23 -19  -2   
             B -26   0 -19  -5  13   
             C -23 -19   0  20   8   
             D -19  -5  20   0 -33   
             E  -2  13   8 -33   0   
--------------------------------------------------------------------------------------------------------------- 
 reliabilities  96  94  95  88  92   std. errors  40  56  46  77  64    
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Appendix Q2: Daily Life Q-study 4-factor solution 
  
=============================================================================================================== 
Factor scores                                                                                
=============================================================================================================== 
Living with RA day by day means.sty file name 
30 sorts 
39 items 
11 piles 
4 centroids 
1 2 3 4 6 7 6 4 3 2 1  frequencies 
5.43589743589744 variance 
  
scores edited scores edited     4:01:02 PM,7/6/2012 
factored factored          4:03:58 PM,7/6/2012 
varimax  
last opened at last opened at     4:00:49 PM,7/6/2012 
  
=============================================================================================================== 
Summary (varimax)                                                                                       
=============================================================================================================== 
23 sorts have been accounted for in 4 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[ 9]  A  |  3  7 16 18 21 23 25 26 28   
[ 3]  B  | 17 19 20   
[ 6]  C  |  1  2  5  9 13 14   
[ 5]  D  |  4 10 15 29 30   
--------------------------------------------------------------------------------------------------------------- 
Factors  
 have no loadings greater or equal to 41 
--------------------------------------------------------------------------------------------------------------- 
[ 2]      Confounded:  8,12,  
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[ 5] Not significant:  6,11,22,24,27,  
=============================================================================================================== 
Factor A for Living with RA day by day means.sty (varimax)                                       
===============================================================================================================  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 18  19  15   1   4   5  10  13   3   6  33   
     25  16   2  22   8  14  17   7  35       
         39  12  23   9  27  28  21           
             24  29  11  30  36               
                 31  20  37                   
                 34  26  38                   
                     32                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI61MBL                     3  0.48          COSS79FGK                    7  0.47 
CH72FEH                     16  0.73          CH61MSB                     18  0.54 
BRI55MAA                    21  0.44          COSS55FDH                   23  0.42 
BRI52MMH                    25  0.62          BRI50BD                     26  0.42 
BRI46FGB                    28  0.48            
  
=============================================================================================================== 
Factor B for Living with RA day by day means.sty (varimax)                   
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 35  34   5  27   6   1  12   4   2  11  20   
     36  31  29   8   3  14  18  13  25       
         32  38  15   7  17  24  16           
             39  19   9  26  28               
                 22  10  30                   
                 37  21  33                   
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                     23                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
CH63FMN                     17 -0.57          COSS51FKP                   19 -0.80 
COSS41FCS                   20 -0.80            
  
=============================================================================================================== 
Factor C for Living with RA day by day means.sty (varimax) 
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 24  13  19   5   3   2   1  15  12   4   9   
     33  30  22   7  10   6  18  14  28       
         35  27  11  17   8  34  23           
             38  16  21  25  39               
                 20  29  31                   
                 26  36  32                   
                     37                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1 -0.50          COSS33FHJ                    2 -0.62 
COSS30FSB                    5 -0.46          CH50FJM                      9 -0.68 
CH43FNS                     13 -0.57          CH39FDV                     14 -0.47 
  
 
 
 
=============================================================================================================== 
Factor D for Living with RA day by day means.sty (varimax)                                              
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 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 22   7  12   8   1   4   2  18  25  11  16   
     13  20   9   6   5   3  29  28  34       
         24  17  10  14  27  36  37           
             21  19  15  31  39               
                 23  26  35                   
                 32  30  38                   
                     33                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI67FJF                     4 -0.59          CH66FOM                     10 -0.59 
CH72MDP                     15 -0.56          BRI60FSY                    29 -0.68 
BRI65FVV                    30 -0.45            
  
=============================================================================================================== 
Item scores  (varimax)                                                             
=============================================================================================================== 
                                                Factors  A    B    C    D     
                                                        ---- ---- ---- ----   
  1.I sometimes have to cancel plans due to my RA         -2    0    1   -1   
  2.Being more spontaneous with life                      -2    3    0    1   
  3.Struggling to do certain things                        3    0   -1    1   
  4.Choosing my clothes according to how easy they        -1    2    4    0   
    are to put on and take off                            
  5.I am able to predict how bad my symptoms will be       0   -3   -2    0   
    each day                               
  6.Taking longer to get things done than I think it       4   -1    1   -1   
   should                                                
  7.Finding different ways of doing things                 3    0   -1   -4   
  8.Giving myself permission to leave a task half          0   -1    1   -2   
    finished                                              
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  9.Using tools or devices to aid me in daily tasks        0    0    5   -2   
 10.Finding a balance between asking for help and          1    0    0   -1   
    remaining independent                                 
 11.Doing what I want to do regardless of the              0    4   -1    4   
    consequences                                          
 12.Choosing to prioritise pleasurable activities         -2    1    3   -3   
    against chores                                        
 13.Not letting my RA get me down                          2    3   -4   -4   
 14.Relying on support from my family / friends /          1    1    3    0   
    other                                                 
 15.Talking to other people with RA who are similar       -3   -1    2    0   
    to me helps                                           
 16.Using alternative medicines / therapies to manage     -3    3   -1    5   
    my RA symptoms                                        
 17.Distracting myself from my symptoms                    2    1    0   -2   
 18.Trying not to eat certain foods                       -5    2    2    2   
 19.I am cautious of gaining weight and putting extra     -4   -1   -3   -1   
    stress on my joints                                   
 20.Exercising as much as I can                            0    5   -1   -3   
 21.Making small adjustments to my day or activities       3    0    0   -2   
    constantly because of my RA                           
 22.Taking my medication exactly as prescribed            -1   -1   -2   -5   
 23.Planning rest time into my week                       -1    0    3   -1   
 24.Feeling lucky in comparison to others                 -2    2   -5   -3   
 25.I have periods of being completely symptom free       -4    4    1    3   
 26.Dealing with the severity of my symptoms going up      0    1   -1    0   
    and down                                              
 27.Getting frustrated due to my RA                        1   -2   -2    1   
 28.Feeling guilty about holding others back due to        2    2    4    3   
    my RA                                                 
 29.Feeling that my body has let me down                  -1   -2    0    2   
 30.Trying to forget that I have RA                        1    1   -3    0   
 31.Worrying because of my RA                             -1   -3    1    1   
 32.Repetitive tasks make my RA symptoms worse             0   -3    1   -1   
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 33.Being determined not to allow my RA to interfere       5    1   -4    0   
    with my responsibilities                              
 34.Being angry because of my RA                          -1   -4    2    4   
 35.Experiencing unexplainable fatigue / exhaustion        4   -5   -3    1   
    daily                                                 
 36.Experiencing pain daily                                2   -4    0    2   
 37.Experiencing swelling daily                            1   -1    0    3   
 38.Experiencing stiffness daily                           1   -2   -2    1   
 39.Struggling to explain to family and friends what      -3   -2    2    2   
    life is like for me                                   
  
===============================================================================================================
Consensus statements  (varimax)                                                         
===============================================================================================================
--------------------------------------------------------------------------------------------------------------- 
          There are no consensus item for Living with RA day by day means.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
  
=============================================================================================================== 
Differentiating statements   (varimax)                                                               
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
  3 items distinguish Factor A from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
 18.Trying not to eat certain foods                      -5   2   2   2   
 25.I have periods of being completely symptom free      -4   4   1   3   
 33.Being determined not to allow my RA to interfere      5   1  -4   0   
  
--------------------------------------------------------------------------------------------------------------- 
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3 items distinguish Factor B from all other factors 
 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
 20.Exercising as much as I can                           0   5  -1  -3   
 24.Feeling lucky in comparison to others                -2   2  -5  -3   
 36.Experiencing pain daily                               2  -4   0   2   
  
--------------------------------------------------------------------------------------------------------------- 
  2 items distinguish Factor C from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
  9.Using tools or devices to aid me in daily tasks       0   0   5  -2   
 33.Being determined not to allow my RA to interfere      5   1  -4   0   
  
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor D 
--------------------------------------------------------------------------------------------------------------- 
   
=============================================================================================================== 
Factor correlations   (varimax)                                                         
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
        Factors  A   B   C   D    
--------------------------------------------------------------------------------------------------------------- 
             A   0 -20 -26 -19   
             B -20   0   0  -8   
             C -26   0   0  17   
             D -19  -8  17   0   
--------------------------------------------------------------------------------------------------------------- 
reliabilities  97  92  95  95    
   std. errors  38  64  46  50    
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Appendix Q3: Daily Life Q-study 3-factor solution 
 
=============================================================================================================== 
Factor scores                                                                                          
=============================================================================================================== 
Living with RA day by day means.sty file name 
30 sorts 
39 items 
11 piles 
4 centroids 
1 2 3 4 6 7 6 4 3 2 1  frequencies 
5.43589743589744 variance 
  
scores edited scores edited     4:01:02 PM,7/6/2012 
factored factored          4:32:59 PM,7/6/2012 
varimax  
last opened at last opened at     4:32:53 PM,7/6/2012 
  
=============================================================================================================== 
Summary (varimax)                                                   
=============================================================================================================== 
23 sorts have been accounted for in 4 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[ 9]  A  |  3  7 16 18 21 23 25 26 28   
[ 3]  B  | 17 19 20   
[ 6]  C  |  1  2  5  9 13 14   
[ 5]  D  |  4 10 15 29 30   
--------------------------------------------------------------------------------------------------------------- 
Factors  
 have no loadings greater or equal to 41 
--------------------------------------------------------------------------------------------------------------- 
[ 2]      Confounded:  8,12,  
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[ 5] Not significant:  6,11,22,24,27,  
===============================================================================================================
Factor A for Living with RA day by day means.sty (varimax)                                           
===============================================================================================================  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 18  19  15   1   4   5  10  13   3   6  33   
     25  16   2  22   8  14  17   7  35       
         39  12  23   9  27  28  21           
             24  29  11  30  36               
                 31  20  37                   
                 34  26  38                   
                     32                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI61MBL                     3  0.48          COSS79FGK                    7  0.47 
CH72FEH                     16  0.73          CH61MSB                     18  0.54 
BRI55MAA                    21  0.44          COSS55FDH                   23  0.42 
BRI52MMH                    25  0.62          BRI50BD                     26  0.42 
BRI46FGB                    28  0.48            
  
===============================================================================================================
Factor B for Living with RA day by day means.sty (varimax)                         
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 35  34   5  27   6   1  12   4   2  11  20   
     36  31  29   8   3  14  18  13  25       
         32  38  15   7  17  24  16           
             39  19   9  26  28               
                 22  10  30                   
                 37  21  33                   
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                     23                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
CH63FMN                     17 -0.57          COSS51FKP                   19 -0.80 
COSS41FCS                   20 -0.80            
  
=============================================================================================================== 
Factor C for Living with RA day by day means.sty (varimax)                                        
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 24  13  19   5   3   2   1  15  12   4   9   
     33  30  22   7  10   6  18  14  28       
         35  27  11  17   8  34  23           
             38  16  21  25  39               
                 20  29  31                   
                 26  36  32                   
                     37                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1 -0.50          COSS33FHJ                    2 -0.62 
COSS30FSB                    5 -0.46          CH50FJM                      9 -0.68 
CH43FNS                     13 -0.57          CH39FDV                     14 -0.47 
  
  
===============================================================================================================
Factor D for Living with RA day by day means.sty (varimax)      
=============================================================================================================== 
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 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 22   7  12   8   1   4   2  18  25  11  16   
     13  20   9   6   5   3  29  28  34       
         24  17  10  14  27  36  37           
             21  19  15  31  39               
                 23  26  35                   
                 32  30  38                   
                     33                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI67FJF                     4 -0.59          CH66FOM                     10 -0.59 
CH72MDP                     15 -0.56          BRI60FSY                    29 -0.68 
BRI65FVV                    30 -0.45            
  
  
=============================================================================================================== 
Item scores  (varimax)                               
=============================================================================================================== 
                                                Factors  A    B    C    D     
                                                        ---- ---- ---- ----   
  1.I sometimes have to cancel plans due to my RA         -2    0    1   -1   
  2.Being more spontaneous with life                      -2    3    0    1   
  3.Struggling to do certain things                        3    0   -1    1   
  4.Choosing my clothes according to how easy they        -1    2    4    0   
    are to put on and take off                            
  5.I am able to predict how bad my symptoms will be       0   -3   -2    0   
    each day                                              
  6.Taking longer to get things done than I think it       4   -1    1   -1   
    should                                                
  7.Finding different ways of doing things                 3    0   -1   -4   
  8.Giving myself permission to leave a task half          0   -1    1   -2   
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    finished                                              
  9.Using tools or devices to aid me in daily tasks        0    0    5   -2   
 10.Finding a balance between asking for help and          1    0    0   -1   
    remaining independent                                 
 11.Doing what I want to do regardless of the              0    4   -1    4   
    consequences                                          
 12.Choosing to prioritise pleasurable activities         -2    1    3   -3   
    against chores                                        
 13.Not letting my RA get me down                          2    3   -4   -4   
 14.Relying on support from my family / friends /          1    1    3    0   
    other                                                 
 15.Talking to other people with RA who are similar       -3   -1    2    0   
    to me helps                                           
 16.Using alternative medicines / therapies to manage     -3    3   -1    5   
    my RA symptoms                                        
 17.Distracting myself from my symptoms                    2    1    0   -2   
 18.Trying not to eat certain foods                       -5    2    2    2   
 19.I am cautious of gaining weight and putting extra     -4   -1   -3   -1   
    stress on my joints                                   
 20.Exercising as much as I can                            0    5   -1   -3   
 21.Making small adjustments to my day or activities       3    0    0   -2   
    constantly because of my RA                           
 22.Taking my medication exactly as prescribed            -1   -1   -2   -5   
 23.Planning rest time into my week                       -1    0    3   -1   
 24.Feeling lucky in comparison to others                 -2    2   -5   -3   
 25.I have periods of being completely symptom free       -4    4    1    3   
 26.Dealing with the severity of my symptoms going up      0    1   -1    0   
    and down                                              
 27.Getting frustrated due to my RA                        1   -2   -2    1   
 28.Feeling guilty about holding others back due to        2    2    4    3   
    my RA                                                 
 29.Feeling that my body has let me down                  -1   -2    0    2   
 30.Trying to forget that I have RA                        1    1   -3    0   
 31.Worrying because of my RA                             -1   -3    1    1   
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 32.Repetitive tasks make my RA symptoms worse             0   -3    1   -1   
 33.Being determined not to allow my RA to interfere       5    1   -4    0   
    with my responsibilities                              
 34.Being angry because of my RA                          -1   -4    2    4   
 35.Experiencing unexplainable fatigue / exhaustion        4   -5   -3    1   
    daily                                                 
 36.Experiencing pain daily                                2   -4    0    2   
 37.Experiencing swelling daily                            1   -1    0    3   
 38.Experiencing stiffness daily                           1   -2   -2    1   
 39.Struggling to explain to family and friends what      -3   -2    2    2   
    life is like for me                                   
  
===============================================================================================================
Consensus statements  (varimax) 
=============================================================================================================== 
---------------------------------------------------------------------------------------------------------------          
There are no consensus item for Living with RA day by day means.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
  
=============================================================================================================== 
Differentiating statements   (varimax)                                                                  
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
  3 items distinguish Factor A from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
 18.Trying not to eat certain foods                      -5   2   2   2   
 25.I have periods of being completely symptom free      -4   4   1   3   
 33.Being determined not to allow my RA to interfere      5   1  -4   0   
  
---------------------------------------------------------------------------------------------------------------  
3 items distinguish Factor B from all other factors 
--------------------------------------------------------------------------------------------------------------- 
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Factors  A   B   C   D    
                                                        --- --- --- ---   
 20.Exercising as much as I can                           0   5  -1  -3   
 24.Feeling lucky in comparison to others                -2   2  -5  -3   
 36.Experiencing pain daily                               2  -4   0   2   
  
--------------------------------------------------------------------------------------------------------------- 
  2 items distinguish Factor C from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
  9.Using tools or devices to aid me in daily tasks       0   0   5  -2   
 33.Being determined not to allow my RA to interfere      5   1  -4   0   
  
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor D 
--------------------------------------------------------------------------------------------------------------- 
  
  
=============================================================================================================== 
Factor correlations   (varimax)                          
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
        Factors  A   B   C   D    
--------------------------------------------------------------------------------------------------------------- 
             A   0 -20 -26 -19   
             B -20   0   0  -8   
             C -26   0   0  17   
             D -19  -8  17   0   
--------------------------------------------------------------------------------------------------------------- 
reliabilities  97  92  95  95    
   std. errors  38  64  46  50    
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Appendix Q4: Daily Life Q-Study 2-factor solution 
  
=============================================================================================================== 
Factor scores                                                                 
=============================================================================================================== 
Living with RA day by day means.sty file name 
30 sorts 
39 items 
11 piles 
2 centroids 
1 2 3 4 6 7 6 4 3 2 1  frequencies 
5.43589743589744 variance 
  
scores edited scores edited     4:01:02 PM,7/6/2012 
factored factored          4:04:54 PM,7/6/2012 
varimax  
last opened at last opened at     4:00:49 PM,7/6/2012 
  
===============================================================================================================
Summary (varimax)                                     
=============================================================================================================== 
18 sorts have been accounted for in 2 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[ 9]  A  |  1  8  9 13 15 16 28 29 30   
[ 9]  B  |  3 12 17 18 19 20 21 22 25   
--------------------------------------------------------------------------------------------------------------- 
Factors  
 have no loadings greater or equal to 41 
--------------------------------------------------------------------------------------------------------------- 
[ 0]      Confounded:   
[12] Not significant:  2, 4, 5, 6, 7,10,11,14,23,24,26,27,  
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=============================================================================================================== 
Factor A for Living with RA day by day means.sty (varimax)         
=============================================================================================================== 
  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 34  18  16   4   1   2   3  10   7  33  13   
     25  28  11   9   8   5  19  22  35       
         39  14  12  15   6  21  24           
             37  23  26  17  38               
                 31  27  20                   
                 32  29  30                   
                     36                       
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1  0.63          COSS39FKK                    8  0.45 
CH50FJM                      9  0.47          CH43FNS                     13  0.69 
CH72MDP                     15  0.49          CH72FEH                     16  0.53 
BRI46FGB                    28  0.52          BRI60FSY                    29  0.49 
BRI65FVV                    30  0.45            
  
=============================================================================================================== 
Factor B for Living with RA day by day means.sty (varimax)                                             
===============================================================================================================  
 -5  -4  -3  -2  -1   0   1   2   3   4   5   
-------------------------------------------- 
 34  35   5   3  10   1   9   4   2  18  20   
     36  27   6  21   7  15  11  13  25       
         31  32  28   8  17  12  16           
             38  29  14  22  24               
                 37  19  23                   
                 39  26  30                   
                     33                       
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 Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI61MBL                     3 -0.48          CH50MLC                     12  0.72 
CH63FMN                     17 -0.47          CH61MSB                     18 -0.51 
COSS51FKP                   19 -0.70          COSS41FCS                   20 -0.86 
BRI55MAA                    21 -0.52          BRI60MCS                    22 -0.44 
BRI52MMH                    25 -0.43            
  
  
===============================================================================================================
Item scores  (varimax)                                   
=============================================================================================================== 
                                                Factors  A    B     
                                                        ---- ----   
  1.I sometimes have to cancel plans due to my RA         -1    0   
  2.Being more spontaneous with life                       0    3   
  3.Struggling to do certain things                        1   -2   
  4.Choosing my clothes according to how easy they        -2    2   
    are to put on and take off                            
  5.I am able to predict how bad my symptoms will be       1   -3   
    each day                                              
  6.Taking longer to get things done than I think it       1   -2   
    should                                                
  7.Finding different ways of doing things                 3    0   
  8.Giving myself permission to leave a task half          0    0   
    finished                                              
  9.Using tools or devices to aid me in daily tasks       -1    1   
 10.Finding a balance between asking for help and          2   -1   
    remaining independent                                 
 11.Doing what I want to do regardless of the             -2    2   
    consequences                                          
 12.Choosing to prioritise pleasurable activities         -1    2   
    against chores                                        
 13.Not letting my RA get me down                          5    3   
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 14.Relying on support from my family / friends /         -2    0   
    other                                                 
 15.Talking to other people with RA who are similar        0    1   
    to me helps                                           
 16.Using alternative medicines / therapies to manage     -3    3   
    my RA symptoms                                        
 17.Distracting myself from my symptoms                    1    1   
 18.Trying not to eat certain foods                       -4    4   
 19.I am cautious of gaining weight and putting extra      2    0   
    stress on my joints                                   
 20.Exercising as much as I can                            1    5   
 21.Making small adjustments to my day or activities       2   -1   
    constantly because of my RA                           
 22.Taking my medication exactly as prescribed             3    1   
 23.Planning rest time into my week                       -1    1   
 24.Feeling lucky in comparison to others                  3    2   
 25.I have periods of being completely symptom free       -4    4   
 26.Dealing with the severity of my symptoms going up      0    0   
    and down                                              
 27.Getting frustrated due to my RA                        0   -3   
 28.Feeling guilty about holding others back due to       -3   -1   
    my RA                                                 
 29.Feeling that my body has let me down                   0   -1   
 30.Trying to forget that I have RA                        1    1   
 31.Worrying because of my RA                             -1   -3   
 32.Repetitive tasks make my RA symptoms worse            -1   -2   
 33.Being determined not to allow my RA to interfere       4    0   
    with my responsibilities                              
 34.Being angry because of my RA                          -5   -5   
 35.Experiencing unexplainable fatigue / exhaustion        4   -4   
    daily                                                 
 36.Experiencing pain daily                                0   -4   
 37.Experiencing swelling daily                           -2   -1   
 38.Experiencing stiffness daily                           2   -2   
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 39.Struggling to explain to family and friends what      -3   -1   
    life is like for me                                   
  
=============================================================================================================== 
Consensus statements  (varimax)                                                                        
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
          There are 11 consensus item for Living with RA day by day means.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B    
                                                        --- ---   
  1.I sometimes have to cancel plans due to my RA        -1   0   
  2.Giving myself permission to leave a task half         0   0   
  3.Talking to other people with RA who are similar       0   1   
  4.Distracting myself from my symptoms                   1   1   
  5.Feeling lucky in comparison to others                 3   2   
  6.Dealing with the severity of my symptoms going up     0   0   
  7.Feeling that my body has let me down                  0  -1   
  8.Trying to forget that I have RA                       1   1   
  9.Repetitive tasks make my RA symptoms worse           -1  -2   
 10.Being angry because of my RA                         -5  -5   
 11.Experiencing swelling daily                          -2  -1   
=============================================================================================================== 
Differentiating statements   (varimax)                  
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
  11 items distinguish Factor A from all other factors 
                                                Factors  A   B    
                                                        --- ---   
  4.Choosing my clothes according to how easy they       -2   2   
  5.I am able to predict how bad my symptoms will be      1  -3   
 11.Doing what I want to do regardless of the            -2   2   
 16.Using alternative medicines / therapies to manage    -3   3   
 18.Trying not to eat certain foods                      -4   4   
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 20.Exercising as much as I can                           1   5   
 25.I have periods of being completely symptom free      -4   4   
 33.Being determined not to allow my RA to interfere      4   0   
 35.Experiencing unexplainable fatigue / exhaustion       4  -4   
 36.Experiencing pain daily                               0  -4   
 38.Experiencing stiffness daily                          2  -2   
  
--------------------------------------------------------------------------------------------------------------- 
  11 items distinguish Factor B from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B    
                                                        --- ---   
  4.Choosing my clothes according to how easy they       -2   2   
  5.I am able to predict how bad my symptoms will be      1  -3   
 11.Doing what I want to do regardless of the            -2   2   
 16.Using alternative medicines / therapies to manage    -3   3   
 18.Trying not to eat certain foods                      -4   4   
 20.Exercising as much as I can                           1   5   
 25.I have periods of being completely symptom free      -4   4   
 33.Being determined not to allow my RA to interfere      4   0   
 35.Experiencing unexplainable fatigue / exhaustion       4  -4   
 36.Experiencing pain daily                               0  -4   
 38.Experiencing stiffness daily                          2  -2   
 
=============================================================================================================== 
Factor correlations   (varimax)                                                                         
===============================================================================================================
--------------------------------------------------------------------------------------------------------------- 
        Factors  A   B    
--------------------------------------------------------------------------------------------------------------- 
             A   0  -7   
             B  -7   0   
--------------------------------------------------------------------------------------------------------------- 
reliabilities  97  97   std. errors  38  38    
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Appendix R1: Flare Help-Seeking Q-study 4-factor solution 
  
===============================================================================================================
Factor scores                                               
=============================================================================================================== 
Seeking help for RA flares.sty file name 
29 sorts 
23 items 
9 piles 
4 centroids 
1 2 3 3 5 3 3 2 1  frequencies 
4.26086956521739 variance 
  
scores edited scores edited     11:44:38 AM,7/20/2011 
factored factored          4:07:47 PM,7/6/2012 
varimax  
last opened at last opened at     4:05:51 PM,7/6/2012 
  
=============================================================================================================== 
Summary (varimax)                                                         
=============================================================================================================== 
20 sorts have been accounted for in 4 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[13]  A  |  1  3  6  7  8 10 11 13 17 19 26 27 28   
[ 4]  B  |  2 16 20 23   
[ 2]  C  | 14 25   
[ 1]  D  |  4   
--------------------------------------------------------------------------------------------------------------- 
Factors  
 have no loadings greater or equal to 54 
--------------------------------------------------------------------------------------------------------------- 
[ 1]      Confounded: 12,  
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[ 8] Not significant:  5, 9,15,18,21,22,24,29,  
=============================================================================================================== 
Factor A for Seeking help for RA flares.sty (varimax)              
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
 13   3   5   4   1   2   9  16   8   
     17   6   7  11  10  15  21       
         18  12  14  19  22           
                 20                   
                 23                   
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1  0.77          CH50FJM                      3  0.73 
CH50MLC                      6  0.87          CH43FNS                      7  0.71 
CH39DDV                      8  0.75          CH63FMN                     10  0.77 
CH61MSB                     11  0.71          COSS62MRC                   13  0.75 
BRI67FJF                    17  0.80          COSS41FCS                   19  0.84 
BRI46FGB                    26  0.58          BRI68MDP                    27  0.79 
BRI65FVV                    28  0.80       
  
=============================================================================================================== 
Factor B for Seeking help for RA flares.sty (varimax)             
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
  6  10  11   8  15   2   5   1  13   
     12  14   9  18   3  17   4       
         20  16  21   7  19           
                 22                   
                 23                   
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 Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
COSS33FHJ                    2 -0.64          BRI61MBL                    16 -0.77 
COSS55FDH                   20 -0.63          BRI52MMH                    23 -0.64 
  
  
=============================================================================================================== 
Factor C for Seeking help for RA flares.sty (varimax)                 
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
 13  11   4   5   1   2   3  10   9   
     18   7   6  12  16  21  17       
         15   8  14  19  22           
                 20                   
                 23                   
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
COSS79FGK                   14  0.67          COSS48FDN                   25  0.56 
  
  
=============================================================================================================== 
Factor D for Seeking help for RA flares.sty (varimax)                      
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
  3  21   6  17   1   4  10   2  13   
     22  11  18   5  14  15   8       
         16  23   7  20  19           
                  9                   
                 12                   
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 Sort with significant loadings: 
--label-------------------sort--load 
CH66FOM                      4 -0.86            
  
  
=============================================================================================================== 
Item scores  (varimax)                                      
=============================================================================================================== 
                                                Factors  A    B    C    D     
                                                        ---- ---- ---- ----   
  1.I feel the flare will last until I seek medical        0    3    0    0   
    help                                                  
  2.I will contact the medical team as soon as             1    1    1    3   
    possible                                              
  3.I m reluctant to seek medical help as I worry         -3    1    2   -4   
    about wasting the Rheumatology Team's time            
  4.I am more reluctant to seek medical help when I       -1    3   -2    1   
    think I've caused the flare                           
  5.I am reluctant to seek medical help as I don't        -2    2   -1    0   
    think the Dr can do anything to help                  
  6.I am reluctant to seek medical help as I hope         -2   -4   -1   -2   
    it'll go away on its own                              
  7.I avoid seeking medical help as I don't like          -1    1   -2    0   
    taking drugs                                          
  8.I seek help from the medical team once flare           4   -1   -1    3   
    starts to affect my quality of life too much          
  9.I know I don't have to manage my flare alone           2   -1    4    0   
 10.Easy access to the medical team is part of my          1   -3    3    2   
    decision to seek help for my flare                    
 11.A loved one tells me I ought to seek medical help      0   -2   -3   -2   
 12.I don't like admitting that I need to ask for         -1   -3    0    0   
    help                                                  
 13.I am reluctant to seek medical help as I don't        -4    4   -4    4   
    get on well with my Rheumatology team                 
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 14.I manage my symptoms until the flare stops             0   -2    0    1   
 15.I seek help from the medical team as I worry           2    0   -2    2   
    about long term damage to my joints                   
 16.I seek help from the medical team when the pain        3   -1    1   -2   
    becomes too intense                                   
 17.I wait until my next scheduled appointment with       -3    2    3   -1   
    the Rheumatologist before seeking help                
 18.I am reluctant to seek medical help as I don't        -2    0   -3   -1   
    want to waste my own time                             
 19.I seek help from the medical team when I know my       1    2    1    2   
    Flare needs to be controlled by new medication        
 20.I control my flare symptoms with medication            0   -2    0    1   
    before contacting the medical team                    
 21.I seek help from the medical team when my              3    0    2   -3   
    symptoms become uncontrollable                        
 22.I seek help from the medical team when the flare       2    0    2   -3   
    has gone on longer than expected                      
 23.I wait until I have more than one flare symptoms       0    0    0   -1   
    before seeking medical help                           
  
=============================================================================================================== 
Consensus statements  (varimax)                   
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
          There are 2 consensus item for Seeking help for RA flares.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
  1.I seek help from the medical team when I know my      1   2   1   2   
  2.I wait until I have more than one flare symptoms      0   0   0  -1   
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=============================================================================================================== 
Differentiating statements   (varimax)                  
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor A 
--------------------------------------------------------------------------------------------------------------- 
  
--------------------------------------------------------------------------------------------------------------- 
  1 item distinguishes Factor B from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
 10.Easy access to the medical team is part of my         1  -3   3   2   
  
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor C 
--------------------------------------------------------------------------------------------------------------- 
  
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor D 
--------------------------------------------------------------------------------------------------------------- 
  
=============================================================================================================== 
Factor correlations   (varimax)                                 
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
        Factors  A   B   C   D    
--------------------------------------------------------------------------------------------------------------- 
             A   0 -32  34   5   
             B -32   0 -17  20   
             C  34 -17   0 -28   
             D   5  20 -28   0   
--------------------------------------------------------------------------------------------------------------- 
 reliabilities  98  94  88  80      std. errors  28  50  68  92    
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Appendix R2: Flare Help-Seeking Q-Study 3-factor solution 
 
=============================================================================================================== 
Factor scores                                        
===============================================================================================================
Seeking help for RA flares.sty file name 
29 sorts 
23 items 
9 piles 
4 centroids 
1 2 3 3 5 3 3 2 1  frequencies 
4.26086956521739 variance 
  
scores edited scores edited     11:44:38 AM,7/20/2011 
factored factored          4:07:47 PM,7/6/2012 
varimax  
last opened at last opened at     4:05:51 PM,7/6/2012 
  
===============================================================================================================
Summary (varimax)                                 
=============================================================================================================== 
20 sorts have been accounted for in 4 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[13]  A  |  1  3  6  7  8 10 11 13 17 19 26 27 28   
[ 4]  B  |  2 16 20 23   
[ 2]  C  | 14 25   
[ 1]  D  |  4   
--------------------------------------------------------------------------------------------------------------- 
Factors  
 have no loadings greater or equal to 54 
--------------------------------------------------------------------------------------------------------------- 
[ 1]      Confounded: 12,  
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[ 8] Not significant:  5, 9,15,18,21,22,24,29,  
=============================================================================================================== 
Factor A for Seeking help for RA flares.sty (varimax)   
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
 13   3   5   4   1   2   9  16   8   
     17   6   7  11  10  15  21       
         18  12  14  19  22           
                 20                   
                 23                   
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1  0.77          CH50FJM                      3  0.73 
CH50MLC                      6  0.87          CH43FNS                      7  0.71 
CH39DDV                      8  0.75          CH63FMN                     10  0.77 
CH61MSB                     11  0.71          COSS62MRC                   13  0.75 
BRI67FJF                    17  0.80          COSS41FCS                   19  0.84 
BRI46FGB                    26  0.58          BRI68MDP                    27  0.79 
BRI65FVV                    28  0.80            
  
=============================================================================================================== 
Factor B for Seeking help for RA flares.sty (varimax)              
===============================================================================================================  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
  6  10  11   8  15   2   5   1  13   
     12  14   9  18   3  17   4       
         20  16  21   7  19           
                 22                   
                 23                   
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Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
COSS33FHJ                    2 -0.64          BRI61MBL                    16 -0.77 
COSS55FDH                   20 -0.63          BRI52MMH                    23 -0.64 
  
  
=============================================================================================================== 
Factor C for Seeking help for RA flares.sty (varimax)       
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
 13  11   4   5   1   2   3  10   9   
     18   7   6  12  16  21  17       
         15   8  14  19  22           
                 20                   
                 23                   
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
COSS79FGK                   14  0.67          COSS48FDN                   25  0.56 
 
 
=============================================================================================================== 
Factor D for Seeking help for RA flares.sty (varimax)    
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
  3  21   6  17   1   4  10   2  13   
     22  11  18   5  14  15   8       
         16  23   7  20  19           
                  9                   
                 12                   
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Sort with significant loadings: 
--label-------------------sort--load 
CH66FOM                      4 -0.86            
  
 
=============================================================================================================== 
Item scores  (varimax)                                 
=============================================================================================================== 
                                                Factors  A    B    C    D     
                                                        ---- ---- ---- ----   
  1.I feel the flare will last until I seek medical        0    3    0    0   
    help                                                  
  2.I will contact the medical team as soon as             1    1    1    3   
    possible                                              
  3.I m reluctant to seek medical help as I worry         -3    1    2   -4   
    about wasting the Rheumatology Team's time            
  4.I am more reluctant to seek medical help when I       -1    3   -2    1   
    think I've caused the flare                           
  5.I am reluctant to seek medical help as I don't        -2    2   -1    0   
    think the Dr can do anything to help                  
  6.I am reluctant to seek medical help as I hope         -2   -4   -1   -2   
    it'll go away on its own                              
  7.I avoid seeking medical help as I don't like          -1    1   -2    0   
    taking drugs                                          
  8.I seek help from the medical team once flare           4   -1   -1    3   
    starts to affect my quality of life too much          
  9.I know I don't have to manage my flare alone           2   -1    4    0   
 10.Easy access to the medical team is part of my          1   -3    3    2   
    decision to seek help for my flare                    
 11.A loved one tells me I ought to seek medical help      0   -2   -3   -2   
 12.I don't like admitting that I need to ask for         -1   -3    0    0   
    help                                                  
 13.I am reluctant to seek medical help as I don't        -4    4   -4    4   
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    get on well with my Rheumatology team                 
 14.I manage my symptoms until the flare stops             0   -2    0    1   
 15.I seek help from the medical team as I worry           2    0   -2    2   
    about long term damage to my joints                   
 16.I seek help from the medical team when the pain        3   -1    1   -2   
    becomes too intense                                   
 17.I wait until my next scheduled appointment with       -3    2    3   -1   
    the Rheumatologist before seeking help                
 18.I am reluctant to seek medical help as I don't        -2    0   -3   -1   
    want to waste my own time                             
 19.I seek help from the medical team when I know my       1    2    1    2   
    Flare needs to be controlled by new medication        
 20.I control my flare symptoms with medication            0   -2    0    1   
    before contacting the medical team                    
 21.I seek help from the medical team when my              3    0    2   -3   
    symptoms become uncontrollable                        
 22.I seek help from the medical team when the flare       2    0    2   -3   
    has gone on longer than expected                      
 23.I wait until I have more than one flare symptoms       0    0    0   -1   
    before seeking medical help                           
  
===============================================================================================================
Consensus statements  (varimax)                                                                         
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
          There are 2 consensus item for Seeking help for RA flares.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
  1.I seek help from the medical team when I know my      1   2   1   2   
  2.I wait until I have more than one flare symptoms      0   0   0  -1   
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=============================================================================================================== 
Differentiating statements   (varimax)           
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor A 
--------------------------------------------------------------------------------------------------------------- 
  
--------------------------------------------------------------------------------------------------------------- 
  1 item distinguishes Factor B from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B   C   D    
                                                        --- --- --- ---   
 10.Easy access to the medical team is part of my         1  -3   3   2   
  
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor C 
--------------------------------------------------------------------------------------------------------------- 
 
--------------------------------------------------------------------------------------------------------------- 
  No items distinguish Factor D 
---------------------------------------------------------------------------------------------------------------  
 
=============================================================================================================== 
Factor correlations   (varimax)                             
=============================================================================================================== 
---------------------------------------------------------------------------------------------------------------        
Factors  A   B   C   D    
--------------------------------------------------------------------------------------------------------------- 
             A   0 -32  34   5   
             B -32   0 -17  20   
             C  34 -17   0 -28   
             D   5  20 -28   0   
--------------------------------------------------------------------------------------------------------------- 
 reliabilities  98  94  88  80      std. errors  28  50  68  92    
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Appendix R3: Flare Help-Seeking Q-study 2-factor solution 
 
=============================================================================================================== 
Factor scores                                   
=============================================================================================================== 
Seeking help for RA flares.sty file name 
29 sorts 
23 items 
9 piles 
2 centroids 
1 2 3 3 5 3 3 2 1  frequencies 
4.26086956521739 variance 
  
scores edited scores edited     11:44:38 AM,7/20/2011 
factored factored          5:41:34 PM,7/6/2012 
varimax  
last opened at last opened at     5:41:26 PM,7/6/2012 
  
=============================================================================================================== 
Summary (varimax)                                                            
=============================================================================================================== 
22 sorts have been accounted for in 2 factors. 
  n    fac    sorts contributing to each factor 
--------------------------------------------------------------------------------------------------------------- 
[16]  A  |  1  5  6  7  8 10 11 13 17 18 19 22 24 26 27 28   
[ 6]  B  |  2  4 12 16 23 29   
--------------------------------------------------------------------------------------------------------------- 
Factors  
 have no loadings greater or equal to 54 
--------------------------------------------------------------------------------------------------------------- 
[ 0]      Confounded:   
[ 7] Not significant:  3, 9,14,15,20,21,25,  
=============================================================================================================== 
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Factor A for Seeking help for RA flares.sty (varimax)         
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
 13   3   7   4   1   2   9  16   8   
      5  17   6  11  10  19  21       
         18  12  14  15  22           
                 20                   
                 23                   
  
Sort with significant loadings: 
--label-------------------sort--load          --label-------------------sort--load 
BRI63FJE                     1  0.90          CH53FSC                      5  0.55 
CH50MLC                      6  0.86          CH43FNS                      7  0.67 
CH39DDV                      8  0.78          CH63FMN                     10  0.78 
CH61MSB                     11  0.60          COSS62MRC                   13  0.76 
BRI67FJF                    17  0.86          COSS51FKP                   18  0.58 
COSS41FCS                   19  0.76          BRI55MAA                    22  0.57 
BRI50FBD                    24  0.62          BRI46FGB                    26  0.70 
BRI68MDP                    27  0.81          BRI65FVV                    28  0.89 
  
=============================================================================================================== 
Factor B for Seeking help for RA flares.sty (varimax)         
=============================================================================================================== 
  
 -4  -3  -2  -1   0   1   2   3   4   
------------------------------------ 
  6  16  11   8   3   5   4   1  13   
     21  12   9  10  15   7   2       
         22  14  18  17  19           
                 20                   
                 23                   
Sort with significant loadings: 
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--label-------------------sort--load          --label-------------------sort--load 
COSS33FHJ                    2 -0.60          CH66FOM                      4 -0.70 
COSS30FSB                   12 -0.71          BRI61MBL                    16 -0.72 
BRI52MMH                    23 -0.63          BRI61FHD                    29 -0.59 
  
  
=============================================================================================================== 
Item scores  (varimax)                                         
=============================================================================================================== 
                                                Factors  A    B     
                                                        ---- ----   
  1.I feel the flare will last until I seek medical        0    3   
    help                                                  
  2.I will contact the medical team as soon as             1    3   
    possible                                              
  3.I m reluctant to seek medical help as I worry         -3    0   
    about wasting the Rheumatology Team's time            
  4.I am more reluctant to seek medical help when I       -1    2   
    think I've caused the flare                           
  5.I am reluctant to seek medical help as I don't        -3    1   
    think the Dr can do anything to help                  
  6.I am reluctant to seek medical help as I hope         -1   -4   
    it'll go away on its own                              
  7.I avoid seeking medical help as I don't like          -2    2   
    taking drugs                                          
  8.I seek help from the medical team once flare           4   -1   
    starts to affect my quality of life too much          
  9.I know I don't have to manage my flare alone           2   -1   
 10.Easy access to the medical team is part of my          1    0   
    decision to seek help for my flare                    
 11.A loved one tells me I ought to seek medical help      0   -2   
 12.I don't like admitting that I need to ask for         -1   -2   
    help                                                  
 13.I am reluctant to seek medical help as I don't        -4    4   
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    get on well with my Rheumatology team                 
 14.I manage my symptoms until the flare stops             0   -1   
 15.I seek help from the medical team as I worry           1    1   
    about long term damage to my joints                   
 16.I seek help from the medical team when the pain        3   -3   
    becomes too intense                                   
 17.I wait until my next scheduled appointment with       -2    1   
    the Rheumatologist before seeking help                
 18.I am reluctant to seek medical help as I don't        -2    0   
    want to waste my own time                             
 19.I seek help from the medical team when I know my       2    2   
    Flare needs to be controlled by new medication        
 20.I control my flare symptoms with medication            0    0   
    before contacting the medical team                    
 21.I seek help from the medical team when my              3   -3   
    symptoms become uncontrollable                        
 22.I seek help from the medical team when the flare       2   -2   
    has gone on longer than expected                      
 23.I wait until I have more than one flare symptoms       0    0   
    before seeking medical help                           
  
=============================================================================================================== 
Consensus statements  (varimax)                               
===============================================================================================================
--------------------------------------------------------------------------------------------------------------- 
          There are 7 consensus item for Seeking help for RA flares.sty Q-study 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B    
                                                        --- ---   
  1.Easy access to the medical team is part of my         1   0   
  2.I don't like admitting that I need to ask for        -1  -2   
  3.I manage my symptoms until the flare stops            0  -1   
  4.I seek help from the medical team as I worry          1   1   
  5.I seek help from the medical team when I know my      2   2   
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  6.I control my flare symptoms with medication           0   0   
  7.I wait until I have more than one flare symptoms      0   0   
  
===============================================================================================================
Differentiating statements   (varimax)                                                        
=============================================================================================================== 
--------------------------------------------------------------------------------------------------------------- 
  7 items distinguish Factor A from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B    
                                                        --- ---   
  5.I am reluctant to seek medical help as I don't       -3   1   
  7.I avoid seeking medical help as I don't like         -2   2   
  8.I seek help from the medical team once flare          4  -1   
 13.I am reluctant to seek medical help as I don't       -4   4   
 16.I seek help from the medical team when the pain       3  -3   
 21.I seek help from the medical team when my             3  -3   
 22.I seek help from the medical team when the flare      2  -2   
  
--------------------------------------------------------------------------------------------------------------- 
  7 items distinguish Factor B from all other factors 
--------------------------------------------------------------------------------------------------------------- 
                                                Factors  A   B    
                                                        --- ---   
  5.I am reluctant to seek medical help as I don't       -3   1   
  7.I avoid seeking medical help as I don't like         -2   2   
  8.I seek help from the medical team once flare          4  -1   
 13.I am reluctant to seek medical help as I don't       -4   4   
 16.I seek help from the medical team when the pain       3  -3   
 21.I seek help from the medical team when my             3  -3   
 22.I seek help from the medical team when the flare      2  -2   
  
  
=============================================================================================================== 
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Factor correlations   (varimax)                         
=============================================================================================================== 
---------------------------------------------------------------------------------------------------------------        
Factors  A   B    
--------------------------------------------------------------------------------------------------------------- 
             A   0 -41   
             B -41   0   
--------------------------------------------------------------------------------------------------------------- 
 reliabilities  98  95    
   std. errors  25  41    
A
p
p
e
n
d
ix
 R
3
 
 
  
4
4
8
 
Appendix S: Graph displaying Study 3b patients' individual coping, managing and involvement scores 
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Appendix T: Dissemination of this thesis 
 
This includes 
T1 List of events where this thesis has been disseminated 
 
and the following peer reviewed abstracts: 
 
T2 Flurey, C. A. (2010) Capturing the patient perspective: Characterising daily 
fluctuations, ‘flare’ and self-management in rheumatoid arthritis [abstract]. 
OMERACT10, Kota Kinabalu 
 
T3 Flurey, C. A. (2011) The patient experience of Daily Life and ‘Flare’ with 
Rheumatoid Arthritis [abstract]. Rheumatology, 50 (Suppl. 3): iii9-iii10, IP44 
 
T4 Flurey, C. A. (2012) “It gets me down every single day”: Are men with RA 
getting the support they need? [abstract]. Arthritis Research UK Fellows Meeting, 
Loughborough 
 
T5 Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., Hewlett, S. 
(2012a) Will I waste your time? Delays in help seeking for RA flares [abstract] 
Annals of the Rheumatic Diseases, 71 (Suppl. 3), p737   
Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., Hewlett, S. 
(2012b) Will I waste your time? Delays in help seeking for RA flares [abstract] 
Rheumatology, 51 (Suppl. 3): iii19-iii26 
 
T6 Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., Hewlett, S. 
(2012c) “You make your own luck” Three different perceptions of living with RA: A 
Q-methodological study [abstract]. Rheumatology, 51 (Suppl. 3): iii52-iii92 
 
T7 Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., Hewlett, S. (In 
Press) “A Computer Virus...An Endless Loop That Won’t Stop”: Making sense of the 
inexplicable [abstract]  British Pychological Society Division of Health Psychology 
Annual Conference. Liverpool 2012 
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Appendix T1: List of dissemination events 
Bristol rheumatology post-graduate seminar, 2009: Oral presentation and 
discussion, “Characterising daily fluctuations, flare and self-management in 
rheumatoid arthritis: The patient perspective” 
 
OMERACT 10 Conference, 2010: Poster presentation, “Capturing the patient 
perspective: Characterising daily fluctuations, flare and self-management in 
rheumatoid arthritis” (Abstract in Appendix S2) 
 
UWE H&SC research student training and support day, 2010: Oral presentation 
and discussion, “What is it like to live with rheumatoid arthritis?” 
 
Bristol rheumatology post-graduate seminar, 2011: Oral presentation and 
discussion, “PhD research update: Methods and Phase 1 results”   
 
Arthritis Research UK fellows annual meeting, 2011: Poster presentation, “Daily 
life, flare and self-management in rheumatoid arthritis: The patient perspective” 
 
British Society for Rheumatologists (BSR) and British Society for 
Rheumatology Health Professionals (BHPR) annual conference, 2011: Invited 
talk, “The patient experience of daily life and flare with rheumatoid arthritis” (Abstract 
in Appendix S3) 
 
South West Rheumatology Nurses training day, 2011: Oral presentation and 
discussion, “Using metaphors to explore patients’ experiences of rheumatoid 
arthritis” 
 
UWE H&SC research student training and support day, 2011: Oral presentation 
and discussion, “Using Q-methodology to explore patients’ experiences of 
rheumatoid arthritis 
 
Bristol rheumatology post-graduate seminar, 2012: Oral presentation and 
discussion, ““It gets me down every single day”: Are men with RA getting the 
support they need?” 
 
Arthritis Research UK fellows annual meeting, 2012: Oral presentation (Won 
prize for best oral presentation: PhD Student), ““It gets me down every single day”: 
Are men with RA getting the support they need?” (Abstract in Appendix S4) 
 
BSR/BHPR annual conference, 2012: Plenary presentation (“Jewels in the 
crown”), “Will I waste your time? Delays in help-seeking for RA flares” (Abstract in 
Appendix S5) 
 
BSR/BHPR annual conference, 2012: Poster presentation (Won the Chris Moran 
poster prize), “”You make your own luck”: Three different perspectives of living with 
RA: A Q-methodological study” (Abstract in Appendix S6) 
 
European League Against Rheumatology (EULAR) annual conference, 2012: 
Poster presentation, “Will I waste your time? Delays in help-seeking for RA flares” 
(Abstract in Appendix S5) 
 
Division of Health Psychology (DHP) annual conference, 2012: Poster 
presentation, ““A computer virus...an endless loop that won’t stop”: Making sense of 
the inexplicable in rheumatoid arthritis” (Abstract in Appendix S7) 
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Appendix T2: Flurey, C. A. (2010) Capturing the patient perspective: 
Characterising daily fluctuations, ‘flare’ and self-management in rheumatoid 
arthritis [abstract]. OMERACT10, Kota Kinabalu 
 
Background: OMERACT 9 identified that patient’s experience of symptoms associated with 
flare differs from the traditional inflammatory paradigm of number of painful, swollen joints.  
This series of studies will apply novel methodologies capturing the patient perspective in the 
management of ‘flare’ in order to explore new outcome measures. 
 
Aims: This doctorate aims to identify the nature and effect of daily symptoms experienced in 
RA, how patients manage these, how patients differentiate the important symptom 
differences between daily fluctuation and ‘flare,’ and the level, variation and clustering of 
symptoms that patients experience as both daily life and ’flare’. 
 
Methods: Phase 1 will use interviews with RA patients, to qualitatively explore the patient 
perspective of daily symptoms and flare symptoms.  Interpretative Phenomenology will be 
utilized to understand the lived experience of RA, and also patients’ visual representations 
(drawings) of disease patterns for different symptoms, to understand their complexity and 
nature. The use of ‘Framework’ allows exploration of emerging collective themes (tabulated 
in rows) but also personal schema of symptoms (cross-tabulated in columns), thus 
preserving the individual context that is lost in focus group methodology. These data will 
highlight flare symptoms or symptom clusters - potential domains for flare and daily life 
measures.   
 
Phase 2 will comprise Q-sort methodology with patients as experts.  In Q-sort methodology 
patients rank the symptoms generated in Phase I (forced into a normal distribution) and the 
resulting item scores are analysed to produce the best clusters.  The clusters are then 
interpreted against the characteristics of the patients in each cluster.  These data will be 
compared with the data emerging from the OMERACT patient focus group study on flare, 
and their Delphi technique, which explores clinicians’ and patients’ views on flare.  A set of 
key domains will be proposed from Phase II data.   
 
Also in this Phase an expert patient group will design simple numerical rating scales (NRS) 
for any symptoms arising in Phase 1 which do not have existing measures (e.g. flare 
prodrome). 
 
Phase 3 will provide preliminary data on the patient’s perspective of the frequency and 
severity of daily symptoms, flare and flare prodrome (from Phases I and II).  100 patients will 
be sampled to represent patients in ‘flare’ and not in ‘flare’, with predictable ‘flares’ and those 
with frequent but unpredictable ‘flares’.  NRS emerging from Phases I and II will be 
completed each night to describe the preceding 24 hours for 3 months. Novel methods of 
data capture may be trialled, such as PDAs, a secure website, email or mail.  Qualitative 
diaries will also be completed once a week for the same 3 months.  Patients will be asked to 
comment on their symptoms, thoughts, feelings and actions, to help clarify cognitions around 
their decision making on the important difference between daily variation and flare.  
Longitudinal analysis of the frequency and intensity of daily and ‘flare’ symptoms will be 
performed, plus analyses to explore symptom groupings and patterns using hierarchical 
statistical techniques (multidimensional scaling and cluster analysis).  A form of qualitative 
analysis will be used to analyse the qualitative diaries.   
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Appendix T3: Flurey, C. A. (2011) The patient experience of daily life and ‘flare’ 
with rheumatoid arthritis [abstract]. Rheumatology, 50 (Suppl. 3): iii9-iii10, 
IP44 
 
‘Flare’ underpins requests for help and treatment decisions, with potentially significant impact 
on outcome, yet it has not been defined.  Informal work suggests a serious mismatch 
between patient and clinician perception of ‘flare,’ with patients perceiving a range of ‘flare’ 
symptoms and even early warning signs, of which clinicians are unaware.  Little is known 
about daily variation in symptoms within current treatment regimens, how patients self-
manage these, patient language for ‘flare,’ how they differentiate ‘flare’ from normal daily 
variation, what prompts patients to seek help, nor how these relate to adaptation to and 
experience of RA.  If we can identify these features we may be able to improve explanations 
to newly-diagnosed patients and clarify discussions regarding ‘flare’ and reduce distress of 
delayed help seeking.  The results from Phase 1 of a 3-Phase PhD will be presented. 
 
20 semi-structured interviews were conducted. RA patients who have experienced a ‘flare’ 
during their RA trajectory were purposefully sampled to reflect a range of age, gender, 
disease duration, disability, current therapies and current ‘flare’ status.  The selection criteria 
included patients who have had a diagnosis of RA (Arnett et al 1990) for at least 2 years and 
who have experienced an RA ‘flare’ during their disease duration, who are over 18 and who 
speak English as a first language.  11 patients were sampled from The Bristol Royal 
Infirmary where Direct Access (Hewlett et al 2005) is being used, whereby patients initiate 
their own medical reviews when in ‘flare’.  9 patients were sampled from Cossham Hospital 
which uses the traditional method of Rheumatologist-initiated reviews. The interviews were 
analysed using Inductive Thematic Analysis. 
 
The results of the interviews will be presented. These will cover how patients experience 
daily life, how they manage their day-to-day symptoms, how patients decide they are in a 
'flare' and distinguish this from a 'bad day', how patients manage their 'flare' symptoms and 
how they decide it is time to seek help from the Rheumatology team. 
 
Patients' experiences of daily life will provide professionals with real examples to assist them 
in explaining what life will be like to newly diagnosed patients.  Understanding why patients 
wait to seek help has the potential for creating an intervention to encourage help seeking.  A 
contribution to a global definition of 'Flare' would have the potential to improve 
communication between Clinicians and patients and to improve clarity in RCT outcomes.  
Further research is necessary, this research will be continued with a further 2 studies as part 
of the PhD project.
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Appendix T4: Flurey, C. A. (2012) “It gets me down every single day”: Are men 
with RA getting the support they need? [abstract]. Arthritis Research UK 
Fellows Meeting, Loughborough 
 
Background: Daily life with RA has been explained as unpredictable and full of uncertainty. 
However, most research about daily life with RA was conducted before current more 
aggressive medications.  
 
Objectives: To explore daily life on modern therapies. 
 
Methods: 30 RA patients sorted 39 statements (generated in previous qualitative interviews) 
about daily life with RA across a forced distribution, in ranked order of agreement. Data were 
analysed using centroid factor analysis with varimax rotation (i.e. the participants and not the 
items are the variables). Demographic and clinical data were collected and patients 
completed comments booklets about their rationale for sorting the statements. 
 
Results: Three factors were generated, which explained 33% of the study variance and 
accounted for 23 of the 30 participants. None of the Q-sorts were confounded (loading on 
more than one factor). A participant loading of 0.41 reached significance at p<.01 Factors A 
& B have been reported elsewhere and therefore only the descriptive statistics are 
presented:  
 
 Factor A: Taking Control: “Just a fact of life”:Seven participants: mean disease duration 
22.7yrs (SD 10.8), age 61.7yrs (SD 10.3), HAQ score 2.0 (SD 0.6), patient global 3.1 (SD 
1.7), 86% female, 71% on biologic therapies. 
 
Factor B: Keeping RA in its place: “It’s a very small part of you”:Seven participants: mean 
disease duration 9.9yrs (SD 10.1), age 42.4yrs (SD 11.2), HAQ score 0.5 (SD 0.5), patient 
global 1.7 (SD 1.0), 100% female, 71% employed, 86% mothers, 43% on biologic therapies. 
 
Factor C: Struggling Through: “It gets me down every single day”:Eight participants: mean 
disease duration 15.3yrs (SD 14.3), age 55.5yrs (SD 7.1), HAQ score 1.3 (SD 0.9), patient 
global 4.8 (SD 2.5), 63% Male, 50% on biologic therapies. 
These predominantly male patients are never symptom free, experiencing pain and fatigue 
daily: “It’s like feeling ill all the time” and describing fatigue as “the worst symptom”. They 
worry and get angry and frustrated about their RA. It gets them down daily: 
 “I get very frustrated with it, the problem is then I get irritated and take it out on the wife”   
 
These RA patients report being unable to be spontaneous or to exercise and they struggle to 
explain their experience to their family. They feel their body has let them down and the idea 
that they are lucky is “ridiculous”.  
In the previous qualitative interviews, which were used to inform the statements for this 
study, men discuss the need to adopt new coping strategies due to their RA: “you can’t go 
and thump a wall because you end up with a flare and you can’t go and kick a football 
around or anything like that, so you need to find an outlet and talking is the outlet I 
suppose”.  They also find support groups unhelpful: “The self help groups don’t confront it 
enough, it might be all lovey dovey but sometimes you have got to be quite hard about it”. 
 
Conclusions: Whilst some patients cope well with their RA, others struggle to accept and 
adapt to their condition; the majority of these being male. This study indicates a need for an 
increased awareness of the support needs of male RA patients. 
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Appendix T5: Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., 
Hewlett, S. (2012a) Will I waste your time? Delays in help seeking for RA flares 
[abstract] Annals of the Rheumatic Diseases, 71 (Suppl. 3), p737   
 and 
Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., Hewlett, S. (2012b) 
Will I waste your time? Delays in help seeking for RA flares [abstract] 
Rheumatology, 51 (Suppl. 3): iii19-iii26 
 
Background: Anecdotal evidence suggests that patients vary in how long they wait before 
seeking medical help for an RA flare. The aim of this research is to explore why, and their 
tipping points for seeking help. 
 
Methods: Q-Methodology: 29 RA patients sorted 23 statements (generated in previous 
qualitative interviews) about their help seeking behaviours when in a flare, across a forced 
distribution in ranked order of agreement. Data were analysed using centroid factor analysis 
with varimax rotation (i.e. the participants and not the items are the variables). Demographic 
and clinical data were collected and patients completed comments booklets about their 
rationale for sorting the statements. 
 
Results: Consensus was reached on 9 statements and two factors were produced, which 
explained 51% of the study variance and accounted for 22 of the 29 participants. None of the 
Q-sorts were confounded (loading on more than one factor). A participant loading of 0.54 
reached significance at p<.01. 
 
Consensus: “When I just don’t know what to do anymore”: The top 3 of the 9 consensus 
statements are ‘when the pain becomes too intense’, ‘when the Flare has gone on longer than 
expected’ and ‘when the symptoms become uncontrollable’, suggesting these are the tipping 
points for seeking help.  
 
Factor A: Definite Decision: “It won’t go away, so I won’t wait”: Sixteen participants: mean 
disease duration 15.2yrs (SD 10.3), age 54.8yrs (SD 9.6), HAQ score 1.360 (SD 0.8), 69% 
female, 69% on biologic therapies. 
These patients will seek help quickly when they are in a flare, they know that their medical 
team can help and that their flare won’t go away on its own. They don’t worry about wasting 
their own or the Rheumatologist’s time and will not wait until their next scheduled appointment 
for help. Tipping points for seeking help for these patients are worries about long term 
damage to their joints, knowing their flare needs to be controlled by new medication and their 
quality of life being affected.  
 
Factor B: Cautious Indecision: “Lying down and not moving until it goes”: Six participants: 
mean disease duration 18.7yrs (SD 13.9), age 50.5yrs (SD 15.4), HAQ score 1.23 (SD 0.9) 
67% female, 0% on biologic therapies. 
These patients wait to contact the medical team when they are in a flare. They are reluctant to 
seek help as they hope the flare will go away on its own and do not believe it will last until they 
seek medical help. They don’t like asking for help and worry about wasting the 
Rheumatologist’s time. They may wait until their next scheduled appointment before seeking 
help and will try to manage their symptoms themselves. These patients need to be prompted 
by a friend or family member to seek help. 
 
Conclusions: Whilst consensus indicates pain is a tipping point, for some patients a complex 
interaction of beliefs hinders their help-seeking behaviour. Health care professionals should 
be aware that some patients delay help-seeking due to fears of time wasting, thus potentially 
risking further damage. 
Appendix S6 
455 
 
Appendix T6: Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., 
Hewlett, S. (2012c) “You make your own luck” Three different perceptions of 
living with RA: A Q-methodological study [abstract]. Rheumatology, 51 (Suppl. 
3): iii52-iii92 
 
Background: Most research about daily life with RA was conducted before current more 
aggressive medication. The aim of this research is to explore daily life on modern therapies. 
 
Methods: Q-Methodology: 30 RA patients sorted 39 statements (generated in previous 
qualitative interviews) about daily life with RA across a forced distribution, in ranked order of 
agreement. Data were analysed using centroid factor analysis with varimax rotation (i.e. the 
participants and not the items are the variables). Demographic and clinical data were 
collected and patients completed comments booklets about their rationale for sorting the 
statements.  
 
Results: Three factors were generated, which explained 33% of the study variance and 
accounted for 23 of the 30 participants. None of the Q-sorts were confounded (loading on 
more than one factor). A participant loading of 0.41 reached significance at p<.01  
 
Factor A: Taking Control: “Just a fact of life”: Seven participants: mean disease duration 
22.7yrs (SD 10.8), age 61.7yrs (SD 10.3), HAQ score 2.0 (SD 0.6), patient global 3.1 (SD 
1.7), 86% female, 71% on biologic therapies. 
These patients constantly micromanage their RA, find different ways of doing the things they 
want to and will not let RA interfere with their responsibilities. They take their medication 
exactly as prescribed and will not ‘over-do it’. Theyalso use tools as aids and plan rest time 
into their week. They do not believe in alternative medicines or special diets. 
 
Factor B: Struggling Through: “It gets me down every single day”: Eight participants: mean 
disease duration 15.3yrs (SD 14.3), age 55.5yrs (SD 7.1), HAQ score 1.3 (SD 0.9), patient 
global 4.8 (SD 2.5), 63% Male, 50% on biologic therapies. 
These patients are never symptom free, experiencing pain and fatigue daily. They worry and 
get angry and frustrated about their RA. It gets them down daily. They report being unable to 
be spontaneous or to exercise and they struggle to explain their experience to their family. 
They feel their body has let them down and consider themselves unlucky. 
 
Factor C: Keeping RA in its place: “It’s a very small part of you”: Seven participants: mean 
disease duration 9.9yrs (SD 10.1), age 42.4yrs (SD 11.2), HAQ score 0.5 (SD 0.5), patient 
global 1.7 (SD 1.0), 100% female, 71% employed, 86% mothers, 43% on biologic therapies. 
These patients do not allow RA to interfere with their responsibilities, nor hold others back. 
Fatigue is their highest ranked symptom, but they do not plan rest time into their week as 
they are too busy. They are often able to forget about their RA as they do not need to use 
tools or ask for help and they will not consider their RA when choosing their clothes. They do 
not allow RA to get them down and consider themselves lucky in comparison to others. 
 
Conclusions: Whilst some patients cope well with their RA, others struggle to accept and 
adapt to their condition. This study indicates a need for an increased awareness of the 
support needs of male RA patients.
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Appendix T7: Flurey, C.A., Morris, M., Pollock, J., Hughes, R., Richards, P., 
Hewlett, S. (In Press) “A Computer Virus...An Endless Loop That Won’t Stop”: 
Making sense of the inexplicable [abstract]  British Pychological Society 
Division of Health Psychology Annual Conference. Liverpool 2012 
 
Background: Metaphors allow for expression of concepts that cannot easily be described, 
including various health conditions.  The aim of this research was to explore whether 
patients use metaphors to make sense of life with Rheumatoid Arthritis (RA).  
Methods: Semi-structured one to one interviews with RA patients sampled to reflect a range 
of age, gender, disease duration and drug treatments, explored daily life with RA. Interviews 
underwent secondary content analysis searching for metaphors. The broad use of the term 
metaphor has been used, to include all forms of abstract thought. 
Findings: Patients used a range of metaphors to explain their experiences of living with RA. 
Metaphors are used to describe the physical symptoms of RA, which appears to be an 
attempt to improve the explanation of their symptoms. Wild animals are used to 
conceptualise the unpredictable, uncertain and aggressive nature of RA (“[A tiger] stealthy, 
creeps up on you”), whilst domestic animals or rodents typify RA being a disease that whilst 
unwelcome, patients have learnt to live with (“My companion, but it [cat] can be quite vicious 
sometimes”). Patients were careful to choose metaphors that were acceptable to them, for 
example rejecting ugly animals for cuter ones, indicating that RA has been incorporated into 
their identity. 
Discussion: Patients use metaphors to communicate intangible thoughts, experiences of 
living with RA and to indicate distress. It is therefore vital that health psychologists listen for 
and respond to these subtle ways patients express their concerns to facilitate and effect 
change in managing their long term condition 
 
 
 
 
 
